WASM 2013 Valencia Final Program 1

S
Abstra
Re

_________________________________________________________________
2DGA9 CDC<G:HH DC .A::E (:9>8>C:
__________________________________________________________________
.:EI:B7:G 28 - *8ID7:G 2, 2013 16A:C8>6, .E6>C
L6HB8DC<G:HH.8DB
5
I=
2DGA9 AHHD8>6I>DC D; .A::E (:9>8>C: $ .E6C>H= .A::E .D8>:IN
+G:H>9:CIHQ 2:A8DB:
Dear Colleagues and Friends,
On behalf of the World Association of Sleep Medicine (WASM) and the Spanish Sleep Society
(SES), we are delighted to welcome you to our joint congress: the 5th World Congress on Sleep
Medicine and the 22nd Annual Congress of the Spanish Sleep Society in Valencia, Spain, from
September 28th to October 2nd, 2013. The congress provides an international discussion forum
of sleep professionals from the entire world. It focuses particularly on the interdisciplinary
character of our field. Sleep clinicians, technologists, trainees, educators and scientists from
around the world will meet here to advance knowledge on sleep science, sleep in public health,
sleep health and the sleep-wake disorders, their diagnosis and treatments. We seek to maximize
learning both from formal presentations by the leading experts in their fields and from informal
discussion groups emphasizing opportunities for your participation. The social events and the
Mediterranean magic of Valencia also support productive professional and personal interactions.
The global character and reach of WASM in collaboration with the knowledge of the local
Spanish Sleep Society brings the best of sleep medicine to Valencia.
Your involvement in this congress will be greatly valued. You may learn and also share
knowledge and skills that will advance sleep health around the world.
We hope that youll enjoy the science, learning, collegiality and social events at our world sleep
conference in this lively city with great history, architecture, art and music. Sunny weather
matching the warm Spanish hospitality is nearly guaranteed. Welcome to Valencia!

Warm Greetings,
Claudia Trenkwalder, MD Diego Garcia-Borreguero, MD, PhD
Prof. of Neurology, Director of the Sleep Research Institute
Univ. Goettingen/Kassel, Germany Madrid, Spain
President President
World Association of Sleep Medicine Sociedad Espaola de Sueo
1
2A.( (>HH>DC .I6I:B:CI
Te fundamental mission of the WASM is to advance sleep health worldwide. WASM will fulfll this mission by
promoting and encouraging education, research and patient care throughout the world, particularly in those parts
of the world where the practice of sleep medicine is less developed. WASM will act as a bridge between diferent
sleep societies and cultures, supporting and encouraging worldwide exchange of clinical information and scientifc
studies related to sleep medicine. WASM will seek to encourage development and exchange of information for
world-wide and regional standards of practice for sleep medicine.
Because sleep health will be advanced by information, WASM will strive to advance knowledge about sleep and its
disorders amongst both healthcare workers and the general public. Tis will include both education about the
means to healthy sleep as well as awareness of the adverse consequences of sleep dysfunction on the quality of
life and the health of an individual. To address the concerns of specifc areas of the world, WASM will provide a
forum for discussion and consideration of issues of relevance to particular regions and cultures.
To achieve these goals, WASM will act in several directions including but not limited to: WASM will share
information both through its scientifc congresses and by organization of intercontinental and regional educational
courses, symposia and workshops.
WASM will encourage international and regional collaborative research, keeping in mind that the customs,
cultures and priorities for sleep medicine may vary among diferent continents of the world.
WASM will help develop national and regional sleep organizations where none exist.
WASM will participate in preparation of reviews, guidelines, and standards emphasizing preventive measures for
the practicing sleep specialists and taking into consideration regional customs, cultures and habits.
WASM will collaborate with lay and professional sleep organizations in order to disseminate information about
sleep health to the public and the profession.
WASM will encourage collaboration between sleep clinicians and basic scientists to bring sleep medicine from
the bench to the bedside, promoting sleep medicine around the globe. In particular WASM will encourage
development of clinical methods appropriate for regional conditions and cultures.
WASM will be open to establishing closer relationships with individuals and regional associations by ofering
memberships at a modest cost, taking into consideration local economic issues.
WASM will maintain an ofcial journal available at a modest fee to its members that will focus on the full range
of sleep medicine around the world.
WASM provides an International Sleep Specialist Board Examination in collaboration with local societies and
issues a certifcation of expertise to individuals who qualify and/or pass the test.
2
/67A: D; CDCI:CIH
CDBB>II::H ....................................................................................................4 - 5
2A.( BD6G9 D; *;;>8:GH, +6HI +G:H>9:CIH, .I6;; ..............................................7
":C:G6A $C;DGB6I>DC......................................................................................8 - 10
/DJG>HB 6C9 #DI:AH .....................................................................................11 - 12
&:NCDI: .E:6@:GH 6C9 26NC: #:C>C< ':8IJG: ................................................13
+GD<G6B 6I 6 "A6C8:...................................................................................14 - 17
.6IJG96N +GD<G6BH ....................................................................................20 - 25
.JC96N +GD<G6BH.......................................................................................26 - 36
(DC96N +GD<G6BH......................................................................................37 - 70
/J:H96N +GD<G6BH......................................................................................71 - 96
2:9C:H96N +GD<G6BH...............................................................................97 - 114
+DHI:G +G:H:CI6I>DCH................................................................................115 - 151
!ADDG +A6C 6C9 M=>7>I>DC !ADDG +A6C...................................................18 6C9 154
.EDCHDGH............................................................................................................155
CDBB:G8>6A CDBE6C>:H 6C9 M=>7>IDGH...................................................156 -161
3
5I= 2DGA9 CDC<G:HH DC .A::E (:9>8>C: CDBB>II::H
+GD<G6B *G<6C>O>C< CDBB>II::
Richard Allen, co-chair
Javier Puertas Cuesta, co-chair
Diego Garcia Borreguero
Christian Guilleminault
Max Hirshkowitz
Charles Morin
Allan OBryan
Virend Somers
Claudia Trenkwalder
/:8=CDAD<>HI CDBB>II::
Maxime Elbaz
Simone de Lacy
CDJGH: CDBB>II::
Josep Montserrat
Robert Tomas
*G<6C>O>C< .:8G:I6G>6IH
World Association of Sleep Medicine Foundation
3270 19th St. NW Suite 109
Rochester, MN 55901 USA
#DCDG6GN CDBB>II::
President:
S.M. Don Juan Carlos I, King of Spain
Members:
M. H. Sr. Don Alberto Fabra,
President of Valencia Regional Government
Excma. Sra. Doa Ana Mato,
Minister of Health of Spain
Excma. Sra. Doa Rita Barber,
Mayor of Valencia City
H. Sr. Don Manuel Llombart,
Vice-Minister of Health of Valencia Regional Government
Ilmo Sr Don Alfonso Rus,
President, Diputacin of Valencia
Excmo. y Magfco. Sr. Don Esteban Morcillo,
President of University of Valencia
Excmo. y Magfco. Sr. Don Jose Alfredo Peris,
President of Catholic University of Valencia
Excmo. Sr. Don Santiago Grisolia,
Secretary of Valencia Foundation for Advanced Research
Monica Andersen
Isabelle Arnulf
Najib Ayas
Michel Billiard
Bjorn Bjorvatn
Diane Boivin
Douglas Bradley
Oliviero Bruni
Michael Chee
Ron Chervin
Yong-Won Cho
Sudhansu Chokroverty
Kimberly Cote
Antonio Culebras
Yves Dauvilliers
Valerie Cochen De Cock
Joseph De Koninck
Luis de Lecea
Colin Espie
Luigi Ferini-Strambi
Raffaele Ferri
Arturo Garay
Nadia Gosselin
Leja Dolenz Groselj
Reut Gruber
Fang Han
Jan Hedner
Raphael Heinzer
Max Hirshkowitz
Birgit Hogl
Seung Chul Hong
Seung Bong Hong
Magda Hornyak
Yu-Shu Huang
Poul Jennum
Sharon Keenan
Jun Kohyama
P. Vijaya Krishnan
Gert Lammers
Damien Leger
Lena Leissner
Geraldo Lorenzi-Filho
Pierre-Herv Luppi
Geert Mayer
Jacques Montplaisir
Charles Morin
Sona Nevsimalova
F. Javier Nieto
Judith Owens
Teresa Paiva
Sylvia Paez
Liborio Parrino
Markku Partinen
Rafael Pelayo
Thomas Penzel
Pierre Philip
Claudio Podesta
Dalva Poyares
M. Antonia Quera-Salva
Daniel Rodenstein
Leon Rosenthal
Charles Samuels
Julia Santin
Toshiaki Shiomi
Garima Shukla
Michael Smith
Karel Sonka
Eva Svanborg
Nana Tachibana
Mehdi Tafti
Robert Thomas
Eus Van Someren
Claudia Trenkwalder
Marco Venegas
Maria Pia Villa
Shelly Weiss
Yun Kwok Wing
Juliane Winkelmann
Philis Zee
Marco Zucconi
2A.( $CI:GC6I>DC6A .8>:CI>;>8 CDBB>II::
4
)6I>DC6A .8>:CI>;>8 CDBB>II::
Ferran Barb
Antonio Benet
Antonio Bov-Rib
Francesca Caellas
Teresa Canet
Pilar Cuartero-Rios
Isabel De Andrs
Luis Dominguez-Ortega
Joaquin Durn-Cantolla
Eduard Estivill
Enrique Fernndez-Julin
Diego Garcia Borreguero
Sandra Gimnez-Badia
Enriqueta Gmez-Siurana
Nicols Gonzlez-Mangado
Alex Iranzo
Jorge Iriarte-Franco
Juan Antonio Madrid
Miguel Angel Martnez-Garca
Juan Fernando Masa
Milagros Merino-Andreu
Josep M. Montserrat
Gonzalo Pin-Arboledas
Inmaculada Pitarch
Fernando Prieto
Odile Romero
Teresa Sagals
M Montserrat Snchez-Ortuo
Oscar Sans-Capdevila
Joan Santamaria
Joaquin Tern
5
Conselleria de Sanitat Ajuntament de Valencia
Direccin General del Trfco Diputacin de Valencia
Sociedad Espaola de Neumologa y
Ciruga Torcica (SEPAR)
Sociedad Espaola de OR y Patologa
Cervico-facial (SEORL PCF)
Universitat de Valncia Universidad Catlica de Valencia
Hospital Universitario de la Ribera
/=: 2DGA9 AHHD8>6I>DC D; .A::E (:9>8>C: 6C9 I=:
.E6C>H= .A::E .D8>:IN LDJA9 A>@: ID I=6C@ I=: ;DAADL>C<
>CHI>IJI>DCH, H8>:CI>;>8 HD8>:I>:H 6C9 JC>K:GH>I>:H ;DG I=:>G
HJEEDGI D; I=: 5I= 2DGA9 CDC<G:HH DC .A::E (:9>8>C:.
6
2A.( CDBB>II::H C=6>G 6C9 CD-C=6>GH
2A.( *;;>8:GH
President
Claudia Trenkwalder (Germany)
President-Elect
Richard Allen (USA)
Past Presidents
Christian Guilleminault (USA)
Markku Partinen (Finland)
Founding President
Sudhansu Chokroverty (USA)
Secretary
Max Hirshkowitz (USA)
Assistant Secretary
Carlos Schenck (USA)
Treasurer
Birgit Hgl (Austria)
Assistant Treasurer
Alex Iranzo (Spain)
(:B7:GH 6I-'6G<:
Europe
Luigi Ferini-Strambi (Italy)
North America
Charles Atwood (USA)
Charles Morin (Canada)
Robert Thomas (USA)
South America
Sergio Tufik (Brazil)
Africa
Lamia Afifi (Egypt)
Asia
Suresh Kumar (India)
Nana Tachibana (Japan)
Australia-Oceania
Karen Waters (Australia)
Executive Committee
Claudia Trenkwalder, President
Richard Allen, President-elect
Max Hirshkowitz, Secretary
Birgit Hgl, Treasurer
Christian Guilleminault, Past-President
Valencia 2013 Committee
Richard Allen
Diego Garcia-Borreguero
Javier Puertas
World Sleep Day Committee
Antonio Culebras
Liborio Parrino
Education Committee
Max Hirshkowitz
Birgit Hgl
Sharon Keenan
Bylaws Committee
Membership Committee
Luigi Ferini-Strambi
Claudia Trenkwalder
Scientific Affairs Committee
Sonia Ancoli-Israel
Kingman Strohl
Nominating Committee
Awards Committee
Antonio Culebras
Manvir Bhatia
Publication Committee
2DGA9 AHHD8>6I>DC D; .A::E (:9>8>C:
Paracelsus-Elena-Klinik
Klinikstrasse 16
34128 Kassel, Germany
Carmen Castells, WASM Administrative Secretary
email: WASMsecretary@gmx.de
3270 19th Street NW, Suite 109
Rochester, MN 55901 (U.S.A.)
Allan OBryan, WASM Executive Director
Bryan Weiss, WASM Associate Director
email: info@wasmonline.org wasmonline.org
7
'D86I>DC
Palacio de Congresos Valencia
Avda. Cortes Valencianas, n 60
46015 Valencia (Spain)
Tel.:+34 96 317 94 00
Fax: +34 96 317 94 01
www.palcongres-vlc.com
*C-H>I: -:<>HIG6I>DC #DJGH
Friday, September 27, 2013: 7:00pm 9:00pm*
Saturday, September 28, 2013: 7:00am 9:00pm
Sunday, September 29, 2013: 7:00am 9:00pm
Monday, September 30, 2013: 7:00am 9:00pm
Tuesday, October 1, 2013: 7:00am 9:00pm
Wednesday, October 2, 2013: 7:00am 7:00pm
*Registration on Friday is only for course attendees.
Registration materials (including badges, final programs,
tickets, etc.) will be provided at the registration
counter located in the Palacio de Congresos Valencia
convention center.
Tickets are required for entry for Saturday and Sundays
pre-congress courses, Monday and Tuesdays discussion
symposia, and Mondays presidential dinner. Tickets
can be purchased online at www.wasmonline.org or at
the registration desk.
"J:HI +6HH:H
A registered attendee may elect to buy a guest pass at cost of
US$100. Guest passes allow entrance to the exhibit hall,
opening and closing cermonies, and industry sponsored
events only. Guests are not permitted to attend any of the
general scientific sessions or ticketed sessions.
B69<: $9:CI>;>86I>DC
All congress participants and guests must wear a WASM
congress badge. Badges allow entrance to the scientific
sessions and access to the convention center. Your
cooperation with this policy is appreciated. Recycle
your badge holder after the congress by dropping it off
at the registration desk area. Replacement badges can
be obtained at the registration desk for a fee.
M=>7>IH 6C9 M=>7>I>C< #DJGH
The 5
th
World Congress on Sleep Medicine provides an
opportunity for commercial companies to network,
educate, and provide information about sleep related
products and services. Exhibiting is open during the
following hours:
Monday, September 30, 2013: 11:00AM to 5:00PM
Tuesday, October 1, 2013: 11:00AM to 5:00PM
Wednesday, October 2, 2013: 11:00AM to 5:00PM
The exhibition areas will be closed and monitored by
security before 11:00AM and after 5:00PM. Exhibitor
personnel are allowed in their booths one hour prior and
one hour after exhibition times. We require that all
exhibit booths be staffed only during the exhibit hours.
.E:6@:G -:69N -DDB
Presenting speakers can use the Speaker Ready Room,
located across from the registration desk (room #13),
to upload their PowerPoint presentations, test software,
and make changes and adjustments to their presentations.
Speakers are required to upload their presentation in the
speaker ready room 12 hours prior to their session. A
technician will be available to assist as needed.
Speaker Ready Room hours are:
Friday, September 27, 2013: 7:00pm 9:00pm
Saturday, September 28, 2013: 7:00am 5:00pm
Sunday, September 29, 2013: 7:00am 5:00pm
Monday, September 30, 2013: 7:00am 9:00pm
Tuesday, October 1, 2013: 7:00am 9:00pm
Wednesday, October 2, 2013: 7:00am 1:00pm
+G:HH -DDB
Members of the press are encouraged to utilize the
Speaker Ready Room to work on their stories, internet
access, and other resources that are needed.
2A.( (:B7:GH=>E BDDI=
WASM membership records may be reviewed and
purchased at the WASM Booth #2. Details about
WASM membership can be directed to registration
or WASM booth staff.
-:8DG9>C< D:K>8: +DA>8N
No recording devices, audio or visual, may be used
during scientific sessions and congressactivities.
Duplication, distribution, or excerpting of this
program, without the express written permission
of Mayo Clinic and the World Association of Sleep
Medicine, is strictly prohibited.
All of the proceedings of this program, including the
presentation of scientific papers, are intended for
limited publication only, and all property rights in the
material presented, including common-law copyright,
are expressly reserved by the Faculty, World Association
of Sleep Medicine, and/or Mayo Clinic. No statement
of presentation made is to be regarded as dedicated to
the public domain. Any sound reproduction, transcript
or other use of the material presented at this CME
activity without the permission of the World Association
of Sleep Medicine and Mayo Clinic is prohibited to the
full extent of common-law copyright in such material.
":C:G6A $C;DGB6I>DC
8
Cameras and recording devices are not allowed to be used
in the scientific meeting rooms at any time. Violation of
this rule could result in removal from the WASM 5
th
World Congress on Sleep Medicine congress and Palacio
de Congresos Valencia convention center along with the
confiscation of the film and/or recording device.
A:8IGDC>8 D:K>8:H
Please turn all electronic devices (cellular telephones,
pagers, etc.) to silent mode. As a courtesy to the
presenters and other participants, phone calls should
be taken outside of the scientific sessions.
.:6I>C<
Scientific session are filled on a first-come, first served
basis. WASM along with the Program Committee
reviewed the scientific sessions to anticipate demand
to match the room size with expected seating.
Occasionally, a talk will have higher demand than
expected. Seating limits are strictly enforced by the
Palacio de Congresos Valencia convention center and
City of Valencia. We encourage delegates to arrive
early for best possible seating.
A7HIG68I .JEEA:B:CI
Abstracts from the 5
th
World Congress on Sleep Medicine
are published in an online abstract supplement of the
journal Sleep Medicine. To view a PDF of the abstracts,
please visit: www.wasmcongress.com/abstracts/.
CDCI>CJ>C< (:9>8>C: 9J86I>DC
Continuing Medical Education (CME) Credit for
Physicians Accreditation Statement
WASM 5
th
World Congress
on Sleep Medicine congress
activities have been planned
and implemented in accordance
with the Essential Areas and policies
of the Accreditation Council for
Continuing Medical Education (ACCME) through the
joint sponsorship of Mayo Clinic College of Medicine
and the World Association of Sleep Medicine. Mayo
Clinic College of Medicine is accredited by the ACCME
to provide continuing medical education for physicians.

The World Association of Sleep Medicine designates
this live educational activity for a maximum of 43.5
AMA PRA Category 1 Credits. Physicians should
claim only the credit commensurate with the extent
of their participation in the activity. The maximum
number of credits that can be earned for the
pre-congress courses is 16. The maximum number
of credits that can be earned for the congress is 27.5.
CME is awarded for pre-congress courses, keynote
lectures, symposia sessions, oral presentations, discussion
symposium, and technologist workshops. A CME fee of
US$10 is payable online at www.wasmonline.org or at
the registration desk to obtain CME documentation.
C( -:8DG9 D; AII:C96C8:
A CME Record of Attendance is provided to attendees
who have paid the $10 CME fee at on-site registration.
The Record of Attendance allows attendees to calculate
their own credits of participation in the educational activity.
The total number of credits participants can earn per day
is noted on the Record of Attendance form. Below each
day is a line to record the actual number of credits during
which you participated in the educational activity. It is
recommended that you record your actual credits daily as
you proceed through the CME activity.
Upon conclusion of the CME activity, please total the
number of credits you have recorded on the top half of the
form, sign it, and return it to the registration desk.
The bottom half of the form represents your Record of
Attendance, which you must retain for your records.
Please make sure the number of credits claimed in both
sections coincide. No other documentation is
provided to you after this CME activity.
The CME Record of Attendance can be used for
requesting credits in accordance with state licensing
boards, specialty societies, or other professional associations.
Please note this CME Record of Attendance is different
than the WASM Congress Certificate which all attendees
receive in their registration packet.
C( A8I>K>IN K6AJ6I>DC
The overall CME activity evaluation will be emailed
following the activity to the email address that was
provided when you registered. The CME activity
evaluation is brief and will only take a few minutes
to complete.
Faculty evaluation forms will be provided electronically
via email to registrants. Completed faculty evaluation
forms should be completed online at the conclusion of
the CME activity and within one week of the congress.
Your feedback is very important to us and will be used
for planning future programs, as well as identifying
faculty strengths and opportunity for growth.
":C:G6A $C;DGB6I>DC
9
*E:C>C< C:G:BDCN
Join us for the Opening Ceremony of the 5th World
Congress on Sleep Medicine!
Sunday, September 29, 2013
7:00pm to 10:00pm
Palau de les Arts Reina Sofia (www.lesarts.com)
The Opening Ceremony will take place at the Palau
de les Arts, a world class venue in the City of Arts and
Sciences. Enjoy a selection of Opera arias and Zarzuela
offered by Centro de Perfeccionamiento 'Plcido
Domingo' de Valencia.
Awards will be presented to the following individuals
and sleep societies:
Christian Guilleminault Award:
Diego Robles Mazzotti (Brazil)
Prevalence and correlates for sleep complaints in older
adults in low and middle income countries: a 10/66
Dementia Research Group study
Lugaresi Award:
Paresh Zanzmera (India)
Effect of successful epilepsy surgery on subjective and
objective sleep parameters a prospective study
World Sleep Day Distinguished Activities Awards:
2012 Gyrgy G. Nmeth (Hungary)
2012 Spanish Sleep Society Teresa Canet (Spain)
2013 Portuguese Sleep Association -
2013 Marta Gonalves (Portugal)
2013 Bolivian Society of Internal Medicine,
2013 chapter La Paz - Ximena Alvarado (Bolivia)
2013 CENC Sleep Medicine Center and
2013 Professor Teresa Paiva (Portugal)
Young Investigators:
Yo-El Ju (USA)
Lena Tholfsen (Norway)
Jason Valerio (Canada)
Nicholas-Tiberio Economou (Greece)
Alia Mansour (Egypt)
Claudio Liguori (Italy)
Preeti Devnani (India)
Chilean Sleep Society Abstract Awards:
Andrea Zuniga
Maria Jose Elso
After the music and awards program we will retire
outside to network while enjoying wine, appetizers and
fireworks. More than 20 gourmet tapas appetizers and
Spanish red and white wine and other beverages will be
available as well. The cost of this event is included in
your registration.
Transportation will be provided from the congress
venue area to the Palau de les Arts. Buses will run
from 5:00pm to 7:00pm and return from 10:00pm
to 11:00pm.
+G:H>9:CIHQ D>CC:G 6C9 -:8:EI>DC
Monday, September 30, 2013
8:30pm to 11:00pm
Balneario Las Arenas Resort
Come enjoy the beautiful beach view, gourmet cuisine
and the classical Spanish guitar music and Spanish
concert of Ricardo Ramirez-Aranda.
The cost of this event is $150.
Transportation will be provided from the convention
center to the Palau de les Arts. Buses will run from
8:10pm to 8:40pm and return when the dinner is
concluded.
CADH>C< C:G:BDCN
Wednesday, October 2, 2013
7:00pm to 7:45pm
Auditorium 1
Join us for a final presentation as we acknowledge the
hard work of the 2013 Program Committee and listen
to a special presentation from the 2015 Program
Committee co-chairs. Information will be shared
about the 6th World Congress on Sleep Medicine held
March 21-25, 2015 in Seoul, Korea. Afterwards, join
us for a toast and a last chance to say good-bye to
your colleagues.
":C:G6A $C;DGB6I>DC
10
Discovering Valencia is a true pleasure for the senses. The legacy left by the cultures and civilizations which have
reached these shores in the past still remains alive in the citys monuments and streets, not to mention in its
peoples hearts. Valencia is a city that never sleeps. It has a rich cultural life with festivals, concerts, shows and
exhibitions year round. You may experience the Valencian culture by joining one of the following tour options
presented by Kenes.
For more information please visit the Kenes booth in the registration area. Kenes is the official organizer of local tours
for the 5th World Congress on Sleep Medicine. You may also send an email to wcsm2013-ac@kenes.com or visit
www.wasmcongress.com.
/DJG>HB 6C9 #DI:AH
11
*EI>DC A:
Old Town of Valencia
and Oceanografico
9:30am to 5:00pm
50
*EI>DC B:
Albufera Natural Park,
Fallero Museum and
Port Americas Cup
and F1 Street Circuit
9:30am to 5:00pm
35
*EI>DC C:
Requena, Wine with
D.O. and the Wine
Route
10:00am to 5:00pm
45
*EI>DC D:
Alboraya Horchata
with D.O. and Lladr
Porcelein Factory
9:30am to 1:30pm
35
C( -:<>HIG6I>DC -:FJ>G:9
Please complete the following steps to receive CME credit:
1. Purchase the $10 CME fee at www.wasmonline.org or at registration desk.
2. Obtain the CME Record of Attendance at registration desk.
3. Turn in CME Record of Attendance once completed to registration desk or
2. email to info@wasmonline.org by October 3, 2013.
4. Complete the faculty, session, and congress evaluations. Evaluations will be
2. collected electronically and sent via e-mail each day.
For more information please visit the Kenes booth in the registration area. Kenes is the official organizer of the
hotel accommodations for the 5th World Congress on Sleep Medicine. You may also send an email to
wcsm2013-ac@kenes.com or visit www.wasmcongress.com.
(6E D; 16A:C8>6
#DI:AH
12
Balneario Las Arenas Resort
C/ Eugenia Vies, 22-24
en.hotel-lasarenas.com
The Westin Valencia
Amadeo de Saboya 16
www.westinvalencia.com/en
MELI Valencia Palacio de Congresos
Avenida Cortes Valencianas 52
www.melia.com
Eurostars Gran Valencia
VALLE DE AYORA No. 3
www.eurostarsgranvalencia.com
Sercotel Sorolla Palace
Avda. de las Cortes Valencianas, 58
en.hotelsorollapalace.com
NH Center
Ricardo Mic, 1.46009 Valencia
www.nh-hotels.com
Ibis Valencia
Calle Valle de Ayora, 5
www.ibis.com
NH Jardines del Turia
Pintor Velzquez s/n. 46100 Burjasot
www.nh-hotels.com
Hotel Vora Fira
Cullera 67
www.hotelvorafira.es
&:NCDI: .E:6@:GH
Virend Somers, MD, PhD (USA)
Mayo Clinic
Sleep, Death and the Heart
Monday, September 30, 2013 9:00am - 10:00am Auditorium 1
Gran Hajak, MD, PhD (Germany)
University of Erlangen, Social Foundation Bamberg
Emerging Treatments for Insomnia
Monday, September 30, 2013 3:30pm - 4:30pm Auditorium 1
Phyllis Zee, MD (USA)
Northwestern University, Feinberg School of Medicine
Circadian Disorders and Associated Risks
Tuesday, October 1, 2013 9:00am - 10:00am Auditorium 1
Pierre-Herv Luppi, PhD (France)
Centre National de la Recherche, Scientifque
Neurobiology of Sleep
Tuesday, October 1, 2013 3:30pm - 4:30pm Auditorium 1
Demin Han, MD, PhD (China)
Chinese Medical Doctor Association Otolaryngology
Surgery of Obstructive Sleep Apnea
Wednesday, October 2, 2013 9:00am - 10:00am Auditorium 1
Mehdi Tafti, PhD (Switzerland)
University of Lausanne
Genetics and Epigenetics of Sleep Disorders
Wednesday, October 2, 2013 3:30pm - 4:30pm Auditorium 1
26NC: #:C>C< (:BDG>6A ':8IJG:
Isabelle Arnulf, MD, PhD (France)
Pierre and Marie Curie University, Piti-Salptrire Hospital
Neurodegeneration and Sleep
Wednesday, October 2, 2013 1:40pm - 2:40pm Auditorium 1
13
14
+GD<G6B 6I 6 "A6C8:
!G>96N, .:EI:B7:G 27, 2013
_____________________________________________________________________________________________________________________
5:00EB - 10:00EB *C-.>I: -:<>HIG6I>DC
_____________________________________________________________________________________________________________________
.6IJG96N, .:EI:B7:G 28, 2013
_____________________________________________________________________________________________________________________
7:006B - 9:006B *C-.>I: -:<>HIG6I>DC
8:006B - 6:45EB $CI:GC6I>DC6A -'. .IJ9N "GDJE ACCJ6A (::I>C< $ CDBB>II:: -DDB 1
_____________________________________________________________________________________________________________________
8:006B - 5:00EB CDJGH: 1: D:CI6A G:8DC;><JG6I>DC 6C9 G:8DCHIGJ8I>DC ;DG .DB B6C6<:B:CI
_____________________________________________________________________________________________________________________
8:006B - 12:00EB CDJGH: 3: (:9>86A IG:6IB:CI D; .DB P 7:NDC9 C6H6A EDH>I>K: EG:HHJG:
_____________________________________________________________________________________________________________________
1:00EB - 5:00EB CDJGH: 4: C>G869>6C 9NH;JC8I>DC >C =:6AI= 6C9 9>H:6H:
.JC96N, .:EI:B7:G 29, 2013
7:006B - 9:006B *C-.>I: -:<>HIG6I>DC
8:006B - 5:00EB CDJGH: 5: A9K6C8:H >C I=: B6C6<:B:CI D; E:9>6IG>8 HA::E 9>HDG9:GH
___________________________________________________________________________________________
8:006B - 12:00EB CDJGH: 6: -:HIA:HH A:<H 6C9 BDIDG 68I>K6I>DC 9JG>C< HA::E
___________________________________________________________________________________________
CDJGH: 7: $CHDBC>6 9>HDG9:G: !GDB :E>9:B>DAD<N ID 9>HH:B>C6I>DC D;
:K>9:C8:-76H:9 I=:G6E:JI>8 6EEGD68=:H
_____________________________________________________________________________________________________________________
8:306B - 4:30EB .E6C>H= .A::E .D8>:IN ":C:G6A (::I>C< $ .:G8DI:A #DI:A
_____________________________________________________________________________________________________________________
9:006B - 5:00EB /:8=CDAD<>HI (::I>C< $ CDBB>II:: -DDBH 1 6C9 2
_____________________________________________________________________________________________________________________
1:00EB - 5:00EB: CDJGH: 8: 0E96I: >C HA::E B:9>8>C: I:8=CDAD<N
___________________________________________________________________________________________
CDJGH: 9: .A::E 6C9 I=: =:6GI
___________________________________________________________________________________________
CDJGH: 10: -:8DG9>C< 6C9 H8DG>C< D; BDK:B:CI 9>HDG9:GH D; HA::E 6C9 -BD
7:00EB - 8:30EB *E:C>C< C:G:BDCN $ +6A6J 9: A:H AGIH -:>C6 .D;>6
(DC96N, .:EI:B7:G 30, 2013
_____________________________________________________________________________________________________________________
7:006B - 9:006B *C-.>I: -:<>HIG6I>DC
_____________________________________________________________________________________________________________________
8:306B - 9:006B ACCDJC8:B:CIH
9:006B - 10:006B &:NCDI:: .A::E, D:6I= 6C9 I=: #:6GI Virend Somers $ AJ9>IDG>JB 1
10:006B - 11:306B .1: ):L D>6<CDHI>8 /:8=CDAD<>:H ;DG .A::E D>HDG9:G:9 BG:6I=>C< $ AJ9>IDG>JB 2
___________________________________________________________________________________________
.2: CD<C>I>K: B:=6K>DG6A /=:G6EN ;DG $CHDBC>6 (CB/-$): &CDLA:9<: /G6CH;:G
6C9 /G:6IB:CI D>HH:B>C6I>DC $ (JAI>EJGEDH: -DDB 1
___________________________________________________________________________________________
.3: CDCK:G<>C< 0C9:GHI6C9>C< D; I=: B>DAD<N D; -:HIA:HH ':<H .NC9GDB: $ AJ9>IDG>JB 3
___________________________________________________________________________________________
.4: /=: AJIDCDB>8 ):GKDJH .NHI:B 6C9 .A::E >C #JB6C )6G8DA:EHN: DD +6I>:CIH #6K: 6C
$C8G:6H:9 C6G9>DK6H8JA6G ->H@? $ CDBB>II:: -DDBH 1 6C9 2
11:306B - 12:00EB CD;;:: BG:6@ 6C9 M=>7>I>DC
12:00EB - 1:30EB .5: /=: -DA: D; .A::E >C BDI>DC6A (:BDGN +GD8:HH>C< 6C9 D:K:ADEB:CI DG
+G:K:CI>DC D; +/.D $ (JAI>EJGEDH: -DDB 1
___________________________________________________________________________________________
.6: .A::E D>HDG9:GH 6C9 C6C8:G $ AJ9>IDG>JB 2
___________________________________________________________________________________________
.7: BG6>C $B6<>C< .IJ9>:H >C .A::E D>HDG9:GH 6C9 .A::E D:EG>K6I>DC $ AJ9>IDG>JB 1
___________________________________________________________________________________________
*-01: A<>C< 6C9 D:K:ADEB:CI6A $HHJ:H $ CDBB>II:: -DDB 1
___________________________________________________________________________________________
*-02: .A::E BG:6I=>C< D>HDG9:GH $ AJ9>DG>JB 3
___________________________________________________________________________________________
/:8=CDAD<>HI +GD<G6B: 21 AD0'/ +." (6HI:G8A6HH: .A::E (DCI6<: #DD@-JE;
.A::E .I6<>C< 6C9 K:CI .8DG>C< $ CDBB>II:: -DDBH 3 6C9 4
_____________________________________________________________________________________________________________________
1:40EB - 3:10EB $C9JHIGN .NBEDH>JB: B:G<>C< .IG6I:<>:H >C .A::E D>HDG9:GH $ AJ9>IDG>JB 1
___________________________________________________________________________________________
$C9JHIGN .NBEDH>JB: A9K6C8:H >C +A+ /=:G6EN $ (JAI>EJGEDH: -DDB 1
15
+GD<G6B 6I 6 "A6C8:
3:10EB - 3:30EB CD;;:: BG:6@ 6C9 M=>7>I>DC
3:30EB - 4:30EB &:NCDI:: B:G<>C< /G:6IB:CIH ;DG $CHDBC>6 Gran Hajak $ AJ9>IDG>JB 1
_________
4:30EB - 5:30EB *-03: C=GDCD7>DAD<N & C>G869>6C D>HDG9:GH $ AJ9>IDG>JB 3
___________________________________________________________________________________________
*-04: $CHDBC>6 (:8=6C>HBH $ (JAI>EJGEDH: -DDB 1
___________________________________________________________________________________________
*-05: CD<C>I>DC 6C9 -BD $ CDBB>II:: -DDBH 1 6C9 2
_____________________________________________________________________________________________________________________
5:30EB - 7:00EB .8: *7HIGJ8I>K: .A::E AEC:6, (DIDG 1:=>8A:H A88>9:CIH 6C9 DG>K>C<
'>8:CH: -:<JA6I>DCH $ AJ9>IDG>JB 1
___________________________________________________________________________________________
.9: ):JGD8D<C>I>DC 6C9 B:=6K>DG, .A::E D>HIJG76C8: 6C9 .A::E D>HDG9:G:9 BG:6I=>C< $ AJ9>IDG>JB 2
___________________________________________________________________________________________
.10: $9:CI>;>86I>DC D; I=: ):JGDC6A ):ILDG@ -:<JA6I>C< I=: .A::E-L6@>C<
CN8A:: A ):K:G C9>C< .IDGN? $ AJ9>IDG>JB 3
___________________________________________________________________________________________
.11: $CCDK6I>DCH >C .A::E AEC:6 (6C6<:B:CI $ (JAI>EJGEDH: -DDB 1
___________________________________________________________________________________________
.12: .A::E 6C9 C>G869>6C -=NI=B A7CDGB6A>I>:H >C (DD9 D>HDG9:GH $ CDBB>II:: -DDBH 1 6C9 2
___________________________________________________________________________________________
/:8=CDAD<>HI +GD<G6B: 22 +AD +." (6HI:G8A6HH: #DD@-JE; .A::E .I6<>C< 6C9 K:CI .8DG>C<;
/DE />EH ;DG CDBEA>6C8: $ CDBB>II:: -DDBH 3 6C9 4
_____________________________________________________________________________________________________________________
7:00EB - 8:00EB D.-(-01: .A::E AEC:6 6C9 I=: ->H@ D; .IGD@:* $ CDBB>II:: -DDB 1
___________________________________________________________________________________________
D.-(-02: .A::E >C /G6JB6I>8 BG6>C $C?JGN: CJGG:CI &CDLA:9<: 6C9 !JIJG: D>G:8I>DCH*
CDBB>II:: -DDB 2
___________________________________________________________________________________________
D.-(-03: +=6GB68D-.A::E: I=: AHH:HHB:CI D; DGJ< ;;:8IH DC #JB6C .A::E* $ CDBB>II:: -DDB 3
___________________________________________________________________________________________
D.-(-04: 2DG@, .8=DDA, .A::E, 6C9 *88JE6I>DC6A #:6AI= 6C9 .6;:IN >C A9DA:H8:CIH 6C9 4DJC<
A9JAIH* $ CDBB>II:: -DDB 4
___________________________________________________________________________________________
D.-(-05: $BEGDK>C< I=: .8DG>C< D; -( .A::E 2>I=DJI AIDC>6 6C9 D; (JH8A: A8I>K>IN DJG>C<
-( .A::E* $ CDBB>II:: -DDB 5
___________________________________________________________________________________________
D.-(-06: $H /=:G: 6 -DA: ;DG .JG<:GN >C I=: (6C6<:B:CI D; *7HIGJ8I>K: .A::E AEC:6?*
CDBB>II:: -DDB 6
___________________________________________________________________________________________
D.-(-07: #DL ID AHH:HH 6C9 /G:6I .A::E D>HDG9:GH >C +G:<C6CI 2DB:C* $ CDBB>II:: -DDB 7
___________________________________________________________________________________________
D.-(-08: +:G>D9>8 '>B7 (DK:B:CIH JC9:G C+A+ >C *7HIGJ8I>K: .A::E AEC:6 .NC9GDB:*
CDBB>II:: -DDB 8
___________________________________________________________________________________________
D.-(-09: A7DG96?: 9:A .A#. 9:H9: A6 E:GHE:8I>K6 9:A *-'/CA>C>86A B6C6<:B:CI D; *.A:
/=: )/ K>:LED>CI* $ CDBB>II:: -DDB 9
___________________________________________________________________________________________
D.-(-10: -:8:CI 0E96I:H >C I=: D>6<CDH>H D; $CHDBC>6 P D.(5 6C9 $C.D-3: $BEA>86I>DCH ;DG
-:H:6G8= 6C9 CA>C>86A +G68I>8:* $ AJ9>IDG>JB 3
___________________________________________________________________________________________
D.-(-11: (DK:B:CI D>HDG9:GH 6C9 .A::E - A 1>9:D .:B>C6G* $ (JAI>EJGEDH: -DDB 1
* />8@:I G:FJ>G:9 - EJG8=6H: 6I G:<>HIG6I>DC 9:H@

8:30EB ID 11:00EB +G:H>9:CIHQ D>CC:G 6C9 -:8:EI>DC* $ B6AC:6G>D '6H AG:C6H -:HDGI
/J:H96N, *8ID7:G 1, 2013
7:006B - 9:006B *C-.>I: -:<>HIG6I>DC
_____________________________________________________________________________________________________________________
9:006B - 10:006B &:NCDI:: C>G869>6C D>HDG9:GH 6C9 AHHD8>6I:9 ->H@H Phyllis Zee I AJ9>IDG>JB 1
10:006B - 11:306B .13: .A::E, C>G869>6C -=NI=BH 6C9 BG6>C #:6AI= >C A<>C< $ AJ9>IDG>JB 2
___________________________________________________________________________________________
.14: MEA6>C>C< D>;;:G:C8:H >C E>9:B>DAD<N D; .A::E D>HDG9:GH A8GDHH I=: 2DGA9:
/=: C6H: D; .DB 6C9 -'. $ AJ9>IDG>JB 3
___________________________________________________________________________________________
.15: +G:<C6C8N 6C9 .A::E $ CDBB>II:: -DDBH 1 6C9 2
___________________________________________________________________________________________
.16: $CI:GEG:I>C< 6C9 K6AJ6I>C< +6G6HDBC>6H: ):L +:GHE:8I>K:H $ (JAI>EJGEDH: -DDB 1
11:306B - 12:00EB CD;;:: BG:6@ 6C9 M=>7>I>DC
+GD<G6B 6I 6 "A6C8:
16
/J:H96N, *8ID7:G 1, 2013 8DCI>CJ:9
12:00EB - 1:30EB .17: )DK:A $CH><=IH >CID C6G9>DB:I67DA>8 (:8=6C>HBH D; *.A $ AJ9>IDG>JB 2
___________________________________________________________________________________________
.18: /=DH: CDBDG7>9>I>:H I=6I $CK69: I=: )><=I:/G:6I>C< .A::E +GD7A:BH
>C +6I>:CIH L>I= +HN8=>6IG>8 D>HDG9:GH $ (JAI>EJGEDH: -DDB 1
___________________________________________________________________________________________
*-06: +6G6HDBC>6, ):JG6A +A6HI>8>IN, 6C9 ):JGDAD<>86A D>HDG9:GH CDBB>II:: -DDB 1
___________________________________________________________________________________________
*-07: .A::E BG:6I=>C< D>HDG9:GH $ AJ9>IDG>JB 3
___________________________________________________________________________________________
/:8=CDAD<>HI +GD<G6B: 23 +:G;DGB>C< 6C9 $CI:GEG:I>C< I=: (.C/ $ CDBB>II:: -DDBH 3 6C9 4
_____________________________________________________________________________________________________________________
1:40EB - 3:10EB $C9JHIGN .NBEDH>JB /G6CH8JI6C:DJH C*2 (DC>IDG>C< 6C9 >IH -DA: >C .A::E (:9>8>C:
(JAI>EJGEDH: -DDB 1
___________________________________________________________________________________________
$C9JHIGN .NBEDH>JB: />B: ID BG:6@ I=: -'./2D /G:6IB:CI +6G69><B $ AJ9>IDG>JB 1
3:10EB - 3:30EB CD;;:: BG:6@ 6C9 M=>7>I>DC
3:30EB - 4:30EB &:NCDI:: ):JGD7>DAD<N D; .A::E Pierre-Herv Luppi $ AJ9>IDG>JB 1
4:30EB - 5:30EB *-08: $CHDBC>6 /G:6IB:CI $ (JAI>EJGEDH: -DDB 1
___________________________________________________________________________________________
*-09: ):JGD7>DAD<N D; -'./+'(. $ AJ9>IDG>JB 3
___________________________________________________________________________________________
*-10: .A::E BG:6I=>C< D>HDG9:GH $ CDBB>II:: -DDBH 1 6C9 2
_____________________________________________________________________________________________________________________
5:30EB - 7:00EB .19: +6>C, *E>D>9H 6C9 .A::E BG:6I=>C< D>HDG9:G: AC $CI:G68I>DC ID (6C6<: $ AJ9>IDG>JB 2
___________________________________________________________________________________________
.20: .A::E 6C9 "AJ8DH: (:I67DA>HB $ AJ9>IDG>JB 3
___________________________________________________________________________________________
.21: .A::E AEC:6 6C9 /=: A9>ED8NI:: /G:C9H 6C9 /G:6IB:CIH $ (JAI>EJGEDH: -DDB 1
___________________________________________________________________________________________
/:8=CDAD<>HI +GD<G6B24 C+A+ (6HI:G8A6HH: (6H@ !>II>C<, CDBEA>6C8: $HHJ:H, />IG6I>DC
CDBB>II:: -DDBH 3 6C9 4
___________________________________________________________________________________________
*-12: )6G8DA:EHN 6C9 M8:HH>K: D6NI>B: .A::E>C:HH $ CDBB>II:: -DDB 1
_____________________________________________________________________________________________________________________
7:00EB - 8:00EB D.-/-01: +HN8=DAD<N 6C9 $CHDBC>6* $ CDBB>II:: -DDB 1
___________________________________________________________________________________________
D.-/-02: .A::E #67>IH 6C9 .A::E CK>GDCB:CI >C -JG6A '>K>C< 6C9 )6I>K: CDBBJC>I>:H D;
.DJI= AB:G>86* $ CDBB>II:: -DDB 2
___________________________________________________________________________________________
D.-/-03: ,J6A>IN AHHJG6C8: >C .A::E (:9>8>C:* $ CDBB>II:: -DDB 3
___________________________________________________________________________________________
D.-/-04: 0CJHJ6A )D8IJGC6A B:=6K>DG >C +:9>6IG>8H -D>;;:G:CI>6I>C< .:>OJG:H ;GDB )DC-E>A:EI>8
K:CIH: A 1>9:D-C6H: D>H8JHH>DC* $ CDBB>II:: -DDB 4
___________________________________________________________________________________________
D.-/-05: 2DB:C AG: !GDB 1:CJH 6C9 (:C AG: !GDB (6GH* $ CDBB>II:: -DDB 5
___________________________________________________________________________________________
D.-/-06: C6C 2: +G:K:CI *.A?* $ CDBB>II:: -DDB 6
___________________________________________________________________________________________
D.-/-07: C=GDCD7>DAD<N/C>G869>6C D>HDG9:GH* $ CDBB>II:: -DDB 7
___________________________________________________________________________________________
D.-/-08: .A::E BGJM>HB : D>6<CDHI>8 6C9 /=:G6E:JI>8 AEEGD68=:H !GDB 6 (JAI>9>H8>EA>C6GN
+D>CI D; 1>:L* $ CDBB>II:: -DDB 8
___________________________________________________________________________________________
D.-/-09: B:G<>C< $C9>6 6C9 $IH .A::E $HHJ:H* $ CDBB>II:: -DDB 9
___________________________________________________________________________________________
D.-/-10: CDCIGDK:GH>:H >C -'. L>I= +'(H: .><C>;>86C8:, .A::E, C1 ->H@** $ AJ9>IDG>JB 3
*/>8@:I G:FJ>G:9 - EJG8=6H: 6I G:<>HIG6I>DC 9:H@ **!G:: HNBEDH>6 - E>8@ JE NDJG I>8@:I 6I G:<>HIG6I>DC 9:H@
_____________________________________________________________________________________________________________________
8:30EB ID 9:30EB 2A.( (:B7:G (::I>C< $ (JAI>EJGEDH: -DDB 1
2:9C:H96N, *8ID7:G 2, 2013
7:006B - 7:00EB *C-.>I: -:<>HIG6I>DC
_____________________________________________________________________________________________________________________
9:006B - 10:006B &:NCDI:: .JG<:GN D; *7HIGJ8I>K: .A::E AEC:6 Demin Han, MD, PhD $ AJ9>IDG>JB 1
10:006B - 11:306B .24: /=: C=6AA:C<:H ;DG D:;>C>C< )DGB6I>K: D6I6 ;DG .A::E D>HDG9:G:9 BG:6I=>C< A8GDHH
'>;:HE6C $ AJ9>IDG>JB 2
17
+GD<G6B 6I 6 "A6C8:
2:9C:H96N, *8ID7:G 2, 2013 8DCI>CJ:9
.25: #NED8G:I>C/DG:M>C 6H 6 /=:G6E:JI>8 /6G<:I ;DG .A::E D>HDG9:GH $ AJ9>IDG>JB 3
___________________________________________________________________________________________
.26: .E>C6A (:8=6C>HBH >C -'. $ CDBB>II:: -DDBH 1 6C9 2
___________________________________________________________________________________________
.27: $9>DE6I=>8 #NE:GHDBC>6: +6HI, +G:H:CI 6C9 !JIJG: $ (JAI>EJGEDH: -DDB 1
11:306B - 12:00EB CD;;:: BG:6@ 6C9 M=>7>I>DC
12:00EB - 1:30EB .28: D:CI6A (6C6<:B:CI D; *.A >C A9JAIH 6C9 C=>A9G:C $ (JAI>EJGEDH: -DDB 1
___________________________________________________________________________________________
.29: )6G8DA:EHN 0E96I: $ AJ9>IDG>JB 2
___________________________________________________________________________________________
.35: 4DJC< $CK:HI><6IDG .NBEDH>JB: .A::E 6C9 ):JGD9:<:C:G6I>DC $ AJ9>IDG>JB 1
___________________________________________________________________________________________
*-11: +:9>6IG>8H .DB $ AJ9>IDG>JB 3
___________________________________________________________________________________________
/:8=CDAD<>HI +GD<G6B: 25 -( 6C9 .ADL 26K: +6G6HDBC>6H: 1>9:D 6C9 +." $9:CI>;>86I>DC
CDBB>II:: -DDBH 3 6C9 4
_____________________________________________________________________________________________________________________
1:40EB - 3:10EB .34: %D>CI .NBEDH>6 L>I= 2A.( 6C9 $!C) $ AJ9>IDG>JB 2
1:40EB - 2:40EB #:C>C< (:BDG>6A ':8IJG:: ):JGD9:<:C:G6I>DC 6C9 .A::E Isabelle Arnulf $ AJ9>IDG>JB 1
3:10EB - 3:30EB CD;;:: BG:6@ 6C9 M=>7>I>DC
3:30EB - 4:30EB &:NCDI:: ":C:I>8H 6C9 E><:C:I>8H D; .A::E D>HDG9:GH Mehdi Tafti, PhD $ AJ9>IDG>JB 1
4:30EB - 5:30EB *-13: +6G6HDBC>6 6C9 +HN8=>6IG>8 D>HDG9:GH $ CDBB>II:: -DDB 1
___________________________________________________________________________________________
*-14: -'./+'(.: )6IJG6A CDJGH:, ->H@ !68IDGH 6C9 #:6AI= $ AJ9>IDG>JB 3
___________________________________________________________________________________________
*-15: .A::E 6C9 #:6AI= $ (JAI>EJGEDH: -DDB 1
_____________________________________________________________________________________________________________________
5:30EB - 7:00EB .30: 0H>C< I=: D>B '><=I (:A6IDC>C *CH:I (D'(*) ID K6AJ6I: C>G869>6C />B>C< >C CA>C>86A
+DEJA6I>DCH $ (JAI>EJGEDH: -DDB 1
___________________________________________________________________________________________
.31: .A::E (>8GDHIGJ8IJG:, AGDJH6AH 6C9 AJIDCDB>8 !JC8I>DCH: ):L $CH><=IH 6C9 CA>C>86A
$BEA>86I>DCH $ AJ9>IDG>JB 3
___________________________________________________________________________________________
.32: *7:H>IN 6C9 .A::E AEC:6 >C C=>A9G:C $ AJ9>IDG>JB 2
___________________________________________________________________________________________
.33: %D>CI .NBEDH>6 D; 2A.( 6C9 .+A- $ AJ9>IDG>JB 1
___________________________________________________________________________________________
/:8=CDAD<>HI +GD<G6B: 26 A8I><G6E=N (6HI:G8A6HH:FJ>EB:CI, .:I JE, -:H:6G8= 0H6<:, CA>C>86A
$CI:GEG:I6I>DC $ CDBB>II:: -DDBH 3 6C9 4
___________________________________________________________________________________________
*-16: DGJ<H, /:8=CDAD<N, 6C9 $CHJ;;>8:CI .A::E $ CDBB>II:: -DDB 1
7:00EB - 7:45EB CADH>C< C:G:BDCN $ AJ9>IDG>JB 2

Second Floor:
- Pre-Congress Courses
- Poster Presentations
- Discussion Symposia
- Technologist Program
- Committee Rooms 1-7
First Floor:
- Pre-Congress Courses
- Symposia
- Committee Rooms 8 and 9
Ground Floor:
- Exhibitor Booths
- Registration
- Closing Ceremony
- Industry Symposia
- Keynote Lectures
- Symposia
- Cofee Breaks
- WASM Member Lounge
- WASM Membership Info
- Speaker Ready Room
8
9
1
2
6
5
4
3
7
Posters
+6A68>D 9: CDC<G:HDH 16A:C8>6 - !ADDG +A6C
18
19
.6IJG96N
.8=:9JA: 6I 6 "A6C8: .6IJG96N, .:EI:B7:G 28, 2013
_________________________________________________________________
-:<>HIG6I>DC 7:006B - 9:00EB
_________________________________________________________________
CDJGH: 1: D:CI6A G:8DC;><JG6I>DC 6C9 G:8DCHIGJ8I>DC ;DG .DB B6C6<:B:CI 8:006B - 5:00EB
_________________________________________________________________
CDJGH: 3: (:9>86A IG:6IB:CI D; .DB P 7:NDC9 C6H6A EDH>I>K: EG:HHJG: 8:006B - 12:00EB
_________________________________________________________________
$CI:GC6I>DC6A -'. .IJ9N "GDJE (::I>C< 9:006B - 6:45EB
_________________________________________________________________
CDJGH: 4: C>G869>6C 9NH;JC8I>DC >C =:6AI= 6C9 9>H:6H: 1:00EB - 5:00EB
_________________________________________________________________
20
.6IJG96N, .:EI:B7:G 28, 2013
CDJGH: 1: D:CI6A -:8DC;><JG6I>DC 6C9 -:8DCHIGJ8I>DC ;DG
.DB (6C6<:B:CI
8:006B ID 5:00EB CDBB>II:: -DDB 6
C=6>G:
Gilles Lavigne (Canada)
.E:6@:GH:
Raphael Heinzer (Switzerland), Stacey Quo (USA), Marc Blumen (France), Marie Marklund (Sweden),
Gilles Lavigne (Canada), Christian Guilleminault (USA), Bernard Fleury (France)
.JBB6GN:
Tis course will provide a comprehensive and integrated management approach of orodental approaches to sleep apnea
management. Topics will span the normal and abnormal development of the face and dental structures, measurement
approaches including radiology, device biomechanics, devices, rapid maxillary expansion, distraction osteogenesis and
related procedures, clinical outcomes and the role for a multi-disciplinary management of challenging cases. Te course
will also review the diagnostic and polysomnographic criteria for sleep-disordered-breathing in adults and children,
and review the state of the art approaches when using dental devices as treatment of OSA, and results of follow-up.
Maxillo-mandibular advancement in teen-agers and adults, and an update on myofunctional therapy will be provided.
*K:GK>:L DC HA::E 9>HDG9:G:9 7G:6I=>C< (.DB) 6C9 9:CI>HIGN GDA:
Raphael Heinzer (Switzerland)
-:8D<C>I>DC D; 8=>A9G:C 6C9 NDJC< 69JAI L>I= .DB >C 9:CI6A B:9>8>C:
Stacey Quo (USA)
CG6C>D;68>6A <GDLI= 6C9 .DB G>H@
Marc Blumen (France)
*GI=D9DCI>8 IG:6IB:CI >C 8=>A9G:C 6C9 69JAI L>I= .DB: >C9>86I>DCH 6C9 G>H@H
Marie Marklund (Sweden)
DD .DB 6C9 HA::E 7GJM>HB =6K: 6 A>C@? A 8A>C>86A >BEG:HH>DC DG HJEEDGI:9 7N :K>9:C8:H
(ND;JC8I>DC6A G:-:9J86I>DC 6H 6C >CI:G8:EI>K: 6AI:GC6I>K: ;DG .DB EG:K:CI>DC 6C9 B6C6<:B:CI
A9K6C8:H >C DG6A 6EEA>6C8:H JH: 6C9 B>HJH:H: AC JE96I:
Bernard Fleury (France)
ACCDJC8:B:CI:
CDJGH: 2 86C8:AA:9
21
.
A
/
0
-
D
A
4
.6IJG96N, .:EI:B7:G 28, 2013
CDJGH: 3: (:9>86A /G:6IB:CI D; .DB P B:NDC9 )6H6A
+DH>I>K: +G:HHJG:
C=6>G:
Robert Thomas (USA)
.E:6@:GH:
David Rapoport (USA), Jed Black (USA), Carmen Monasterio Ponsa (Spain), Robert Tomas (USA)
.JBB6GN:
Te course will discuss options for sleep apnea management outside traditional mask-positive pressure approaches
but not including reconstructive surgery or oral appliances. Topics that should be covered include nasal expiratory
resistance, hypoglossal nerve stimulation, weight loss including bariatric surgery, and gas/pharmacological options
based on sleep apnea phenotyping for arousability and chemorefex instability.
)6H6A :ME>G6IDGN EDH>I>K: EG:HHJG:
David Rapoport (USA)
*G6A EG:HHJG: (2>CM)
Jed Black (USA)
BD9N B6HH G:<JA6I>DC ;DG HA::E 6EC:6 IG:6IB:CI
Carmen Monasterio Ponsa (Spain)
"6HH:H 6C9 9GJ<H
Robert Tomas (USA)
22
.
A
/
0
-
D
A
4
.6IJG96N, .:EI:B7:G 28, 2013
CDJGH: 4: C>G869>6C DNH;JC8I>DC >C #:6AI= 6C9 D>H:6H:
1:00EB ID 5:00EB CDBB>II:: -DDB 4
CD-C=6>GH:
Till Roenneberg (Germany), Phyllis C. Zee (USA)
.E:6@:GH:
Till Roenneberg (Germany), Phyllis C. Zee (USA), Diane Boivin (Canada), Robert Thomas (USA)
.JBB6GN:
Following an update on circadian phototransduction, the role of the circadian system in whole-body regulation of core
processes (including metabolism, endocrine and cardiovascular regulation) will be discussed. Next, an update on shift
work and counter measures will be presented, followed by performance in conditions requiring sustained attention and
executive function (including transportation, health care personnel, and military operations). Methods to assess sleep
debt and prediction of performance deterioration will be discussed.
1:00pm - 1:10pm
$CIGD9J8I>DC
Till Roenneberg (Germany)
1:10pm - 1:40pm
-:<JA6I>DC D; 8>G869>6C G=NI=BH: HA::E 6C9 7:NDC9
Phyllis C. Zee (USA)
1:40pm - 2:10pm
.A::E 6C9 8>G869>6C G:<JA6I>DC D; B:I67DA>HB
2:10pm - 2:45pm
C>G869>6C G=NI=B >C;AJ:C8:H DC E=NH>DAD<N 6C9 EHN8=DAD<N
Diane Boivin (Canada)
2:45pm - 2:55pm
BG:6@
2:55pm - 3:35pm
/=: 8DCH:FJ:C8:H D; A>K>C< 6<6>CHI I=: 8>G869>6C 8AD8@
Till Roenneberg (Germany)
3:35pm - 4:15pm
C>G869>6C 9>HDG9:GH >C 9>H:6H:
4:15pm - 4:50pm
C=6AA:C<>C< 8>G869>6C G=NI=B 9>HDG9:G 86H:H
Robert Thomas (USA)
4:50pm - 5:00pm
+6C:A 9>H8JHH>DC 6C9 FJ:HI>DCH
23
.
A
/
0
-
D
A
4
.6IJG96N, .:EI:B7:G 28, 2013
$CI:GC6I>DC6A -'. .IJ9N "GDJE ACCJ6A (::I>C<
8:00:am - 9:00am
-:<>HIG6I>DC 6C9 C:ILDG@>C<
9:00am - 9:15am
2:A8DB: & >CIGD9J8I>DC
9:15am 12:15pm AC>B6A BD9:AH >C -'.
(each 15 min talk + 5 min discussion)
9:15am C=6AA:C<: 6C9 EGD7A:BH D; -'. 6C>B6A BD9:A R. Allen
9:35am )6IJG6A <:C:I>8 K6G>6I>DC BJG>C: >GDC 9:;>8>:C8N BD9:A C. Earley
9:55am +:G>D9>8 A>B7 BDK:B:CIH >C GD9:CIH M. Manconi
10:15am DGDHDE=>A6 =DBDAD< C"1826 (9B/BD9) A. Freeman
10:35am CD;;:: 7G:6@
10:55am A11 A:H>DCH >C GD9:CIH A. M. Esteves
11:15am (DJH: 6C9 LDGB BD9:AH D; -'.: ;D8JH DC B/BD9 Y. Li
11:35am AJIDCDB>8 C:GKDJH HNHI:B BD9:A B. Koo
11:55am +'( BD9:A: E6I=L6NH 6C9 <AJI6B6I: B:8=6C>HBY. Lai
12:15 'JC8=
1:15pm 2:45pm 26NC: #:C>C< 4$ AL6G9H
(each 8 min talk + 3 min discussion)
1:15pm ):JGDE=NH>DAD<>86A :K6AJ6I>DC D; HE>C6A :M8>I67>A>IN >C E6I>:CIH 6;;:8I:9 7N EG>B>I>K:
-:HIA:HH ':<H .NC9GDB: Patrizia Congiu
1:26pm +/+-D MEG:HH>DC G:<JA6I:H HA::E 8DCHDA>96I>DC >C 9GDHDE=>A6 Amanda Freeman
1:37pm -:HIA:HH A:<H HNC9GDB: 6C9 >IH 6HHD8>6I>DC L>I= EDDG HA::E FJ6A>IN, BDD9 9>HDG9:GH,
6C9 DC: N:6G 86G9>DK6H8JA6G BDGI6A>IN >C E6I>:CIH DC 8=GDC>8 9>6ANH>H Ali Gholamrezaei
1:48pm -:;A:M I:HI>C< G:K:6AH 8>G869>6C K6G>6I>DC D; HE>C6A :M8>I67>A>IN >C G:HIA:HH
A:<H HNC9GDB: E6I>:CIH Samantha Kerr
1:59pm -:HIA:HH A:< HNC9GDB: >C NDJC< 8=>A9G:C L>I= DGD;68>6A 8A:;I Marta MoraledaCibrin
2:10pm +:G>D9>8 A:< BDK:B:CIH >C HE>C6A 8DG9 >C?JGN: K6AJ6I>DC D; 6GDJH6AH 6C9
IG:6IB:CI :;;:8I Aaro Salminen
2:21pm (JAI>BDG7>9>IN 6C9 I=: G>H@ D; G:HIA:HH A:<H HNC9GDB: >C ILD EGDHE:8I>K:
8D=DGI HIJ9>:H Andras Szentkiralyi
2:32pm +DANHDBCD<G6E=>8 :K6AJ6I>DC D; 6J<B:CI6I>DC >C E6I>:CIH L>I= G:HIA:HH
A:<H HNC9GDB: Irina Zavalko
2:45pm AG: 9GJ< =DA>96NH C::9:9? C. Earley & C. Trenkwalder
3:15pm CD;;:: 7G:6@
3:35pm +'( 6C9 6EC:6 S. Fulda
3:55pm /=: :8DCDB>8 8DHI D; -'.. A HIJ9N >C D:CB6G@ P. Jennum
4:15pm 'DC<-I:GB HIJ9>:H >C -'.: AG: 68I>K: 8DBE6G6IDGH 9>HE:CH67A:? R. Allen, DGB, & R.Kohnen
4:45pm !JIJG: HIJ9>:H HEDCHDG:9 7N I=: $-'.." D. GarciaBorreguero
5:00pm !>C6A G:B6G@H - :C9 D; H8>:CI>;>8 B::I>C<
5:15pm 6:45pm $-'.." BJH>C:HH (::I>C< - DE:C ID $-'.." B:B7:GH=>E
8:00pm - 8:30pm -:8:EI>DC
8:30pm - 9:30pm D>CC:G
9:30pm - +G:H:CI6I>DC D; AL6G9H
24
.
A
/
0
-
D
A
4
25
.
A
/
0
-
D
A
4
.JC96N
.8=:9JA: 6I 6 "A6C8: .JC96N, .:EI:B7:G 29, 2013
_________________________________________________________________
-:<>HIG6I>DC 7:006B - 9:00EB
_________________________________________________________________
CDJGH: 5: A9K6C8:H >C I=: B6C6<:B:CI D; E:9>6IG>8 HA::E 9>HDG9:GH 8:006B - 5:00EB
_________________________________________________________________
CDJGH: 6: -:HIA:HH A:<H 6C9 BDIDG 68I>K6I>DC 9JG>C< HA::E 8:006B - 12:00EB
_________________________________________________________________
CDJGH: 7: $CHDBC>6 9>HDG9:G: !GDB :E>9:B>DAD<N ID 9>HH:B>C6I>DC D;
:K>9:C8:-76H:9 I=:G6E:JI>8 6EEGD68=:H 8:006B - 12:00EB
_________________________________________________________________
.E6C>H= .A::E .D8>:IN (::I>C< 8:306B - 4:30EB
_________________________________________________________________
/:8=CDAD<>HI +GD<6B 9:006B - 5:00EB
_________________________________________________________________
CDJGH: 8: 0E96I: >C HA::E B:9>8>C: I:8=CDAD<N 1:00EB - 5:00EB
_________________________________________________________________
CDJGH: 9: .A::E 6C9 I=: =:6GI 1:00EB - 5:00EB
_________________________________________________________________
CDJGH: 10: -:8DG9>C< 6C9 H8DG>C< D; BDK:B:CI 9>HDG9:GH D; HA::E 6C9 -BD 1:00EB - 5:00EB
_________________________________________________________________
*E:C>C< C:G:BDCN 7:00EB -10:00EB
_________________________________________________________________
26
.
0
)
D
A
4
.JC96N, .:EI:B7:G 29, 2013
CDJGH: 5: A9K6C8:H >C I=: (6C6<:B:CI D; +:9>6IG>8 .A::E D>HDG9:GH
CD-C=6>GH:
Shelly Weiss (Canada), Daniel Ng (Hong Kong)
.E:6@:GH:
Rosana Cardoso Alves (Brazil), Oliviero Bruni (Italy) Christian Guilleminault (USA); Sanjeev Kothare (USA); Oscar
Sans Capdevila (Spain) Daniel Ng (Hong Kong); Shelly Weiss (Canada)
*7?:8I>K:H:
Review sleep disordered breathing that occur from neonates to adolescence, and understand their management strategies.
Understand the differences in the interpretation of neonatal vs pediatric vs. adult polysomnography.
Understand the role of pharmacotherapy in the treatment of pediatric insomnia.
Review and update knowledge on pediatric sleep disorders in diverse medical conditions (mental health disorders, epilepsy)
and its impact on neurobehavior
.JBB6GN:
The course will cover the spectrum of pediatric sleep disorders, with a focus on what is unique in children. Topics will
include (sleep abnormalities and management in) epilepsy, neuromuscular disorders, developmental disorders, and disorders
of attention. Other topics will include the normal development of sleep, sleep apnea including systemic effects and the possible
role of home testing is resource poor environments. Pediatric aspects of polysomnography will be discussed.
8:00am - 8:15am
$CIGD9J8I>DC
8:15am - 12:00pm
+:9>6IG>8 .A::E D>HDG9:G:9 BG:6I=>C<
+DANHDBCD<G6E=N >C +6:9>6IG>8H: 0E96I: DC H8DG>C< E:9>6IG>8 HA::E HIJ9>:H
Oscar Sans Capdevila (Spain)
):DC6I6A .A::E +DANHDBCD<G6E=N 6C9 :C9DH8DEN: $C9>86I>DCH 6C9 >CI:GEG:I6I>DC HIG6I:<>:H
Daniel Ng (Hong Kong)
K6AJ6I>DC D; HA::E-9>HDG9:G:9 7G:6I=>C< >C 8=>A9G:C; >CI:GEG:I>C< 96I6 ;GDB C6H6A G:H>HI6C8:
6C9 ;ADL A>B>I6I>DC B:6HJG:H
+6C:A: C6H: 9>H8JHH>DCH
The panel will present cases related to sleep disordered breathing in pediatrics including review of the limitation of
adenotonsillectomy, home vs laboratory investigations, issues related to home ventilation and SDB in children with
neuromuscular disorders.
Oscar Sans Capdevila (Spain), Daniel Ng (Hong Kong), Christian Guilleminault (USA)
12:00pm - 1:15pm
'JC8=
1:15pm - 5:00pm
.A::E, $CHDBC>6 6C9 D6NI>B: .A::E>C:HH
/G:6IB:CI D; >CHDBC>6 >C INE>86AAN 9:K:ADE>C< >C;6CIH 6C9 8=>A9G:C
Oliviero Bruni (Italy)
/G:6IB:CI D; >CHDBC>6 >C 8=>A9G:C 6C9 I::C6<:GH L>I= AJI>HB .E:8IGJB D>HDG9:GH- B:=6K>DJG6A
6C9 E=6GB68DAD<>8 HIG6I:<>:H
Shelly Weiss (Canada)
+:9>6IG>8 .A::E 6C9 E>A:EHN- 0E96I: DC I=: :K6AJ6I>DC 6C9 B6C6<:B:CI D; 8=>A9G:C L>I=
CD8IJGC6A H:>OJG:H
Sanjeev Kothare (USA)
M8:HH>K: 96NI>B: HA::E>C:HH 6C9 C6G8DA:EHN
Rosana Cardoso Alves (Brazil)
+6C:A: C6H: 9>H8JHH>DCH
The panel will present cases related to insomnia in children with neurologic and mental health disorders, including
ADHD, depression, epilepsy, and headaches.
Oliviero Bruni (Italy), Shelly Weiss (Canada), Sanjeev Kothare (USA)
Note: Participants who register for this course will have the opportunity (optional) to submit pediatric cases for the panel to
present and discuss.
27
.
0
)
D
A
4
.JC96N, .:EI:B7:G 29, 2013
CDJGH: 6: -:HIA:HH ':<H 6C9 (DIDG A8I>K6I>DC DJG>C< .A::E
C=6>G:
Richard P Allen (USA)
.E:6@:GH:
Diego Garcia Borreguero (Spain), Stephany Fulda (Germany), Raffaele Ferri (Italy),
Richard P Allen (USA), Christopher Earley (USA), Arthur Walters (USA)
*7?:8I>K:H:
How and when to use the expanded treatment options for RLS particularly for iron (oral and IV), opioids and drug holidays
How to plan treatments to reduce RLS augmentation risks
How to change or adjust RLS medications
Measurement options for periodic limb movements using physiological recordings or ambulatory leg activity monitoring
Methods to evaluate daytime symptoms of RLS including the use of the multiple suggested immobilization test
.JBB6GN:
The course will provide a targeted update. Topics covered will include augmentation, new medical options, epidemiology
and diagnostic approaches / criteria including the Suggested Immobilization Test and neuroimaging, and instrumentation.
Speakers will review and update the relevant basic science so that recommendations for practice are grounded on the best
current science.
$CIGD9J8I>DC
ME6C9:9 :K6AJ6I>DC B:I=D9H:
(:I=D9H ID :K6AJ6I: 96N I>B: HNBEIDBH
Diego Garcia Borreguero (Spain)
(:6HJG>C< E:G>D9>8 A:< BDK:B:CIH DC I=: EDANHDBCD<G6B: CJGG:CI HI6C96G9H 6C9 EGD7A:BH
Stephany Fulda (Germany)
(:6HJG>C< E:G>D9>8>IN D; A:< BDK:B:CIH
Raffaele Ferri (Italy)
ME6C9:9 IG:6IB:CI DEI>DCH:
#DB: 68I>K>IN BDC>IDG>C< D; E:G>D9>8 A:< BDK:B:CIH
-:9J8>C< 6J<B:CI6I>DC G>H@H: 'DC< I:GB IG:6IB:CI <J>9:A>C:H
$GDC IG:6IB:CIH: DG6A 6C9 $1
Christopher Earley (USA)
*E>D>9 IG:6IB:CIH: *EI>DCH ID 8DCH>9:G
Arthur Walters (USA)
DGJ< =DA>96NH
Richard P Allen, PhD (USA)
-:HEDC9>C< ID 6J<B:CI6I>DC: AAI:GC6I: 6EEGD68=:H
Christopher Earley (USA)
D>H8JHH>DC: /G:6IB:CI 8=6AA:C<:H
Faculty
28
.
0
)
D
A
4
.JC96N, .:EI:B7:G 29, 2013
CDJGH: 7: $CHDBC>6 D>HDG9:G: !GDB E>9:B>DAD<N ID D>HH:B>C6I>DC
D; K>9:C8:-B6H:9 /=:G6E:JI>8 AEEGD68=:H
C=6>G:
.E:6@:GH:
Yun-Kwok Wing (Hong Kong), Jack Edinger (USA), Ruth Benca (USA), Charles Morin (Canada),
Leon Lacks (Australia), Rachel Manber (USA), Colin Espie (UK)
.JBB6GN:
Insomnia is a common complaint in clinical practice and it can pose a significant challenge both at the diagnostic and therapeutic
levels. This course will present an overview of the epidemiology of insomnia and its burden on mental, physical, and occupational
health. It will then summarize recent diagnostic updates and present the most up-to-date evidence on current therapeutic options
for the management of insomnia, including cognitive-behavioral, pharmacological, and bright light therapies. Clinical guidelines
for the management of insomnia comorbid with medical and psychiatric disorders will be discussed, as well as dissemination and
practical treatment implementation issues.
E>9:B>DAD<N 6C9 EJ7A>8 =:6AI= 7JG9:C D; >CHDBC>6
Yun-Kwok Wing (Hong Kong)
$CHDBC>6 9>6<CDHI>8 JE96I:H: D.(-5 6C9 $C.D-3
Jack Edinger (USA)
):JGD7>DAD<N 6C9 E=6GB68DAD<>86A B6C6<:B:CI D; >CHDBC>6
Ruth Benca (USA)
CD<C>I>K: 7:=6K>DG6A I=:G6E>:H ;DG >CHDBC>6
C>G869>6C ;68IDGH 6C9 7G><=I A><=I I=:G6EN
Leon Lacks (Australia)
CA>C>86A B6C6<:B:CI D; 8DBDG7>9 >CHDBC>6
Rachel Manber (USA)
D>HH:B>C6I>DC 6C9 EG68I>86A >BEA:B:CI6I>DC >HHJ:H
Colin Espie (UK)
29
.
0
)
D
A
4
.JC96N, .:EI:B7:G 29, 2013
+GD<G6B6 %DGC696 .E6C>H= .A::E .D8>:IN (..)
8:306B ID 4:30EB #DI:A .:G8DI:A .DGDAA6 +6A68:
8:30am - 8:45am
$CIGD9J8I>DC
8:45am - 10:00am
.:H>C 1. CDBJC>868>DC:H *G6A:H
Moderadores: Miguel ngel Martnez (Valencia), Irene Cano (Madrid)
A C:L K>7G6IDGN EDHIJG6A 9:K>8: ;DG I=: IG:6IB:CI D; EDH>I>DC6A *7HIGJ8I>K: .A::E AEC:6
(*.A). A E>ADI HIJ9N. Joaquin Durn - Cantolla
C>G8JA6I>C< !AB+4 6C9 HJ78A>C>86A AI=:GDH8A:GDH>H >C *7HIGJ8I>K: .A::E AEC:6
.NC9GDB:. Raquel Catal
*7?:8I>K: :K6AJ6I>DC D; -'. 96NI>B: HNBEIDBH 7N B:6CH D; I=: (JAI>EA: .J<<:HI:9
$BBD7>A>O6I>DC /:HI (B-.$/) Domingo Snchez Ruiz
)6G8DA:EHN 6C9 D9DJG: +G:A>B>C6GN -:EDGI. Luis Dominguez Ortega
$BE68I D; 9>6<CDH>H 6C9 IG:6IB:CI D; *7HIGJ8I>K: .A::E AEC:6 .NC9GDB: (*.A.) L>I=
)DC-$CK6H>K: 1:CI>A6I>DC ()$1). Vanessa Ferreira
10:00am - 10:15am
+6JH6 C6;
10:15am - 11:45am
.:H>C +HI:GH
.:H>C 1.
Moderadores: Eduard Esteller (Barcelona), Juan Jos Poza (San Sebastin)
.:H>C 2.
Moderadores: Carlos Egea (Vitoria-Gasteiz), Enriqueta Gmez Siurana (Valencia)
11:45am-1:00pm
.:H>C 2. CDBJC>868>DC:H *G6A:H
Moderadores: Juan Jos Ortega (Castelln), M Jos Jurado (Barcelona)
+6GI>6A G:H:8I>DC D; I=: 76H: D; I=: IDC<J: L>I= =6GBDC>8 H86AE:A: A EGDB>H>C< 6JG<>86A
6EEGD68= ;DG HA::E 6EC:6.
*G6A AEEA>6C8:H >C D7HIGJ8I>K: HA::E 6EC:6 HNC9GDB:: DJG :ME:G>:C8:. Mercedes Martn Romero
(:I67DADB>8 ;>C<:GEG>CI>C< 6EEGD68= ID HA::E 6EC:6 9>HDG9:G >C =JB6C EA6HB6. Teresa Gmez Garca
0I>A>IN D; HA::E HIJ9N >C 8=>A9G:C L>I= A6GNC<DB6A68>6. Rogelio Peralta Lepe
-:HIA:HH A:<H HNC9GDB: >C EG:<C6C8N. Paula Gimnez
1:00pm-2:30pm
'JC8= .>BEDH>JB: HI69D 68IJ6A N 8DCIGDK:GH>6H 9: ADH IG6HIDGCDH 9:A HJ:D :C ADH C>DH N
69DA:H8:CI:H: 0C6 K>H>C BJAI>9>H8>EA>C6G
Moderadores: Oscar Sans (Barcelona), Teresa Canet (Alcoy, Alicante)
HI69D 68IJ6A 9:A 9>6<CHI>8D N IG6I6B>:CID 9: A6 C6G8DA:EH>6 :C C>DH
N 69DA:H8:CI:H Milagros Merino (Madrid)
HI69D 68IJ6A 9:A 9>6<CHI>8D N IG6I6B>:CID 9:A .A#. :C C>DH N 69DA:H8:CI:H M Luz Alonso (Burgos)
HI69D 68IJ6A 9:A 9>6<CHI>8D N IG6I6B>:CID 9:A .+$ :C C>DH N 69DA:H8:CI:H Vctor Soto (Madrid)
+G:<JCI6H N 9>H8JH>C
2:30pm-4:30pm
AH6B7A:6 ":C:G6A 9: A6 ..
30
.JC96N, .:EI:B7:G 29, 2013
/:8=CDAD<>HI +GD<G6B
9:006B ID 5:00EB CDBB>II:: -DDBH 1 6C9 2
CD-C=6>GH:
Simone de Lacy (Spain), Lizzie Hill (UK), Maxine Elbaz (France)
.E:6@:GH:
Dirk Pevernagie (Belgium), Lizzie Hill (UK), Elena Diaz (Spain), Andrew Morley (UK),
Irma van Velzen (Te Netherlands), Simone de Lacy (Spain), Sebastiaan Overteem (Belgium), Maxime Elbaz (France),
Sarah Keane (Ireland), Montemayor (France), Quera (France),
9:15am - 10:00am
&:NCDI:: ):L 9>6<CDHI>8 I:8=C>FJ:H 6C9 I=: GDA: D; HDJC9 G:8DG9>C< >C *.A
Dirk Pevernagie (Belgium)
10:00am - 10:30am
AA.( H8DG>C< B6CJ6A K:GH>DC 2.0- ):L GJA:H
Lizzie Hill (UK)
10:30am - 11:00am
#DB: K:GHJH A67 76H:9 HA::E HIJ9>:H
Elena Diaz (Spain)
11:00am - 11:30am
CD;;:: BG:6@
11:30am - 12:00pm
!JC96B:CI6A 9>;;:G:C8:H 7:IL::C E6:9>6IG>8 & 69JAI HA::E
Andrew Morley (UK)
12:00pm - 12:30pm
)D8IJGC6A .:>OJG:H: EG:H:CI6I>DC >C I=: .A::E '67
Irma van Velzen (Te Netherlands)
12:30pm - 1:00pm
+." 6C9 (:9>86I>DC ;;:8IH
Simone de Lacy (Spain)
1:00pm - 2:00pm
'JC8= BG:6@
2:00pm - 2:30pm
.A::E 6C9 .A::E D>HDG9:GH >C +6G@>CHDC'H D>H:6H:
Dr. Sebastiaan Overeem (Te Netherlands)
2:30pm - 3:00pm
16A>96I>DC D; 6 C:L A8I><G6E= (DI>DC26I8= K:GHJH +DANHDBCD<G6E=N
Maxime Elbaz (France)
3:00pm - 3:30pm
)6G8DA:EHN 6C9 #1)1 1688>C:
Sarah Keane (Ireland)
3:30pm - 4:00pm
CD;;:: BG:6@
4:00pm - 4:30pm
.A::E 6C9 A<>C<
Dr Montemayor (France)
4:30pm - 5:00pm
(:A6IDC>C 6C9 D:EG:HH>DC
Dr Quera (France)
31
.
0
)
D
A
4
.
0
)
D
A
4
.JC96N, .:EI:B7:G 29, 2013
CDJGH: 8: 0E96I: >C .A::E (:9>8>C: /:8=CDAD<N
C=6>G:
Tomas Penzel (Germany)
.E:6@:GH:
Thomas Penzel (Germany), Josep M Montserrat (Spain), Robert Thomas (USA), Ramon Farre (Spain)
*7?:8I>K:H:
Management of sleep disorders with comprehensive sleep centers, sleep centers, dedicated sleep labs, and
sleep medicine practice
Diagnostic tools with cardiorespiratory polysomnography, portable sleep monitoring, single channel systems
for sleep disorders
Innovative internet tools and telemedicine approaches
Signal processing to assess physiology and pathology of sleep
Cardiopulmonary coupling basics and applications
Modes of ventilation and their application
.JBB6GN:
The course will update participants on cutting edge diagnostic and therapeutic advances, including expanded
compliance / adherence tracking, and ventilation for non-classic sleep-disordered breathing syndromes (adaptive
ventilation, volume target pressure ventilation, neuromuscular disorders), and novel sleep tracking devices.
The course will present management basics from the comprehensive sleep center with all possibilities down to dedicated sleep
labs for specific disorders and to sleep physicians outside a sleep center. This includes the diagnostic tools from cardiorespiratory
polysomnography and portable sleep apnea diagnostic methods up to single channel tools for sleep apnea or insomnia
quantification. The course will present new internet methods and their use for diagnostic and therapeutic monitoring. This is of
high impact when coping with limited economic resources. Cardiopulmonary coupling is a method to investigate stable and
unstable sleep. This allows to quantify the impact of sleep disordered breathing as well as to quantify other sleep disorders such
as insomnia. Today new therapeutic modalities of ventilation are presented in order to improve therapy adherence. Some
ventilation modes mimic physiological breathing. Their application is presented and their impact on therapy adherence as well.
(6C6<:B:CI D; HA::E 9>HDG9:G:9 7G:6I=>C< JH>C< 9>;;:G:CI 9>6<CDHI>8 IDDAH >CH>9: 6C9
DJIH>9: I=: HA::E 8:CI:G
Thomas Penzel (Germany)
$CCDK6I>K: >CI:GC:I IDDAH ;DG I=: 9>6<CDH>H 6C9 I=:G6E:JI>8 8DCIGDA D; G:HE>G6IDGN HA::E 9>HDG9:GH
Josep M Montserrat (Spain)
C6G9>DEJABDC6GN 8DJEA>C< H:GK:H 6H 6 B6G@:G ;DG JCHI67A: HA::E
Robert Thomas (USA)
/=:G6E:JI>8 69K6C8:H L>I= C:L BD9:H D; K:CI>A6I>DC ;DG G:HE>G6IDGN EGD7A:BH 9JG>C< HA::E
Ramon Farre (Spain)
32
33
.
0
)
D
A
4
.JC96N, .:EI:B7:G 29, 2013
CDJGH: 9: .A::E 6C9 I=: #:6GI
CD-C=6>GH:
Robert Tomas (USA), Virend Somers (USA)
.E:6@:GH:
Virend Somers (USA), Jean Louis Pepin (Belgium), Winfried Randerath (Germany)
D:H8G>EI>DC
The course will provide a comprehensive update on hypoxia biology, the interaction of sleep and sleep apnea with
cardiovascular and autonomic regulation, including arrhythmogenesis, myocardial function, stroke and vascular dysfunction.
.JBB6GN:
The interactions of sleep with the cardiovascular system have been of interest to a wide range of clinicians and researches for
decades. If manipulation of sleep can modify cardiovascular risk, the implication for individual and population health are
large. The bidirectional relationships are now the focus of major multi-center and multi-national clinical trials. This course
will provide a summary of much of the clinical science in the area, including relationships to hypertension, congestive heart
failure, sympathetic system activity, endothelial dysfunction, cardiac arrhythmias, and treatment of sleep apnea in congestive
heart failure.
.A::E 6EC:6 6C9 HA::E 9:EG>K6I>DC - $BEA>86I>DCH ;DG 86G9>68 6C9 B:I67DA>8 G>H@
Virend Somers (USA)
.A::E 6EC:6 6C9 86G9>68 6GG=NI=B>6H
Jean Louis Pepin (Belgium)
.A::E 6EC:6 6C9 8DC<:HI>K: =:6GI ;6>AJG:
Winfried Randerath (Germany)
.
0
)
D
A
4
34
.
0
)
D
A
4
35
.JC96N, .:EI:B7:G 29, 2013
CDJGH: 10: -:8DG9>C< 6C9 .8DG>C< D; (DK:B:CI D>HDG9:GH D;
.A::E 6C9 -BD
C=6>G:
.E:6@:GH:
Gilles Lavgne (Canada), Federica Provini (Italy), Joan Santamaria (Spain), Birgit Hgl (Austria)
.JBB6GN:
This course deals with practical recording and scoring issues for movement disorders in sleep (specifically bruxism,
myoclonus, rhythmic movement disorders, PLM and RBD). How to select appropriate muscles, good montages for
different settings (clinical, research, basic, advanced), how to obtain good records, advantages and disadvantages of
specific muscles for recording during PSG, how to analyze and quantify. The speakers in this course are experts in their
field and will give theoretical background as well as practical tips, and time for questions and answers as well as discussion.
/>EH 6C9 IG>8@H ;DG +." G:8DG9>C< D; HA::E 7GJM>HB 6C9 9>;;:G:CI>6A DM
Gilles Lavgne (Canada)
1>9:D 6C9 +." :M8:GEIH ;DG G:8DG9>C< 6C9 H8DG>C< D; +'(, EGDEG>DHE>C6A BND8ADCJH, ;G6<B:CI6GN
BND8ADCJH 6C9 :M8:HH>K: ;G6<B:CI6GN BND8ADCJH, HA::E HI6GIH 6C9 G=NI=B>8 BDK:B:CI 9>HDG9:GH
Federica Provini (Italy)
.:A:8I>DC D; BJH8A:H ;DG G:8DG9>C< -( 6C9 )-( E6G6HDBC>6H: #DL ID EG:E6G: 6 <DD9
BDCI6<:/ 69K6CI6<:H 6C9 9>H69K6CI6<:H D; HE:8>;>8 BJH8A:H L>I= :M6BEA:H
Joan Santamaria (Spain)
.8DG>C< D; IDC>8, E=6H>8 6C9 R6CNS BJH8A: 68I>K>IN >C -BDS. A9K6CI6<:H 6C9 EGD7A:BH D; I=:
9>;;:G:CI HNHI:BH D; FJ6CI>;>86I>DC L>I= :M6BEA:H
.
0
)
D
A
4
36
(DC96N
.8=:9JA: 6I 6 "A6C8: (DC96N, .:EI:B7:G 30, 2013
_________________________________________________________________
-:<>HIG6I>DC 7:006B - 9:00EB
_________________________________________________________________
ACCDJC8:B:CIH 8:306B - 9:006B
_________________________________________________________________
&:NCDI: 9:006B - 10:006B
_________________________________________________________________
.NBEDH>JB .1-4 10:006B - 11:306B
_________________________________________________________________
M=>7>I>DC 11:006B - 5:00EB
_________________________________________________________________
CD;;:: BG:6@ 11:306B - 12:00EB
_________________________________________________________________
.NBEDH>JB .5-7, /:8=CDAD<>HI +GD<G6B, *G6A +G:H:CI6I>DCH *-1 6C9 *-2 12:00EB - 1:30EB
_________________________________________________________________
BG:6@ 1:30EB - 1:40EB
_________________________________________________________________
(JC9>E=6GB6 $C9JHIGN .NBEDH>JB 1:40EB - 3:10EB
_________________________________________________________________
+=>AA>EH -:HE>GDC>8H $C9JHIGN .NBEDH>JB 1:40EB - 3:10EB
_________________________________________________________________
CD;;:: 6C9 M=>7>I 3:10EB - 3:30EB
_________________________________________________________________
&:NCDI: 3:30EB - 4:30EB
_________________________________________________________________
+DHI:GH 6C9 *G6A +G:H:CI6I>DCH *-3, *-4 6C9 *-5 4:30EB - 5:30EB
_________________________________________________________________
.NBEDH>JB .8-12 6C9 /:8=CDAD<>HI +GD<G6B 5:30EB - 7:00EB
_________________________________________________________________
D>H8JHH>DC .NBEDH>JB />8@:I -:FJ>G:9 7:00EB - 8:00EB
_________________________________________________________________
+G:H>9:CI>6A D>CC:G />8@:I -:FJ>G:9 8:30EB - 11:00EB
_________________________________________________________________
37
(
*
)
D
A
4
(DC96N, .:EI:B7:G 30, 2013
9:006B ID 10:006B AJ9>IDG>JB 1
&:NCDI:: .A::E, D:6I= 6C9 I=: #:6GI
Virend Somers, MD, PhD
Mayo Clinic
USA
Te work of Virend Somers, M.D., Ph.D., at Mayo Clinic in Rochester, Minn.,
examines the mechanisms that infuence the brain's regulation of the heart and
blood vessels in both health and disease. His research includes sleep and its
interaction with circulatory control, as well as the mechanisms linking obesity to
heart disease.
)DI:H:
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
38
(
*
)
D
A
4
(DC96N, .:EI:B7:G 30, 2013
10:006B ID 11:306B AJ9>IDG>JB 2
.1: ):L D>6<CDHI>8 /:8=CDAD<>:H ;DG .A::E D>HDG9:G:9 BG:6I=>C<
C=6>G:
.E:6@:GH:
Thomas Penzel (Germany), Robert Thomas (USA), Robert Poirrier (Belgium), Ludger Grote (Sweden),
Pierre Escourrou (France), Chen Lin (USA),
':6GC>C< *7?:8I>K:H:
New methods for portable diagnosis of sleep apnea possibilities and limitations
Modern diagnostic methods give new chances to investigate pathophysiology in sleep apnea and cardiovascular consequences
in order to improve predictors for outcome
Therapy compliance monitoring does become a part of diagnostic follow up studies
/6G<:I AJ9>:C8::
Sleep physicians who want to learn about new options in diagnostic tools. Sleep physicians who want to see the state of
the art in technological developments supporting the diagnosis of sleep disordered breathing. Sleep technologist who
want to learn about upcoming developments for the sleep laboratory environment.
.JBB6GN:
The symposium educates about new technical developments for the diagnosis of sleep disorders. This includes
education on sleep disordered breathing with consequences for cardiovascular disorders and for sleep fragmentation.
One talk is addressing the issues of new technologies in the follow up of compliance with therapy again in patients with
sleep disordered breathing. New telemedicine techniques allow a rapid check of patient adherence to therapy with
CPAP and other ventilation techniques. In addition to these pathophysiological and technical issues, the management
of sleep centers is addressed. Do we need full sleep centers which cope with all sleep disorders? Do we need specialized
sleep centers which focus on respiratory or neurological problems alone? Do we need centers which only perform
portable sleep studies?
10:00am - 10:00am
$CIGD9J8I>DC
10:00am - 10:15am
C6G9>DEJABDC6GN 8DJEA>C< >C I=: 9>6<CDH>H D; >CHI67A: HA::E 6C9 HA::E 9>HDG9:G:9 7G:6I=>C<
Robert Thomas (USA)
10:15am 10:30am
.6<>II6A BDK:B:CI G:8DG9>C< ;DG I=: 9:I:8I>DC D; HA::E 9>HDG9:G:9 7G:6I=>C< 6C9 HA::E HI6<:H
Robert Poirrier (Belgium)
10:30am 10:45am
AJIDCDB>8 HI6I: >C9>86IDG ;DG I=: 6HH:HHB:CI D; 86G9>DK6H8JA6G G>H@ >C E6I>:CIH L>I= HA::E 9>HDG9:G
Ludger Grote (Sweden)
10:45am 11:00am
/:A:B:9>8>C: 6EEGD68= ID 6HH:HH C+A+ 8DBEA>6C8:
Pierre Escourrou (France)
11:00am 11:15am
D>;;:G:CI 68I>K6I>DC D; 6JIDCDB>8 C:GKDJH HNHI:B L>I= ;ADL A>B>I6I>DC
Chen Lin (USA)
11:15am 11:30am
(6C6<:B:CI D; HA::E 9>HDG9:G:9 7G:6I=>C< >CH>9: 6C9 DJIH>9: I=: HA::E A67DG6IDGN
39
(
*
)
D
A
4
(DC96N, .:EI:B7:G 30, 2013
10:006B ID 11:306B (JAI>EJGEDH: -DDB 1
.2: CD<C>I>K: B:=6K>DG6A /=:G6EN ;DG $CHDBC>6 (CB/-$):
&CDLA:9<: /G6CH;:G 6C9 /G:6IB:CI D>HH:B>C6I>DC
CD-8=6>GH:
Charles M. Morin (Canada), Yun Kwok Wing (China)
.E:6@:GH:
Charles M. Morin (Canada), Yun Kwok Wing (China), Josee Savard (Canada), Rachel Manber (USA),
Colin Espie (United Kingdom)
':6GC>C< *7?:8I>K:H:
Describe innovative methods to deliver treatment and transfer knowledge
Summarize recent fndings on the impact of these treatment delivery models and web-based technologies to
disseminate interventions for insomnia/sleep disturbances
/6G<:I AJ9>:C8::
Tis symposium is likely to be of signifcant interest for both sleep clinicians providing insomnia treatment and
investigators conducting clinical trials on insomnia therapies.
.JBB6GN:
Tere is solid evidence that cognitive-behavioral therapy for insomnia (CBT-I) is efective, produces sustained benefts
over time, and is well accepted by patients. An important challenge that remains, however, is to translate this evidence
into practical applications and to disseminate it to potential users, i.e., individuals with insomnia and health-care
practitioners who work with sleep patients in diverse settings. Te main objectives of this symposium are to describe
innovative methods and technologies to disseminate CBT-I and optimize knowledge transfer. Five speakers from
diferent part of the world will present evidence from recent clinical trials documenting the impact of self-help therapies
using the Internet and web-based applications, training workshops, and sleep education programs as implemented in
community, hospital, and school settings.
10:00am - 10:02am
$CIGD9J8I>DC
Charles M. Morin (Canada)
10:02am - 10:19am
&CDLA:9<: IG6CH;:G I=GDJ<= HA::E :9J86I>DC 6BDC< H8=DDA-6<:9 8=>A9G:C
Yun Kwok Wing (China)
10:19am 10:36am
;;>868N D; 6 K>9:D-76H:9 CB/ ;DG >CHDBC>6 >C 86C8:G E6I>:CIH
Josee Savard (Canada), H. Ivers, M-H. Savard, J. Villa, C.M. Morin
10:36am 10:53am
/G6>C>C< 9>HH:B>C6I>DC D; CB/-$ >C K:I:G6CH 69B>C>HIG6I>DC =:6AI= 86G: HNHI:B
Rachel Manber (USA)
10:53am - 11:10am
A L:7-76H:9 >CI:GK:CI>DC ;DG >CHDBC>6
Colin Espie (United Kingdom)
11:10am - 11:27am
$CI:GC:I-9:A>K:G:9 CB/ ;DG >CHDBC>6
Charles Morin, L. Ritterband, F. Thorndike, L. Gonder-Frederick, K. Ingersoll
11:27am 11:30am
,J:HI>DC 6C9 6CHL:G
Charles M. Morin (Canada)
40
(
*
)
D
A
4
(DC96N, .:EI:B7:G 30, 2013
10:006B ID 11:306B AJ9>IDG>JB 3
.3: CDCK:G<>C< 0C9:GHI6C9>C< D; I=: B>DAD<N D; -:HIA:HH ':<H .NC9GDB:
C=6>G:
.E:6@:GH:
Richard P Allen (USA), James R. Connor (USA), Christopher J. Earley (USA), Juliane Winkelmann (USA),
Yong-Won Cho (South Korea)
':6GC>C< *7?:8I>K:H:
Biological significance of RLS genetics for brain development and iron regulation
Role of hypoxic and related pathways in expression of RLS symptoms
Differing pathways and neurochemical systems for spinal and cortical excitability in RLS
Brain connectivity differences supporting development of RLS symptoms
Possibilities of biologically based developments of new approaches to diagnosis, evaluation and treatment of RLS
/6G<:I AJ9>:C8::
Intermediate to advanced clinical and scientific interest in RLS and new diagnostic and treatment considerations
developing from understanding the biology of RLS.
.JBB6GN:
A wide range in disparate biological features of RLS have each been advanced as the biological basis for RLS, e.g.:
peripheral nervous system, spinal mechanisms, dopaminergic systems (A11, nigro-striatal), thalamo-pathways, cortical
arousal, pain/sensory systems, glutamatergic activation, hypoxic pathways, iron regulation, genetics. There is now the
beginning of understanding how these various biological features of RLS converge to reveal both underlying biological
diatheses for RLS and pathways for expression of the disease. This symposium will present some of the initial findings
that begin to reveal this complicated biological network for RLS. First, new advances in understanding the biological
significance of RLS genetics reveal pathways for producing both basic iron regulation problems, particularly at the
blood-brain-barrier and also basic alterations in development of major brain systems, particularly the nigro-striatal
system. Second, alternate pathways leading to expression of the disease have been found involving activation of hypoxic
and related pathways in peripheral and central tissue that also may relate to RLS genetics and peripheral as well as brain
features of RLS. Finally brain connectivity imaging, spectroscopy and recent neurophysiological studies provide an
interesting picture of divergent paths for expression of the disease. These involve altered thalmo-connectivity and
possibly spinal systems with putative somewhat separate pathways and neurochemistry expressing the hyperarousal
versus periodic leg movements of RLS. The insights provided by these studies on the biology of RLS impact
developments for better diagnosis, evaluation and treatment of RLS.
10:00am - 10:03am
$CIGD9J8I>DC
10:03am - 10:18am
($.1, >GDC 6C9 -'.: ":C:I>8 :;;:8IH DC >GDC G:<JA6I>DC 6C9 7ADD9 7G6>C 76GG>:G >C -'.
James R. Connor (USA)
10:18am 10:33am
-'. 7>DAD<>86A E6I=L6NH: =NEDM>8 6C9 G:A6I:9 E6I=L6NH >C 7G6>C 6C9 E:G>E=:G6A HNHI:BH
Christopher J. Earley (USA)
10:33am 10:48am
":C:I>8H 6C9 9:K:ADEB:CI6A >HHJ:H >C -'. 7>DAD<N
Juliane Winkelmann (USA)
10:48am - 11:03am
-'. CDGI>86A/HE>C6A :M8>I67>A>IN, +'( KH =NE:G6GDJH6A: $GDC, 9DE6B>C: 6C9 <AJI6B6I:
11:03am - 11:15am
BG6>C >B6<>C<: (-$ 8DCC:8I>K>IN, >GDC 6C9 9DE6B>C:
Yong-Won Cho (South Korea)
11:15am - 11:30am
,J:HI>DC 6C9 6CHL:G
41
(
*
)
D
A
4
(DC96N, .:EI:B7:G 30, 2013
10:006B ID 11:306B CDBB>II:: -DDBH 1 6C9 2
.4: /=: AJIDCDB>8 ):GKDJH .NHI:B 6C9 .A::E >C #JB6C
)6G8DA:EHN: DD +6I>:CIH #6K: 6C $C8G:6H:9 C6G9>DK6H8JA6G ->H@?
C=6>G:
Pietro Cortelli (Italy)
.E:6@:GH:
Pietro Cortelli (Italy), Daniela Grimaldi (USA-Italy), Stine Knudsen (Denmark), Yves Dauvilliers (France),
Rolf Fronczek (The Netherlands)
':6GC>C< *7?:8I>K:H:
Gain insight in what is known about how the autonomic nervous system is affected in hypocretin-deficient human narcolepsy
Learn the results of several recent sleep studies with autonomic measurements in human narcolepsy
Understand the broader impact of hypocretin deficiency in human narcolepsy in relation to possible cardiovascular
risk and obesity
/6G<:I AJ9>:C8::
Advanced topic for clinical sleep specialists and basic researchers with a special interest in the autonomic nervous system
effects of hypocretin deficiency in human narcolepsy.
.JBB6GN:
Almost all narcolepsy with cataplexy patients lack the neuropeptide hypocretin (orexin). The hypocretin system plays a
key role in the complex interaction between sleep and the autonomic nervous system. It is hypothesized that hypocretin
deficiency thus affects cardiovascular risk factors in narcolepsy. In this symposium results of several recent studies will be
presented, with a focus on the autonomic nervous system in relation to sleep in human narcolepsy. This includes blood
pressure rhythms and spectral analysis of heart rate variability as a reflection of sympathovagal balance during sleep,
which reveals an abnormal sleep-cardiovascular system interaction. Furthermore, recent data indicate a reduced heart
rate response to arousals and leg movements during sleep in narcolepsy patients that lack hypocretin. In another study,
a higher percentage of non-dipping blood pressure profiles (defined as < 10% drop in blood pressure during sleep)
was found in drug-free patients with narcolepsy-cataplexy compared to controls without evidence for endothelial
dysfunction. Thermoregulation is also controlled by the autonomic nervous system and is altered around sleep onset
and during sleep in human narcolepsy. To conclude, the broader impact of these recent insights will be summarized in
relation to a possible increased cardiovascular risk in human narcolepsy and to the obesity that is characteristic for
narcolepsy.
10:00am - 10:05am
$CIGD9J8I>DC
10:05am - 10:25am
A7CDGB6A HA::E-86G9>DK6H8JA6G HNHI:B >CI:G68I>DC >C C6G8DA:EHN L>I= 86I6EA:MN:
:;;:8IH D; =NED8G:I>C
Daniela Grimaldi (USA-Italy)
10:25am 10:45am
AII:CJ6I:9 6JIDCDB>8 G:HEDCH: ID C><=II>B: 6GDJH6A 6C9 A:< BDK:B:CIH >C =JB6C C6G8DA:EHN
Stine Knudsen (Denmark)
10:45am 11:05am
)DC-9>EE>C< 7ADD9 EG:HHJG: EGD;>A: >C C6G8DA:EHN L>I= 86I6EA:MN
Yves Dauvilliers (France)
11:05am - 11:25am
-:<JA6I>DC D; =:6GI G6I:, 7D9N I:BE:G6IJG:, B:I67DA>HB 6C9 HA::E >C =JB6C C6G8DA:EHN
Rolf Fronczek (The Netherlands)
11:25am 11:30am
,J:HI>DC 6C9 6CHL:G
42
(
*
)
D
A
4
(DC96N, .:EI:B7:G 30, 2013
12:00EB ID 1:30EB (JAI>EJGEDH: -DDB 1
.5: /=: -DA: D; .A::E >C BDI>DC6A (:BDGN +GD8:HH>C< 6C9
D:K:ADEB:CI DG +G:K:CI>DC D; +/.D
C=6>G:
Gina R. Poe (USA)
.E:6@:GH:
Gina R. Poe (USA), Anne Germain (USA), Maria Corsi-Cabrera (Mexico), Subimal Datta (USA),
William Vanderheyden (USA)
':6GC>C< *7?:8I>K:H:
Understand the traits of sleep important to processing memories
Learn which sleep traits change after PTSD induction
Observe how sleep normally changes after fear learning and extinction training
Build a comprehensive model of abnormal processing of fearful memories after PTSD
Gain insight as to how the more successful PTSD treatments may work and how reestablishing normal sleep function for
memory processing could recover normal function after PTSD
/6G<:I AJ9>:C8::
The content is appropriate for a broad audience familiar with sleep. Presentations will be basic as well as clinical and
include conceptual models that tie the results together.
.JBB6GN:
Attendees should be able to identify traits of sleep that change after traumatic events that induce PTSD, and further
understand how such traits are altered during fear conditioning and extinction in those with and without PTSD.
Human and basic animal studies will be presented. Mechanistic models and areas of coherence as well as disagreement
will be directly addressed. The symposium will concentrate on the physiological characteristics of sleep that are
influenced by and influence the adaptive vs. maladaptive sleep processing of traumatic memories.
12:00pm - 12:02pm
$CIGD9J8I>DC
Gina R. Poe (USA)
12:02pm - 12:17pm
-DA: D; HA::E IG6>IH >C I=: >C9J8I>DC D; +/.D, ;:6G 8DC9>I>DC>C<, 6C9 ;:6G :MI>C8I>DC
Gina R. Poe (USA)
12:17pm - 12:34pm
BG6>C >B6<>C< ;>C9>C<H >C 8DB76I-:MEDH:9 1:I:G6CH L>I= 6C9 L>I=DJI +/.D
Anne Germain (USA)
12:34pm - 12:51pm
BDI>DC G:<JA6I>DC 6;I:G HA::E 9:EG>K6I>DC >C =JB6CH
Maria Corsi-Cabrera (Mexico)
12:51pm - 1:08pm
-DA: D; -( HA::E +-L6K: 68I>K>IN >C ;:6G :M-I>C8I>DC B:BDGN
Subimal Datta (USA)
1:08pm - 1:25pm
(D9:A>C< +/.D >C I=: G6I: HA::E 6C9 A:6GC>C< E=:CDINE:H
William Vanderheyden (USA)
1:25pm 1:30pm
,J:HI>DC 6C9 6CHL:G
Gina R. Poe (USA)
12:00pm-1:30pm Committee Rooms 3 and 4
21 AD0'/ +." (6HI:G8A6HH: .A::E (DCI6<: #DD@-JE; .A::E .I6<>C< 6C9
K:CI .8DG>C<
43
(
*
)
D
A
4
(DC96N, .:EI:B7:G 30, 2013
12:00EB ID 1:30EB AJ9>IDG>JB 2
.6: .A::E D>HDG9:GH 6C9 C6C8:G
CD-8=6>GH:
Miguel ngel (Spain), Javier Nieto (USA)
.E:6@:GH:
Miguel ngel (Spain), Javier Nieto (USA), Sonia Ancoli-Israel (USA), Ramon Farr (Spain),
Francisco Campos-Rodrguez (Spain)

':6GC>C< *7?:8I>K:H:
Relationship between sleep metabolism, circadian rh ythm and cancer risk
Sleep disturbances and cancer risk (especially sleep duration)
Role of Melatonine and hypnotic treatments in cancer
New discoveries. Intermittent hypoxia and cancer in animal models
New discoveries. Sleep apnea and risk of cancer. Incidence and mortality
The future. New studies needed and the role sleep disorders treatment in cancer
/6G<:I AJ9>:C8::
Everyone with interest in sleep disorders.
.JBB6GN:
The relationship between different aspects of non-apneic sleep disorders, particularly sleep duration and some drugs
intake, and cancer has been studied by various authors. Some studies have shown an association between short sleep
duration, long sleep duration or prolonged naps and an increased incidence of cancer, particularly breast cancer.
Several mechanisms have been postulated as explanations for this association, most notably the increased production
of pro-inflammatory cytokines and the suppression of melatonin secretion, which has been shown to inhibit cancer
development and growth. Moreover, recently three large observational studies from Wisconsin (Nieto J, et al, 1500
patients, follow up 22 years, population-based study. Am Respir J Critr Care Med 2012) and Spain (Campos-Rodrguez
F, et al and Martnez-Garca MA, et al. Clinical cohort of more than 5,000 patients with suspected OSA with a
follow-up 5 years. Am Respir J Crit Care Med 2013 and ATS Congress 2012) have shown a relationship between
severe sleep apnea (measured by an hypoxemia index) and an increased incidence and mortality from cancer. All these
studies have been presented in USA and Europe with great interest of the Scientific Community and Press (New York
Times, Lancet, Sky news and others). The pathophisiological mechanism proposed to link sleep apnea and cancer is
intermittent hypoxia as has been previously observed by Farr et al in an animal model. Some editorials have been
recently written about it (Redline S in Am Respir J Crit Care Med, Martnez-Garca MA et al. European Respiratory
Journal). Some studies will begin in 2013 on this topic specially from the Spanish Sleep and Breathing group.
12:00pm - 12:05pm
$CIGD9J8I>DC
Miguel ngel (Spain)
12:05pm - 12:10pm
$CIGD9J8I>DC
Javier Nieto (USA)
12:10pm - 12:30pm
)DC-6EC:>8 HA::E 9>HDG9:GH 6C9 86C8:G
Sonia Ancoli-Israel (USA)
12:30pm - 12:50pm
$CI:GB>II:CI =NEDM>6 6C9 86C8:G. +6I=DE=NH>DAD<N 6C9 HIJ9>:H >C 6C>B6A BD9:AH
Ramon Farr (Spain)
12:50pm - 1:10pm
.A::E 6EC:6 6C9 G>H@ D; 86C8:G >C8>9:C8: 6C9 BDGI6A>IN
Francisco Campos-Rodrguez (Spain)
1:10pm 1:30pm
,J:HI>DC 6C9 6CHL:G
Miguel ngel (Spain) and Javier Nieto (USA)
44
(
*
)
D
A
4
(DC96N, .:EI:B7:G 30, 2013
.7: BG6>C $B6<>C< .IJ9>:H >C .A::E D>HDG9:GH 6C9 .A::E D:EG>K6I>DC
C=6>G:
Seung Bong Hong (South Korea)
.E:6@:GH:
Seung Bong Hong (South Korea), Luigi Ferini-Strambi (Italy), Eus JW Van Someren (The Netherlands),
Michael Chee (Singapore), In-young Yoon (South Korea)
':6GC>C< *7?:8I>K:H:
Does OSA cause structural abnormalities in brain and is there a correlation between brain changes and cognitive dysfunction
in OSA patients?
Is brain metabolism and EEG changes reversible by nasal CPAP treatment in OSA patients?
Heterogeneity of insomnia may have impeded progress in our understanding of underlying causes and depending on the
phenotype, remarkably different cerebral mechanisms can underlie seemingly similar subjective sleep complaints
Are there structural changes in brain of narcolepsy patients and the relationship between brain changes and narcolepsy symptoms?
What is the consequence of sleep deprivation in cognitive function and how does fMRI elucidate the effect of sleep
deprivation on brain function?
/6G<:I AJ9>:C8::
Sleep physicians, professors, clinical and basic researchers, students.
.JBB6GN:
The changes of brain function or structures are suspected in various sleep disorders such as OSA, narcolepsy, insomnia and others.
Recently both functional and structural abnormalities have been reported in sleep disorders. Neuroimaging such as brain MRI,
fMRI, PET, SPECT is a useful research tool for studying brain pathology or dysfunction related to sleep disorders and sleep
deprivation in live human. This symposium will present the results of brain imaging studies in OSA, insomnia, narcolepsy and sleep
deprivation. In OSA, two(#1, 5) speakers will present structural brain abnormalities and their relationship with cognitive
dysfunction, and changes of brain glucose metabolism and quantitative EEG after CPAP treatment respectively. The 2nd speaker
will talk about the relationship between brain imaging and different phenotypes of insomnia such as primary insomnia, insomnia
with major depression and insomnia with anxiety disorder, and implications for our understanding of insomnia; depending on the
phenotype, remarkably different cerebral mechanisms can underlie seemingly similar subjective sleep complaints. Despite evidence of
disturbances of the hypothalamic hypocretin system in idiopathic narcolepsy patients, a gross inspection of brain MRI is usually
normal and computer-aided studies of brain MRI revealed conflicting results and there is limited data on possible structural brain
changes that might be associated with idiopathic narcolepsy. So the 3rd speaker will review neuroimaging studies using brain MRI
including gray and white matter changes and cortical thickness and discuss their relation to the pathogenesis of narcolepsy. The
brain dysfunctions have been reported in people with sleep deprivation. The 4th speaker will present the techniques and results of
brain dysfunctions related to sleep deprivation studied by functional MRI (fMRI).
12:00pm - 12:00pm
$CIGD9J8I>DC
12:00pm - 12:17pm
BG6>C <G6N/L=>I: B6II:G 67CDGB6A>IN 6C9 8DGI>86A I=>8@C:HH 8=6C<:H >C C6G8DA:EHN
12:17pm - 12:34pm
.IGJ8IJG6A 7G6>C 8=6C<:H 6C9 8D<C>I>K: 9NH;JC8I>DC >C *.A E6I>:CIH
12:34pm - 12:51pm
BG6>C >B6<>C< :AJ8>96I:H 9>;;:G:CI >CHDBC>6 :C9DE=:CDINE:H
Eus JW Van Someren (The Netherlands)
12:51pm - 1:08pm
;(-$ HIJ9N DC 8D<C>I>K: 9NH;JC8I>DC >C E:DEA: L>I= HA::E 9:EG>K6I>DC
Michael Chee (Singapore)
1:08pm 1:25pm
BG6>C B:I67DA>HB 6C9 ," 8=6C<:H 6;I:G C+A+ IG:6IB:CI >C *.A E6I>:CIH
In-young Yoon (South Korea)
1:25pm 1:30pm
,J:HI>DC 6C9 6CHL:G
45
(
*
)
D
A
4
(DC96N, .:EI:B7:G 30, 2013
*-01: A<>C< 6C9 D:K:ADEB:CI6A $HHJ:H
C=6>G:
Oliviero Bruni (Italy)
/LD =DJGH D; :K:C>C< A><=I EGD9J8:H H><C>;>86CI 8>G869>6C E=6H: 9:A6N H=>;IH >C DA9:G 69JAIH
Jeanne F. Dufy (USA)
(:6C HIG:HH G6I>C<H 68GDHH 6 L::@H 6G: G:A6I:9 ID >C8G:6H:9 A:K:AH D; .I6<: 1 6C9 2A.*
9JG>C< 4 (=DB:) G:8DG9:9 HA::E E:G>D9H
Torbjorn Akerstedt (Sweden)
.A::E 8DBEA6>CIH 6C9 86G9>D-8:G:7GDK6H8JA6G 9>H:6H:H >C I=: :A9:GAN: 6 6-N:6G EGDHE:8I>K: HIJ9N
Isabelle Jaussent (France)
/D C6E DG CDI ID C6E: :K>9:C8: DC 96NI>B: C6EE>C< 6C9 >C8G:6H:9 13-N:6G BDGI6A>IN
>C 6 BG>I>H= EDEJA6I>DC
Yue Leng (UK)
A<:-G:A6I:9 8=6C<:H >C HA::E E6II:GC 6C9 HA::E HIGJ8IJG: 6C9 I=: 6HHD8>6I>DC ID 8D<C>I>K:
E:G;DGB6C8:; /=: (:IGDEDA>I 1953 D6C>H= (6A: B>GI= CD=DGI
Linda Waller (Denmark)
.A::E FJ6A>IN 6C9 6GI:G>6A HI>;;C:HH >C B>99A:-6<:9 6C9 DA9:G LDB:C
Youngju Choi (Japan)
46
(DC96N, .:EI:B7:G 30, 2013
12:00EB ID 1:30EB AJ9>DG>JB 3
*-02: .A::E BG:6I=>C< D>HDG9:GH
CD-C=6>GH:
Josep Monserrat (Spain), Stuart Quan (USA)
A8JI: :;;:8IH D; D7HIGJ8I>K: HA::E 6EC:6 DC 6JIDCDB>8 C:GKDJH HNHI:B, 6GI:G>6A HI>;;C:HH 6C9
=:6GI G6I: >C C:LAN 9>6<CDH:9 JCIG:6I:9 E6I>:CIH
Ren-Jing Huang (Taiwan)
/=: :MEG:HH>DC D; I=: +:G2 8AD8@ <:C: >H JE-G:<JA6I:9 >C CDC-IG:6I:9 *.A. E6I>:CIH 6C9
CDGB6A>O:H >IH B-)A A:K:AH JEDC EDH>I>K: EG:HHJG: IG:6IB:CI
Luis Ferreira Moita (Portugal)
AHI=B6 +G:9>8IH 8-4:6G >C8>9:C8: D; D7HIGJ8I>K: HA::E 6EC:6 >C I=: 2>H8DCH>C HA::E 8D=DGI
Erika Hagen (USA)
/=: 6HHD8>6I>DC D; HA::E-9>HDG9:G:9 7G:6I=>C< L>I= D7?:8I>K:AN-6HH:HH:9 G>H@ D; ;6AAH
Paul E. Peppard (USA)
*7HIGJ8I>K: HA::E 6EC:6 >C G>H@ ;DG ;>GHI 86G9>DK6H8JA6G :K:CI 6C9 6AA-86JH: BDGI6A>IN:
A 8DBE:I>C< G>H@H 6EEGD68=
Tetyana Kendzerska (Canada)
.JGK>K6A 6C9 69=:G:C8: ID C+A+ >C I=: :A9:GAN
Daniel Lpez-Padilla (Spain)
47
(
*
)
D
A
4
(DC96N, .:EI:B7:G 30, 2013
B:G<>C< .IG6I:<>:H >C
.A::E D>HDG9:GH
A<:C96:
1:40pm - 1:45pm
$CIGD9J8I>DC 6B9 DK:GK>:L
Professor Claudia Trenkwalder
1:45pm - 2:05pm
/=: G:A6I>DC D; E6>C, E6>C I=:G6EN 6C9 HA::E
Professor Sam Ahmedzai
2:05pm - 2:10pm
,J:HI>DCH & 9>H8JHH>DC
2:10pm - 2:30pm
-'. E6I=DE=NH>DAD<N: I=: 8JGG:CI =NEDI=:H>H
Professor Arthur Walters
2:30pm - 2:35pm
2:35pm - 2:55pm
B:NDC9 9DE6B>C:G<>8H P >H I=:G: HI>AA 6
8=6C8: D; 6 <DD9 C><=IQH HA::E?
2:55pm - 3:00pm
3:00pm - 3:10pm
.JBB6GN 6C9 E6C:A 9>H8JHH>DC
Sponsor:
(DC96N, .:EI:B7:G 30, 2013
1:40EB ID 3:10EB
(JAI>EJGEDH: -DDB 1
A9K6C8:H >C +A+ /=:G6EN
A<:C96:
CD-C=6>GH:
Dr Montserrat (Spain), Dr. Santiago Juarros (Spain)
1:40pm - 2:10pm
#DL 86C E6I>:CI 96I6 =:AE NDJ 9:A>K:G
=:6AI=>:G E6I>:CIH
Prof. Escourrou (France)
2:10pm - 2:40pm
/=: JH: D; .:GKDK:CI>A6I>DC >C 8DBEA>86I:9
E6I>:CIH
Dr. Fernanda Troncoso (Spain)
2:40pm - 3:10pm
+HN8=DAD<>86A >CI:GK:CI>DCH ID >BEGDK: +A+
8DBEA>6C8:
Mark Aloia (USA)
Sponsor:
BDM 'JC8=:
Box lunch is provided to satellite symposia attendees. Delegates can purchase
a lunch ticket for Wednesday prior to noon Tuesday for a cost of 10 at the
registration desk.
48
(
*
)
D
A
4
(DC96N, .:EI:B7:G 30, 2013
&:NCDI:: B:G<>C< /G:6IB:CIH ;DG $CHDBC>6
Gran Hajak, MD, PhD
University of Erlangen, Social Foundation Bamberg
Germany
Since his involvement in neuropsychic research began in the late 1980s, Dr. Hajaks
interests have included the clinical and pathophysiological aspects of afective,
emotional, somatoform and sleep disorders, the mechanisms of neuroplasticity and
brain networking, psychopharmacology, and health management. He has been
serving in boards and expert groups of several international institutions such as
the Drug Commission of the German Medical Profession, Federation of Societies
of Biological Psychiatry, German Sleep Society, and Green Cross.
)DI:H:
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
49
(
*
)
D
A
4
(
*
)
D
A
4
(DC96N, .:EI:B7:G 30, 2013
*-03: C=GDCD7>DAD<N & C>G869>6C D>HDG9:GH
C=6>G:
Phyllis Zee (USA)
.A::E 9>HIJG76C8:H 6C9 I=:>G G:A6I>DCH=>E L>I= :M8:HH>K: :MEDHJG: ID A><=I 6I C><=I: /=: &DG:6C
<:CDB: 6C9 :E>9:B>DAD<N HIJ9N
Yong Seo Koo (South Korea)
AHH:HH>C< I=: 9:A6N:9 HA::E E=6H: 9>HDG9:G 7N 6B7JA6IDGN 8>G869>6C BDC>IDG>C<
Eduard Estivill (Spain)
K6AJ6I>DC D; 8>G869>6C <:C: :MEG:HH>DC 8=6C<:H >C =JB6C E:G>E=:G6A 7ADD9 8:AAH 6H
7>DB6G@:GH D; 8>G869>6C 9>HGJEI>DC >C H=>;I LDG@:GH: AEEA>86I>DC ID HIJ9>:H D; 7G:6HI 6C9 EGDHI6I:
86C8:G 8=:BDEG:K:CI>DC
Helmut Zarbl (USA)
C>G869>6C 68I>K>IN G=NI=B 9>HIJG76C8:H EG:9>8I BDGI6A>IN
Lisette A. Zuurbier (Te Netherlands)
50
(
*
)
D
A
4
(DC96N, .:EI:B7:G 30, 2013
*-04: $CHDBC>6 (:8=6C>HBH
C=6>G:
Kai Spiegelhalder (Germany)
A:8IGD:C8:E=6AD<G6E=>8 8DGG:A6I:H D; DC-I=:-GD69 9G>K>C< ;6I><J: >C JCIG:6I:9 >CHDBC>68 E6I>:CIH
Joy Perrier (Framce)
$CHDBC>6 HNBEIDBH 6C9 HJ7H:FJ:CI 86G9>DK6H8JA6G B:9>86I>DC: 6 G:<>HI:G-A>C@:9 ;DAADL-JE HIJ9N
6BDC< B>99A:-6<:9 :BEADN::H
Peija Haaramo (Finland)
.E:8IG6A 6C6ANH>H >C JCIG:6I:9 EG>B6GN >CHDBC>68H: K>9:C8: ;DG 8DGI>86A =NE:G6GDJH6A 6C9
EG:;GDCI6A =NEDB:I67DA>HB 9JG>C< HA::E
Joy Perrier (France)
CD<C>I>K: >BE6>GB:CIH >C >C9>K>9J6AH L>I= >CHDBC>6: CA>C>86A H><C>;>86C8: 6C9 8DGG:A6I:H
Emilie Fortier-Brochu (Canada)
51
(
*
)
D
A
4
(DC96N, .:EI:B7:G 30, 2013
4:30EB ID 5:30EB CDBB>II:: -DDBH 1 6C9 2
*-05: .A::E CD<C>I>DC 6C9 -BD
C=6>G:
$C8G:6H:9 /1 K>:L>C< I>B: >H 6HHD8>6I:9 L>I= A:HH HA::E 6C9 BDG: HA::E 9>;;>8JAI>:H >C 6 A6G<:
EDEJA6I>DC-76H:9 8D=DGI
Yue Leng (UK)
.A::E 9:EG>K6I>DC 8DGG:A6I>DCH L>I= G>H@ 7:=6K>DGH >C 69DA:H8:CIH: -:HJAIH ;GDB 6 +DGIJ<J:H:
C6I>DC6A HJGK:N
Teresa Paiva (Portugal)
-( HA::E 7:=6K>DG 9>HDG9:G >H 6HHD8>6I:9 ID >C8G:6H:9 G>H@ D; >BEJAH: 8DCIGDA HNBEIDBH >C
E6I>:CIH L>I= +6G@>CHDCQH 9>H:6H:
Fantini Maria Livia (France)
#DL H=DJA9 L: 9:6A L>I= I=: EDHH>7A: 9:K:ADEB:CI >CID ':LN 7D9N 9>H:6H:H ;GDB >9>DE6I=>8
-( HA::E 7:=6K>DG 9>HDG9:G >C I=: G:6A LDGA9 8A>C>86A EG68I>8:?
Naoko Tachibana (Japan)
52
(
*
)
D
A
4
53
(
*
)
D
A
4
54
(DC96N, .:EI:B7:G 30, 2013
.8: *7HIGJ8I>K: .A::E AEC:6, (DIDG 1:=>8A:H A88>9:CIH 6C9 DG>K>C<
'>8:CH: -:<JA6I>DCH
Tis symposium is supported by an unrestricted educational grant from General Directorate for trafc (Direccin de Trfco).
C=6>G:
Daniel Rodenstein (Belgium), Jean Krieger (France)
.E:6@:GH:
Daniel Rodenstein (Belgium), Joaquin Teran-Santos (Spain), Maria Segui (Spain), Julia Kremer (Belgium)
':6GC>C< *7?:8I>K:H:
After a general introduction of the subject under the perspective of the literature available up 2013, the symposium will examine
how different countries are implementing solutions for this issue.
/6G<:I AJ9>:C8::
Although not strictly speaking a medical matter, the issue is even more important since most physicians have little
knowledge of the driving license regulations and to their role as physicians in the process of authorizing or limiting or
preventing someone to access to a driving capacity.
.JBB6GN:
Every sleep specialist dealing with patients will be confronted to the question of motor vehicles driving obligations and
rights. This applies specially to obstructive sleep apnea, probably the medical disorder carrying the higher risk for
motor vehicle accidents.
5:00pm - 5:35pm
$CIGD9J8I>DC
Daniel Rodenstein (Belgium)
5:35pm - 5:50pm
*7HIGJ8I>K: HA::E 6EC:6 6C9 BDIDG K:=>8A: 688>9:CIH: I=: :K>9:C8:
Joaquin Teran-Santos (Spain)
5:50pm - 6:10pm
*7HIGJ8I>K: HA::E 6EC:6 6C9 GD69 EDA>8N. /=: .E6C>H= :ME:G>:C8:
Maria Segui (Spain)
6:10pm - 6:25pm
*7HIGJ8I>K: HA::E 6EC:6 6H 6 G>H@ ;68IDG ;DG GD69 H6;:IN. $C H:6G8= ;DG G:8D<C>I>DC
6:25pm - 6:45pm
*7HIGJ8I>K: HA::E 6EC:6 6C9 GD69 H6;:IN. /=: 0 6EEGD68=.
Julia Kremer (Belgium)
6:45pm 6:50pm
CDC8AJH>DC
Joaquin Teran-Santos (Spain)
6:50pm 7:00pm
,J:HI>DC 6C9 6CHL:G
22 +AD +." (6HI:G8A6HH: #DD@-JE; .A::E .I6<>C< 6C9 K:CI .8DG>C<;
/DE I>EH ;DG 8DBEA>6C8:
(
*
)
D
A
4
(DC96N, .:EI:B7:G 30, 2013
.9: ):JGD8D<C>I>DC 6C9 B:=6K>DG, .A::E D>HIJG76C8: 6C9 .A::E
D>HDG9:G:9 BG:6I=>C<
C=6>G:
.E:6@:GH:
Christian Guilleminault (USA), Sarah Biggs (Australia), Yu-shu Huang (Taiwan), Louise OBrien (USA),
Karen Spruyt (USA)
':6GC>C< *7?:8I>K:H:
There is very little knowledge on what happen following T&A perform for SDB on neurocognition. The symposium will
present new information on the impact of SDB and snoring in different age groups of children including pre-school and school
age children. It will also explore the impact of treatment on neurocognition, and the risks associated with currently untreated
mild sleep-disordered breathing on neurocognition and behavior.
/6G<:I AJ9>:C8::
Clinician involved in pediatric sleep, researchers involved in sleep disordered research, in psychological and cognitive
outcome and in assessment of cognitive risks and schooling impact.
.JBB6GN:
Neurocognition can be impaired in association with sleep disordered breathing. This impairment may impact learning
and behavior in children and may lead to behavioral changes. The symposium will present the results of 4-year
longitudinal data of behavioral and neurocognitive outcomes in children with sleep disordered breathing, comparing
those treated to those untreated in a cohort of Australian children; the results of a study looking at neurocognitive
changes within 6 months post adenotonsillectomy and follow-up of neurocognitive development of children during the
following 36 months and the results of longitudinal neurocognitive changes pre and post adenotonsillectomy in a
cohort of US school-age children and similar neurocognitive evaluation in pre-school and school-age children with cleft
palate, finally presentation of the impact on behavior and neurocognition on pre-school children in New-Zealand.
5:30pm - 5:32pm
$CIGD9J8I>DC
5:32pm - 5:52pm
.A::E-9>HDG9:G:9 7G:6I=>C< 6C9 C:JGD8D<C>I>K: 9:K:ADEB:CI: ;;:8I D; IG:6I>C< DG CDI
IG:6I>C< .DB->C
Sarah Biggs (Australia)
5:52pm - 6:12pm
A ADC< I:GB (36 BDCI=H) ;DAADL-JE HIJ9N D; 8=>A9G:C EDHI-/&A: C:JGD8D<C>I>K: 8=6C<:H:
:;;:8I D; 6<:
Yu-shu Huang (Taiwan)
6:12pm - 6:32pm
!DAADL-JE 8D=DGIH D; 8=>A9G:C L>I= *.A 6C9 CA:;I-E6A6I: 6C9 .DB: C:JGD8D<C>I>K: DJI8DB:
Louise OBrien (USA)
6:32pm - 6:52pm
*7:H>IN HA::E 9>HDG9:G:9 7G:6I=>C< 6C9 8D<C>I>DC >C 8=>A9G:C
Karen Spruyt (USA)
6:52pm 7:00pm
,J:HI>DC 6C9 6CHL:G
55
(
*
)
D
A
4
(DC96N, .:EI:B7:G 30, 2013
.10: $9:CI>;>86I>DC D; I=: ):JGDC6A ):ILDG@ -:<JA6I>C< I=:
.A::E-L6@>C< CN8A:: A ):K:G C9>C< .IDGN?
C=6>G:
Pierre Herve Luppi (France)
.E:6@:GH:
Pierre Herve Luppi (France), Antoine Adamantidis (Belgium), John Peever (Canada), Luis de Lecea (USA),
Christelle Peyron (France)
':6GC>C< *7?:8I>K:H:
This symposium will provide up to date information on the mechanisms and the neuronal network generating the
sleep-waking cycle.
/6G<:I AJ9>:C8::
The expected audience is a mix of basic and clinical researcher interested to obtain latest hypotheses on the mechanisms
controlling sleep.
.JBB6GN:
The purpose of this symposium is to provide latest update on the mechanisms at the origin of the sleep-waking cycle.
Combination of classical methods with latest advances in genetic manipulation of neurons (optogenetic,
pharmacogenetic, transgenic models) have been used to progress in the identification of the neuronal network
responsible for all sleep-wake stages. In particular, the role in sleep control of the posterior hypothalamus and of the
nucleus accumbens will be adressed. Brainstem network controlling REM sleep atonia will also be clarified.
5:30pm - 5:35pm
$CIGD9J8I>DC
5:35pm - 5:53pm
*EID<:C:I>8 9>HH:8I>DC D; =NEDI=6A6B>8 HA::E-L6@: 8>G8J>IH
Antoine Adamantidis (Belgium)
5:53pm - 6:11pm
/=: >9:CI>;>86I>DC D; I=: -( HA::E 8>G8J>I
John Peever (Canada)
6:11pm - 6:29pm
D>;;:G:CI ;A6KDGH D; DEID<:C:I>8 6L6@:C>C<H
Luis de Lecea (USA)
6:29pm - 6:47pm
/=: GDA: D; I=: =NEDI=6A6BJH >C -( HA::E 8DCIGDA
Christelle Peyron (France)
6:47pm 7:00pm
,J:HI>DC 6C9 6CHL:G
56
(
*
)
D
A
4
(DC96N, .:EI:B7:G 30, 2013
.11: $CCDK6I>DCH >C .A::E AEC:6 (6C6<:B:CI
C=6>G:
Meir Kryger (USA)
.E:6@:GH:
Meir Kryger (USA), David White (USA), Klar Yaggi (USA), Winfried Randerath (Germany)
':6GC>C< *7?:8I>K:H:
When CPAP therapy is not acceptable that there are alternative treatments to consider in selected patients
End expiratory airway pressure (EPAP), and oral pressure therapy (OPT) can be useful in selected OSA patients
Hypoglossal nerve stimulation is a potentially promising therapy in OSA
Treatment of OSA may prevent strokes
/6G<:I AJ9>:C8::
Clinicians and scientists managing OSA.
.JBB6GN:
This symposium will review management innovations in the treatment of OSA. The topics to be discussed include new
therapeutic modalities including EPAP, OPT and hypoglossal N stimulation, and whether CPAP can prevent strokes.
$CIGD9J8I>DC
Meir Kryger (USA)
+A+ I=:G6EN >C *.A
Meir Kryger (USA)
*+/ (*G6A +G:HHJG: /=:G6EN) >C *.A
David White (USA)
C6C C+A+ EG:K:CI HIGD@:H?
Klar Yaggi (USA)
#NED<ADHH6A ):GK: .I>BJA6I>DC >C *.A
Winfried Randerath (Germany)
,J:HI>DC 6C9 6CHL:G
Meir Kryger (USA)
57
(
*
)
D
A
4
(DC96N, .:EI:B7:G 30, 2013
.12: .A::E 6C9 C>G869>6C -=NI=B A7CDGB6A>I>:H >C (DD9 D>HDG9:GH
C=6>G:
Ruth Benca (USA)
.E:6@:GH:
Ruth Benca (USA), Kathleen Ries Merikangas (USA), Ian Hickie (Australia), Tiina Paunio (Finland)
':6GC>C< *7?:8I>K:H:
To gain understanding of the current status of research on activity patterns, sleep and circadian rhythms in relation to
mood disorders.
To appreciate the role of genetic and epigenetic mechanisms linking sleep and emotions.
To learn about changes in sleep-related brain plasticity in mood disorders.
To recognize the importance of varied research approaches to identify sleep and circadian targets for treatment
interventions in mood disorders.
/6G<:I AJ9>:C8::
This presentation is intended for both clinicians and scientists who are interested in the role of sleep and circadian rhythm
disturbances in mood disorders, including those with backgrounds in sleep and/or psychiatry. The presentations should be
accessible to those with more basic knowledge in the area, but will be of greater interest to the more advanced attendees.
.JBB6GN:
Abnormalities in the sleep-wake cycle, patterns of physical activity and circadian rhythms are core features of mood
disorders. Moreover, sleep and circadian rhythm disruptions are predictive of the onset of mood disorders and likely
contribute to their progression. This symposium will provide an overview of recent advances in our understanding of
the relationships between sleep and circadian rhythm abnormalities and mood disorders. Dr. Merikangas will discuss
findings from an epidemiologic family study enriched for people with mood disorders, including the relationship
between patterns of sleep and activity and mood disorder subtypes as well as ordinal associations between daily mood
fluctuations and sleep/activity patterns. Dr. Hickie will review work demonstrating that disrupted circadian function is
characteristic of young people with emerging mood disorders and is likely to be a key pathophysiological aspect of these
conditions. Dr. Paunio will describe the identification of DNA variants that affect both regulation of sleep and mood,
showing that at least some of the genetic variability in regulation of sleep and mood is shared. Finally, Dr. Benca will
discuss data from high density EEG studies of sleep and waking brain activity in depressed subjects that suggest
alterations in brain plasticity mechanisms. Taken together, these findings suggest that an increased focus on objective
measures of activity, sleep and circadian rhythms may provide key biomarkers for the onset, course and response to
treatment of mood disorders, as well as targets for clinical interventions.
5:30pm - 5:32pm
$CIGD9J8I>DC
Ruth Benca (USA)
5:32pm - 5:52pm
D6>AN G=NI=BH D; 68I>K>IN, HA::E 6C9 BDD9 >C 6 ;6B>AN HIJ9N D; 6;;:8I>K: HE:8IGJB 9>HDG9:GH
Kathleen Ries Merikangas (USA)
5:52pm - 6:12pm
.A::E 6C9 8>G869>6C G=NI=B 9>HGJEI>DC >C NDJC< E:DEA: L>I= :B:G<>C< BDD9 9>HDG9:GH
Ian Hickie (Australia)
6:12pm - 6:32pm
":C:I>8 G:<JA6I>DC D; HA::E 6C9 :BDI>DCH
Tiina Paunio (Finland)
6:32pm - 6:52pm
#><=-9:CH>IN " 6C6ANH>H D; HA::E >C 9:EG:HH>DC
Ruth Benca (USA)
6:52pm 7:00pm
,J:HI>DC 6C9 6CHL:G
Ruth Benca (USA)
58
(
*
)
D
A
4
59
(
*
)
D
A
4
(DC96N, .:EI:B7:G 30, 2013
D.-(-01: .A::E AEC:6 6C9 I=: ->H@ D; .IGD@:
/>8@:I G:FJ>G:9 - EJG8=6H: 6I G:<>HIG6I>DC 9:H@
C=6>G:
Antonio Culebras (USA)
/6G<:I AJ9>:C8::
Sleep practitioners, neurosomnologists, cardiologists, pulmonary physicians and internists, in practice or in training.
.JBB6GN:
To review the risk of stroke created by uncontrolled sleep apnea. The discussion will cover systemic hypertension, atrial fibrillation
and systemic inflammation as principal facilitators of stroke risk. Management options will be discussed.
60
(
*
)
D
A
4
(DC96N, .:EI:B7:G 30, 2013
D.-(-02: .A::E >C /G6JB6I>8 BG6>C $C?JGN: CJGG:CI &CDLA:9<: 6C9
!JIJG: D>G:8I>DCH />8@:I G:FJ>G:9 - EJG8=6H: 6I G:<>HIG6I>DC 9:H@
CD-C=6>GH:
Catherine Duclos (Canada), Tatyana Mollayeva (Canada)
.E:6@:GH:
Peter Meerlo (The Netherlands), Catherine Duclos (Canada), Tatyana Mollayeva (Canada)
':6GC>C< *7?:8I>K:H:
Have a grasp of the multifactorial etiology of sleep dysfunction post TBI
Recognize the role of the disruption in the neuroanatomical structures which can result in impaired sleep
Understand current techniques to measure sleep after TBI
Establish appropriate assessment of sleep in TBI practice to enhance patient outcomes and reduce treatment errors
Define future directions in the area of sleep post TBI
/6G<:I AJ9>:C8::
Clinicians and researchers with interest in sleep and TBI. Level of symposium content: Advanced.
.JBB6GN:
Sleep-wake dysfunction is common following Traumatic Brain Injury (TBI), and has intensified many threats post-injury. These
threats are not isolated to any particular organ or system; individuals with sleep disruption face increased threats of diminished
functioning and recovery in physical, behavioural, cognitive and emotional aspects. The aetiology of sleep-wake dysfunction is
poorly understood and reports on its incidence have also been problematic some cited a wide range between 21% and 73%.
Hidden in the statistics are even more troubling trends, such as ones ability to sustain purposeful, goal-oriented mental effort to
function independently after the injury. It is critical to note that sleep dysfunction is a major concern for individuals with TBI,
clinicians who attend to persons with TBI, and policyholders who allocate resources to mitigate this health concern.
Our discussion will review the available knowledge concerning sleep functioning in the TBI population. Our intent is to
simultaneously educate and increase the audiences interest and understanding of aetiology of sleep dysfunction post-TBI and to
facilitate a discussion in this critical area, resulting in multidisciplinary efforts (collaboration of sleep and TBI research) addressing
the problem of sleep disruption. The set of presenters in our symposium includes a neuroscientist from the University of Groningen
from the Netherlands and researchers in the field of sleep after brain injury from University of Toronto and Universit de Montral.
Our presentations will cover a range of topics, from understanding the underlying pathophysiological pathways through animal
models, to issues of identification, assessment and outcomes of sleep in human.
The first presentation discusses the underlying neuroanatomy associated with known pathophysiological mechanisms of TBI, and
types of injuries that lead to a disruption in the neuroanatomical structures that sub serve sleep-wake dysregulation. The
presentation is intended to emphasize the underlying pathophysiology after experimentally provoked brain injury in animals,
supporting that any primary or secondary damage to the areas that coordinate sleep-wake cycle (e.g. suprachiasmatic nucleus
(SCN) of the hypothalamus, reticular activating system, pontine nuclei) can be sufficient to cause dysregulation in sleep-wake
cycles. More specifically, this presentation will aim to address whether disrupted sleep may influence the course and outcome of
brain damage. Outline of possible future directions in these areas will follow.
The second presentation will discuss circadian rhythm disturbances in the acute phase of moderate to severe TBI, with a particular
focus on how circadian rhythms in the acute phase can provide indications on patient outcome at hospital discharge. The presenter
will raise pertinent question on how sleep disturbances may arise and evolve following TBI in human. Discussion of the future
directions in this area of research will follow.
The third presentation will discuss current methods of measuring sleep in TBI. A notable feature will be coverage on
comprehensive assessment of sleep functioning post-TBI in accordance with the ICSD. Relative indications, advantages,
disadvantages and limitations of self-report instruments, evidence on psychometric properties in the TBI population will be
presented. The presentation will conclude with a discussion of the future directions in measuring sleep after TBI, and will provide
information on the potential of new techniques available in the field.
Our sessions will end with a discussion, which will allow for potential formation of international collaborations and networks
between sleep and TBI researchers.
7:00pm - 7:15pm
AC>B6A BD9:AH ;DG :ME:G>B:CI6A HIJ9>:H DC HA::E 6C9 /B$
Peter Meerlo (The Netherlands)
7:15pm - 7:25pm
/=: 68JI: E=6H: D; /B$: 8>G869>6C G=NI=BH 6C9 E6I>:CI DJI8DB:
Catherine Duclos (Canada)
7:25pm - 7:40pm
.A::E B:6HJG:H >C /B$: >HHJ:H 6C9 DEEDGIJC>I>:H
Tatyana Mollayeva (Canada)
61
(
*
)
D
A
4
(DC96N, .:EI:B7:G 30, 2013
D.-(-03: +=6GB68D-.A::E: I=: AHH:HHB:CI D; DGJ< ;;:8IH DC
#JB6C .A::E />8@:I G:FJ>G:9 - EJG8=6H: 6I G:<>HIG6I>DC 9:H@
CD-C=6>GH:
Sandra Gimnez Badia (Spain), Peter Anderer (Austria)
.E:6@:GH:
Rapahelle Winsky Sommerer (UK), Peter Anderer (Austria), Barry T. Peterson (USA)
':6GC>C< *7?:8I>K:H:
Provide support for the design and analysis of pharmaco-sleep studies in human
Assist reseachers using sleep EEG in clinical and basic research, giving specific recommendations, and thereby enabling
standardisation of methodology and facilitating comparability of data across labs
The utility of PSG (and sleep EEG) measures as translatable biomarkers of central pharmacology in the development of drugs
The role of actigraphy in pharmaco-sleep studies
Provide from basic to advance level a multidisciplinary approach to asses drug effects on human sleep
/6G<:I AJ9>:C8::
Audience interested in sleep human psychopharmacology, basic level. Researchers and sanitary workers with basic and advance
experience of design, implementation, analysis and reporting of Human Pharmaco- Sleep Studies trials. Advance researchers using
sleep EEG in clinical research, giving specific recommendations, and thereby enabling standardisation of methodology and
facilitating comparability of data across labs. From basic to advance level provide to all personal working in the sleep field a
multidisciplinary and translational evaluation of drug effects on sleep: subjective scales, objective tests, sleep recording tools,
clinical, human performance measurement and circadian variations.
.JBB6GN:
Sleep complaints are very common in our society. Efforts in pharmacological treatment research are therefore constantly increasing.
However, evaluating effectiveness of drug treatment on sleep and sleep disorders needs to be accurate and with a multidisciplinary
analysis approach. In the present symposia, a multidisciplinary but integrated assessment of drug effects on human sleep are presented.
1. The International Pharmaco-EEG Society (IPEG) recently presented guidelines summarising the requirements for the recording and
computerised evaluation of pharmaco-sleep data in man(1). These guidelines provide a set of recommendations enabling the
standardisation of both the experimental conditions and the data processing approaches, thereby promoting a framework aimed at
facilitating the comparison of pharmaco-sleep studies across laboratories, a crucial aspect in the context of drug development programs
and the evaluation of the CNS penetration or toxicity of compounds. Ultimately, this standardisation will enable the pooling of data
which is a requirement for sufficiently powering the validation of novel analytical algorithms and the detection of EEG-based
(translatable) biomarkers. [1] Jobert M, Wilson FJ, Roth T, Ruigt GSF, Anderer P, Drinkenburg WHIM, et al.: Guidelines for the
recording and evaluation of pharmaco-sleep studies in man - International Pharmaco-EEG Society (IPEG). Neuropsychobiology 2013
(in press).. 2. Based on the polysomnographic (PSG) databases recorded in the EU-funded projects SIESTA and SENSATION, we
established a normative database for sleep macro- and microstructure. The database covers healthy subjects from 20 to 95 years (90
males, 99 females), nearly equally distributed in all decades. The meaningful use of this normative data requires an analysis method that
results in unbiased and reproducible scorings. We will show examples for the usage of the database in sleep medicine (determining
deviations of patients individual sleep characteristics from normative values) and sleep research (assisting in the interpretation of results
of pharmaco sleep studies). 3. Sleep architecture and sleep EEG measures are useful translatable biomarkers of central pharmacology
with utility in drug development. However interpretation is not always straightforward due to the large number of potential endpoints
and hence it can be difficult to make the clear decisions that are essential to the industry. This talk will discuss how preclinical sleep data
and knowledge of translatability can be used to generate robust hypotheses for testing in early clinical studies and hence enable robust
decision-making. 4. Activity-based sleep-wake monitoring using accelerometer-based devices (actigraphy) has become a major tool in
sleep research and sleep medicine, as a potential alternative to the standard neurophysiological techniques ( polisomnography). Several
reviews have established the use of actigraphy as a reliable and valid assessment method to document sleep-wake patterns, circadian
activity and daytime sedation in pharmaco-sleep studies, not only to evaluate the acute drug effects, but particularly when there is a
need to assess the drug effects on the rest-activity cycle over long time periods. Moreover, it has the advantage of providing objective
information of the repercussion of the drug administration in the patient's natural sleep environment and habits or to ensure the
compliance in drug development. 5. The assessment of drug effects on psychometrics of psychological performance, cognitive function
and memory will be presented. Translational evaluation of these drug effects on sleep by means of different objective tests, skills,
physiological and subjective rating scales will be discussed.
"J>9:A>C:H ;DG E=6GB68D-HA::E HIJ9>:H >C B6C
Peter Anderer (Austria)
/=: >BEDGI6C8: D; D7?:8I>K: 6HH:HHB:CIH D; =DB: HA::E E6II:GCH >C HA::E G:H:6G8= 6C9 =:6AI=86G:
Barry T. Peterson (USA)
(JAI>9>H8>EA>C6GN 6C9 IG6CHA6I>DC6A :K6AJ6I>DC D; 9GJ<H :;;:8IH DC HA::E.
Rapahelle Winsky Sommerer (UK)
62
(
*
)
D
A
4
(DC96N, .:EI:B7:G 30, 2013
D.-(-04: 2DG@, .8=DDA, .A::E, 6C9 *88JE6I>DC6A #:6AI= 6C9 .6;:IN
>C A9DA:H8:CIH 6C9 4DJC< A9JAIH
C=6>G:
Luc Laberge (Canada)
.E:6@:GH:
Luc Laberge (Canada), Frida M. Fischer (Brazil), Christopher P. Landrigan (USA), Lilian R. Teixeira (Brazil)
':6GC>C< *7?:8I>K:H:
Describe the consequences of long working hours on sleep, academic performance, social behavior, and substance
abuse of students
Recognize the impact of long work hours and sleep restriction on occupational health and safety of students
Translate and apply recent sleep research findings into practice to promote occupational health and safety risks for physicians
in training
Acknowledge the important role played by sleep physicians and researchers in preventing sleep-related injuries and deaths by
assessment and follow-up of excessive sleepiness in their adolescent and young adult patients
/6G<:I AJ9>:C8::
This symposium is intended for occupational health and environmental physicians, primary care physicians, nurses,
nurse practitioners, pediatricians, physician assistants, and other healthcare professionals involved in the routine
preventive care of adolescents and young adults.
.JBB6GN:
Twenty-five years ago, the National Institutes of Health (NIH) targeted adolescents and young adults (ages 12 to 25 years) as a
population at high risk for problem sleepiness. Today, excessive daytime sleepiness in this age group still constitutes a widespread
problem and has potential deleterious effects on the individuals performance, health, and safety. Over the past three decades, it has
been noted that students in many countries have increased the amount of time they dedicate to paid work during the school year.
However, sleep curtailment remains an insufficiently acknowledged factor of why employment may prove detrimental to the
academic achievement and occupational health and safety of students who work extensive hours. Also, the downside of student
employment during the school year has been mainly discussed in terms of the number of hours dedicated to paid work (more than
20 hours per week) and its relationship with sleep duration but more rarely in terms of exposure to physical, psychosocial, and
organizational work constraints. This symposium will first present the latest evidence on the relationship between sleep, work
characteristics, and occupational health and safety in student workers. In addition, this symposium will discuss the necessary
revisions to medical residents workloads and duty hours so to protect patients against fatigue-related errors and to enhance the
learning environment for doctors in training, namely by providing regular opportunities for sleep each day and each week during
resident training.
$CIGD9J8I>DC
7:00pm - 7:15pm
.D8>6A 6C9 LDG@ ;68IDGH DC NDJI= :BEADNB:CI: >BE68I DC HA::E, HA::E>C:HH 6C9 =:6AI= HNBEIDBH
Frida M. Fischer (Brazil)
7:15pm - 7:30pm
.A::E, LDG@-G:A6I:9 ;6I><J: 6C9 D88JE6I>DC6A H6;:IN >C HIJ9:CI LDG@:GH
7:30pm - 7:45pm
-:H>9:CI-E=NH>8>6CHQ HA::E 9:EG>K6I>DC: :;;:8IH DC D88JE6I>DC6A 6C9 E6I>:CI H6;:IN
Christopher P. Landrigan (USA)
7:45pm - 8:00pm
$CI:GK:CI>DC HIJ9>:H ID >BEGDK: HA::E 9JG6I>DC 6C9 HA::E>C:HH 6BDC< 69DA:H8:CIH 6C9
NDJC< 69JAIH.
Lilian R. Teixeira (Brazil)
63
(
*
)
D
A
4
(DC96N, .:EI:B7:G 30, 2013
D.-(-05: $BEGDK>C< I=: .8DG>C< D; -( .A::E 2>I=DJI AIDC>6 6C9
D; (JH8A: A8I>K>IN DJG>C< -( .A::E
C=6>G:
Marco Zucconi (Italy)
.E:6@:GH:
Raffaele Ferri (Italy), Birgit Hgl (Austria)
':6GC>C< *7?:8I>K:H:
To show a new validated visual method to better catch phasic muscle activity in different body segments and its
usefulness for diagnosing RBD
To discuss the value of including potential screening and diagnostic criteria such as an automated and/or visual
scoring techniques of tonic/phasic EMG activity during REM sleep in RBD
To apply these new methods in the clinical practice of scoring RBD polysomnography
/6G<:I AJ9>:C8::
This proposal is intended for clinicians, fellows, students and PSG technicians involved in patient management and
scientists interest in evaluating objectively RBD and their associated features.
.JBB6GN:
The main polysomnographic feature of RBD, REM sleep without atonia (RWA), needs to be better defined because its current
description has no quantitative character. Until now, there has not been a generally accepted consensus on how muscle activity
during REM sleep should be scored, and which muscles or muscle combinations are the most suitable for differentiating between
RBD and non-RBD subjects. In recent years some methods have been proposed for the analysis of both the EMG activity in
different muscles and the automatic quantification of the amplitude of the chin EMG signal during REM sleep, with the aim to
use them as a markers of REM sleep atonia alteration and, eventually, to support the diagnosis of RBD. The simultaneous EMG
recording of the mentalis, flexor digitorum superficialis and extensor digitorum brevis muscles and the quantitative method (atonia
index) will be discussed and it will be showed that the new methods are able not only to disclose differences between normal
controls and patients with RBD, but also between nosologically different groups of patients who seem to present with different
types of REM sleep-related motor disturbances.
/=: JH:;JAC:HH D; I=: AIDC>6 $C9:M ;DG FJ6CI>;N>C< -.2A >C -BD 6C9 >C 9>;;:G:CI 8DC9>I>DCH
(" 68I>K>IN 6HH:HHB:CI >C 9>;;:G:CI BJH8A:H ID >BEGDK: I=: 9>6<CDH>H D; -'.
64
(
*
)
D
A
4
(DC96N, .:EI:B7:G 30, 2013
D.-(-06: $H /=:G: 6 -DA: ;DG .JG<:GN >C I=: (6C6<:B:CI D;
*7HIGJ8I>K: .A::E AEC:6?
C=6>G:
Vijaya Krishnan (India)
.E:6@:GH:
Vijaya Krishnan (India), Srinivas Kishore (India), Vikas Agrawal (India)
':6GC>C< *7?:8I>K:H:
To determine the significance of identifying the level of obstruction and to formulate a rationale approach in the
management of Obstructive Sleep Apnea
To discuss the newer concepts of various surgical modalities available and also to decide - when not to do surgery
/6G<:I AJ9>:C8::
ENT Surgeon, Faciomaxillary Surgeon, Chest Physician, Sleep Physician.
.JBB6GN:
There are various modalities such as drug induced sleep endoscopy, dynamic sleep MRI, Apnoeagraph are available for assessment
of level of obstruction which will help to decide appropriate surgery in properly selected cases for a successful outcome.
7:00pm - 7:05pm
$H I=:G: 6 GDA: ;DG .JG<:GN >C I=: (6C6<:B:CI D; *.A.?
7:05pm - 7:20pm
):L:G 8DC8:EIH >C 699G:HH>C< I=: E6A6I6A A:K:A D7HIGJ8I>DC
Srinivas Kishore (India)
7:20pm - 7:35pm
):L:G 8DC8:EIH >C 699G:HH>C< I=: /DC<J: 76H: D7HIGJ8I>DC
Vikas Agrawal (India)
7:35pm - 7:50pm
CDC8AJH>DC -:B6G@H 6C9 D>H8JHH>DC
65
(
*
)
D
A
4
(DC96N, .:EI:B7:G 30, 2013
D.-(-07: #DL ID AHH:HH 6C9 /G:6I .A::E D>HDG9:GH >C
+G:<C6CI 2DB:C
CD-C=6>GH:
Rosalia Silvestri (Italy), Mauro Manconi (Switzerland)
.E:6@:GH:
Rosalia Silvestri (Italy), Jennifer Hensley (USA), Mauro Manconi (Switzerland), Cinzia Castronovo (Italy)
':6GC>C< *7?:8I>K:H:
Learn about adverse outcomes of sleep disorders on maternal and fetal health
Learn how to assess sleep disorders in pregnancy across the trimesters
Learn safe and effective treatment options for sleep disorders in pregnancy
Discuss how to prevent and treat sleep disorders in pregnancy according to the latest evidence-based consensus
guidelines in the fields of sleep & obstetrics
/6G<:I AJ9>:C8::
Sleep clinicians, gynecologists, pediatricians, nurses, and sleep technicians.
.JBB6GN:
The outlines and endpoints of the Italian multicenter study on sleep disorders in pregnancy will be presented to open a
discussion on the most recent data concerning the epidemiology and impact of sleep disorders across the different
trimesters of pregnancy. The different speakers will emphasize the assessment therapy of OSAS, the prognosis and
treatment of RLS/WED in pregnancy according to the new guidelines, and the non-pharmacological approach via
cognitive behavioral therapy for insomnia in pregnant women.
A (JAI>8:CI:G $I6A>6C .IJ9N DC HA::E 9>HDG9:GH >C EG:<C6C8N: I=: GDA: D; *.A. DC
B6I:GC6A 6C9 ;:I6A
Rosalia Silvestri (Italy)
+G:K6A:C8: & E>9:B>DAD<N D; 2D/-'. >C +G:<C6C8N
Jennifer Hensley (USA)
"J>9:A>C:H DC -'./2D IG:6IB:CI >C EG:<C6C8N
Mauro Manconi (Switerland)
A CDC-E=6GB68DAD<>8 6EEGD68= ID >CHDBC>6 IG:6IB:CI >C EG:<C6C8N: 8D<C>I>K:-7:=6K>DG6A I=:G6EN
Cinzia Castronovo (Italy)
66
(
*
)
D
A
4
(DC96N, .:EI:B7:G 30, 2013
D.-(-08: +:G>D9>8 '>B7 (DK:B:CIH JC9:G C+A+ >C *7HIGJ8I>K:
.A::E AEC:6 .NC9GDB:
C=6>G:
Gimbada B. Mwenge (Belgium)
.E:6@:GH:
Gimbada B. Mwenge (Belgium), Daniel Rodenstein (Belgium)
':6GC>C< *7?:8I>K:H:
Prevalence of PLM's in patients with severe OSAS
Changes in PLM's in these patients when treated with CPAP.
Effects of these PLM's in the absence of apneas on sleep
Relate the presence and evolution of PLM's to the long-term compliance with CPAP.
/6G<:I AJ9>:C8::
Physicians interested in sleep- related movements disorders and in obstructive sleep apnea diagnosis and treatment.
.JBB6GN:
A large cohort of patients with complaints suggestive of OSAS was prospectively included. PLM's were determined during the
diagnostic polysomnography. Patients were habituated to CPAP during 2-3 nights using the Hoffstein-Mateika pressure prediction
formula. PLM's were again determined during the treatment polysomnography performed in the same week. PLM's could
decrease, increase, or remain stable. Patients were followed for one year, and long-term compliance was obtained from the CPAP
devices. these data will be presented and analyzed.
PLM's assessment is time consuming and their added value as a diagnostic or prognostic indicator re unknown in OSAS. If PLM's
in OSAS are simple epiphenomena without influence on sleep quality, symptoms or long-term compliance with CPAP, then they
could be ignored without harm.
67
(
*
)
D
A
4
(DC96N, .:EI:B7:G 30, 2013
D.-(-09: A7DG96?: 9:A .A#. 9:H9: A6 E:GHE:8I>K6 9:A
*-'/CA>C>86A B6C6<:B:CI D; *.A: I=: )/ K>:LED>CI
'6C<J6<:: Spanish
Supported by Spanish ENT Society
C=6>G:
Eduard Esteller (Spain)
.E:6@:GH:
Enrique Fernandez Julin (Spain), Eugenio Vicente (Spain), Javier Vila (Spain), Carlos Oconnor (Spain)
':6GC>C< *7?:8I>K:H:
Last update to ENT surgeons in the diagnosis and treatment of OSAS approach. Revision of the different indications,
techniques and results to treat and exanimate airway collapsibility.
/6G<:I AJ9>:C8::
Advanced primarily for specialists surgeons dedicated to treat sleep disorders.
.JBB6GN:
Respiratory disorders are a pathology that requires a multidisciplinary approach. Following that idea, otolaryngologist
has been and must keep fundamental. In this round table, basic guidelines are presented where the ent specialist has
main relevance, especially in newest surgical and examination techniques to evaluate the upper airway.
7:00pm - 7:15pm
.JG<>86A EA6CC>C< 6;I:G HA::E C6HD:C9DH8DEN K:GHJH 6L6@: I:8=C>FJ:H >C D7HIGJ8I>K: HA::E 6EC:6
Enrique Fernandez Julin (Spain)
7:15pm - 7:30pm
#NEDE=6GNC<:6A HJG<:GN ;DG *.A.
Eugenio Vicente (Spain)
7:30pm - 7:45pm
*I=:G IG:6IB:CIH ;DG *.A DI=:G I=6C C+A+ 6C9 .JG<:GN: I=: B6C9>7JA6G 69K6C8:B:CI HEA>CIH
Javier Vila (Spain)
7:45pm - 8:00pm
)6H6A 6C9 E6A6I6A HJG<:GN ;DG *.A. IG:6IB:CI: ID96N'H >C9>86I>DCH
Carlos Oconnor (Spain)
68
(
*
)
D
A
4
(DC96N, .:EI:B7:G 30, 2013
D.-(-10: -:8:CI 0E96I:H >C I=: D>6<CDH>H D; $CHDBC>6 P D.(5 6C9
$C.D-3: $BEA>86I>DCH ;DG -:H:6G8= 6C9 CA>C>86A +G68I>8:
CD-C=6>GH:
Charles Morin (Canada), Jack Edinger (USA)
.E:6@:GH:
Colin Espie (United Kingdom), Jack Edinger (USA), Leon Lack (Austrailia), Charles Morin (Canada),
Ruth OHara (USA), Michael Thorpy (USA), Kai Spiegelhalder (Germany), Eus Van Someren (The Netherlands)
':6GC>C< *7?:8I>K:H:
To review recent updates in the diagnosis of insomnia according to DSM-5 and ICSD-3 nosologies.
To discuss the potential implications of these changes on the epidemiology, assessment, and treatment of insomnia
/6G<:I AJ9>:C8::
This session is intended both for sleep medicine clinicians and researchers.
.JBB6GN:
Significant changes have been made to the diagnostic criteria of insomnia in DSM-5 and ICSD-3, including the
elimination of the distinction between Primary and Secondary Insomnia, the dropping of non-restorative sleep
from the insomnia definition. This session is intended to provide a forum to review these updated diagnostic criteria
and discuss their potential implications for clinical practice and future research. Selected key issues will be addressed by
the panelists and an open discussion with follow with the audience (e.g., are these changes likely to improve case
definition, recognition and diagnostic accuracy, and promote treatment?).
69
(
*
)
D
A
4
(DC96N, .:EI:B7:G 30, 2013
D.-(-11: (DK:B:CI D>HDG9:GH 6C9 .A::E - A 1>9:D .:B>C6G
CD-C=6>GH:
Friederike Sixel-Dring (Germany), Yves Dauvilliers (France)
.E:6@:GH:
Alex Iranzo (Spain), Guiseppe Plazzi (Italy), Friederike Sixel-Dring (Germany)
':6GC>C< *7?:8I>K:H:
To learn the wide spectrum of motor manifestations occurring in patients with RLS and PLMS (from movements
affecting only the big toe to those affecting the whole body), and how to distinguished them from other abnormal
movements involving the lower limbs (alternating leg movements, hypnic jerks, foot tremor, etc)
To learn the wide motor (punching, kicking, gesticulations, etc) and vocal (yelling, talking, giving a speech, etc)
manifestations occurring in REM sleep. To show that the most common behaviors seen on video are prominent jerks
but may differ according to underlying pathologies.
To learn other unusual movements and behaviors (head banging, hallucinations in sleep, confusional arousals in
dementia, sleep-related eating syndrome) and vocal (stridor, catathrenia, bruxism, snoring) occurring in sleep
To learn the different manifestations of RBD in the setting of Parkinsons disease that can be captured on video
during polysomnography
To learn how a wide variety of sleep disorders are presented as inserts in several films and cartoons
/6G<:I AJ9>:C8::
The sleep specialist, the movement disorder specialist and the general neurologist.
.JBB6GN:
Movement disorders during sleep are common and include a wide variety of abnormal motor (punching, repetitive leg
movements, jumping out of bed, seizures, head banging, etc) and vocal manifestations (shouting, crying, stridor,
cathatrenia, etc) . They are usually linked to neurological conditions such as restless legs syndrome, sleepwalking, REM
sleep behavior disorder, narcolepsy, epilepsy and neurodegenerative diseases including Parkinsons disease. They should
be recognized by the sleep specialist, the movement disorder specialist and the general neurologist.
7:00pm - 7:12pm
/=: L>9: 8A>C>86A HE:8IGJB D; -'. 6C9 +'(.
Alex Iranzo (Spain)
7:12pm - 7:24pm
-BD HE:8IGJB, HA::EL6A@>C< 6C9 CD8IJGC6A :E>A:EHN
Guiseppe Plazzi (Italy)
7:24pm - 7:36pm
0CJHJ6A BDK:B:CIH 6C9 CD>H:H D88JGG>C< 9JG>C< HA::E
Alex Iranzo (Spain)
7:36pm - 7:48pm
-BD >C +6G@>CHDCQH D>H:6H:
Friederike Sixel-Dring (Germany)
7:48pm - 8:00pm
.A::E G:A6I:9 BDK:B:CI 9>HDG9:GH >C 86GIDDCH 6C9 ;>ABH
Alex Iranzo (Spain)
70
/J:H96N
.8=:9JA: 6I 6 "A6C8: /J:H96N, *8ID7:G 1, 2013
_________________________________________________________________
-:<>HIG6I>DC 7:006B - 9:00EB
_________________________________________________________________
_________________________________________________________________
&:NCDI: 9:006B - 10:006B
_________________________________________________________________
.NBEDH>JB .13-16 10:006B - 11:306B
_________________________________________________________________
M=>7>I>DC 11:006B - 5:00EB
_________________________________________________________________
CD;;:: BG:6@ 11:306B - 12:00EB
_________________________________________________________________
.NBEDH>JB .17-18, /:8=CDAD<>HI +GD<G6B, *G6A +G:H:CI6I>DCH *-6 6C9 *-7 12:00EB - 1:30EB
_________________________________________________________________
BG:6@ 1:30EB - 1:40EB
_________________________________________________________________
0CB $C9JHIGN .NBEDH>JB 1:40EB - 3:10EB
_________________________________________________________________
.:C/:8 $C9JHIGN .NBEDH>JB 1:40EB - 3:10EB
_________________________________________________________________
CD;;:: 6C9 M=>7>I 3:10EB - 3:30EB
_________________________________________________________________
&:NCDI: 3:30EB - 4:30EB
_________________________________________________________________
_________________________________________________________________
.NBEDH>JB .19-21 6C9 /:8=CDAD<>HI +GD<G6B, *G6A +G:H:CI6I>DC *-12 5:30EB - 7:00EB
_________________________________________________________________
D>H8JHH>DC .NBEDH>JB 7:00EB - 8:00EB
_________________________________________________________________
2A.( (:B7:G (::I>C< 8:30EB - 9:30EB
_________________________________________________________________
71
/
0
.
D
A
4
/J:H96N, *8ID7:G 1, 2013
9:006B ID 10:006B AJ9>IDG>JB 1
&:NCDI:: C>G869>6C D>HDG9:GH 6C9 AHHD8>6I:9 ->H@H
Phyllis Zee, MD
Northwestern University, Feinberg School of Medicine
USA
Dr. Zee's research has focused on the efects of age on sleep and circadian rhythms,
genetic regulation of circadian sleep disorders, and behavioral interventions to
improve sleep and performance. Current NIH-funded research projects include
studies to examine the ability of exercise to improve sleep and health in older people
with insomnia, phenotypic characterization and genetic analysis of circadian rhythm
sleep disorders, relationship between sleep, metabolic and cardiovascular risk and
the efects of age on the neural response to sleep loss.
)DI:H:
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
72
/
0
.
D
A
4
/J:H96N, *8ID7:G 1, 2013
10:006B ID 11:306B AJ9>IDG>JB 2
.13: .A::E, C>G869>6C -=NI=BH 6C9 BG6>C #:6AI= >C A<>C<
CD-8=6>GH:
Aleksandar Videnovic (USA), Nadia Gosselin (Canada)
.E:6@:GH:
Symposium Chairs (USA/Canada), Sonia Ancoli-Israel (USA), Nadia Gosselin (Canada), Aleksandar Videnovic (USA),
Alex Iranzo (Spain), Alpar S. Lazar (United Kingdom)
':6GC>C< *7?:8I>K:H:
Discuss sleep and circadian dysfunction in Alzheimer's disease.
Understand the impact of sleep disordered breathing on cognition.
Discuss how circadian dysregulation and impaired sleep-wake cycle impact Parkinson's disease.
Understand the interface of RBD and neurogenerration.
Identify sleep and circadian rhythms disturbances in Huntington's disease.
/6G<:I AJ9>:C8::
Practitioners, academicians, residents, postdoctoral fellows.
.JBB6GN:
Sleep dysfunction in neurological diseases remains frequently under-recognized by physicians and under-reported by
patients. Some of the clearest evidence of the bidirectional relationship between sleep and circadian rhythms and
expression of disease is seen in neurodegenerative disorders. This program emphasizes the role of impaired sleep,
alertness and circadian rhythmicity in three major neurodegenerative disorders, AD, PD and HD. REM sleep behavior
disorder and its associations with neurodegenerative disorders will be discussed. The program encompasses fields of
neurodegeneration, sleep, and circadian biology, integrating basic science with clinical practice of neurology and sleep
medicine. Greater understanding of the underlying mechanisms of circadian and sleep disturbances has transformative
potential for neurodegenerative disorders and provides new dimension in neurology and sleep medicine.
10:00am - 10:05am
$CIGD9J8I>DC
Symposium Chairs (USA/Canada)
10:05am - 10:20am
.A::E 6C9 8>G869>6C 9>HDG9:GH 6C9 I=:>G B6C6<:B:CI >C AAO=:>B:GQH 9>H:6H:
Sonia Ancoli-Israel (USA)
10:20am - 10:35am
CDCH:FJ:C8:H D; D7HIGJ8I>K: HA::E 9>HDG9:G:9 7G:6I=>C< DC 8D<C>I>DC 6C9 7G6>C =:6AI=
>C I=: :A9:GAN
Nadia Gosselin (Canada)
10:35am - 10:50am
.A::E 6C9 C>G869>6C -=NI=B DNH;JC8I>DC - $BEA>86I>DCH ;DG +6G@>CHDCQH D>H:6H:
Aleksandar Videnovic (USA)
10:50am - 11:05am
-( HA::E 7:=6K>DG 9>HDG9:G 6C9 C:JGD9:<:C:G6I>K: 9>H:6H:H
Alex Iranzo (Spain)
11:05am 11:20am
D>HGJEI>DC D; .A::E 6C9 C>G869>6C />B>C< >C #JCI>C<IDC'H D>H:6H:
Alpar S. Lazar (United Kingdom)
11:20am 11:30am
,J:HI>DC 6C9 6CHL:G
Symposium Chairs (USA/Canada)
73
/
0
.
D
A
4
/J:H96N, *8ID7:G 1, 2013
10:006B ID 11:306B AJ9>IDG>JB 3
.14: MEA6>C>C< D>;;:G:C8:H >C E>9:B>DAD<N D; .A::E D>HDG9:GH
A8GDHH I=: 2DGA9: /=: C6H: D; .DB 6C9 -'.
C=6>G:
.E:6@:GH:
Diego Garcia Borreguero (Spain), Manuel Sanchez de la Torre (Spain), Klaus Berger (Germany), Yuichi Inoue (Japan),
Juliane Winkelman (USA), Christian Guilleminault (USA)
':6GC>C< *7?:8I>K:H:
Relationship between sleep metabolism, circadian rythm and cancer risk
Sleep disturbances and cancer risk (especially sleep duration)
Role of Melatonine and hypnotic treatments in cancer
New discoveries. Intermittent hypoxia and cancer in animal models
New discoveries. Sleep apnea and risk of cancer. Incidence and mortality
The future. New studies needed and the role sleep disorders treatment in cancer
/6G<:I AJ9>:C8::
Everyone with interest in sleep disorders.
.JBB6GN:
There are differences in the rate of sleep disorders throughout the world, and genetics behind these disorders may explain
these differences, genetic and epidemiology are very much linked when considering our understanding of the clinical findings.
Two major sleep disorders are considered in the symposium: OSA and RLS. The current understanding of the genetics behind
OSA will be presented, and the racial differences in OSA noted in a multi-racial population (Australia) will be outlined.
Similarly, prevalence of RLS has been consistently high in western countries; however studies performed in non-Caucasians
have been lower. Our understanding of the genetics behind these disorders may explain some of the discrepancies noted
depending of the racial presentation.
10:00am - 10:05am
$CIGD9J8I>DC
10:05am - 10:20am
":C:I>8H D; .A::E AEC:6
Manuel Sanchez de la Torre (Spain)
10:20am - 10:35am
-68>6A 9>;;:G:C8:H >C HA::E-9>HDG9:G:9 7G:6I=>C< HE:8>;>8 EDEJA6I>DC
10:35am - 10:50am
-'. EG:K6A:C8: 6GDJC9 I=: LDGA9 P CJB7:GH, B:I=D9H, 6C9 >CI:GEG:I6I>DCH
Klaus Berger (Germany)
10:50am - 11:05am
-'. :E>9:B>DAD<N >C AH>6: /=: %6E6C:H: E:GHE:8I>K:
Yuichi Inoue (Japan)
11:05am - 11:20am
D>;;:G:C8: >C :I=CD-<:C:I>8H EG:9>HEDH>I>DC ID -'. 68GDHH I=: LDGA9
Juliane Winkelman (USA)
11:20am - 11:30am
,J:HI>DC 6C9 6CHL:G
74
/
0
.
D
A
4
/J:H96N, *8ID7:G 1, 2013
.15: +G:<C6C8N 6C9 .A::E
C=6>G:
Leigh Signal (New Zealand)
.E:6@:GH:
Louise OBrien (USA), Mauro Manconi (Switzerland), Maria Sarberg (Sweden), Leigh Signal (New Zealand)
':6GC>C< *7?:8I>K:H:
Understand how sleep changes during pregnancy and how these changes impact health, particularly the need for
medical intervention at birth and maternal mental health.
Educate Sleep clinicians and researchers on the need to consider pregnant women with sleep disorders differently than
the general population.
Suggest new field of research on sleep and woman.
.JBB6GN:
Pregnancy is a period when sleep change and some of the changes may have negative outcome for women and
offspring. An understanding of these changes and to recognize them to prevent as much as possible negative outcome is
an important goal. Mother may present significant and dangerous depression that may imacvt well been of both mother
and child. Sleep in late pregnancy will have a clear impact in general on the immediat post-partum period. And
presence or development of well-known sleep disorders such as abnormal breathing during sleep and Restless Leg will
impact both mother and child. The understanding on how fetal development may be affected, and also how mother
health can be greatly disturb will be presented in this symposium
$CIGD9J8I>DC
.CDG>C< >C EG:<C6C8N: ;;:8IH DC I=: D;;HEG>C<
Louise OBrien (USA)
-:HIA:HH A:<H 6C9 EG:<C6C8N - L=:C, =DL 6C9 L=N?
Mauro Manconi (Switzerland)
.A::E>C< EGD7A:BH 6C9 EDHI-E6GIJB 9:EG:HH>DC
Maria Sarberg (Sweden)
.A::E >C A6I: EG:<C6C8N 6C9 I=: G:A6I>DCH=>E ID B6I:GC6A =:6AI=
75
/
0
.
D
A
4
/J:H96N, *8ID7:G 1, 2013
.16: $CI:GEG:I>C< 6C9 K6AJ6I>C< +6G6HDBC>6H: ):L +:GHE:8I>K:H
C=6>G:
.E:6@:GH:
Federica Provini (Italy), Lino Nobili (Italy), Isabelle Arnulf (France), Thanh Dang-Vu (Canada)
':6GC>C< *7?:8I>K:H:
To understand that sleep is not simply a quiescent state, but can involve behaviours of varying complexity. To
understand that during arousal disorders EEG features of sleep and wakefulness might be simultaneously present in
different cerebral regions suggesting that sleep depth is not evenly distributed within the brain. To understand that
dreamlike mentation may occasionally exist during arousal disorders, suggesting that a complex mental activity also
takes place during SWS. To understand how neuroimaging methods might be a useful approach to assess the structural
and functional correlates of sleep impairments enhancing our understanding of the pathophysiological mechanisms of
sleep disorders, including parasomnias. To understand that wake and sleep behaviour and body homeostasis are
controlled by a neuronal network running from the brainstem to the cerebral cortex and working in a unitary fashion
according to a caudorostral organization.
/6G<:I AJ9>:C8::
Neurologists, Paediatricians, Psychiatrists, Psychologists Level of symposium: advanced.
.JBB6GN:
Parasomnias are very common, especially among children, but there are many misconceptions about them and
neuropathological abnormalities have not been identified for most of the common parasomnias. The study of
parasomnias provides unique opportunities to understand the mechanisms that regulate sleep and wakefulness. In this
symposium we will present recent data obtained using intracerebral electroencephalographic recordings suggesting that
arousal disorders are not a global cerebral phenomenon, but the coexistence of different local states of being. We will
present the latest data on the complex mental activity taking place during REM and NREM parasomnias and the
specific changes in brain structure or regional activity obtained with functional neuroimaging techniques. Lastly, we
will present data on Agrypnia Excitata (AE), a syndrome characterized by loss of sleep and permanent motor and
autonomic hyperactivation, making some general reflections on the composition and function of the cerebral neuronal
network generating wake and sleep behaviour and regulating body homeostasis.
10:00am - 10:05am
$CIGD9J8I>DC
10:05am - 10:25am
'D86A 68I>K6I>DCH >C +6G6HDBC>6H: 96I6 ;GDB >CIG68:G:7G6A G:8DG9>C<H
Lino Nobili (Italy)
10:25am - 10:45am
.A::E B:CI6I>DC 9JG>C< )-( 6C9 -( E6G6HDBC>6H
Isabelle Arnulf (France)
10:45am - 11:05am
):JGD>B6<>C< D; -( 6C9 )-( E6G6HDBC>6H
Thanh Dang-Vu (Canada)
11:05am - 11:20am
*C:>G>8 HIJEDG 6C9 6<GNEC>6 :M8>I6I6
11:20am 11:30am
,J:HI>DC 6C9 6CHL:G
76
/
0
.
D
A
4
/J:H96N, *8ID7:G 1, 2013
*-06: +6G6HDBC>6, ):JG6A +A6HI>8>IN, 6C9 ):JGDAD<>86A D>HDG9:GH
CD-C=6>GH:
Sudhansu Chokroverty (USA), Federica Provini (Italy)
/=: :;;:8I D; D7HIGJ8I>K: HA::E 6EC:6 DC 9:8A6G6I>K: B:BDGN 8DCHDA>96I>DC
Ina Djonlagic (USA)
.8G::C>C< ;DG HA::E 9NH;JC8I>DC 6;I:G IG6JB6I>8 7G6>C $C?JGN
Tatyana Mollayeva (Canada)
-( HA::E 7:=6K>DG 9>HDG9:G ;DAADL>C< 8:G:7GDK6H8JA6G HIGD@: : A EDANHDBCD<G6E=>8 HIJ9N >C 6C <NEI>6C H6BEA:
Tarek Asaad (Egypt)
+G:K6A:C8: D; C><=IB6G:H 6BDC< I=: <:C:G6A !>CC>H= 69JAI EDEJA6I>DC 6C9 K:I:G6CH D; I=: H:8DC9 LDGA9 L6G
Nils Sandman (Finland)
.A::E :C68IB:CI 7:=6K>DGH >C +6G@>CHDC'H 9>H:6H: 6C9 BJAI>EA: HNHI:B 6IGDE=N: B:NDC9 -( 7:=6K>DG 9>HDG9:G
Pietro-Luca Ratti (France)
"$ 86CCDI HA::E >; $ 9DC'I :6I" 6 9NH;JC8I>DC6A 7:A>:;H 8DJA9 HJHI6>C CD8IJGC6A :6I>C<
Piergiuseppe Vinai (Italy)
23 +:G;DGB>C< 6C9 $CI:GEG:I>C< I=: (.C/
77
/
0
.
D
A
4
/J:H96N, *8ID7:G 1, 2013
*-07: .A::E BG:6I=>C< D>HDG9:GH
CD-C=6>GH:
Joaquin Tern (Spain), Makoto Kikuchi (Japan)
+6I>:CIH L>I= H:K:G:/BD9:G6I: 6HI=B6 8G>H>H H=DL 67CDGB6A .I6C;DG9 HA::E>C:HH H86A: H8DG:
Carolina Fransolin (Brazil)
):JGDEHN8=>6IG>8 8DCH:FJ:C8:H >C HA::E 7G:6I=>C< 9>HDG9:GH
Antje Buettner-Teleaga (Germany)
A 9:CI>HI >C 6 HA::E B:9>8>C: HE:8>6A>HI I:6B: ;>GHI G:HJAIH ;DG I=: IG:6IB:CI D; D7HIGJ8I>K: HA::E
6EC:6 E6I>:CIH L>I= DG6A 6EEA>6C8:H
C>G8JA6I>C< !AB+4 6C9 HJ78A>C>86A 6I=:GDH8A:GDH>H >C D7HIGJ8I>K: HA::E 6EC:6 HNC9GDB:
Raquel Catal (Spain)
AAA:G<N 6H 6 G>H@ ;68IDG ;DG HA::E 9>HDG9:G:9 7G:6I=>C<
Lia Oliveira (Portugal)
.6;:IN 6C9 :;;>868N D; JEE:G 6>GL6N HI>BJA6I>DC >C IG:6IB:CI D; D7HIGJ8I>K: HA::E 6EC:6
Patrick J Strollo, Jr (USA)
78
/
0
.
D
A
4
/J:H96N, *8ID7:G 1, 2013
.17: )DK:A $CH><=IH >CID C6G9>DB:I67DA>8 (:8=6C>HBH D; *.A
CD-8=6>GH:
Jan Hedner (Sweden), Brian Kent (Ireland)
.E:6@:GH:
Jan Hedner (Sweden), Brian Kent (Ireland), Richard Schulz (Germany), Jan Hedner (Sweden),
Nikolas Bchner (Germany), Ludger Grote (Sweden)
':6GC>C< *7?:8I>K:H:
To expand on the epidemiological association between OSA and cardiometabolic disease. To review hypoxic pathways
that potentially link OSA with cardiometabolicdisease. To understand and apply appropriate measures of cardiovascular
dysfunction in OSA.
/6G<:I AJ9>:C8::
Physicians and researchers with an interest in sleep disordered breathing and its links to cardiometabolic disease.
Level: Advanced
.JBB6GN:
This session aims to describe novel insights into the association between sleep disordered breathing and cardiometabolic
disorders. Speakers will address information from large scale epidemiological data bases. Novel mechanisms linking
OSA and cardiovascular and metabolic disease will be presented. Additional topics include new methods and targets to
characterize cardiovascular disease in OSA.
$CIGD9J8I>DC
Jan Hedner (Sweden)
C6G9>DB:I67DA>8 9>HDG9:GH >C JGDE:6C HA::E 6EC:6 E6I>:CIH
Brian Kent (Ireland)
*M>96I>K: HIG:HH 6C9 86G9>DB:I67DA>8 9>H:6H: >C *.A
Richard Schulz (Germany)
A8>9-76H: 76A6C8: 6C9 86G7DC>8 6C=N9G6H: 68I>K>IN >C *.A 6C9 >IH 8DBEA>86I>DCH
Jan Hedner (Sweden)
16H8JA6G =:BD9NC6B>8H >C *.A - 2=6I >H 6EEGDEG>6I: ID BDC>IDG?
Nikolas Bchner (Germany)
AHH:HHB:CI D; K6H8JA6G ;JC8I>DC 7N 8DCI>CJDJH BDC>IDG>C< >C *.A
,J:HI>DC 6C9 6CHL:G
Jan Hedner (Sweden)
79
/
0
.
D
A
4
/J:H96N, *8ID7:G 1, 2013
.18: /=DH: CDBDG7>9>I>:H I=6I $CK69: I=: )><=I:
/G:6I>C< .A::E +GD7A:BH >C +6I>:CIH L>I= +HN8=>6IG>8 D>HDG9:GH
C=6>G:
Jack D. Edinger (USA)
.E:6@:GH:
Jack D. Edinger (USA), Colleen E. Carney (Canada), Anne Germain (USA), Daniel Freeman (United Kingdom)
':6GC>C< *7?:8I>K:H:
Discuss and demonstrate helpful intervention strategies for managing patients with comorbid depression or nocturnal
panic attacks
Demonstrate how to implement Imagery Rehearsal Therapy for Chronic nightmares
Demonstrate the implementation of graded exposure therapy for CPAP-related anxiety and claustrophobic reactions
/6G<:I AJ9>:C8::
Clinicians who wish to learn how to implement a number of useful behavioral sleep medicine interventions with patients that
have complicating comorbidities associated with their sleep problems. Sleep researchers interested in the nature and impact of
mood and anxiety disorders on comorbid sleep problems.
.JBB6GN:
Patients who present with sleep complaints in association with comorbid anxiety and mood disorders represent
signficant challenges to providers charged with their management. Although various behavioral sleep medicine strategies
have been developed for managing the anxiety and mood problems that commonly occur in association with various
sleep disorders, many sleep professionals do not have training or skills in implementing these techniques. This
symposium will review the evidence for and methods of managing common mood related and anxiety problems
presented by sleep disorders patients. Specific techniques for managing obstacles to adherence with CBT related to
depression and noturnal panic attacks will be presented. Methods for dealing with CPAP-related claustrophobia and the
recurrent nightmares common in patients with PTSD will be discussed and demonstrated via video vignettes.
12:00pm - 12:02pm
$CIGD9J8I>DC
12:02pm - 12:22pm
"G69:9 MEDHJG: /=:G6EN ;DG CA6JHIGDE=D7>8 -:68I>DCH ID C+A+ /=:G6EN
12:22pm - 12:42pm
(6C6<:B:CI D; HA::E 9>HIJG76C8:H 9J: ID CD8IJGC6A E6C>8 6II68@H
Colleen E. Carney (Canada)
12:42pm - 1:02pm
$B6<:GN G:=:6GH6A I=:G6EN ;DG 6CM>:IN-EGDKD@>C< 9G:6BH 6C9 C><=IB6G:H
Anne Germain (USA)
1:02pm - 1:22pm
/6G<:I:9 CB/ ;DG $CHDBC>6 .NBEIDBH >C .8=>ODE=G:C>6
Daniel Freeman (United Kingdom)
1:22pm 1:30pm
,J:HI>DC 6C9 6CHL:G
80
/
0
.
D
A
4
BDM 'JC8=:
Box lunch is provided to satellite symposia attendees. Delegates can purchase
a lunch ticket for Wednesday prior to noon Tuesday for a cost of 10 at the
registration desk.
/J:H96N, *8ID7:G 1, 2013
1:40EB ID 3:10EB
AJ9>IDG>JB 1
/>B: ID BG:6@ I=: -'./2D
/G:6IB:CI +6G69><B
CD-C=6>GH:
Diego Garcia Borreguero (Spain), Yves Dauvilliers (France)
A<:C96:
AC -'./ 2D E6I>:CI'H ?DJGC:N: :M6B>C>C< I=:
96>AN 6C9 ADC<-I:GB 9>H:6H: 7JG9:C; L=6I B6I-
I:GH BDHI 6C9 L=N
Luigi Ferini- Strambi (Italy)
-'./2D IG:6IB:CI <J>9:A>C:H: -DI><DI>C:'H
7:C:;>I/ G>H@ G6I>D
Alex Iranzo (Spain)
):L (>A:HIDC:H ;DG I=: +'(H/-'./ C1 G>H@
IG>69: 6C :K6AJ6I>DC D; A>I:G6IJG: 6C9 I=: )-
C*- IG>6A
Claudia Trenkwalder (Germany)
$BE68I 6C9 GDA: D; 8D-BDG7>9>I>:H 6C9
-'./ 2D
David Rye
Sponsor:
/J:H96N, *8ID7:G 1, 2013
1:40EB ID 3:10EB
(JAI>EJGEDH: -DDB 1
/G6CH8JI6C:DJH C*2 (DC>IDG>C<
6C9 >IH -DA: >C .A::E (:9>8>C:
A<:C96:
+G>C8>EA:H 6C9 :KDAJI>DC D; +I8C*2
B:6HJG:B:CIH
Jan H. Storre (Germany)
A9JAIH L>I= #NEDK:CI>A6I>DC .NC9GDB:H:
A )DGI= AB:G>86C +:GHE:8I>K:
Patrick J Strollo, Jr., MD, FCCP, FAASM USA)
/=: $BEDGI6C8: D; CDC>CK6H>K: K:CI>A6I>DC
BDC>IDG>C< 9JG>C< HA::E. /=: GDA: D; +C*2
BDC>IDG>C<
Dr. J. Tern Santos, M.D. (Spain)
Sponsor:
81
/
0
.
D
A
4
/J:H96N, *8ID7:G 1, 2013
&:NCDI:: ):JGD7>DAD<N D; .A::E
Pierre-Herv Luppi, PhD
Centre National de la Recherche, Scientifque
France
Sleep researcher since 1983. Specialized in paradoxical (REM) sleep.
)DI:H:
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
82
/J:H96N, *8ID7:G 1, 2013
*-08: $CHDBC>6 /G:6IB:CI
C=6>G:
Lynda Blanger (Canada)
$CHDBC>6 IG:6IB:CI >C I=: I=>G9 IG>B:HI:G D; EG:<C6C8N EG:K:CIH EDHIE6GIJB 9:EG:HH>DC:
A G6C9DB>O:9 8A>C>86A IG>6A
Masoud Tahmasian (Iran)
$BE68I D; 8DBDG7>9>IN DC >CHDBC>6 IG:6IB:CI G:HEDCH: ;DAADL>C< 8D<C>I>K:-7:=6K>DG I=:G6EN,
7:=6K>DG I=:G6EN, 6C9 8D<C>I>K: I=:G6EN
Lynda Blanger (Canada)
$H >CHDBC>6 IG:6IB:CI HJE:G>DG ID 9:EG:HH>DC IG:6IB:CI ;DG E6I>:CIH L>I= 7DI= 9>6<CDH:H? -
-:HJAIH D; 6 G6C9DB>O:9 8DCIGDAA:9 IG>6A
Kerstin Blom (Sweden)
CD<C>I>K: IG6>C>C< >BEGDK:H HA::E FJ6A>IN 6C9 8D<C>I>K: ;JC8I>DC 6BDC< DA9:G 69JAIH L>I= >CHDBC>6
Iris Haimov (Israel)
_____________________________________________________________________
/J:H96N, *8ID7:G 1, 2013
*-09: ):JGD7>DAD<N D; -'./+'(.
C=6>G:
Yong-Won Cho (Republic of Korea)
A8I>K>IN 6C9 HA::E >C 6 BDJH: BD9:A D; +6G@>CHDCQH 9>H:6H:
Irina Zavalko (Russia)
#NE:G68I>K>IN 6C9 6AI:G6I>DCH >C >GDC =DB:DHI6H>H >C BJ DE>D>9 G:8:EIDG @CD8@DJI B>8::
+DHH>7A: >BEA>86I>DCH ;DG -:HIA:HH ':<H .NC9GDB:/2>AA>H-@7DB D>H:6H:
Mark DeAndrade (USA)
+:G>E=:G6A =NEDM>6 >C E6I>:CIH L>I= G:HIA:HH A:<H HNC9GDB:
Aaro Salminen (Finland)
+/+-D :MEG:HH>DC G:<JA6I:H HA::E 8DCHDA>96I>DC >C 9GDHDE=>A6
Amanda Freeman (USA)
83
/
0
.
D
A
4
/J:H96N, *8ID7:G 1, 2013
*-10: +:9>6IG>8H .A::E BG:6I=>C< D>HDG9:GH
CD-C=6>GH:
Daniel Ng (Hong Kong), Suresh Kotagal (USA)
C=>A9 .A::E P /=: !>CC>H= 7>GI= 8=DGI HIJ9N: /=: :;;:8I D; B6I:GC6A HA::E 9JG>C< EG:<C6C8N DC 6
C:L7DGC L:AA7:>C< 6C9 6 BDI=:GQH A67DG :ME:G>:C8:
Outi Saarenp-Heikkil (Finland)
.A::E E6II:GCH 6I 6 BDCI=H 6C9 4/5 N:6GH D; 6<: >C 6 +DGIJ<J:H: 7>GI= 8D=DGI
Marta Gonalves (Portugal)
.A::E DCH:I 9:A6N 6C9 C><=I 6L6@:C>C<H >C EG:H8=DDA 8=>A9G:C: I=: ":C:G6I>DC 33$ 7>GI= 8D=DGI
Ana Rute Costa (Portugal)
.A::E CN8A>8 AAI:GC6I>C< +6II:GC (CA+) 8=6C<:H ;GDB H8=DDA-6<: ID 69DA:H8:C8: >C =:6AI=N HJ7?:8IH
Patricio Peirano (Chile)
84
/
0
.
D
A
4
/
0
.
D
A
4
/J:H96N, *8ID7:G 1, 2013
.19: +6>C, *E>D>9H 6C9 .A::E BG:6I=>C< D>HDG9:G -
AC $CI:G68I>DC ID (6C6<:
CD-8=6>GH:
Gilles Lavigne (Canada), Raphael Heinzer (Switzerland), Michael T. Smith (USA)
.E:6@:GH:
Gilles Lavigne (Canada), Giancarlo Vanini (USA), Michael T. Smith (USA), Raphael Heinzer (Switzerland),
':6GC>C< *7?:8I>K:H:
Understand the interaction between pain conditions and sleep breathing.
Understand the perception of pain in presence of sleep breathing disorders.
Understand and estimate the risk of pain management on sleep breathing disorders.
Explore alternative avenues to manage concomitant pain and breathing disorders.
/6G<:I AJ9>:C8::
Physicians, dentists, psychologists, nurses and investigators in sleep and pain management and in research.
.JBB6GN:
Chronic pain is concomitant in many patients with sleep disorders. Pain perception can be modified by the changes in
breathing. Use of opioids, e.g., codeine or morphine, can aggravate breathing disorders. The pain specialist needs to
better understand such risk, from basic science up to clinical consequences. Alternative in pain management needs to
be discussed. Sleep specialist should be able to guide pain colleagues facing sleep disorders breathing cases.
5:30pm - 5:40pm
$CIGD9J8I>DC ID I=: >CI:G68I>DC 7:IL::C E6>C 6C9 G:HE>G6I>DC
5:40pm - 6:00pm
):JGD8=:B>86A 8DCIGDA D; E6>C, HA::E 6C9 7G:6I=>C<
Giancarlo Vanini (USA)
6:00pm - 6:20pm
.A::E 9>HDG9:GH 6C9 E6>C E:G8:EI>DC
Michael T. Smith (USA)
6:20pm - 6:40pm
*E>D>9H 6C9 CD8IJGC6A 7G:6I=>C< 9>HDG9:GH
Raphael Heinzer (Switzerland)
6:40pm - 6:50pm
/6@: =DB: B:HH6<: DC H6;:IN 6C9 :;;>8>:CI E6>C G:A>:;
6:50pm 7:00pm
":C:G6A 9>H8JHH>DC
24 C+A+ (6HI:G8A6HH: (6H@ !>II>C<, CDBEA>6C8: >HHJ:H, />IG6I>DC
85
/
0
.
D
A
4
/J:H96N, *8ID7:G 1, 2013
.20: .A::E 6C9 "AJ8DH: (:I67DA>HB
C=6>G:
Karine Spiegel (France)
.E:6@:GH:
Karine Spiegel (France), Luiz Menna-Barreto (Brazil), Rachel Leproult (Belgium), Mark Barone (Brazil)
':6GC>C< *7?:8I>K:H:
Understand how sleep loss affects metabolism, leading to type 2 diabetes mellitus;
Understand the association between poor glycemic control and sleep impairments;
Understand rhythmicity as an important component to health.
/6G<:I AJ9>:C8::
Researchers who work in the field of sleep restriction, sleep disorders and diabetes; Clinicians, and Health Care Professionals
in general. Although the topic is very specific, the present Symposium will be comprehensible by the Congress audience.
.JBB6GN:
In this Symposium, the association of diabetes mellitus and sleep impairment will be explored. Some of the most recent
findings concerning how sleep loss favors the development of diabetes and impact glycemic control, and, conversely,
how glycemic impairment may affect sleep, will be discussed. The effects of circadian misalignment on glucose
metabolism will also be discussed.
5:30pm - 5:35pm
$CIGD9J8I>DC L>I= HDB: 8DCH>9:G6I>DC 67DJI I=: IDE>8
5:35pm - 6:00pm
$CHJA>C -:H>HI6C8: 6C9 .A::E/26@: CN8A:, =DL I=: >BE6>GB:CI D; I=:H: G=NI=BH A:69 ID 9>H:6H:H
Luiz Menna-Barreto (Brazil)
6:00pm - 6:25pm
$BE68I D; HA::E ADHH 6C9 8>G869>6C B>H6A><CB:CI DC 9>67:I:H G>H@
Rachel Leproult (Belgium)
6:25pm - 6:50pm
.A::E 6C9 INE: 1 9>67:I:H, L=6I >H I=: 6HHD8>6I>DC?
Mark Barone (Brazil)
6:50pm 7:00pm
,J:HI>DC 6C9 6CHL:G
86
/
0
.
D
A
4
/J:H96N, *8ID7:G 1, 2013
.21: .A::E AEC:6 6C9 /=: A9>ED8NI:: /G:C9H 6C9 /G:6IB:CIH
C=6>G:
Gary S. Richardson (USA)
.E:6@:GH:
Gary S. Richardson (USA), Joseph M. Ojile (USA), David M. Rapoport (USA)
':6GC>C< *7?:8I>K:H:
The participant will become familiar with the physiology of the adipocyte, including central mechanisms controlling
appetite and metabolism
The participant will appreciate the multidirectional relationships among sleep, sleep apnea and obesityboth the
mechanisms linking obesity to sleep pathology and those linking sleep disturbance to obesity
The participant will review and evaluate data regarding CPAP as a therapy that effectively addresses the underlying
obesity factor
The participant will examine and evaluate the current data as a compelling factor in potential changes in treatment for
Sleep Apnea
/6G<:I AJ9>:C8::
Physicians in sleep medicine, endocrinology and internal medicine in academic, research and clinical settings. Research and
clinical scientists and clinical technologists and medical providers (Advanced Practice Nurses, Physicians Assistants) at an
advanced level.
.JBB6GN:
The symposium will provide an accessible overview of the multidirectional relationships among sleep, sleep apnea and
obesity. Recent advances have substantially enhanced our understanding of the basic physiology of the adipocyte, and
of the role of adipose inflammation in the pathogenesis of obesity and insulin resistance. As these mechanisms are
elucidated, it also becomes clear that obstructive sleep apnea (OSA), with attendant hypoxia and sympathetic nervous
system (SNS) activation, represents a singular challenge to the adipocyte, and potently accelerates the indigenous
inflammatory response. These data also provide a basic foundation for the observed relationships among OSA and
insulin resistance and the metabolic syndrome, and highlight a second path connecting obesity, inflammation, cytokines
and persistent sleepiness in OSA patients after CPAP therapy. Recent work suggests that adipose remodeling in
response to OSA may not be reversible with treatment of the hypoxia and sleep disruption. These results provide a
perspective for consideration of the growing body of clinical data examining the effects of CPAP therapy on obesity
measures. Several recent controlled and open trials of CPAP in OSA have produced a mixed picture of the impact of
current OSA therapy on obesity and its consequences. Last, the faculty will consider whether these data should dictate
the consideration of alternate treatment strategies that more directly address the adipose tissue pathology.
5:30pm - 5:35pm
$CIGD9J8I>DC
5:35pm - 6:00pm
/=: E=NH>DAD<N D; HA::E, HA::E 9>HDG9:GH 6C9 I=: 69>ED8NI:
6:00pm - 6:25pm
DD:H C+A+ I=:G6EN :;;:8I>K:AN 699G:HH I=: JC9:GAN>C< D7:H>IN ;68IDG?
Joseph M. Ojile (USA)
6:25pm - 6:50pm
DD:H 6K6>A67A: 96I6 DC I=: 7>-9>G:8I>DC6A>IN D; HA::E 6EC:6 6C9 D7:H>IN HJEEDGI 8=6C<:H >C IG:6IB:CI?
David M. Rapoport (USA)
6:50pm 7:00pm
,J:HI>DC 6C9 6CHL:G
87
/J:H96N, *8ID7:G 1, 2013
*-12: )6G8DA:EHN 6C9 M8:HH>K: D6NI>B: .A::E>C:HH
CD-C=6>GH:
Michel Billiard (France), Joan Santamara (Spain)
2=6I >H >9>DE6I=>8 =NE:GHDBC>6 L>I=DJI ADC< HA::E? -:I=>C@>C< I=: 9:;>C>I>DCH 7N HA::E
L6@: 9>6GN 96I6
Andrea Rodenbeck (Germany)
*EID<:C:I>8 68I>K6I>DC D; HE:8>;>8 C:JGDCH ID 6B:A>DG6I: HNBEIDBH D; C6G8DA:EHN >C B>8:
Priyattam Shiromani (USA)
/=: :;;:8IH D; HD9>JB DMN76I: IG:6IB:CI DC K><>A6C8: >BE6>GB:CI >C C6G8DA:EHN P 6 8DBE6G>HDC
7:IL::C >C-;>:A9 6C9 >C-A67DG6IDGN B:6HJG:B:CIH
Mojca van Schie (Te Netherlands)
$!3" >H 6HHD8>6I:9 ID C6G8DA:EHN
Anja Holm (Denmark)
C.! =NED8G:I>C A:K:A >C E6I>:CIH L>I= &A:>C:-':K>C HNC9GDB:
Qinghua Li (China)
88
/
0
.
D
A
4
/J:H96N, *8ID7:G 1, 2013
D.-/-01: +HN8=DAD<N 6C9 $CHDBC>6
C=6>G:
Wang Weidong (China)
.E:6@:GH:
Wang Weidong (China), Liu Yanjiao (China), Zhang Haisheng (China)
':6GC>C< *7?:8I>K:H:
To know the potential psychopathological factors for insomnia
To get knowledge about an indigenous psychotherapy in China
To get understanding into how to get rid of hypnotic drugs gradually combining with Complementary alternative medicine
To get information about the characteristics of insomnia patients in general hospital in China
/6G<:I AJ9>:C8::
Those who are interested in psychological treatment, non-drug therapy, Chinese medical treatment for insomnia.
.JBB6GN:
In China, a lot of insomnia patients come to Chinese medicine hospital for treatment, as they are worried about the
side effects of hypnotic drugs. In addition, we have found that various psychological factors are contributing to getting
insomnia. We are hoping to share our research and clinical experiences with colleagues from the world. The topics will
involve following: personality, psychopathology and insomnia; Low Resistance Thought Induction Psychotherapy for
insomnia; Relaxation Therapy in Chinese medicine for insomnia.
7:00pm - 7:15pm
.A::E G:<JA6I>DC I:8=C>FJ: D; ADL G:H>HI6C8: I=DJ<=I >C9J8I>DC EHN8=DI=:G6EN ;DG >CHDBC>6
Wang Weidong (China)
7:15pm - 7:30pm
#DL ID 8DB7>C: C=>C:H: B:9>86A B:I=D9H >CID >CHDBC>6 IG:6IB:CI
Liu Yanjiao (China)
7:30pm - 7:45pm
/=: A6I:HI 9:K:ADEB:CI D; ADL G:H>HI6C8: I=DJ<=I $BEG>CI EHN8=DI=:G6EN HA::E-G:<JA6I>C<
I:8=C>FJ: D; >CHDBC>6
Zhang Haisheng (China)
7:45pm - 8:00pm
,J:HI>DC 6C9 6CHL:G
89
/
0
.
D
A
4
/J:H96N, *8ID7:G 1, 2013
D.-/-02: .A::E #67>IH 6C9 .A::E CK>GDCB:CI >C -JG6A '>K>C< 6C9
)6I>K: CDBBJC>I>:H D; .DJI= AB:G>86
C=6>G:
.E:6@:GH:
Birgit Hgl (Austria), Fernando Louzada (Brazil)
':6GC>C< *7?:8I>K:H:
To appreciate cultural differences in sleep habits
To learn about sleep disorders in native communities
To understand the specific facts which have an impact on sleep in these communities
/6G<:I AJ9>:C8::
Sleep specialists (neurologists, psychiatrists, psychologists, internal medicine physicians, technicians).
.JBB6GN:
After attending the symposium participants shall be able to appreciate the specific conditions and circumstances
impacting sleep habits and sleep health in individuals belonging to native communities in rural areas of South America,
to appreciate cultural differences in sleep habits.
90
/
0
.
D
A
4
/
0
.
D
A
4
/J:H96N, *8ID7:G 1, 2013
D.-/-03: ,J6A>IN AHHJG6C8: >C .A::E (:9>8>C:
C=6>G:
Geert Mayer (Germany), Andrea Rodenbeck (Germany)
.E:6@:GH:
Juergen Fischer (Germany), Andrea Rodenbeck (Germany), Alexander Blau (Germany)
':6GC>C< *7?:8I>K:H:
Quality of accreditation
Assessment of process quality of diagnosis and therapy of sleep disorder
Networking as part of assurance quality
/6G<:I AJ9>:C8::
Boards of National Sleep Societies and of sleep technologists and officials of Health Authorities.
.JBB6GN:
Quality of health care is a sufficient, patient-orientated, evidence based and qualified professional process aiming
at increasing requested therapy results in individuals as well as in the population in total. In order to improve
continuously the quality of health care in German sleep labs, the German Sleep Society (DGSM) established an
accreditation process that has been incorporated at the European level. Accreditation is assurance of structural quality
of sleep centers. Sleep that pass the examination are accredited by the DGSM. In a second step external structured
peer-review quality rating program was initiated, which has become mandatory for DGSM accredited sleep centers in
2004. Rating in 2001 and 2011 show that participation increases process quality. The efforts to collect the data from
sleep labs and distribute them to the three reviewers is very time and material consuming. The DGSM therefore
initiated an electronic database that meets all the European Security requirements to exchange this data. The details
will be presented and discussed with the audience. The material will be available for other Sleep Societies.
,J6A>IN D; HIGJ8IJG:, EGD8:HH, 6C9 DJI8DB: P ;>GHI HI:EH 6C9 >BE68I DC I=: JGDE:6C A:K:A
Juergen Fischer (Germany)
,J6A>IN 6HH:HHB:CI 6H 6 B6C96IDGN E6GI D; G:-688G:9>I6I>DC P I=: E::G-G:K>:L EGD<G6B
Andrea Rodenbeck (Germany)
.DBCD):IO P 6C DCA>C: HDAJI>DC
Alexander Blau (Germany)
_____________________________________________________________________
/J:H96N, *8ID7:G 1, 2013
D.-/-04: 0CJHJ6A )D8IJGC6A B:=6K>DG >C +:9>6IG>8H - D>;;:G:CI>6I>C<
.:>OJG:H ;GDB )DC-E>A:EI>8 K:CIH: A 1>9:D-C6H: D>H8JHH>DC
C=6>G:
Shelly K. Weiss (Canada)
.E:6@:GH:
Shelly K. Weiss (Canada), Oliviero Bruni (Italy), Lino Nobili (Italy)
':6GC>C< *7?:8I>K:H:
Develop an approach to the evaluation and management of children who present with unusual nocturnal behavior
Apply this knowledge when presented with children who have unusual nocturnal behaviors
/6G<:I AJ9>:C8::
Pediatric and adult health professionals who evaluate children with sleep disorders.
.JBB6GN:
It may be challenging for the clinician to differentiate parasomnias from nocturnal seizures in children. In this interactive
session, which will be entirely case based, pediatric cases will be shown demonstrating different seizure vs non-epileptic
disorders. Each case will generate discussion regarding the evaluation and management of the cases presented.
91
/
0
.
D
A
4
/J:H96N, *8ID7:G 1, 2013
D.-/-05: 2DB:C AG: !GDB 1:CJH 6C9 (:C AG: !GDB (6GH
C=6>G:
Nese Dursunoglu (Turkey)
.E:6@:G:
Nese Dursunoglu (Turkey), Dursun Dursunoglu (Turkey)
':6GC>C< *7?:8I>K:H:
Although the greater sleep-apnea prevalence in men has raised the concern that a selection bias for referral and identification
of the diagnosis may favor men, women also come to the clinical interview accompanied by their partner less frequently than
men. OSAS has also been implicated as an independent risk factor for cardiovascular diseases such as myocardial infarction,
hypertension, heart failure, arrhytmias and stroke . In addition, it was shown that especially female patients referred to the
sleep clinics, evaluation of metabolic syndrome criteria may play an important role in predicting severe OSA with high
sensitivity (86.6%) and negative predictivity (85.7%).
.JBB6GN:
Women with obstructive sleep apnea (OSA) may be under-diagnosed due to circumstances related to the family lifestyle
and socio-cultural factors. Studies have reported that 33-51% of women show a dramatic increase in sleep disturbance
in the mid-life years, a time when they enter menopause. Menopause is an established risk factor for SDBPrimary care
physicians should be aware of OSA in women and the importance of referring women for sleep studies when they
complain of symptoms associated with OSA, even if other non-specific symptoms such as morning headaches are
reported. Also, hypothyroidism and depression are accompanied with sleep disorders especially in women.
_____________________________________________________________________
/J:H96N, *8ID7:G 1, 2013
D.-/-06: C6C 2: +G:K:CI *.A?
C=6>G:
Makoto Kikuchi (Japan)
.E:6@:GH:
Tomonori Iwasaki (Japan), Makoto Kikuchi (Japan), Christian Guilleminault (USA)
':6GC>C< *7?:8I>K:H:
Sleep Apnea Prevention Orthodontic treatment Adenotonsilectomy Craniofacial growth
/6G<:I AJ9>:C8::
All the physician, Dentists, Orthodontists, polysomnographer, the level of symposium content (basic),
.JBB6GN:
There is no evidence about the prevention of sleep apnea at this moment, however we could have a dream and discuss
about the prevention in the cozy atmosphere at Tapas symposium. We could make the airway enlarged by the
orthodontic treatment and we could make the airway patency by removing adenoids & Tonsils. These could be the
ways of prevention of sleep apnea if we know how to grow the craniofacial region.
/DC<J: EDHIJG: >BEGDK:B:CI 6C9 E=6GNC<:6A 6>GL6N :CA6G<:B:CI 6H H:8DC96GN :;;:8IH
D; G6E>9 B6M>AA6GN
Tomonori Iwasaki (Japan)
%JBE>C< I=: 7>I: ;DG :CA6G<>C< I=: 6>GL6N
Makoto Kikuchi (Japan)
C6C L: EG:K:CI *.A?
92
/
0
.
D
A
4
/J:H96N, *8ID7:G 1, 2013
D.-/-07: C=GDCD7>DAD<N/C>G869>6C D>HDG9:GH
C=6>G:
Luciane Ruiz Carmona Ferreira (Brazil)
.E:6@:G:
Luciane Ruiz Carmona Ferreira (Brazil), Milva Maria Figueiredo De Martino (Brazil)
.JBB6GN:
Introduction:
Due to the increasing industrialization of society, the work in shifts is becoming increasingly common, as well as the
development of night work, although with a pronounced negative effect on the workers sleep, performance and health.
Objective:
To investigate the patterns of sleep-wake cycle and the circadian rhythmicity of peripheral body temperature, through
measures taken at the wrist of nursing students who studies during the day and works on the night shift.
Methods:
Longitudinal descriptive study, with a quantitative approach, involving 27 adult subjects, nursing assistants and technicians
who worked in the night shift and were students of undergraduate nursing of a private college in So Paulo State, during the
daytime. The following instruments were used: Identification Form, Morningness Eveningness Questionnaire of Horne and
stberg, Sleep Diary, for 32 days, divided into school term and school vacations, and a thermistor (Thermochron iButton)
on the non-dominant hand wrist to check the temperature of the wrist every 30 minutes.
Results:
The adjustment of the temperature data of the wrist to a cosine curve, within a 24-hour period, a significant
rhythmicity was verified in 35.3% of subjects in the school term and 93.7% of subjects in the vacation period, apart
from the existence of different rhythms of the 24 hours such as 12 and 16 hours. There was a statistically significant
difference in the time that the acrophase occurred, when comparing the school term on the days-off and on working
days (p <0.0001), school vacation on the days-off and working days (p<0.0001) The sleep time during the school
vacation was higher when the subjects didnt sleep immediately after work. There was a significant difference when
comparing the sleep time on the vacation period and days off (8:34) and school term and days off (7:24), p<0.0001,
and also on vacation on working days (4:19), p=0.0496. Middle Phase of Sleep (MPS) there was a statistically
significant difference between the school and vacation periods on working days and days off.
Conclusion:
The presence of rhythms different than 24 hours, was observed especially during the school term, and the phase transfer
of the wrist temperature, according to the period of work/study, with phase opposition on working days when
compared to days off. The greatest spectral power was observed in the 24-hour rhythm, either during school term or
vacation, confirming the hypothesis that the region of the wrist shows a well-defined and robust rhythmic expression.
The findings reinforce the idea that the study favors the establishment of routine, but has little influence in displacing
the body temperature, wich proved to be strongly influenced by the night shift work. Similar to the acrophase, the MPS
showed great diversity in times of occurrence, but with a phase relation maintained between the rhythms on the
different times of study.
93
/
0
.
D
A
4
/J:H96N, *8ID7:G 1, 2013
D.-/-08: .A::E BGJM>HB : D>6<CDHI>8 6C9 /=:G6E:JI>8 AEEGD68=:H
!GDB 6 (JAI>9>H8>EA>C6GN +D>CI D; 1>:L
CD-C=6>GH:
Antonio Romero-Garcia (Spain), Gilles Lavigne (Canada)
.E:6@:GH:
Gilles Lavigne (Canada), Bernard Fleury (France), Guido Maria Macaluso (Italy), Antonio Romero-Garcia (Spain)
':6GC>C< *7?:8I>K:H:
To understand and discuss the main etiological factors linked to the presence of sleep bruxism as well as to discuss the
different pathophysiological mechanisms related to awake vs sleep bruxism.
To review and discuss which are the main diagnostic approaches to diagnose the presence of sleep bruxism
To understand that sleep bruxism diagnosis should be multidisciplinary but the criteria for defining it falls into the
field of Sleep Medicine
To discuss the presence of pain in sleep bruxism patient
To review the main therapeutic approaches for the management of bruxism from a multidisciplinary prespective
including the control of risk factors as well as comorbidities, specially those which fall on the field of Sleep Medicine
(i.e. sleep breathing disorders.)

/6G<:I AJ9>:C8::
Dentists, sleep doctors, psychologists and neurophysiology staff who want to have a more deep knowledge of the last
progresses in the topic Level: Medium/Advanced.
.JBB6GN:
Sleep bruxism (SB) is a common sleep- related motor disorder characterized by tooth grinding and clenching. SB
diagnosis is made on history of tooth grinding and confirmed by polysomnographic recording of electromyographic
(EMG) RMMA (rhythmic masticatory muscle activity ) episodes in the masseter and temporalis muscles. Those
episodes occur in association with sleep arousal and are preceded by physiologic activation of the central nervous and
sympathetic cardiac systems. Sleep bruxism has strongly gained the attention of the dental community because of its
pathological consequences on the masticatory system This session will provide a comprehensive review of the aetiology,
pathophysiology, assessment, and management of SB from a multidisciplinary point of view. This discussion group
session will be divided in three distinctive parts: PART I: The main etiological theories related to sleep bruxism will be
reviewed making special emphasis on the recognition of risk factors an comorbitidies. Among those, we will be
discussing the link among OSA and sleep bruxism. PART II: All the clinical and polysomnographic criteria for the
diagnosis of sleep bruxism will be reviewed. Special emphasis will be given to the research diagnostic criteria used in
sleep labs. The recognition of clinical findings for suspecting bruxism as well as the use of questionnaires will also be
covered. PART III: In this part, we will be stating that management of sleep bruxism should be multidisciplinary.
Treatment strategies such cognitive behavioural and relaxation techniques, biofeedback, therapies preventing damage of
stomatognathic system structures (occlusal splints), control of risk factors, pharmacological approach, treatment of
comorbid conditions such OSA etc.will be also reviewed.
.A::E 7GJM>HB H8G::C>C< &9>6<CDH>H 8=6AA:C<:H: IDDAH K6A>9>IN 6C9 9>;;:G:CI>6A D; 8D BDG7>9>I>:H.
.A::E 7GJM>HB 6C9 G:HE>G6IDGN :K:CIH
.A::E 7GJM>HB 6C9 E6>C
Guido Maria Macaluso (Italy)
C=6C<>C< E6G69><BH >C I=: B6C6<:B:CI D; HA::E 7GJM>HB
Antonio Romero-Garcia (Spain)
94
/
0
.
D
A
4
/J:H96N, *8ID7:G 1, 2013
D.-/-09: B:G<>C< $C9>6 6C9 $IH .A::E $HHJ:H
C=6>G:
Suresh Kumar (India)
.E:6@:GH:
Preeti Devnani (India), Suresh Kumar (India), Garima Shukla (India)
':6GC>C< *7?:8I>K:H:
Epidemiology of OSA and its cardio-cerebrovascular effects
Pediatric sleep disorders and the burden of sleep deprivation
Impact of recognition of the RLS among Indians, on the Indian Sleep Medicine scenario
/6G<:I AJ9>:C8::
Colleagues working in adults & pediatric sleep medicine facing similar challenges of an emerging specialty and addressing the
pitfalls and progress of sleep medicine in a budding society. Understanding the variation of spectrum of RLS in India.
.JBB6GN:
Epidemiology of OSA and its cardio-cerebrovascular effects
Obstructive sleep apnea (OSA) is a independent risk factor which poses a significant public health problem and its
consequences are well known. In India the current obesity and diabetes epidemic is bound to increase the prevalence
of OSA as a major public health issue in the coming future. Research on sleep in India will not only have to focus
on other sleep disorders but also majorly on cause and effects of OSA and its consequences. There are only a few
community based studies which address the prevalence in India.
Pediatric Sleep Medicine in India
The recognition of the burden of sleep disturbances in the pediatric population in India is a work in progress as is
with several counterparts across the globe. Cross cultural studies in a diverse society as India have shed light on the
magnitude of their prevalence and emphasized the impact of cultural, social and co-sleeping factors. Certain behavioral
strategies with emphasis on familial relationships were emphasized in a large multi center project. Pediatric sleep research
albeit in its infancy is being carried out in ADHD and ASD spectrum population, this preliminary data will be presented.
RLS in India
RLS is among the most under-diagnosed sleep disorders worldwide. Unique problems in recognition and timely
initiation of treatment due to socio-cultural differences in its presentation across populations in India, necessitates
development of more elaborate diagnostic tools. Few prevalence studies have been published from India, and have
reported varying prevalence rates among different populations.
The purpose of this talk will be to summarize the work in the area of RLS conducted in India, and to draw conclusions
regarding unique challenges in diagnosis and management of RLS patients in India.
95
/
0
.
D
A
4
/J:H96N, *8ID7:G 1, 2013
D.-/-10: CDCIGDK:GH>:H >C -'. L>I= +'(H: .><C>;>86C8:, .A::E, C1 ->H@
+>8@ JE NDJG I>8@:I 6I G:<>HIG6I>DC 9:H@
C=6>G:
David Rye (USA)
.E:6@:GH:
David Rye (USA), Mauro Manconi (Switzerland), Luigi Ferini-Strambi (Italy), Raffaele Ferri (Italy),
Stephany Fulda (Germany), John W. Winkelman (USA)
7:00pm - 7:05pm
$CIGD9J8I>DC 6C9 9:76I: GJA:H
David Rye (USA)
7:05pm - 7:25pm
+'(H 6G: I=: HDJG8: D; :A:K6I:9 BDGI6A>IN G>H@ >C -'. P +GD HE:6@:G
Mauro Manconi (Switzerland)
+'(H 6G: I=: HDJG8: D; :A:K6I:9 BDGI6A>IN G>H@ >C -'. P CDC HE:6@:G
7:25pm - 7:45pm
+'(H 6G: 6HHD8>6I:9 L>I= 9>HIJG7:9 HA::E P +GD HE:6@:G
+'(H 6G: 6HHD8>6I:9 L>I= 9>HIJG7:9 HA::E P CDC HE:6@:G
7:45pm - 8:05pm
/G:6I>C< +'(H >C -'. G:9J8:H 86G9>DK6H8JA6G G>H@ P +GD HE:6@:G
John W. Winkelman (USA)
/G:6I>C< +'(H >C -'. G:9J8:H 86G9>DK6H8JA6G G>H@ P CDC HE:6@:G
David Rye (USA)
8:00pm - 8:20pm
!>C6A FJ:HI>DCH 6C9 8DBB:CIH
David Rye (USA)
Sponsor:
96
2:9C:H96N
.8=:9JA: 6I 6 "A6C8: 2:9C:H96N, *8ID7:G 2, 2013
_________________________________________________________________
-:<>HIG6I>DC 7:006B - 7:00EB
_________________________________________________________________
_________________________________________________________________
&:NCDI: 9:006B - 10:006B
_________________________________________________________________
.NBEDH>JB .24-27 10:006B - 11:306B
_________________________________________________________________
M=>7>I>DC 11:006B - 5:00EB
_________________________________________________________________
CD;;:: BG:6@ 11:306B - 12:00EB
_________________________________________________________________
.NBEDH>JB .28, .29 6C9 .35 4DJC< $CK:HI><6IDG .NBEDH>JB,
/:8=CDAD<>HI +GD<G6B, *G6A +G:H:CI6I>DC *-11 12:00EB - 1:30EB
_________________________________________________________________
BG:6@ 1:30EB - 1:40EB
_________________________________________________________________
$H67:AA: AGCJA; (#:C>C< (:BDG>6A ':8IJG:) 1:40EB - 2:40EB
_________________________________________________________________
.NBEDH>JB 34: A %D>CI .NBEDH>JB L>I= I=: $!C). 1:40EB - 3:10EB
_________________________________________________________________
CD;;:: 6C9 M=>7>I 3:10EB - 3:30EB
_________________________________________________________________
&:NCDI: 3:30EB - 4:30EB
_________________________________________________________________
_________________________________________________________________
.NBEDH>JB .30-32, /:8=CDAD<>HI +GD<G6B 6C9 *G6A +G:H:CI6I>DC *-16 5:30EB - 7:00EB
_________________________________________________________________
.33: %D>CI .NBEDH>6 D; 2A.( 6C9 .+A- 5:30EB - 7:00EB
_________________________________________________________________
CADH>C< C:G:BDCN 7:00EB - 7:45EB
_________________________________________________________________
97
2
D
)
.
D
A
4
2:9C:H96N, *8ID7:G 2, 2013
9:006B ID 10:006B AJ9>IDG>JB 1
&:NCDI:: .JG<:GN D; *7HIGJ8I>K: .A::E AEC:6
Demin Han, MD, PhD
Chinese Medical Doctor Association Otolaryngology
China
President of Beijing Tong-Ren afliated Hospital of Capital Medical University
Recipient of National Science and Technology Award
)DI:H:
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
98
2
D
)
.
D
A
4
2:9C:H96N, *8ID7:G 2, 2013
10:006B ID 11:306B AJ9>IDG>JB 2
.24: /=: C=6AA:C<:H ;DG D:;>C>C< )DGB6I>K: D6I6 ;DG .A::E
D>HDG9:G:9 BG:6I=>C< A8GDHH '>;:HE6C
C=6>G:
Hartmut Schneider (USA)
.E:6@:GH:
Hartmut Schneider (USA), Brian McGinley (USA), Joseph M. Monserrat (Spain), Ludger Grote (Sweden),
Olli Polo (Finland), Thomas Penzel (Germany)
':6GC>C< *7?:8I>K:H:
Demonstrate how novel approaches to improve standards for detection and definition of sleep disordered breathing in
clinical and research populations.
Define the challenges of assessing normative data.
Advance sleep field by showing how various age group affect sleep disorders breathing indices
/6G<:I AJ9>:C8::
Epidemiologists in Sleep, Physiologists, Pediatricians and adult sleep doctors.
.JBB6GN:
The standards that have been established for defining sleep disordered breathing have been advanced without a body of
data defining the range of normal breathing in sleep. New studies have revealed a wide range of normality in sleep and
breathing that varies with age and gender. The problem becomes defining the significant respiratory features and the
range that defines abnormality and the clinical significance of this range. This has been complicated by the failure to
appreciate the major differences related to age and gender in human sleep.
10:00am - 10:05am
$CIGD9J8I>DC
10:05am - 10:20am
+=NH>DAD<>8 8=6C<:H D; G:HE>G6IDGN 8DBEDC:CIH 68GDHH I=: A>;:HE6C: $BE68I DC HA::E
9>HDG9:G:9 7G:6I=
10:20am 10:35am
+:9>6IG>8: 69K6C8:H >C 8G>I:G>6 ;DG 9:;>C>C< HA::E 9>HDG9:G:9 7G:6I=>C<
Brian McGinley (USA)
10:35am 10:50am
A9:GAN: +GD7A:BH D; 9:;>C>C< CDGB6A>IN >C I=: DA9:G EDEJA6I>DC
Joseph M. Monserrat (Spain)
10:50am - 11:05am
D:;>C>C< HA::E 9>HDG9:G:9 7G:6I=>C< >C 69JAIH, A:HHDCH ;GDB .ADA.
11:05am 11:20am
":C9:G 9>;;:G:C8:H D; HA::E 9>HDG9:G:9 7G:6I=>C<
Olli Polo (Finland)
11:20am 11:30am
,J:HI>DC 6C9 6CHL:G
99
2
D
)
.
D
A
4
2:9C:H96N, *8ID7:G 2, 2013
10:006B ID 11:306B AJ9>IDG>JB 3
.25: #NED8G:I>C/DG:M>C 6H 6 /=:G6E:JI>8 /6G<:I ;DG .A::E D>HDG9:GH
C=6>G:
Luis de Lecea (USA)
.E:6@:GH:
Luis de Lecea (USA), Jyrki Kukkonen (Finland), Takeshi Sakurai (Japan), W. Joseph Herring (USA)
':6GC>C< *7?:8I>K:H:
Learn about the basic neuroanatomy and pharmacology of the hypocretin/orexin system
Basic connectivity of orexin neurons with monoaminergic systems
Learn about the differential functions of orexin receptors
Learn about optogenetic methods applied to sleep research
Learn about suvorexant and other therapeutic tools targeting orexin receptors
/6G<:I AJ9>:C8::
Specialists in sleep medicine, scientists with an interest in the neurobiology underlying sleep/wake transitions.
Intermediate-advanced level.
.JBB6GN:
This symposium will gather the most current knowledge on the hypocretin/orexin system and the application of orexin
receptorant agonists in the treatment of insomnia and other disorders.
10:00am - 10:02am
$CIGD9J8I>DC
Luis de Lecea (USA)
10:02am - 10:22am
#NED8G:I>CH/DG:M>CH 6H B6HI:GH G:<JA6IDGH D; HA::E/L6@: 8N8A: 6C9 7:NDC9
Luis de Lecea (USA)
10:22am 10:42am
*G:M>C G:8:EIDGH 6C9 H><C6A>C<
Jyrki Kukkonen (Finland)
10:42am 11:02am
*G:M>C HNHI:B
Takeshi Sakurai (Japan)
11:02am - 11:22am
.JGKDG:M6CI: AC DG:M>C G:8:EIDG 6CI6<DC>HI ;DG I=: IG:6IB:CI D; >CHDBC>6
W. Joseph Herring (USA)
11:22am 11:30am
,J:HI>DC 6C9 6CHL:G
Luis de Lecea (USA)
100
2
D
)
.
D
A
4
2:9C:H96N, *8ID7:G 2, 2013
.26: .E>C6A (:8=6C>HBH >C -'.
CD-8=6>GH:
Walter Paulus (Germany), Stefan Clemens (USA)
.E:6@:GH:
Walter Paulus (Germany), Federica Provini (Italy), Cornelius Bachmann (Germany), Stefan Clemens (USA),
Imad Ghorayeb (France)
':6GC>C< *7?:8I>K:H:
Role of dopamine and opioid receptors in the spinal cord
Accessibility of spinal cord function in RLS patients
Augmentation liability in RLS due to spinal specifics
Treatment option by transcutaneously-applied direct current stimulation
How to decide on pharmacotherapy of RLS on the background of spinal specifics
/6G<:I AJ9>:C8::
Physicians involved in diagnosis and treatment of the Restless Legs Syndrome.
.JBB6GN:
Restless Legs Syndrome is a network disorder involving the brain as well as the spinal cord. In this symposium we will
address both the pathophysiology of the spinal cord as well as treatment oriented aspects. Obviously rodent data differ
from primate data, since the former involve dopaminergic neurotransmission, while the latter address L-dopaergic A11
neurones. Differences will be outlined. Aspects such as small fibre neuropathy induced spinal neuron denervation and
lack of spinal dopamine transporter will be discussed on the background of reflex studies and therapeutic consequences,
in particular with regard to dopaminergic augmentation. Recent data on a beneficial effect of spinal direct current
stimulation will complete the overview on spinal mechanisms in RLS.
10:00am - 10:02am
$CIGD9J8I>DC
Stefan Clemens (USA)
10:02am - 10:17am
CDC8:EIH D; .E>C6A E6I=DE=NH>DAD<N >C -'.
Walter Paulus (Germany)
10:17am 10:32am
.E>C6A B:8=6C>HBH D; +'( >C -'. E6I>:CIH
10:32am 10:47am
.E>C6A 9>G:8I 8JGG:CI HI>BJA6I>DC >C -'.
Cornelius Bachmann (Germany)
10:47am - 11:02am
-D9:CI BD9:AH D; HE>C6A E6I=DE=NH>DAD<N
Stefan Clemens (USA)
11:02am 11:17am
+G>B6I: BD9:AH D; HE>C6A E6I=DE=NH>DAD<N
Imad Ghorayeb (France)
11:17am 11:30am
,J:HI>DC 6C9 6CHL:G
Walter Paulus (Germany)
101
2
D
)
.
D
A
4
2:9C:H96N, *8ID7:G 2, 2013
.27: $9>DE6I=>8 #NE:GHDBC>6: +6HI, +G:H:CI 6C9 !JIJG:
CD-C=6>GH:
Michel Billiard (France), Sona Nevsimalova (Czech Republic)
.E:6@:GH:
Michel Billiard (France), Karel Sonka (Czech Republic), Seiji Nishino (USA), Sona Nevsimalova (Czech Republic),
Timothy Morgenthaler (USA)
':6GC>C< *7?:8I>K:H:
To trace the evolution of the concept of idiopathic hypersomnia since its origin
To suggest new limits between the different forms of narcolepsy and idiopathic hypersomnia, based on cluster analysis
To make an update on the role of monoamines, histamine and hypocretin in the pathophysiology of idiopathic
hypersomnia and to suggest new orientations for research
To bring light on the genetics and on the circadian rhythms in idiopathic hypersomnia with and without long sleep time
To propose, based on the largest one-center retrospective review ever published, the most active and the least liable to
side-effects drugs for idiopathic hypersomnia
/6G<:I AJ9>:C8::
Mostly clinicians and researchers interested in hypersomnias of central origin, idiopathic hypersomnia and narcolepsy.
.JBB6GN:
In comparison with narcolepsy and even Kleine-Levin syndrome, idiopathic hypersomnia stands as the least studied
among hypersomnias of central origin.
10:00am - 10:18am
/=: 8DC8:EI D; >9>DE6I=>8 =NE:GHDBC>6 H>C8: >IH DG><>C
Michel Billiard (France)
10:18am - 10:36am
.E:8IG6 D; C6G8DA:EHN 6C9 >9>DE6I=>8 =NE:GHDBC>6
Karel Sonka (Czech Republic)
10:36am 10:54am
):JGD8=:B>HIGN D; >9>DE6I=>8 =NE:GHDBC>6
Seiji Nishino (USA)
10:54am 11:12am
":C:I>8 6HE:8IH D; >9>DE6I=>8 =NE:GHDBC>6
Sona Nevsimalova (Czech Republic)
11:12am - 11:30am
/G:6IB:CI D; >9>DE6I=>8 =NE:GHDBC>6: IG>6AH 6C9 IG>7JA6I>DC
Timothy Morgenthaler (USA)
102
2:9C:H96N, *8ID7:G 2, 2013
*-11: +:9>6IG>8H .A::E D>HDG9:G BG:6I=>C<
C=6>G:
Louise O'Brien (USA)
'>EDEDANH688=6G>9:-7>C9>C< EGDI:>C ('B+) H:GJB A:K:AH >C 8=>A9G:C L>I= *.A 6C9 D7:H>IN
Leila Kheirandish-Gozal (USA)
.CDG>C<, HA::E>C:HH, >C6II:CI>DC, 6C9 =NE:G68I>K>IN >C EG:H8=DDA 6C9 @>C9:G<6GI:C 8=>A9G:C L>I= 6
G:E6>G:9 8A:;I E6A6I:
Marta Moraleda-Cibrian (USA)
#:6GI G6I: K6G>67>A>IN 6C9 6JIDCDB>8 BD9JA6I>DC >C 8=>A9G:C L>I= D7HIGJ8I>K: HA::E 6EC:6 HNC9GDB:
Zhifei XU (China)
/=: 9>6<CDH>H 6C9 B6C6<:B:CI D; 8A>C>86AAN H><C>;>86CI 8:CIG6A HA::E 6EC:6 >C >C;6CIH L>I= +G69:G-2>AA>
HNC9GDB:
Indra Narang (Canada)
.A::E-9>HDG9:G:9 7G:6I=>C< >C 8=>A9G:C L>I= A6GNC<DB6A68>6
Rogelio Peralta Lepe (Spain)
CA>C>86A 8=6G68I:G>HI>8H D; =DHE>I6A>O:9 =:6GI ;6>AJG: E6I>:CIH L>I= 96NI>B: C=:NC:-.ID@:H G:HE>G6I>DC
Yasuhiro Tomita (Japan)
25 -( 6C9 .ADL 26K: +6G6HDBC>6H: 1>9:D 6C9 +." $9:CI>;>86I>DC
103
2
D
)
.
D
A
4
2
D
)
.
D
A
4
2:9C:H96N, *8ID7:G 2, 2013
.28: D:CI6A (6C6<:B:CI D; *.A >C A9JAIH 6C9 C=>A9G:C
CD-8=6>GH:
Flix de Carlos Villafranca (Spain), Emilio Macas Escalada (Spain)
.E:6@:GH:
Flix de Carlos Villafranca (Spain), Christian Guilleminault (USA), Michle Hervy-Auboiron (France),
':6GC>C< *7?:8I>K:H:
Benefits of Dental Devices and dentofacial orthopedics in the sleep-related breathing disorders
/6G<:I AJ9>:C8::
Physicians, Dentists, Pediatricians, Orthodontists interested in treating the syndrome of obstructive sleep apnea in both
children and adults.
.JBB6GN:
The use of intra-oral appliances for the treatment of obstructive problems in the upper airways is not a new concept. Back in 1902,
Pierre Robin recommended the use of an appliance of these characteristics (monoblock) in order to achieve functional mandibular
advancement, moving the mandible to a more advanced position. By doing so, he was able to add traction to the tongue and
prevent it from falling backwards. Passive manipulation of the lower jaw by means of intra-oral mandibular advancement devices
(MAD) involves changes in the morphology and volume of the upper airways. This movement stabilizes and fixes the mandible
and the hyoid bone, preventing posterior rotation of these structures and avoiding occupation of the airway when recumbent.
MAD facilitate an increase in volume and permeability of the upper airways. This increase in the upper airways has been
documented in a large number of studies using different scanning systems and imaging techniques. MAD represent a useful
alternative in patients with chronic snoring and/or obstructive sleep apnoea. They comprise a reasonable alternative with respect to
other existing therapies, as they do not involve a permanent change in the individual (as occurs with surgery) and their use can be
discontinued at any time. However, a suitable risk-benefit assessment of the patient must be carried out on an individual level in
order to determine the best therapy in each particular case. Benefits perceived by the patient are confirmed in polysomnographic
records as: a reduction in the frequency and intensity of snoring, improved oxygen saturation, a reduction in the number of apnoeas
and arousals, decreased blood pressure readings and, ultimately, a significant improvement in sleep structure. Obstructive sleep
apnoea is a common breathing problem with a complex and poorly understood physiopathology which involves changes in neural
control and in the reflexes of the upper airways. In fact, the coordinate neural regulation of the upper airway muscles is basic to
control airway size and resistance. Knowledge of the mechanism of action of these devices and of the facial structures that support
them represents a different approach to the treatment of obstructive diseases of the upper airway. There still remains an important
outstanding issue, however, namely that of intervention at an early age. This should be taken into consideration to establish a
hypothetical prophylaxis of obstructive sleep disease. The possibility of manipulating maxillomandibular growth by orthopaedic
and orthodontic means in children in order to stimulate or inhibit the growth of these structures is of major interest. By doing so,
we induce changes in the airways, thus achieving a conformation that is less susceptible to collapse.
$CIGD9J8I>DC
Flix de Carlos Villafranca (Spain)
*GD-;68>6A <GDLI= 6C9 E:9>6IG>8 HA::E 9>HDG9:G:9 7G:6I=>C<
*GI=DE:9>8H 6C9 DGI=D9DCI>8H IG:6IB:CI D; *.A >C 8=>A9G:C 6C9 EG:K:CI>DC
Michle Hervy-Auboiron (France)
*EI>B>O6I>DC D; DG6A 6EEA>6C8: I=:G6EN ;DG HA::E-G:A6I:9 7G:6I=>C< 9>HDG9:GH
C6G9>DK6H8JA6G >BE68I >C .A*. E6I>:CIH IG:6I:9 L>I= 69K6C8:B:CI B6C9>7JA6G 9:K>8:H
,J:HI>DC 6C9 6CHL:G
104
2
D
)
.
D
A
4
2:9C:H96N, *8ID7:G 2, 2013
.29: )6G8DA:EHN 0E96I:
+6GI $: -:8:CI B>< D6I6 AC6ANH>H D; (DG7>9>IN, (DGI6A>IN 6C9 .D8>:I6A BJG9:C D; )6G8DA:EHN
+6GI $$: )DG9>8 #1)1 1688>C: 6C9 )6G8DA:EHN :ME:G>:C8:: -:8:CI 0C:ME:8I:9 !>C9>C<H
+6GI $ .E:6@:GH:
Maurice Ohayon (USA), Poul Jennum (Denmark), Jed Black, (USA)
+6GI $ ':6GC>C< *7?:8I>K:H:
Describe the higher rates of medical comorbidity in patients with narcolepsy relative to the general population of non-
narcolepsy patients treated within the Danish and US healthcare systems.
Quantify the higher rates of healthcare utilization, and associated costs in narcolepsy patients compared with those
without narcolepsy.
Understand the relationship between narcolepsy and mortality risk.
+6GI $ .JBB6GN:
Part I Summary: While it has long been recognized that narcolepsy can have detrimental impacts on various psychological,
medical, and functional facets of life, the broad impact of the disease on both individuals and society has not been, until recently,
well quantified using large, population-based samples. The three speakers will present original, population-based research addressing
the burden of illness relating to narcolepsy.
Dr. Ohayon will present findings relating to medical comorbidity and mortality risk associated with narcolepsy in a large cohort of
322 well-documented narcolepsy patients within the US population. This cohort is matched with a representative US sample of
15,928 individuals.
Dr. Jennum will review his results of an evaluation of 816 narcolepsy patients from the 5.5 million-patient Danish National patient
registry. These data confirm a significant burden of illness and medical comorbidity presence in patients with narcolepsy compared
with a sample of four-fold, well-matched controls within the registry.
Dr. Black will describe a recent analysis of claims data on 9,312 narcolepsy patients and 46,559 highly-matched controls in the US,
which revealed significantly higher rates of comorbid diseases, healthcare service and drug utilization rates, and associated medical
costs in narcolepsy subjects versus controls. Narcolepsy was also associated with significantly higher rates of short-term disability
related outcomes, including costs.
Combined, these data substantiate the tremendous impact of narcolepsy globally and highlight the importance of ongoing efforts
to facilitate earlier diagnosis and timely implementation of effective therapy in patients suffering from the disorder.
+6GI $$ .E:6@:GH:
+6GI $$ ':6GC>C< *7?:8I>K:H:
Summarize the association of H1N1 vaccination and narcolepsy in Nordic countries and understand the role
that public policy or practices may play in introducing bias in medical practice or scientific discovery.
+6GI $$ .JBB6GN:
Dr. Partinen will provide a general update on the overall pattern of association of H1N1 vaccination and narcolepsy
in Nordic countries and review current findings on narcolepsy symptom evolution in children with recent-onset
narcolepsy. Of particular importance, Dr. Partinen will provide a focused review of the Finnish experience with H1N1
vaccination and the presentation of narcolepsy in over 100 Finnish pediatric and adult cases, highlighting the possibility
that Finnish disability compensation policies may impart a potential source of bias.
105
2
D
)
.
D
A
4
2:9C:H96N, *8ID7:G 2, 2013
12:00EB - 1:30EB AJ9>IDG>JB 1
.35: 4DJC< $CK:HI><6IDG .NBEDH>JB: .A::E 6C9 ):JGD9:<:C:G6I>DC
CD-8=6>GH:
Carlos H. Schenck (USA), Claudia Trenkwalder (Germany)
.E:6@:GH:
Carlos H. Schenck (USA), Yo-El Ju (USA), Jason Valerio (Canada), Alia Mansour (Egypt), Preeti Devnani (India),
Lena Tholfsen (Norway), Nicholas-Tiberio Economou (Greece), Claudio Liguori (Italy)
':6GC>C< *7?:8I>K:H:
To learn about sleep problems associated with neurodegenerative disorders
To learn how idiopathic RBD (iRBD) is a strong risk factor for future parkinsonism
To learn about PET data on cholinergic and striatal dopaminergic dysfunction in iRBD in the context of increased risk
for future neurodegeneration
To become acquainted with an evidence based review of the treatment of RBD
To learn about the correlates of sleep and orexin with cognitive decline in Alzheimer disease (AD).
To become acquainted with how polysomnographic findings can have correlates with mild cognitive impairment and AD
/6G<:I AJ9>:C8::
A broad target audience, including clinicians and basic scientists of all levels of training and experience.
.JBB6GN:
This symposium is dedicated to the recent excellent work of young investigators and those who are new to the area of sleep and
neurodegeneration. It covers areas of abnormal sleep in neurodegenerative disorders, focusing on RBD and excessive sleepiness in
PD, and their clinical, polysomnographic, and brain imaging correlates. Underlying mechanisms are explored by PET cholinergic
and striatal dopaminergic imaging of idiopathic RBD patients, searching for risk factors of future neurodegeneration. An evidence
based review of RBD treatment is presented. In the Introduction, the broad scope of current knowledge on RBD is summarized,
and future directions of RBD research are indicated. Research on Alzheimer disease (AD) is presented in regards to the correlates
of sleep and orexin with cognitive decline. Also, correlates of polysomnographic findings are applied across the spectrum of
normal elderly cognition, mild cognitive impairment, and AD.
$CIGD9J8I>DC: -BD: CJGG:CI &CDLA:9<: 6C9 !JIJG: D>G:8I>DCH
Carlos H. Schenck (USA)
!JC8I>DC6A 7G6>C C:ILDG@H >C -( HA::E 7:=6K>DG 9>HDG9:G
Yo-El Ju (USA)
C=DA>C:G<>8 6C9 HIG>6I6A 9DE6B>C:G<>8 9NH;JC8I>DC JH>C< +/ 6H 6 G>H@ B6G@:G ;DG 9:K:ADE>C< 6
C:JGD9:<:C:G6I>K: 9>H:6H: >C E6I>:CIH L>I= >9>DE6I=>8 -6E>9 N: (DK:B:CI HA::E 7:=6K>DJG 9>HDG9:G
Jason Valerio (Canada)
CA>C>86A 6C9 +DANHDBCD<G6E=>8 HIJ9N D; -BD >C +6G@>CHDCQH 9>H:6H: ;GDB <NEI
Alia Mansour (Egypt)
/G:6IB:CI D; -( B:=6K>DJG D>HDG9:G- AC K>9:C8: B6H:9 -:K>:L
Preeti Devnani (India)
M8:HH>K: 96NI>B: HA::E>C:HH >C :6GAN +6G@>CHDC'H 9>H:6H:: A ;>K: N:6G ;DAADL-JE
Lena Tholfsen (Norway)
!GDB CDGB6A :A9:GAN I=GDJ<= (>A9 CD<C>I>K: $BE6>GB:CI ((C$) ID AAO=:>B:GQH D>H:6H:.
A EGD<G:HH>DC 76H:9 DC HA::E EDANHDBCD<G6E=>8 ;>C9>C<H
Nicholas-Tiberio Economou (Greece)
AAO=:>B:G 9>H:6H:: HA::E, DG:M>C 6C9 8D<C>I>K: 9:8A>C:
Claudio Liguori (Italy)
,J:HI>DC 6C9 6CHL:G
Carlos H. Schenck (USA)
106
2
D
)
.
D
A
4
2:9C:H96N, *8ID7:G 2, 2013
1:40EB - 3:10EB AJ9>IDG>JB 2
%D>CI .NBEDH>JB D; 2A.( L>I= I=: JGDE:6C C=6EI:G D; I=:
$CI:GC6I>DC6A !:9:G6I>DC D; CA>C>86A ):JGDE=NH>DAD<N
.34: -( .A::E: )DGB6A 6C9 A7CDGB6A ):JGDE=NH>DAD<N
CD-8=6>GH:
Luis Garcia-Larrea (France), Walter Paulus (Germany)
.E:6@:GH:
Luis Garcia-Larrea (France), Walter Paulus (Germany), Hlne Bastuji (France), Poul Jennum (Denmark),
Marcello Massimini (Italy), Teresa Paiva (Portugal)
':6GC>C< *7?:8I>K:H:
To understand physiological mechanisms of brain connectivity during sleep with a focus on REM sleep in humans,
integrating animal and human data
To identify REM sleep using an electronic algorithm for detecting RBD
To analyse brain connectivity during sleep using neurophysiological and imaging techniques
To describe the mechanisms and phenotypes of dreaming in neurological patients
/6G<:I AJ9>:C8::
Target audience sleep clinicians, basic researchers and PhD students.
.JBB6GN:
The Symposium will deal with thalamo-cortical interactions during human sleep with special focus on REM
(paradoxical) sleep. It will discuss (a) intracranial data from humans on sensory integration and thalamo-cortical
coupling/decoupling during sleep (H Bastuji, Lyon); (b) the automatic detection of REM sleep in patients with
idiopathic REM behaviour disorder (P Jennum, Glostrup) (c) the changes in effective connectivity during human
REM sleep (M Massimini, Milan) and the particularities of REM sleep and dreaming in patients with neurological
disorders (T Paiva, Lisbon).
1:40pm - 1:42pm
$CIGD9J8I>DC
1:42pm 2:02pm
.:CHDGN >CI:<G6I>DC 6C9 I=6A6BD-8DGI>86A 8DJEA>C</9:8DJEA>C< 9JG>C< HA::E
Hlne Bastuji (France)
2:02pm 2:22pm
AJIDB6I>8 -( HA::E 9:I:8I>DC 6HHD8>6I:9 L>I= >9>DE6I=>8 -( HA::E 7:=6K>DG 9>HDG9:G
Poul Jennum (Denmark)
2:22pm 2:42pm
CDGI>86A G:68I>K>IN 6C9 :;;:8I>K: 8DCC:8I>K>IN 9JG>C< -( HA::E >C =JB6CH 6H G:K:6A:9 7N
;(-> 6C9 "
Marcello Massimini (Italy)
2:42pm 3:02pm
DG:6B>C< >C C:JGDAD<>86A 9>HDG9:GH
Teresa Paiva (Portugal)
3:02pm - 3:10pm
,J:HI>DCH 6C9 6CHL:G
107
2
D
)
.
D
A
4
2:9C:H96N, *8ID7:G 2, 2013
#:C>C< (:BDG>6A ':8IJG:: ):JGD<:C:G6I>DC 6C9 .A::E
Isabelle Arnulf, MD, PhD
Piere and Marie Curit University
France
)DI:H:
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
2:9C:H96N, *8ID7:G 2, 2013
&:NCDI:: ":C:I>8H 6C9 E><:C:I>8H D; .A::E D>HDG9:GH
Mehdi Tafti, PhD
University of Lausanne
Switzerland
Mehdi Tafti received his PhD from the University of Montpellier (France) in 1991
after completing his doctoral thesis on sleep regulation in human narcolepsy. He
performed a postdoctoral fellowship with Dr. Mignot and Dr. Dement and was a
Research Associate at the Department of Psychiatry and Biological Sciences at
Stanford University. In 1995 he moved to the Department of Psychiatry in Geneva
where he established the frst laboratory dedicated to the molecular genetics of sleep
and sleep disorders. He joined the Center for Integrative Genomics in September 2004.
)DI:H:
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
108
2:9C:H96N, *8ID7:G 2, 2013
*-13: +6G6HDBC>6 6C9 +HN8=>6IG>8 D>HDG9:GH
C=6>G:
Geert Mayer (Germany)
CDBE6G6I>K: B:I6-6C6ANH>H D; EG6ODH>C 6C9 >B6<:GN G:=:6GH6A I=:G6EN ;DG C><=IB6G:H, HA::E
9>HIJG76C8: 6C9 EDHI-IG6JB6I>8 HIG:HH
M. Monserrat Sanchez Ortuo (Spain)
C6C CD8IJGC6A HA::E 9>HIJG76C8:H EG:9>8I CDC-G:B>HH>DC 6C9 G:A6EH: >C E6I>:CIH L>I= B6?DG
9:EG:HH>K: 9>HDG9:G? A 5-N:6G C6IJG6A>HI>8 ADC<>IJ9>C6A HIJ9N
Shirley X. Li (China)
.A::E EGD;>A: >C =NEDB6C>6 : A EDANHDBCD<G6E=>8 :K6AJ6I>DC >C 6C <NEI>6C H6BEA:
Tarek Asaad (Egypt)
D>HHD8>6I:9 HA::E HI6I:H >C !>7GDBN6A<>6: +G:K6A:C8: 6C9 8DGG:A6I>DCH
Ligia Ferreira (Portugal)
_____________________________________________________________________
2:9C:H96N, *8ID7:G 2, 2013
*-14: -'./+'(.: )6IJG6A CDJGH:, ->H@ !68IDGH 6C9 #:6AI=
C=6>G:
-:HIA:HH A:< HNC9GDB: >C NDJC< 8=>A9G:C L>I= DGD;68>6A 8A:;I
Marta Moraleda-Cibrian (USA)
/=: C6IJG6A =>HIDGN D; G:HIA:HH A:<H HNC9GDB:: G:IGDHE:8I>K: 96I6 DC 6 8A>C>86A H6BEA:
+6I>:CIH L>I= E:G>D9>8 A>B7 BDK:B:CIH 9>HDG9:G 9D CDI 9>;;:G ;GDB E6I>:CIH L>I= 6CDI=:G HA::E
9>HDG9:GH >C I:GBH D; CD8IJGC6A 7ADD9 EG:HHJG:
Mariusz Sieminski (Portugal)
D>H:6H: 7JG9:C >C E6I>:CIH L>I= G:HIA:HH A:<H HNC9GDB: 8DBE6G:9 L>I= 6C 6EC:6 6C9 6 8DCIGDA 8D=DGI
Solene Tiefry (USA)
_____________________________________________________________________
2:9C:H96N, *8ID7:G 2, 2013
*-15: .A::E 6C9 #:6AI=
C=6>G:
Ferran Barb (Spain)
(DG7>9>IN 6C9 BDGI6A>IN >C 8=>A9G:C L>I= D7HIGJ8I>K: HA::E 6EC:6: 6 8DCIGDAA:9 C6I>DC6A HIJ9N
Poul Jennum (Denmark)
.A::E HIGJ8IJG: 6C9 86G9>DB:I67DA>8 9>HDG9:GH >C I=: <:C:G6A EDEJA6I>DC
Jos Haba-Rubio (Switzerland)
.:K:G>IN D; HA::E 6EC:6 HNC9GDB: >H 6HHD8>6I:9 L>I= 6GI:G>6A HI>;;C:HH >C :A9:GAN EDEJA6I>DC
Tae Kim (South Korea)
*GD;68>6A BND;JC8I>DC6A :K6AJ6I>DC L>I= H8DG:H >C HJ7?:8IH L>I= *.A
Gislaine Aparecida Folha (Brazil)
109
2
D
)
.
D
A
4
2
D
)
.
D
A
4
2:9C:H96N, *8ID7:G 2, 2013
.30: 0H>C< I=: D>B '><=I (:A6IDC>C *CH:I (D'(*) ID K6AJ6I:
C>G869>6C />B>C< >C CA>C>86A +DEJA6I>DCH
C=6>G:
Jeanne Duffy (USA)
.E:6@:GH:
Jeanne Duffy (USA), Shadab Rahman (USA/Canada), Marcel G. Smits (The Netherlands),
Aurelija Jucaite (Lithuania/Sweden), Jung-Hie Lee (Korea)
':6GC>C< *7?:8I>K:H:
Sleep regulation by interaction of circadian and sleep-wake homeostatic processes
The dim light melatonin onset (DLMO) as a marker of circadian timing
In-home and laboratory methods for assessing DLMO
Evidence from clinical populations where the DLMO was used to assess circadian timing
/6G<:I AJ9>:C8::
Clinicians who treat patients with insomnia and circadian rhythm sleep disorders; circadian rhythm researchers; sleep
researchers who want to understand more about circadian rhythms.
.JBB6GN:
Circadian Rhythm Sleep Disorders (CRSD) are typically evaluated on the basis of sleep timing, with the assumption that the cause of
the abnormal sleep timing is an abnormality in the circadian timing system. However, there is evidence that this assumption is not
true for all CRSD patients. CRSD individuals sleeping at abnormal clock times may be sleeping at normal circadian times, which
would suggest their behavioral choices of sleep and light-dark exposure are contributing to their sleep timing problems and should be
the focus of treatment. Similarly, individuals sleeping at conventional clock times may be sleeping at abnormal circadian times, which
could lead to problems with sleep initiation or sleep maintenance; treating such individuals should involve shifting the underlying
circadian timing without changing sleep timing. Thus, circadian timing information may contribute to addressing several types of
sleeping problems beyond the circadian rhythm disorders, and may guide better treatment choices. In research settings, the dim light
melatonin onset (DLMO) is a widely-used tool for determining the timing of circadian rhythms. In clinical settings, serial saliva
samples are collected in dim light conditions for several hours to be assayed for melatonin levels, and the time of the evening rise in
melatonin (the DLMO) is determined and used as a marker of circadian phase. When the phase is compared with habitual sleep
timing, a phase angle can also be determined. While the phase provides information about the clock time of circadian rhythms, the
phase angle provides information about the circadian time of sleep, and can provide insight into whether the individuals sleep is at a
typical or abnormal circadian phase. In this symposium we will describe protocols for assessing DLMO in patient populations and
present findings from several clinical populations where circadian timing information was used to guide treatment.
5:30pm - 5:45pm
$CIGD9J8I>DC ID HNBEDH>JB: -6I>DC6A: ;DG 9>G:8I 6HH:HHB:CI D; 8>G869>6C G=NI=BH >C HA::E
9>HDG9:GH E6I>:CIH
Jeanne Duffy (USA)
5:45pm - 6:00pm
D.+.: B>G9H D; I=: H6B: ;:6I=:G? 0I>A>IN D; I=: D'(* I:HI >C 9>6<CDH>C< D.+. >C 6
8A>C>86A EDEJA6I>DC >C C6C696
Shadab Rahman (USA/Canada)
6:00pm - 6:15pm
0H>C< H6A>K6GN B:A6IDC>C B:6HJG:B:CIH >C E6I>:CIH L>I= >CHDBC>6 6C9 EDHH>7A: HA::E I>B>C<
9>HDG9:GH: ME:G>:C8: L>I= 1,800 E6I>:CIH >C I=: ):I=:GA6C9H
Marcel G. Smits (The Netherlands)
6:15pm - 6:30pm
D>JGC6A B:A6IDC>C E6II:GCH >C 8=>A9G:C: -:69N ID 6EEAN >C 8A>C>86A EG68I>8:?
Aurelija Jucaite (Lithuania/Sweden)
6:30pm 6:45pm
$CI:<G6I>C< D'(* 6HH:HHB:CIH >CID 8A>C>86A EG68I>8: >C &DG:6: +G68I>86A 8DCH>9:G6I>DCH
Jung-Hie Lee (Republic of Korea)
6:45pm 7:00pm
,J:HI>DC 6C9 6CHL:G
Jeanne Duffy (USA)
110
2
D
)
.
D
A
4
2:9C:H96N, *8ID7:G 2, 2013
.31: .A::E (>8GDHIGJ8IJG:, AGDJH6AH 6C9 AJIDCDB>8 !JC8I>DCH: ):L
$CH><=IH 6C9 CA>C>86A $BEA>86I>DCH
CD-C=6>GH:
Liborio Parrino (Italy), Pietro Cortelli (Italy)
.E:6@:GH:
Liborio Parrino (Italy), Pietro Cortelli (Italy), Eduardo Benarroch (USA), Jussi Toppila (Finland), Andrea Grassi (Italy),
':6GC>C< *7?:8I>K:H:
To update the relationship between sleep and autonomic regulation.
To evaluate the time relation between arousal events occurring during sleep and autonomic variations
To identify autonomic markers that correlate with sleep microstructure.
To understand the pathophysiological hemodynamic mechanisms associated with unstable sleep
To disclose the harmful impact of high amounts of CAP in sleep disorders, such as Nocturnal Epilepsy, which are
commonly neglected in terms of autonomic risk.
/6G<:I AJ9>:C8::
Sleep physicians, Neurologists, Neurophysiologists, Pulmonologists, Cardiologists, Sleep technologists
.JBB6GN:
There is an intimate relationship between the autonomic nervous system and sleep from an anatomical, physiological, and
neurochemical point of view. Recording autonomic parameters during sleep can shed light on the biological price and potential
harmful consequences of sleep disorders. A pivotal role is played by the arousal system which modulates ventilation, cardiovascular
control and networks involved in the regulation of motor activities. During non-REM sleep, EEG arousal-related phasic events are
organized in periodic sequences which are associated with oscillatory swings of the autonomic functions. These sequences are
recognized as the cyclic alternating pattern (CAP), which represents the EEG marker of sleep instability. Conditions of reduced sleep
quality are characterized by increased amounts of CAP and by a shift in the sympathetic/parasympathetic balance towards a
sympathetic predominance. CAP-related autonomic alterations have been investigated by means of pulse wave amplitude and heart
rate variability in patients with Nocturnal Frontal Lobe Epilepsy, characterized by an impressive increase of CAP. A novel non-invasive
optical method for monitoring cortical and scalp hemodynamic changes is offered by near-infrared spectroscopy (NIRS), which has
been recorded during CAP in healthy subjects and during apnea-related arousals in patients with obstructive sleep apnea syndrome.
The proposed symposium will allow presentation of these results and outline perspectives for further research.
5:30pm - 5:34pm
$CIGD9J8I>DC
Liborio Parrino (Italy)
5:34pm - 5:38pm
$CIGD9J8I>DC
5:38pm - 5:56pm
AC6IDBD-;JC8I>DC6A >CI:<G6I>DC 7:IL::C HA::E 6C9 6JIDCDB>8 C:GKDJH HNHI:B
Eduardo Benarroch (USA)
5:56pm - 6:14pm
CA+-G:A6I:9 8:G:7G6A =:BD9NC6B>8 K6G>6I>DC B:6HJG:9 L>I= C:6G->C;G6G:9 HE:8IGDH8DEN ()$-.)
Jussi Toppila (Finland)
6:14pm 6:32pm
AJIDCDB>8 C:GKDJH HNHI:B 68I>K>IN 9JG>C< HA::E >C )D8IJGC6A !GDCI6A 'D7: E>A:EHN
Andrea Grassi (Italy)
6:32pm 6:50pm
AJIDCDB>8 6GDJH6A 6C9 BDIDG 7:=6K>DJGH 9JG>C< HA::E
6:50pm 7:00pm
,J:HI>DC 6C9 6CHL:G
Liborio Parrino (Italy)
111
2
D
)
.
D
A
4
2:9C:H96N, *8ID7:G 2, 2013
5:30EB - 7:00EB AJ9>IDG>JB 2
.32: *7:H>IN 6C9 .A::E AEC:6 >C C=>A9G:C
CD-8=6>GH:
Indra Narang (Canada), David Gozal (USA)
.E:6@:GH:
David Gozal (USA), Stijn Verhulst (Belgium), Leila Kheirandish-Gozal (USA), Evan Propst (Canada),
':6GC>C< *7?:8I>K:H:
To understand the current prevalence and anatomical factors associated with obstructive sleep apnea in obese children.
To evaluate the role of the polysomnogram in the diagnosis of paediatric obesity related obstructive sleep apnea.
Outline the current medical options and their pitfalls in the management of obstructive sleep apnea in obese children.
Recognise the adverse consequences of obstructive sleep apnea in obese children and the impact of timely diagnosis and
management of this disorder.
Debate whether tonsillectomy should be a treatment for obstructive sleep apnea in older children.
Discuss advanced surgical techniques for the management of obstructive sleep apnea in obese children.
/6G<:I AJ9>:C8::
The proposed scientific symposium is designed to establish a comprehensive and complete review of the most recent
evidence based practice of sleep medicine in children with obstructive sleep apnea and obesity. The prevalence and
severity of obesity in children referred to sleep clinics has alarmingly increased in the past 2 decade and is indicative of a
dramatic increase in the occurrence of obesity-associated morbidities, and more specifically has increased the prevalence
of obstructive sleep apnea. Since both obesity and OSA are two inflammatory disorders, it is not surprising that
inflammatory cascades might be involved in mediating such processes, whether at the pathophysiology of the disease
themselves or their consequences. Therefore, discussion of novel targeted diagnostic and therapeutic modalities that
may benefit such high-risk pediatricpopulations
.JBB6GN:
This symposium is aimed to review the most recent evidence on obesity, its association with obstructive sleep apnea and
cardiovascular consequences during childhood. The proposed symposium will begin with review and discussion about
pathophysiology and risk of OSA in obese children. The next lecture will link pediatric obstructive sleep apnea to
inflammatory-pathways and present the evidence of systemic inflammation in OSA and obesity, with emphasis on
similar and unique signatures. The symposium continues with discussion about changes in endothelial function in
children with OSA and obesity. Autonomic dysfunction and hypertension will be presented during the 4th lecture and
finally treatment of obese children with OSA will be discussed.
5:30pm - 5:35pm
$CIGD9J8I>DC
David Gozal (USA)
5:35pm 5:55pm
+G:K6A:C8:, 6C6IDB>86A 8DGG:A6I:H 6C9 9>6<CDH>H D; E6:9>6IG>8 D7:H>IN
Stijn Verhulst (Belgium)
5:55pm 6:15pm
.NHI:B>8 >C;A6BB6I>DC >C *.A 6C9 D7:H>IN
David Gozal (USA)
6:15pm 6:35pm
C9DI=:A>6A ;JC8I>DC >C 8=>A9G:C L>I= *.A 6C9 D7:H>IN
Leila Kheirandish-Gozal (USA)
6:35pm 6:55pm
A9K6C8:9 HJG<>86A I:8=C>FJ:H ;DG I=: B6C6<:B:CI D; D7:H>IN G:A6I:9 *.A >C 8=>A9G:C
Evan Propst (Canada)
6:55pm - 7:05pm
,J:HI>DCH 6C9 6CHL:G
112
2
D
)
.
D
A
4
113
2:9C:H96N, *8ID7:G 2, 2013
5:30EB - 7:00EB AJ9>IDG>JB 1
.33: %D>CI .NBEDH>6 D; 2A.( 6C9 .D8>:969 HE6CDA6 9:
):JBDAD<>6 N C>GJ<>6 /DG68>86 (.+A-)
CD-8=6>GH:
Christian Guilleminault (USA), Ferrn Barb (Spain)
.E:6@:GH:
Ferrn Barb (Spain), Manuel Sanchez de la Torre (Spain), Miguel Angel Martinez Garcia (Spain),
Alberto Alonso (Spain), Joaquin Duran (Spain), Christian Guilleminault (USA)
':6GC>C< *7?:8I>K:H:
To evaluate the role of the different pathogenic pathways in the development of atherosclerosis and cardiovascular disease in
OSA patients
To understand the clinical relevance to identify and treat OSA in subjects with hypertension
To explore the relationship between OSA and pulmonary embolism
To highlight the importance to develop international collaborative clinical trials enrolling thousands of patients
/6G<:I AJ9>:C8::
Advanced topic for clinical sleep specialists and basic researchers with a special interest in cardiovascular consequences of OSA
.JBB6GN:
The intermittent collapse of the upper airway during sleep activates different pathways such as oxidative stress,
sympathetic activation, inflammation, hypercoagulability, endothelial dysfunction, and metabolic dysregulation that
predispose patients with OSA to hypertension and atherosclerosis. OSA is a common cause of systemic hypertension
and should be suspected in hypertensive individuals, especially those with resistant hypertension. Recent data suggest
that OSA could be related to an increase in the incidence of pulmonary hypertension and this association could be
based on the existence of hypercolagulability in OSAS patients. In order to modify clinical guidelines and to highlight
the importance of OSA in the development cardiovascular diseases it is necessary to perform international clinical trials.
5:30pm - 5:35pm
$CIGD9J8I>DC
Ferrn Barb (Spain)
5:35pm 5:55pm
+6I=D<:C>8 76H:H D; 86G9>DK6H8JA6G 8DCH:FJ:C8:H >C *.A E6I>:CIH
Manuel Sanchez de la Torre (Spain)
5:55pm 6:15pm
-:H>HI6CI =NE:GI:CH>DC 6C9 *.A
Miguel Angel Martinez Garcia (Spain)
6:15pm 6:35pm
+JABDC6GN :B7DA>HB 6C9 *.A
Alberto Alonso (Spain)
6:35pm 6:55pm
/=: C::9 D; >CI:GC6I>DC6A 8A>C>86A IG>6AH 8DAA67DG6I>DC
Joaquin Duran (Spain)
6:55pm - 7:00pm
CADH>C< G:B6G@H
5:30pm - 7:00pm Committee Rooms 3 and 4
26 A8I><G6E=N (6HI:G8A6HH:FJ>EB:CI, .:I JE, -:H:6G8= 0H6<:,
CA>C>86A >CI:GEG:I6I>DC
2:9C:H96N, *8ID7:G 2, 2013
*-16: DGJ<H, /:8=CDAD<N, 6C9 $CHJ;;>8:CI .A::E
CD-C=6>GH:
Max Hirshkowitz (USA), Tomas Penzel (Germany)
C9D86CC67>CD>9H 6C9 HA::E
Oscar Prospro-Garca (Mexico)
C6;;:>C: L>I=9G6L6A: CDHI DG 7:C:;>I?
Leon Lack (Australia)
.A::E :MI:CH>DC >BEGDK:H ;6HI>C< >CHJA>C A:K:AH >C 69JAIH L=D 6G: =67>IJ6AAN HA::E G:HIG>8I:9
Rachel Leproult (Belgium)
!JAAN 6JIDB6I:9 HA::E 9:EG>K6I>DC >C G6IH JH>C< 6>G EJ;;H
Gina Poe (USA)
"6HIGD>CI:HI>C6A BDI>A>IN 6C9 HA::E E6II:GCH 6HH:HH:9 7N 6B7JA6IDGN IG68@>C< D; I:A:B:IG>8
86EHJA:H 8DB7>C:9 L>I= EDANHDBCD<G6E=N
AnneMette Haase (Denmark)
AJID6CI>7D9>:H 6<6>CHI 9>HI>C8I C:JGDC6A EDEJA6I>DCH >C C6G8DA:EI>8 E6I>:CIH P 6 EDHH>7A: A>C@ ID
K688>C: >C9J8:9 6JID>BBJC>IN?
Peter W. Bergman (Sweden)
114
2
D
)
.
D
A
4
+DHI:G +G:H:CI6I>DCH
!ADDG 2 - (JAI>EJGEDH: -DDB 2
+DHI:G )JB7:G>C< "J>9:A>C:H (:M6BEA:: (-A-001)
_________________________________________________________________
A A<>C< 6C9 D:K:ADEB:CI6A $HHJ:H
_________________________________________________________________
B B:=6K>DG, CD<C>I>DC 6C9 DG:6B>C<
_________________________________________________________________
C C=GDCD7>DAD<N/C>G869>6C D>HDG9:GH
_________________________________________________________________
M8:HH>K: D6NI>B: .A::E>C:HH (CDI )6G8DA:EHN)
_________________________________________________________________
$ $CHDBC>6
_________________________________________________________________
)A )6G8DA:EHN
_________________________________________________________________
( (:BDGN
_________________________________________________________________
)+ ):JG6A +A6HI>8>IN
_________________________________________________________________
) ):JGDAD<>86A .A::E D>HDG9:GH A;;:8I>C< .A::E
_________________________________________________________________
* *I=:G
_________________________________________________________________
+A +6G6HDBC>6
_________________________________________________________________
+# +=6GB68DAD<N
_________________________________________________________________
+. +HN8=>6IG>8 D>HDG9:GH A;;:8I>C< .A::E/26@:
_________________________________________________________________
-( -( B:=6K>DG D>HDG9:GH
_________________________________________________________________
- -:HIA:HH ':<H .NC9GDB: (-'.) 6C9 (DK:B:CI D>HDG9:GH
_________________________________________________________________
. .A::E BG:6I=>C< D>HDG9:GH
_________________________________________________________________
/ /:8=CDAD<N//:8=C>86A
_________________________________________________________________
4$ 4DJC< $CK:HI><6IDG AL6G9
_________________________________________________________________
115
(
*
)
D
A
4
Monday - A - Board #001
Presenting Author: Stphanie Bioulac (France)
SLEEPINESS AND DRIVING PERFORMANCE IN
ADULTS WITH ATTENTION DEFICIT HYPERACTIVITY
DISORDER (ADHD)
Bioulac S, Capelli A, Claret A, Taillard J, Bouvard M, Philip P
Presenting Author: Ana Allen Gomes (Portugal)
DIURNAL TYPE IN CHILDREN: PRELIMINARY RESULTS
ABOUT THE EUROPEAN PORTUGUESE VERSION OF
THE CCTQ
Douto D, Allen Gomes A, Pinto De Azevedo M, Clemente V,
Carvalho Bos S, Silva C
Presenting Author: Jr Garmendia Leiza (Spain)
INFLUENCE OF INSTITUTIONALIZATION ON THE
SLEEP PATTERN IN ELDERLY POPULATION
Garmendia Leiza J, Aguilar Garcia M, Andres De Llano J,
Martin Martinez D, Casaseca De La Higuera P, Alberola Lopez C
Presenting Author: Ali Gholamrezaei (Iran)
RESTLESS LEGS SYNDROME AND ITS ASSOCIATION
WITH POOR SLEEP QUALITY, MOOD DISORDERS,
AND ONE YEAR CARDIOVASCULAR MORTALITY IN
PATIENTS ON CHRONIC DIALYSIS
Gholamrezaei A, Masoumi M, Mortazavi M, Amra B
Presenting Author: Alex Hamel (Canada)
BED PARTNER AND SLEEP QUALITY IN ELDERLY
Hamel A, Desjardins S, Loranger J, Lapierre S, Marcoux L
Presenting Author: Lia Khuchua (Georgia)
MULTIPLE SCLEROSIS ASSOCIATED FATIGUE AND
SLEEP DISTURBANCES
Kiziria M, Chikadze A, Khuchua L, Jibladze M, Tsiskaridze A,
Shakarishvili R
Presenting Author: Mitsuo Kodama (Japan)
CRITICAL PERIODIC LIMB MOVEMENT DISORDER
FOLLOWED BY CARDIO-PULMONARY ARREST (CPA)
TWO MONTHS LATER: A CASE REPORT
Kodama M
Presenting Author: Jonathan Loranger (Canada)
EVENTS DISTRURBING SLEEP QUALITY AMONG ELDERLY
Loranger J, Desjardins S, Hamel A, Lapierre S, Marcoux L
Presenting Author: John Winkelman (United States)
THE EFFECT OF ROTIGOTINE ON
NOCTURNAL BLOOD PRESSURE CHANGES AND
PERIODIC LIMB MOVEMENTS OF SLEEP IN PATIENTS
WITH IDIOPATHIC RLS: THE ENCORE STUDY
Grieger F, Schollmayer E, Moran K, Trenkwalder C
Presenting Author: Miguel Meira E Cruz (Portugal)
SLEEP-RELATED BEHAVIORAL INTERACTION
BETWEEN SCHOOL-AGE SIBLINGS. EVALUATION
WITH CSHQPT
Meira E Cruz M, Duarte I, Loureiro H, Rodrigo M
Presenting Author: Plamen Nedev (Bulgaria)
SURGICAL MANAGEMENT OF NASAL ALAR RIM
AND VALVE COLLAPSE
Nedev P, Milkov M, Iliev G, Iliev G, Benchev R,
Vichevamedical Universiti Plovdiv D
Presenting Author: Paolo Porcacchia (Spain)
SLEEP RELATED RHYTHMIC MOVEMENTS AND
PERIODIC LIMB MOVEMENTS IN SCHIZOPHRENIA:
A CLINICAL CASE.
Porcacchia P, Mora Granizo F, Botebol Benhamou G
Presenting Author: M. Pujol (Spain)
ASSESSMENT OF THE MOVEMENTS IN REM SLEEP
BEHAVIOUR DISORDER (RBD) PATIENTS DURING
THE RAPID OCULAR MOVEMENT IN REM SLEEP.
Pujol M, Cruz F, March J, Gispert L, Barb F
Presenting Author: Eduardo Valle (Brazil)
QUALITY OF LIFE AND SLEEP DISORDERS IN ELDERLY
Ribeiro Do Valle C, Valle E, Valle L, Alves Fior C
Presenting Author: Dittoni Serena (Italy)
DEVELOPMENT OF A SOFTWARE SYSTEM OF VIDEO-
INTEGRATED ANALYSIS MADE FOR THE MOTION
DETECTION AND ANALYSIS OF SLEEP.
A Serena D, Michele S, Riccardo M, Mariano P, Catello V,
Giacomo D
Presenting Author: Erik K. St. Louis (United States)
DIAGNOSTIC THRESHOLDS FOR QUANTITATIVE
REM SLEEP MUSCLE DENSITIES, PHASIC BURST
DURATION, AND REM ATONIA INDEX IN REM
SLEEP BEHAVIOR DISORDER WITH CO-MORBID
OBSTRUCTIVE SLEEP APNEA
St. Louis E, Mccarter S, Sandness D, Boeve B, Silber M
Presenting Author: Erik K. St. Louis (United States)
PREDICTORS OF INJURY IN REM SLEEP BEHAVIOR
DISORDER
St. Louis E, Mccarter S, Boswell C, Boeve B, Silber M
Presenting Author: Nerea Torres Cao (Spain)
EVOLUTION OF SAFETY PROFILE OF DIFFERENT
THERAPEUTIC ALTERNATIVES IN RESTLESS LEGS
SYNDROME (RLS)
Torres Cao N, Giner Bayarri P, Chilet Chilet R, Zalve Plaza G,
Blancas Carrasco A, Moliner Ibez J
Presenting Author: Jiahong Zhang And Lu Ning (China)
THE RELATIONSHIP BETWEEN PERSONALITY
DISORDER AND SLEEP QUALITY IN UNIVERSITY
STUDENTS IN CHINA
Zhang J, Lu N
Monday - I - Board #020
Presenting Author: Yong Won Cho (Republic of Korea)
EFFECTS OF PREGABALIN ON PATIENTS WITH
HYPNOTIC DEPENDENT INSOMNIA
Cho Y, Moon H, Lee Y, Song M
116
(
*
)
D
A
4
Presenting Author: Maria Magdalena Dumitru (Romania)
SLEEP PROBLEMS IN PATIENTS WITH PARKINSONS
DISEASE IN A HOSPITAL SETTING FROM ROMANIA
Dumitru M
Presenting Author: Amanda Hellstrm (Sweden)
ASSOCIATIONS BETWEEN SLEEP DISTURBANCES
AND LEISURE ACTIVITIES IN LATE-LIFE
Hellstrm A, Hellstrm P, Willman A, Fagerstrm C
Presenting Author: Habibolah Khazaie (Iran)
TREATMENT OF PARADOXICAL INSOMNIA WITH
ATYPICAL ANTIPSYCHOTIC DRUGS; A COMPARISON
OF OLANZAPINE AND RISPERIDONE
Khazaie H, Rezaie L, Darvishi F, Najafi F, Avis K
Presenting Author: Tae Won Kim (Republic of Korea)
CASES OF CHRONIC INSOMNIA PATIENTS TREATED
BY GROUP COGNITIVE BEHAVIORAL THERAPY FOR
INSOMNIA
Kim T, Yi M, Joo S, Jeong J, Han J, Hong S
Presenting Author: Wang Weidong (China)
REPETITIVE TRANSCRANIAL MAGNETIC
STIMULATION ENHANCES SLEEP QUALITY OF
PATIENTS WITH COMORBID MAJOR DEPRESSIVE
DISORDER AND INSOMNIA
Li T, Wang W, Hong L, Lin Y, Wang F
Presenting Author: Oscar Medina (Venezuela)
EFFICACY AND TOLERABILITY OF ZOLPIDEM IN A
GROUP OF VENEZUELAN PATIENTS WITH INSOM-
NIA UNDERGOING HEMODIALYSIS
Medina O, Rojas G, Santos E, Moreno C, Paolini M,
Snchez-Mora N
Presenting Author: Yara Fleury Molen (Brazil)
PRE-SLEEP WORRY DECREASE BY ADDING READING
AND GUIDED IMAGERY TO INSOMNIA TREATMENT
Molen Y, Santos G, Carvalho L, Prado L, Prado G
Presenting Author: Laura Palagini (Italy)
POOR SLEEP QUALITY IN SYSTEMIC LUPUS
ERITEMATOSUS: DOES IT DEPEND ON DEPRESSION?
Palagini L, Bruno R, Tani C, Gemignani A, Ciapparelli A,
Mosca M
Presenting Author: Sandra Bos (Portugal)
INSOMNIA IN POSTPARTUM AND PERCEIVED
INFANT DIFFICULT TEMPERAMENT
Quental D, Carvalho Bos S, Marques M, Soares M,
Azevedo M, Macedo A
Presenting Author: Francisco Snchez-Narvez (Mexico)
POLYSOMNOGRAPHIC FEATURES IN THREE
INSOMNIA SUBTYPES.
Snchez-Narvez F, De La Orta D, Labra A, Haro R
Presenting Author: Hiroyuki Sawatari (Japan)
LEG THERMAL THERAPY IMPROVED SLEEP
STRUCTURE AND SUBJECTIVE SLEEP QUALITY IN
CHRONIC HEART FAILURE
Sawatari H, Miyazono M, Nishizaka M, Ando S, Sunagawa K,
Chishaki A
Presenting Author: Manuel Schabus (Austria)
NON-PHARMACOLOGICAL TREATMENT OF
PRIMARY INSOMNIA USING SENSORIMOTOR-
RHYTHM NEUROFEEDBACK
Schabus M, Griessenberger H, Heib D, Lechinger J,
Hoedlmoser K
Presenting Author: Arla Stokes And Henry Stokes (Guatemala)
PSYCOLOGICAL AND BEHAVIORAL TREATMENT
OF PRIMARY AND SECONDARY INSOMNIA IN
PACIENTS FROM SAN JUAN DE DIOS HOSPITAL
SLEEP DEPARTMENT OF GUATEMALA
Stokes A, Stokes H
Presenting Author: Markus Jansson-Frjmark (Sweden)
PRE-SLEEP AROUSAL, UNHELPFUL BELIEFS AND
MALADAPTIVE SLEEP BEHAVIORS AS MEDIATORS IN
COGNITIVE BEHAVIOR THERAPY FOR INSOMNIA
Sunnhed R, Jansson-Frjmark M
Presenting Author: Markus Jansson-Frjmark (Sweden)
BEHAVIOR THERAPY SINGLY AND COMBINED
WITH CONSTRUCTIVE WORRY FOR INSOMNIA:
COGNITIVE AND BEHAVIORAL PROCESSES AS
MEDIATORS
Sunnhed R, Jansson-Frjmark M
Presenting Author: Wei-Dong Wang (China)
CLINICAL STUDY ON SLEEP-REGULATING
TECHNIQUE (TIP3-2) COMBINED WITH
MEDICATION OF TREATING PRIMARY
Wang W, Hong L, Lin Y, Wang F, Li T, Wang W, Li G
Presenting Author: Wei-Dong Wang (China)
STUDY ON CLINICAL EFFICACY OF TREATING
PRIMARY INSOMNIA BY WEN DAN NING XIN GRAIN
Wang W, Liu Y, Hong L, Lin Y, Wang F, Wang W, Li G
Presenting Author: Wang Weidong (China)
THE SLEEP-IMPROVING EFFECT OF AN CHINESE
INDIGENOUS PSYCHOTHERAPY ON DEPRESSION
ASSOCIATED WITH INSOMNIA
Wang W, Lu X, Hong L, Lin Y, Wang F
Presenting Author: Irina Zavalko (Russian Federation)
EFFECTS OF ANTICIPATION OF A SIGNIFICANT
EVENT ON SLEEP DURING LONG-TERM ISOLATION
Zavalko I, Rasskazova E, Kovrov G
117
(
*
)
D
A
4
Monday - M - Board #040
Presenting Author: Ina Djonlagic (United States)
CONSEQUENCES OF REM-PREDOMINANT AND
REM-EXCLUSIVE SLEEP APNEA ON MOTOR MEMORY
CONSOLIDATION DURING SLEEP
Igue M, Guo M, Malhotra A, Stickgold R, Djonlagic I
Presenting Author: Kristy Nga Ting Lau (China)
HOW MUCH ONE SLEEPS AT NIGHT AFFECTS
NAPPING EFFECTS ON EMOTIONAL MEMORY
CONSOLIDATION
Lau K, Wong M, Lau E
Presenting Author: Samuel Laventure (Canada)
MOTOR MEMORY CONSOLIDATION POTENTIATED
BY EXPOSITION TO A CONDITIONED STIMULUS IN
STAGE 2 SLEEP
Laventure S, Fogel S, Albouy G, Svigny-Dupont P, Carrier J,
Doyon J
Presenting Author: Jacky Ho Yin, Wan (Hong Kong)
THE EFFECT OF CAFFEINE NAP ON DECLARATIVE
AND PROCEDURAL MEMORY IN ELDERLY
Wan J, Lau E, Lee T
Presenting Author: Malgorzata Wislowska (Austria)
MECHANISMS UNDERLYING DECLARATIVE MEMORY
CONSOLIDATION ARE CHANGING WITH AGE -
INSIGHT FROM HEALTHY AND DISTURBED SLEEP
Wislowska M, Heib D, Hoedlmoser K, Griessenberger H,
Schabus M
Presenting Author: Karina A. Zanin (Brazil)
EFFECTS OF THE INTERACTION BETWEEN
ZOLPIDEM AND SLEEP DEPRIVATION ON MEMORY
IN MICE
Zanin K, Patti C, Ceccon L, Lopes-Silva L, Poyares D,
Frussa-Filho R
Monday - NP - Board #046
Presenting Author: Fabio Garcia Garcia (Mexico)
SLEEP DEPRIVATION INDUCE MORPHOLOGY
CHANGES IN THE HIPPOCAMPUS AND PREFRONTAL
CORTEX IN YOUNG AND OLD RATS
Garca-Garca F, Acosta Pea E, Melgarejo Gutierrez M, Flores G
Monday - NE - Board #047
Presenting Author: Belia Garcia Parra (Spain)
SLEEP QUALITY IN DRUG RESISTANT EPILEPSY PATIENTS
Alvarez Guerrico I, Garcia Parra B, Lluis P, Royo I, M Isabel F,
Rocamora R
Presenting Author: Yan Dong (China)
RISK FACTORS ASSOCIATED WITH SLEEP DISTURBANCE
FOLLOWING TRAUMATIC BRAIN INJURY
Dong Y, Sheng P, Tong W, Li Z, Xu D, Hou L
Presenting Author: Lobna M Elnabil (Egypt)
POLYSOMNOGRAPHIC PICTURE OF MULTIPLE
SCLEROSIS: CORRELATION WITH MRI FINDINGS
Elnabil L, Ibrahim E
Presenting Author: Isaac Mosquera (Venezuela)
SLEEP DISORDERS IN VENEZUELAN FIBROMYALGIA
PATIENTS.
Isaac M, Franca p, Rafael r, Alonso h, Gabriela P, Maria I L
Presenting Author: Edith Lopez Ruiz (Mexico)
CHANGES IN SLEEP ARCHITECTURE AFTER TYPE 2
DIABETES MELLITUS (T2DM)
Lopez Ruiz E, Rivera Garcia A, Ramirez Salado I
Presenting Author: Shirin Mollayeva (Canada)
FATIGUE IN ONTARIO WORKERS WITH HEAD
TRAUMA: FREQUENCIES AND CORRELATIONS
Mollayeva S, Shapiro C, Mollayeva T, Colantonio A
Presenting Author: Tatyana Mollayeva (Canada)
SELF-REPORT INSTRUMENTS FOR ASSESSING SLEEP
DYSFUNCTION IN AN ADULT TRAUMATIC BRAIN
INJURY POPULATION: A SYSTEMATIC REVIEW.
Mollayeva T, Kendzerska T, Colantonio A
Presenting Author: Cecilia Orellana (Uruguay)
CHRONOTYPES IN AN URUGUAYAN POPULATION
AFFECTED BY MULTIPLE SCLEROSIS
Orellana C, Oheninger C, Gil J, Arbildi M, Martinez F
Presenting Author: Michael Saletu (Austria)
NOCTURNAL BLOOD PRESSURE REGULATION IN
STROKE PATIENTS WITH SLEEP APNEA
Saletu M, Kotzian S, Schiefer I, Hillberger M, Spatt J
Presenting Author: Catherine Wiseman-Hakes (Canada)
EXAMINATION OF POLYSOMNOGRAPHY IN
HOSPITALIZED PATIENTS WITH ACUTE MODERATE-
SEVERE TRAUMATIC BRAIN INJURY
Wiseman-Hakes C, Gaudreault P, Duclos C, Bernard F, Carrier
J, Gosselin N
Presenting Author: Pei-Lu Yi (Taiwan)
AMYGDALA OPIOID RECEPTORS MEDIATE THE
ELECTROACUPUNCTURE-INDUCED DETERIORATION
OF SLEEP DISRUPTIONS IN EPILEPSY RATS
Yi P, Chang F
Monday - O - Board #058
Presenting Author: Tas Arajo (Canada)
SOCIOCULTURAL VARIATIONS OF SLEEP DIFFICULTIES
COPING STRATEGIES IN COUPLE RELATIONSHIPS IN
CANADA AND IN BRAZIL.
Arajo T, Vallires A, Leanza Y
Presenting Author: Bar Baklan (Turkey)
THE CHANGES IN CYCLIC ALTERNATING
PATTERN(CAP) OF EPILEPSY PATIENTS
Baklan B
118
(
*
)
D
A
4
Presenting Author: Cristina Bdalo (Spain)
PGO ACTIVITY AFTER CARBACHOL DELIVERY IN
THE ORAL AND CAUDAL PONTINE RETICULAR
NUCLEI: SIMILARITIES AND DIFFERENCES WITH
SPONTANEOUS REM SLEEP IN CATS.
Bdalo C, Asensio-Gmez L, Rego-Garca I, De Andrs I
Presenting Author: Seiji Nishino (Japan)
EVALUATIONS OF EFFECTS OF HIGH REBOUND AND
LOW REBOUND MATTRESS PADS ON NOCTURANL
SLEEP AND ITS ASSOCIATED PHYSIOLOGY
Chiba S, Yagi T, Ozone M, Sato M, Nishino S
Presenting Author: Shih-Chi Chung (Taiwan)
THE ASSOCIATION BETWEEN SLEEP AND BODY
WEIGHT CHANGES FROM BIRTH TO 3 YEARS
Chung S, Chu S, Huang Y
Presenting Author: Helena Azevedo (Portugal)
SLEEP QUALITY AND EATING BEHAVIOUR IN
FEMALE STUDENTS
Ferreira L, Arruda A, Maia B, Gomes A, Azevedo H,
Marques M
Presenting Author: Emi Hasegawa (Japan)
RESTORATION OF OREXIN SIGNALING IN THE DORSAL
RAPHE AND LOCUS COERULEUS DIFFERNTIALLY
AMELIORATE SYMPTOMS OF NARCOLEPTIC MICE
Hasegawa E, Yanagisawa M, Roth B, Sakurai T, Mieda M
Presenting Author: Rogie Marie A. Ignacio-Alcantara (Phillipines)
THE EFFECT OF CONTINUOUS POSITIVE AIRWAY
PRESSURE (CPAP) TREATMENT ON THE
NEUROCOGNITIVE FUNCTION OF PATIENTS WITH
Ignacio-Alcantara, Md R, Espiritu-Picar R, Ledesma L
Presenting Author: Saba Jafarpour (Iran)
SLEEP QUALITY AND ASSOCIATED FACTORS IN
RESIDENTS OF A MAJOR TEACHING HOSPITAL IN IRAN
Jafarpour S, Sadeghniiat-Haghighi K
Presenting Author: Denise C. Jarrin (Canada)
BEYOND SLEEP DURATION: DISTINCT SLEEP
DIMENSIONS ARE ASSOCIATED WITH OBESITY IN
CHILDREN AND ADOLESCENTS
Jarrin D, Mcgrath J, Drake C
Presenting Author: Ji Young Kim (Republic of Korea)
EFFECT OF BEDSIDE LIGHT ON SLEEP QUALITY AND
BACKGROUND EEG RHYTHMS
Kim J, Hwang K, Cho J, Koo D, Joo E, Hong S
Presenting Author: Zhijun Liu (China)
SLEEP PROBLEMS AMONG CHINESE PRESCHOOL
CHILDREN: PREVALENCE AND ASSOCIATED
FACTORS
Liu Z, Wang G, Geng L, Chen R, Tan G, Wang Z
Presenting Author: Elisa Lopes (Portugal)
SLEEP QUALITY IN COLLEGE STUDENTS: A STUDY
ABOUT THE CONTRIBUTION OF LIFESTYLE,
ACADEMIC PERFORMANCE AND GENERAL
WELL-BEING
Lopes E, Milheiro I, Maia A
Presenting Author: Ning Lu (China)
PROACTIVE COPING MODERATES THE
RELATIONSHIP BETWEEN MEANING OF LIFE AND
SLEEP QUALITY IN UNIVERSITY STUDENTS
Lu N
Presenting Author: Sofiya Lypovetska (Ukraine)
HEART RATE VARIABILITY, T WAVE ALTERATION
AND PROLONGED QT INTERVAL AS MARKERS OF
ARRHYTHMOGENESIS IN PATIENTS WITH SLEEP
APNEA SYNDROME AND ARTERIAL HYPERTENSION
Lypovetska S
RELIABILITY AND INITIAL VALIDATION OF THE
PITTSBURGH SLEEP QUALITY INDEX, EUROPEAN
PORTUGUESE VERSION: A PRELIMINARY STUDY IN
A SAMPLE OF HIGHER EDUCATION STUDENTS
Marques D, Allen Gomes A, Meiavia A, Salgueiro A, Carlos C,
Ribeiro & Dischler J
Presenting Author: Gisle Maury (Belgium)
MANDIBLE BEHAVIOR DURING WAKEFULNESS
AND SLEEP-DISORDERED BREATHING: INTRA- AND
INTER-SCORER VARIABILITY FOR THE VISUAL
RECOGNITION OF THE MANDIBLE MOVEMENT
ISOLATED.
Maury G, Senny F, Laurent C, Albert A, Laurence S, Robert P
Presenting Author: Oguz Osman Erdinc (Turkey)
THE RELATIONSHIP BETWEEN SLEEP DISORDERS
AND EXCESSIVE DAYTIME SLEEPINESS AND ANXIETY
IN SEMI RURAL AREAS IN ESKISEHIR, TURKEY
Metintas S, Erdinc O, Arikan I, Kalyoncu C
Presenting Author: Mario Milkov (Bulgaria)
INTERNATIONAL SCIENTIFIC COMMUNICATIONS IN
SLEEP APNEA-RELATED QUALITY OF LIFE
Milkov M, Tonchev T, Nedev P, Kirov F, Madjova H
Presenting Author: Eleida Camargo (Brazil)
COMIC STRIPS FOR HEALTH EDUCATION -
COMPARATIVE STUDY OF THE EFFECTIVE BETWEEN
CHILDREN WITH LEARNING DISABILITIES AND
REGULAR SCHOOL PERFORMANCE
Pereira Camargo E, Bizari Coin Carvalho L, Bizari Fernandes
Prado L, Fernandes Prado G
Presenting Author: Fen Ren (China)
A TAXOMETRIC ANALYSIS OF THE CHILDRENS
SLEEP HABITS QUESTIONNAIRE
Ren F, Wang G, Wang M, Zhang J
119
(
*
)
D
A
4
Presenting Author: Yuki Saito (Japan)
GABAERGIC TRANSMISSION BY POA NEURONS TO
OREXIN NEURONS
Saito Y, Tsujino N, Mieda M, Abe M, Sakimura K, Sakurai T
Presenting Author: Tamar Shochat (Israel)
LONGER SLEEP DURATION IS RELATED TO INCREASED
PAIN SENSITIVITY IN HEALTHY YOUNG MEN
Shochat T, Aviram J, Pud D
Presenting Author: Masoud Tahmasian (Iran)
EVALUATION OF SLEEP PROBLEMS IN PREECLAMPTIC,
HEALTHY PREGNANTS AND NON-PREGNANT
WOMEN IN KERMANSHAH, IRAN
Tahmasian M, Khazaei H, Heidarpour A, Rezaei M,
Maroufi A, Ghadami M
Presenting Author: Stella Maris Valiensi (Argentina)
POLYSOMNOGRAPHIC CHARACTERISTICS OF SLEEP
IN OLD AGE PATIENTS:
Valiensi S, Maggi S, Leon P, Cristiano E, Lucero C
SLEEP DISORDERS IN CHILDREN
A BRAZILIAN STUDY
Valle E, Ribeiro Do Valle C, Ribeiro Do Valle L, Reimo R
Presenting Author: Mehmet Yildiz (Turkey)
DISLIPIDEMIA WITH OBSTRUCTIVE SLEEP APNEA
(OSAS) IN PATIENTS OVER SIXTY YEARS OLD
Yildiz M, Keskin G, Karaalioglu B, Tekgul B
Presenting Author: Xin Yu; Guanghai Wang; Guangxing Xu (China)
SLEEP DISORDERS AMONG CHILDREN IN CHINA:
A REVIEW OF PULISHED STUDIES IN CHINESE
LANGUAGE
Yu X, Wang G, Xu (Corresponding Author) G
Monday - PA - Board #086
Presenting Author: Antonio Zadra (Canada)
ANALYSIS OF EEG FUNCTIONAL CONNECTIVITY
PRIOR TO SOMNAMBULISM
Desjardins M, Godbout J, Montplaisir J, Carrier J, Zadra A
Presenting Author: Francesca Poli (Italy)
SLEEP FORENSIC CASE REPORTS
Ingravallo F, Poli F, Vignatelli L, Pizza F, Plazzi G
Presenting Author: Yoko Komada (Japan)
COMPARISON OF CLINICAL FEATURES BETWEEN
PRIMARY AND SECONDARY SLEEP-RELATED EATING
SYNDROME
Komada Y, Takaesu Y, Nishida S, Sasai T, Furudate N, Inoue Y
Presenting Author: Shirley Xin Li (Hong Kong)
PREVALENCE AND CORRELATES OF NIGHTMARE
DISTURBANCES IN PATIENTS WITH SLEEP
DISORDERS OTHER THAN REM-PARASOMNIAS
Li S, Lam J, Zhang J, Yu M, Wing Y
Presenting Author: Martnez Martnez M ngeles (Spain)
SLEEP RELATED EATING DISORDER (SRED) AND
NIGHT EATING SYNDROME (NES) : SAME OR
DIFFERENT DISORDERS?
M ngeles M, J.A. G, Marta C, Mnica G, Roberto O, Rosario C
Presenting Author: Yasunori Oka (Japan)
CHILDHOOD NON-REM PARASOMNIA ASSOCIATED
WITH OBSTRUCTIVE SLEEP APNEA: EFFECTIVENESS
OF CPAP TREATMENT
Oka Y, Tokui Y
Presenting Author: Antonio Pedrera Mazarro (Spain)
NOCTURNAL PAROXYSMAL DYSTONIA (NPD),
TWO CASES REPORT
Pedrera-Mazarro A, Escajadillo-Vargas K, lvarez-Snchez J,
Cullar-Ramos N
Presenting Author: Montserrat Pujol (Spain)
STUDY OF NECK MYOCLONUS ISOLATED AND
ASSOCIATED TO OTHER INVOLUNTARY
MOVEMENTS DURING THE SLEEP
Pujol M, March J, Utgs M, Cruz F, Barb F
Presenting Author: Leticia Soster (Brazil)
CLINICAL AND POLYSOMNOGRAPHIC STUDIES ON
NOCTURNAL ENURESIS: ARE THERE ANY NEWS?
Soster L, Rosana Cardoso A, Simone Nascimento F, Adrienne
Suri L, Eliana G, Vera Hermina Kalika K
Monday - PH - Board #095
Presenting Author: Mark Eller (United States)
EVALUATION OF PHARMACOKINETIC AND
PHARMACODYNAMIC INTERACTIONS OF SODIUM
OXYBATE WITH IBUPROFEN: A RANDOMIZED,
DOUBLE-BLIND, PLACEBO-CONTROLLED,
CROSSOVER STUDY
Eller M, Skowronski R, Wesnes K, Alvarez-Horine S, Benson B,
Black J
Presenting Author: Y. Grace Wang (United States)
EVALUATION OF DRUG-DRUG INTERACTIONS OF
SODIUM OXYBATE WITH DIVALPROEX: RESULTS FROM
A PHARMACOKINETIC/PHARMACODYNAMIC STUDY
Eller M, Wang Y, Wesnes K, Alvarez-Horine S, Benson B,
Black J
Presenting Author: Keishi Etori (Japan)
EFFECTS OF A NEWLY DEVELOPED OREXIN-2
RECEPTOR-SELECTIVE ANTAGONIST ON THE
SLEEP/WAKE STATES IN MICE
Etori K, Saito Y, Tsujino N, Sakurai T
Presenting Author: P. Garca-Garca (Spain)
MELATONIN FOR SLEEP DISORDERS:
A BIBLIOMETRIC APPROACH DURING THE
LAST 20 YEARS
Garca-Garca P, Alamo C, Munoz F
120
(
*
)
D
A
4
Presenting Author: Akiko Murakoshi (Japan)
FACTORS ASSOCIATED WITH DEVELOPMENT OF
BENZODIAZEPINE DEPENDENCE.
Murakoshi A, Takausu Y, Komada Y, Ishikawa J, Inoue Y
Presenting Author: Basil N Okeahialam (Nigeria)
DIURETIC DRUGS BENEFIT PATIENTS WITH
HYPERTENSION MORE WITH NIGHT TIME DOSING
Okeahialam B, Ohihoin E, Ajuluchukwu J
Presenting Author: Seiji Nishino (United States)
EDS IN PARKINSONS DISEASE: PHARMACOLOGY
AND NEW MOUSE MODEL
Sakai N, Yoshida Y, Sato M, Okuro M, Nishino S
Presenting Author: Anastasios Bonakis (Greece)
URINE DRUG SCREENING IN THE EVALUATION OF
PATIENTS WITH EXCESSIVE DAYTIME SLEEPINESS
Yogendran D, Hettiarachchi G, Bonakis D, Dargan P, Williams
P, Kosky D
Monday - R - Board #103
Presenting Author: Heike Benes (Germany)
SLEEP IN RESTLESS LEGS SYNDROME IMPROVES
DURING OPIOID TREATMENT - RESULTS FROM A
LARGE 1-YEAR MULTI-CENTER TRIAL
Benes H, Trenkwalder C, Garcia-Borreguero D, Bosse B, Hopp
M, Kohnen R
Presenting Author: Eser Bulus (Turkey)
PERIODIC LEG MOVEMENTS IN SLEEP BEFORE AND
AFTER CONTINUOUS POSITIVE AIRWAY PRESSURE
TREATMENT IN PATIENTS WITH OBSTRUCTIVE
SLEEP APNEA
Bulus E, Benbir G, Karadeniz D
Presenting Author: Luigi Ferini Strambi (Italy)
NEUROCOGNITIVE FUNCTION IN PATIENTS WITH
IDIOPATHIC RESTLESS LEGS SYNDROME (IRLS)
BEFORE AND AFTER TREATMENT WITH
DOPAMINO-AGONIST
Ferini Strambi L, Marelli S, Galbiati A, Giarolli L, Oldani A,
Zucconi M
Presenting Author: Stephany Fulda (Switzerland)
RESPIRATORY-RELATED LEG MOVEMENTS: WHAT IS
THE EVIDENCE BEHIND THE RULES?
Fulda S, Zavalko I, Ferri R, Manconi M
Presenting Author: Suk-Hoon Kang (Republic of Korea)
THE PREVALENCE AND IMPACT ON SLEEP OF
PERIODIC LIMB MOVEMENTS DURING SLEEP IN
THE ELDERLY
Kang S, Yoon I
Presenting Author: Elias Georges Karroum (France)
TOPOGRAPHICAL CARACTERISATION OF THE
PAINFUL RESTLESS LEGS SYNDROME
Karroum E, Leu-Semenescu S, Arnulf I
Presenting Author: David Kemlink (Czech Republic)
RESTLESS LEGS SYNDROME DURING PREGNANCY
IN CZECH WOMEN
Kemlink D, Plchova L, Srutkova Z, Pavlickova J, Sonka K,
Parizek A
Presenting Author: Ralf Kohnen (Germany)
NO AUGMENTATION DURING OPIOID TREATMENT
IN RESTLESS LEGS SYNDROME - RESULTS FROM A 1
YEAR LONG-TERM TRIAL
Kohnen R, Bosse B, Hopp M, Winkelmann J, Allen R, Trenkwalder C
Presenting Author: Michelangelo Maestri (Switzerland)
MANAGEMENT OF AUGMENTATION IN RESTLESS
LEGS SYNDROME WITH PRAMIPEXOLE EXTENDED-
RELEASE
Maestri M, Fulda S, Ferini-Strambi L, Zucconi M, Bassetti C,
Manconi M
Presenting Author: Alia Hassan (Egypt)
CLINICAL CORRELATES OF PERIODIC LIMB
MOVEMENTS IN SLEEP IN PARKINSONS DISEASE
IN EGYPT
Mansour A, Kamel T, Yaser M, Asaad T, Aref H, Salah N
Presenting Author: Abolfazl Mozafari (Iran)
RELATIONSHIP BETWEEN SNORING WITH SLEEP
BEHAVIORAL AND MOVEMENT DISTURBANCE
(SBMD) IN CHILDREN 2-12 YEARS OF QOM CITY
Mozaffari A
Presenting Author: Ibrahim Oztura (Turkey)
SOLEUS MEP-80 RESPONSE LATENCY IN RESTLESS
LEGS SYNDROME
Parlak O, Oztura I, Baklan B
Presenting Author: Rosana Cardoso Alves (Brazil)
THERAPEUTIC USE OF SAINT JOHNS WORT IN
RLS / WILLIS EKBOMS DISEASE
Pereira Jr J, Hallinan M, Alves R
Presenting Author: Lenka Plchov (Czech Republic)
VALIDATION OF THE MINIMUM QUESTION SET FOR
DIAGNOSIS OF THE RESTLESS LEGS SYNDROME IN
EPIDEMIOLOGY STUDY IN THE POPULATION OF
CZECH PREGNANT WOMEN.
Plchov L, rtkov Z, Pavlkov J, Pazek A, Sonka K,
Kemlink D
Presenting Author: J Steven Poceta (United States)
MACDONALD CRITCHLEYS DESCRIPTION OF
EKBOMS SYNDROME IN 1955 WITH A REFERENCE
TO THOMAS WILLIS
Poceta J
Presenting Author: Emmanuelle Pourcher (Canada)
RLS PATIENTS CAN ALSO DEVELOP COMPULSIONS
ON DOPAMINERGIC AGONISTS
Pourcher E, Bond L
121
(
*
)
D
A
4
Presenting Author: Aaro Salminen (Finland)
PERIODIC LEG MOVEMENTS IN SPINAL CORD
INJURY: EVALUATION OF AROUSALS AND
TREATMENT EFFECT
Salminen A, Manconi M, Rimpil V, Luoto T, Ferri R, Polo O
Presenting Author: Mariusz Sieminski (Poland)
PATTERNS OF EEG, BLOOD PRESSURE AND HEART
RATE CHANGES PRECEDING AND FOLLOWING
PERIODIC LIMB MOVEMENTS
Sieminski M, Pyrzowski J, Partinen M
Presenting Author: Yurii Sviryaev (Russian Federation)
ASSOCIATION BETWEEN PERIODIC LIMB
MOVEMENTS AND CO-MORBIDITIES IN HEART
FAILURE
Sviryaev Y, Korostovtseva L, Sazonova Y, Kravchenko S, Konradi
A, Shlyakhto E
Presenting Author: Manami Tanaka (Japan)
DOES THE SUGGESTED IMMOBILIZATION TEST
PERMIT PREDICTING THE EFFICACY OF
DOPAMINERGIC AGONISTS IN THE TREATMENT
OF RLS?
Tanaka M, Okura M, Taniguchi M, Ohi M
Presenting Author: Claudia Trenkwalder (Germany)
OPIOID TREATMENT IS EFFICACIOUS IN THE
SHORT- AND LONG-TERM IN PATIENTS WITH
SEVERE RESTLESS LEGS SYNDROME AFTER FAILURE
OF PREVIOUS MEDICATIONS
Trenkwalder C, Benes H, Garcia-Borreguero D, Grote L, Hopp
M, Kohnen R
BLOOD PRESSURE MONITORING IN RESTLESS LEGS
SYNDROME (WILLIS-EKBOM DISEASE) PATIENTS
Valle E, Valle M, Valle L, Reimo R
Presenting Author: Silja Virolainen (Estonia)
RESTLESS LEGS SYNDROME- PREVALENCE AND
ASSOCIATED FACTORS AMONG UNIVERSITY
STUDENTS IN ESTONIA
Virolainen S
Presenting Author: Arthur S. Walters (United States)
RESTLESS LEGS SYNDROME (WILLIS EKBOM
DISEASE) AND GROWING PAINS, ARE THEY THE
SAME THING ?: A SIDE BY SIDE COMPARISON OF
THE DIAGNOSTIC CRITERIA FOR BOTH AND
RECOMMENDATIONS FOR FUTURE RESEARCH
Walters A, Gabelia D, Frauscher B
Presenting Author: Jihui Zhang (China)
RESTLESS LEGS SYMPTOMS IN ADOLESCENTS:
EPIDEMIOLOGY, HERITABILITY, AND PUBERTAL
EFFECTS
Zhang J, Lam S, Li S, Wing Y
Monday - S - Board #128
Presenting Author: Anniina Alakuijala (Finland)
THE OXFORD SLEEP RESISTANCE TEST (OSLER)
IS SENSITIVE IN SHOWING MODIFICATIONS IN
VIGILANCE WITH CPAP THERAPY IN SLEEP APNEA
PATIENTS
Alakuijala A, Maasilta P, Bachour A
Presenting Author: Javier Albares (Spain)
VALIDATION OF THE EFFICACY OF AN ANTI-
SNORING PILLOW
Albares J, Esteller E, Estivill C, Martinez C, Segarra F, Estivill E
Presenting Author: Mara Luz Alonso Alvarez (Spain)
RELIABILITY OF HOME RESPIRATORY POLYGRAPHY
MONITORING FOR DIAGNOSIS OF SLEEP
PANEA/HIPOPNEA SYNDROME IN CHILDREN
Alonso-Alvarez M, Tern-Santos J, Cordero-Guevara J,
Ordax-Carbajo E, Navazo-Egia A, Tern Perez J
Presenting Author: Gislaine Aparecida Folha (Brazil)
ANALYSIS OF VALIDITY IN ADULTS OF THE
EXPANDED PROTOCOL OF OROFACIAL
MYOFUNCTIONAL EVALUATION WITH SCORES
Aparecida Folha G, Cardoso Pereira Valera F, Giovana Borges C,
Claudia Maria De F
OROFACIAL MYOFUNCTIONAL EVALUATION
WITH SCORES IN SUBJECTS WITH OBSTRUCTIVE
SLEEP APNEA
Aparecida Folha G, Cardoso Pereira Valera F, Dantas Giglio L,
Vitaliano Voi Trawizki L, Maria De Felcio C
Presenting Author: Kevin Chan (Australia)
IMPACT OF CONTINUOUS POSITIVE AIRWAY
PRESSURE (CPAP) ON CHRONIC COUGH IN
OBSTRUCTIVE SLEEP APNOEA (OSA)
A RANDOMIZED CONTROLLED TRIAL
Chan K, Cossa G, Birring S, Laks L, Ing A
Presenting Author: Dagoberto Bejarano Ugalde (Spain)
ONE NIGHT OF AUTO-CPAP TITRATION WITHOUT
PULSE OXIMETRY VERSUS THREE OR FOUR NIGHTS
TITRATION.
Bejarano Ugalde D, Juarros Martnez S, Disdier Vicente C, Del
Olmo Chiches M, Vielba Dueas D, Ramos Cancelo I
Presenting Author: Adriano Braga (Brazil)
SUCCESS PREDICTORS IN UVULOPALATOPHARYN-
GOPLASTIES FOR THE TREATMENT OF OBSTRUC-
TIVE SLEEP APNEA SYNDROME
Braga A, Valera F, Eckeli, A, Kupper D, Grechi T, Trawitzky L
Presenting Author: Letcia Campos (Brazil)
POLYSOMNOGRAPHIC ANALYSIS OF OBSTRUCTIVE
SLEEP APNEA (OSA) IN MIDDLE-AGED ADULTS
FOLLOWING PHARYNGEAL FLAP SURGERY FOR
VELOPHARYNGEAL INSUFFICIENCY TREATMENT
Campos L, Sampaio-Teixeira A, Yamashita R, Trindade-Suedam
I, Lorenzi-Filho G, Trindade I
122
(
*
)
D
A
4
Presenting Author: Tracy Carbone (United States)
MATERNAL OBSTRUCTIVE SLEEP APNEA AND
ADMISSIONS TO THE NEONATAL INTENSIVE
CARE UNIT
Carbone T, Violaris A, Cahill K
Presenting Author: Marina Carrasco (Spain)
DRUG-INDUCED SLEEP ENDOSCOPY: A TWO
DRUG COMPARISON AND SIMULTANEOUS
POLYSOMNOGRAPHY.
Carrasco M, Agostini G, Giner P, Rodrigo A, Gmez F, Dalmau J
Presenting Author: Richard J. Castriotta (United States)
HYPOPNEA-DOMINANT SLEEP-DISORDERED
BREATHING IN EXTREME OBESITY.
Castriotta R, Mathew R
Presenting Author: Chia-Chi Chen (Taiwan)
USING CYCLIC ALTERNATING PATTERN AS A
MARKER FOR CPAP TREATMENT IN PATIENTS
WITH OBSTRUCTIVE SLEEP APNEA
Chen C, Lin C, Lin C, Lo M, Lai C
Presenting Author: Aleksi Chikadze (Georgia)
SLEEP ARCHITECTURE IN PATIENTS WITH SLEEP
APNEA SYNDROME BEFORE CPAP THERAPY AND
AT THE BACKGROUND OF CPAP
Chikadze A, Khuchua L, Burduladze J, Jibladze M, Chikadze T,
Shakarishvili R
Presenting Author: Camila De Castro Corra (Brazil)
OROFACIAL MYOLOGY THERAPY: A CASE REPORT
OF UPPER AIRWAY RESISTANCE SYNDROME
Corra C, Megale S, Berretin-Felix G
Presenting Author: Lusine Dheryan (Armenia)
INFLUENCE OF ARTERIAL HYPERTENSION ON
RENAL FUNCTION IN PATIENTS WITH OBSTRUCTIVE
SLEEP APNEA HYPOPNEA SYNDROME
Dheryan L, Podosyan G, Matevosyan A, Zelveian P
Presenting Author: Margarida Dias (Portugal)
ECHOCARDIOGRAPHIC FINDINGS IN PATIENTS
Dias M, Reis R, Antunes A
Presenting Author: Swati Dixit (India)
A STUDY ON A GENDER BASED COMPARATIVE
ASSOCIATION BETWEEN DIETARY INTAKE AND
OBSTRUCTIVE SLEEP APNEA SYNDROME
Dixit S, Dubey A, Kant S, Tiwari S
Presenting Author: Abhishek Dubey (India)
A STUDY ON ASSOCIATION BETWEEN OBSTRUCTIVE
SLEEP APNEA SYNDROME (OSAS) AND EPWORTH
SLEEPINESS SCORE (ESS), PHYSICAL AND MENTAL
COMPONENTS RELATED WITH QUALITY OF LIFE
(QOL)
Dubey A, Dixit S, Kant S, Tiwari S
Presenting Author: Eri Eguchi (Japan)
ASSOCIATION BETWEEN SUBJECTIVE SLEEPINESS
AND SEVERITY OF SLEEP-DISORDERED BREATHING
AMONG TRUCK DRIVERS IN JAPAN
Eguchi E, Tanigawa T, Takahashi M, Sakurai S, Maruyama K
Presenting Author: Lobna Elnabil (Egypt)
EFFECT OF ADENOTONSILLECTOMY ON
NOCTURNAL ENURESIS IN CHILDREN WITH
Elnabil L, Helmy H
Presenting Author: Mostafa Elshazly (Egypt)
INSULIN RESISTANCE IN OBSTRUCTIVE SLEEP APNEA
Elshazly M
Presenting Author: Jan Hedner (Sweden)
ZONISAMIDE REDUCES OBSTRUCTIVE SLEEP APNEA:
A RANDOMIZED PLACEBO-CONTROLLED STUDY
Eskandari D, Zou D, Karimi M, Stenlf K, Grote L, Hedner J
Presenting Author: Francsico Javier Segarra Isern (Spain)
CORRELATION BETWEEN CLINICAL AND
POLYSOMNOGRAPHY RESPIRATORY DISORDERS IN
CHILDREN SLEEP
Esteller E, Segarra F, Girabent M, Albares J, Roure N, Estivill E
Presenting Author: Francisco Javier Segarra Isern (Spain)
COGNITIVE AND BEHAVIORAL AFTER ADENOTON-
SILLECTOMY IN APNEA SYNDROME OBSTRUCTIVE
SLEEP CHILDHOOD
Esteller E, Segarra F, Barcel M, Girabent M, Roure N, Estivill E
Presenting Author: Jonathan Fernandez Camara (Spain)
EFFICACY OF THE MANDIBULAR ADVANCEMENT
DEVICE IN PATIENTS WITH SLEEP APNEA
SYNDROME AND NO TOLERANCE CPAP
Fernandez Camara J, Maas Baena E, Gotera Rivera C, Barrios
Barreto D, Lazo Meneses P, Esteban Calvo R
Presenting Author: Jonathan Fernandez Camara (Spain)
GENDER DIFFERENCES IN OBSTRUCTIVE SLEEP APNEA
Fernandez Camara J, Gotera Rivera C, Barrios Barreto D, Lazo
Meneses P, Maas Baena E, Esteban Calvo R
Presenting Author: Shinya Furukawa (Japan)
NOCTURNAL INTERMITTENT HYPOXIA AS AN
ASSOCIATED RISK FACTOR FOR MICROALBUMINURIA
IN WOMEN WITH TYPE 2 DIABETES MELLITUS
Furukawa S, Eguchi E, Maruyama K, Tanigawa T
Presenting Author: Katia Gagnon (Canada)
MILD COGNITIVE IMPAIRMENT IN OBSTRUCTIVE
SLEEP APNEA
Gagnon K, Baril A, DÉCary A, Lafond C, Gagnon J,
Gosselin N
123
(
*
)
D
A
4
Presenting Author: Newton S Faria Junior (Brazil)
SLEEP PATTERN IN ADULTS PATIENTS WITH
CEREBRAL PALSY
Giannasi L, Roberto S, S Faria-Junior N, Oliveira L, Gomes M
Presenting Author: Enriqueta Gomez- Siurana (Spain)
SLEEP DIFFERENCES IN AUTO-ADJUSTABLE CPAP
DEVICES AND MANUAL STANDARD CPAP TITRATION
IN A SLEEP LABORATORY
Gomez-Siurana E, Rubio P, Urdanibia O, Blasco M, Diaz M,
Ciopat O
Presenting Author: Marta Gonalves (Portugal)
THE IMPACT OF BENZODIAZEPINE USE IN
NOCTURNAL O2 SATURATION OF OSAS PATIENTS
Gonalves M, Oliveira A, Leo A, Maia S, Brinca P
Presenting Author: Christian Guilleminault (United States)
SLEEP-DISORDERED-BREATHING IN EHLERS-
DANLOS SYNDROME (A GENETIC MODEL OF
OBSTRUCTIVE SLEEP APNEA)
Guilleminault C, Primeau M, Chiu H, Yuen K, Leger D,
Metlaine A
Presenting Author: Banu Gulbay (Turkey)
THE CLINICAL AND POLYSOMNOGRAPHIC
DIFFERENCES ASSOCIATED WITH HYPERTENSION
IN THE PATIENTS THAT HAVE OSA SYMPTOMS AND
THE EFFECT OF OSA ON HYPERTENSION
Gulbay B, Acican T, Ciftci F, Erdemir Isik M, Onen Z
Presenting Author: Firoozbakhsh Habibi (Iran)
SLEEP DISORDERS IN PATIENTS WITH ASTHMA
REFERRING TO GENERAL HOSPITAL OF GACHSARAN
Habibi F
Presenting Author: Milada Hobzov (Czech Republic)
MULTICENTRIC, EPIDEMIOLOGICAL STUDY OF
PREVALENCE OF NEWLY DIAGNOSED SLEEP APNEA
IN PATIENTS WITH NOCTURNAL HYPERTENSION
(ASSESSED BY 24 HOUR BLOOD PRESSURE
MONITORING)
Hobzov M, onka K, Pretl M, Plakov M , Kolek V
PREVALENCE OF SYMPTOMS AND RISK OF
OBSTRUCTIVE SLEEP AP- NEA SYNDROME IN
THE GENERAL POPULATION
Khazaie H, Najafi F, Rezaie L, Tahmasian M, Sepehry A, Herth F
Presenting Author: Leila Kheirandis-Gozal (United States)
REDUCED NITRIC OXIDE PRODUCTION IN
MONOCYTES IS ASSOCIATED WITH ABNORMAL
ENDOTHELIAL DYSFUNCITON IN CHILDREN
WITH OSA.
Kheirandish-Gozal L, Wang Y, Duggan R, Molero Ramirez H,
Harshan Vardhan S, Gozal D
Presenting Author: Dae Lim Koo (Republic of Korea)
RESPIRATORY ANALYSIS IN PATIENTS WITH
OBSTRUCTIVE SLEEP APNEA SYNDROME (OSAS):
MIXED VS. PREDOMINANT OBSTRUCTIVE VS.
PURE OBSTRUCTIVE
Koo D, Kim D, Kim J, Kim J, Joo E, Hong S
Presenting Author: Lyudmila Korostovtseva (Russian Federation)
OCCURRENCE OF SLEEP DISORDERED BREATHING
IN ACROMEGALY
Korostovtseva L, Semenov A, Vaulina D, Kravchenko S, Tsoy U,
Sviryaev Y
Presenting Author: Patricia Lazo Meneses (Spain)
ELDERLY PATIENTS AND SLEEP APNEA
Lazo Meneses P, Barrios Barreto D, Maas Baena E, Gotera
Rivera C, Jurkojc Mohremberger C, Garcia De Leaniz J
ARE CURRENTLY ATTENDED PATIENTS IN A UNIT
OF RESPIRATORY SLEEP DISORDERS DIFFERENT
RESPECT THOSE WHO WERE ATTENDED 5 YEARS AGO?
Lazo Meneses P, Maas Baena E, Barrios Barreto D, Gotera
Rivera C, Jurkojc Mohremberger C, Pedrera Mazarro A
PULSED PORTABLE OXYGEN CONCENTRATORS DO
NOT DETECT INSPIRATION WHEN CONNECTED TO
BILEVEL VENTILATORS OR CPAP
Lazo Meneses P, Barrios Barreto D, Gotera Rivera C,
Diaz Lobato S, Mayoralas Alises S, Perez Rodriguez E
Presenting Author: Chuen Peng Lee (Singapore)
NON-INVASIVE VENTILATION (NIV) IN OBESITY
HYPOVENTILATION SYNDROME (OHS): THE
SINGAPORE EXPERIENCE
Lee C, Pang P, Tan C
Presenting Author: Chi-Hang Lee (Singapore)
EFFECTS OF INTERACTIONS BETWEEN DIFFERENT
CLINICAL PRESENTATIONS OF CORONARY HEART
DISEASE AND TIMING OF POLYSOMNOGRAPHY ON
DIAGNOSIS OF OBSTRUCTIVE SLEEP APNEA
Lee C, Hong W, Low T, Tai B, Tan A, Khoo S
Presenting Author: Byung Jae Yu (Republic of Korea)
ANATOMICAL ANALYSIS OF NASAL CAVITY IN
STUFFY PATIENT WITH SNORING
Lee D, Yu B, Kim J, Yun S, Lee G
Presenting Author: Radka Stepanova (Czech Republic)
CIRCADIAN VARIATION OF MYOCARDIAL
INFARCTION ONSET IN PATIENTS WITH SLEEP APNEA
Ludka O, Stepanova R, Galkova L, Vyskocilova M, Spinar J,
Kara T
124
(
*
)
D
A
4
Presenting Author: I. M. Madaeva (Russian Federation)
ERECTILE DYSFUNCTION IS AN EARLY PREDICTOR
OF CARDIOVASCULAR DISEASES IN MEN WITH
Madaeva I, Kolesnikova L
Presenting Author: Christoph Maier (Germany)
RECOGNITION OF SLEEP-RELATED BREATHING
DISORDERS FROM HOLTER-ECGS C A NEW ROBUST
METHOD SUITABLE FOR CLINICAL SCREENING
APPLICATIONS
Maier C, Wenz H, Dickhaus H
Presenting Author: Mercedes Martn Romero (Spain)
ORAL APPLIANCES IN OBSTRUCTIVE SLEEP
APNEA SYNDROME: OUR EXPERIENCE.
Martn Romero M, Reina Marfil N, Ortega Senz De Tejada E,
Hidalgo Snchez R, Amecrane N, Hidalgo Sanjun M
Presenting Author: Juan F. Masa (Spain)
EFFECTIVENESS OF HOME SINGLE-CHANNEL
NASAL PRESSURE FOR SLEEP APNEA DIAGNOSIS
Masa J
Presenting Author: Geert Mayer (Germany)
THE COSTS OF SLEEP RELATED BREATHING
DISORDERS: A PROSPECTIVE, REPRESENTATIVE
STUDY IN THE GERMAN STATE OF HESSEN
Mayer G, Hessmann P, Reese J, Dodel R, Apelt S, Heitmann J
Presenting Author: Miguel Meira E Cruz (Portugal)
SLEEP BRUXISM AS THE MAIN MANIFESTATION OF
SLEEP DISORDERED BREATHING - CASE REPORT
Meira E Cruz M, Rebocho S, Drummond M
Presenting Author: Mario Milkov (Bulgaria)
USAGE OF COBLATOR-2 (ARTHROCARE) AND ENT
CELON (OLYMPUS) SYSTEMS FOR SOFT PALATE
REDUCTION IN HABITUAL SNORING PATIENTS
Milkov M, Nedev P, Tonchev T, Kirov F, Madjova H
Presenting Author: Vahid Mohsenin (United States)
HYPERTENSION AND ENDOTHELIAL DYSFUNCTION
IN OBSTRUCTIVE SLEEP APNEA (OSA) - IS IT
RELATED TO HYPOXIA?
Mohsenin V, Jafari B
Presenting Author: Tsuguo Nishijima (Japan)
SIGNIFICANCE OF PLASMA APOPTOSIS INHIBITOR
OF MACROPHAGES LEVELS IN PATIENTS WITH
OBSTRUCTIVE SLEEP APNEA SYNDROME: A NEW
BIOLOGICAL INDICATOR OF SEVERITY AND
TREATMENT RESPONSES
Nishijima T
Presenting Author: zge Oral Tapan (Turkey)
EFFECT OF NASAL CPAP THERAPY ON FUNCTIONAL
RESPIRATORY PARAMETERS AND CARDIOPULMONARY
EXERCISE TEST IN OBSTRUCTIVE SLEEP APNEA
SYNDROME
Oral Tapan , Sevin C, til B, ztura , Kayatekin M,
Demiral Y
Presenting Author: Francisco Snchez-Nrvez (Mexico)
NICTURIA AND MORBID OBESITY: PREDICTORS
FOR SEVERE AH AND SAO2 DECREASE
Palacios A, Snchez-Narvez F, Labra A, Haro R
Presenting Author: Hyelim Son (Republic of Korea)
ASSOCIATION BETWEEN THE ACTIVITY OF SALIVARY
ALPHA-AMYLASE AND THE SEVERITY OF PEDIATRIC
SLEEP DISORDERED BREATHING(SDB)
Park C, Son H, Hong H
Presenting Author: Reyes Haro (Mexico)
MORBID OBESITY AND WOMEN AGE ARE RELATED
TO THE OBSTRUCTIVE SLEEP APNEA SYNDROME.
Perez J, Snchez-Narvez F, Labra A, Haro R
Presenting Author: Joana Pires (Portugal)
OSA IN REM AND NREM - INDIVIDUAL SUBJECTIVE
COMPLAINTS
Pires J, Bentes C, Peralta A
Presenting Author: M. Quera Salva (France)
SLEEP DISORDERS AND NEAR-MISS ACCIDENTS
AMONG SUMMER LONG-DISTANCE HIGHWAY
DRIVERS
Quera-Salva M, Barbot F, Hartley S, Sauvagnac R, Machou M,
Philip P
Presenting Author: Andrea Romigi (Italy)
SLEEP DISORDERS IN MYOTONIC DYSTROPHY TYPE
2: A CONTROLLED POLYSOMNOGRAPHIC STUDY
AND SELF-REPORTED QUESTIONNAIRES
Romigi A, Albanese M, Placidi F, Izzi f, Marciani m, Massa R
Presenting Author: Roser Cambrod (Spain)
OBSTRUCTIVE SLEEP APNEA IN A CLINICAL
SETTING OF EPILEPSY PATIENTS: PREVALENCE
AND POLYSOMNOGRAPHIC FEATURES OF 100
CONSECUTIVE CASES
Roser C, Lorena G, Marta T, Xavier S, Manuel T, Patricia L
Presenting Author: Sylvie Royant-Parola (France)
IMPROVING CPAP USE WITH TELEMONITORING
AND SOCIAL MEDIA
Royant-Parola S, Hartley S, Violaine L, Lefevre P, Dagneaux S,
Escourrou P
125
(
*
)
D
A
4
Presenting Author: Ahmad Khajeh Mehrizi (Iran)
PREVALENCE AND RISK FACTORS OF THE
OBSTRUCTIVE SLEEP APNEA AMONG IRANIAN
PATIENTS WITH TYPE 2 DIABETES MELLITUS
Sadeghniiat-Haghighi K, Mohajeri-Tehrani M, Khajeh Mehrizi
A, Fathi F, Saremi-Rasouli F, Larijani B
Presenting Author: Takeshi Tanigawa (Japan)
A CROSS-SECTIONAL STUDY ON THE ASSOCIATIONS
OF SLEEP-DISORDERED BREATHING WITH
SUBJECTIVE AND OBJECTIVE SLEEPINESS AMONG
LOCAL POLICE OFFICERS
Saeki A, Tanigawa T, Maruyama K, Eguchi E, Saito I
Presenting Author: S. Sousa (Portugal)
IMPACT OF BARIATRIC SURGERY ON OSAS IN
OBESE INDIVIDUALS
Santos S, Caramujo C, Silva M, Duarte P
Presenting Author: S. Sousa (Portugal)
PREVALENCE OF OSAS IN OBESE INDIVIDUALS.
Santos S, Caramujo C, Silva M, Duarte P
Presenting Author: Sang-Wook Kim (Republic of Korea)
PALATAL SENSORY THRESHOLD REFLECTS
NOCTURNAL HYPOXEMIA AND AIRWAY OCCLUSION
IN SNORERS AND OBSTRUCTIVE SLEEP APNEA
PATIENTS
Seoul S, Chang D, Won S, Jeon S, Kim D
Presenting Author: Garima Shukla (India)
SPECTRUM OF SLEEP DISORDERED BREATHING
AMONG PATIENTS WITH MUCOPOLYSACCHARIDOSES:
A CLINICO-POLYSOMNOGRAPHIC STUDY
Shukla G, Gupta A, Gupta N, Kabra M
Presenting Author: Natalia Strueva (Russian Federation)
OBSTRUCTIVE SLEEP APNEA SYNDROME AND
HORMONAL STATUS OF OBESE PATIENTS
Strueva N, Poluektov M, Melnithenko G, Saveleva L, Katsya G,
Goncharov N
Presenting Author: Sunchen Sun (China)
HERBA SCHIZONEPETAE VERSUS NASAL STEROID:
HOW DO THEY AFFECT CPAP PRESSURE ON OSAHS
PATIENTS?
Sun S, Zhao Y, Qiao J, Ma Y
Presenting Author: Andreea Coman (Romania)
RELATIONSHIP OF ARTERIAL HYPERTENSION
AND OBSTRUCTIVE SLEEP APNEA SYNDROME
Todea D, Todor I, Coman A
Presenting Author: Tsiala Ustyan (Armenia)
OBSTRUCTIVE SLEEP APNEA-HYPOPNEA SYNDROME
EXACERBATES THE PULMONARY HYPERTENSION?
Ustyan T, Podosyan G, Matevosyan A, Zelveian P
Presenting Author: Pedro Pileggi Vinha (Brazil)
MAXILLARY TRANSVERSE DISTRACTION
OSTEOGENESIS FOR THE TREATMENT OF OSAS
Vinha P, Mello-Filho F, Faria A, Xavier S, Eckeli A
Presenting Author: Kim Ward (New Zealand)
WHAT IS KNOWN ABOUT THE EXPERIENCE OF
CPAP FOR OSA FROM THE USERS PERSPECTIVE? A
SYSTEMATIC INTEGRATIVE LITERATURE REVIEW.
Ward K, Gott M, www.Fmhs.Auckland.Ac.Nz/Staff/K.H D
Presenting Author: Aika Yanai (Japan)
INFLUENCE OF APPLICATION OF THE NEW RULE
FOR HYPOPNEA IN CARDIAC PATIENTS
Yanai A
Presenting Author: Hiroko Tsuda (Japan)
SLEEP MEDICINE IN JAPANESE PRE-DOCTORAL
DENTAL CURRICULUM
Yoshinori Higuchi H
Presenting Author: Ph Zelveian (Armenia)
INFLUENCE OF NOCTURNAL HYPOXAEMIA
ON RENAL IMPAIRMENT IN PATIENTS WITH
OBSTRUCTIVE SLEEP APNEA-HYPOPNEA SYNDROME
AND ARTERIAL HYPERTENSION
Zelveian P, Dheryan L, Matevosyan A, Podosyan G
Presenting Author: Zhang Xilong (China)
EFFICACY OF AUTO-TRILEVEL POSITIVE AIRWAY
VENTILATION ON PATIENTS WITH BOTH OBESITY
HYPOVENTILATION AND MODERATE TO SEVERE
OBSTRUCTIVE SLEEP APNEA SYNDROMES
Zhang Z
Presenting Author: Zhang Xilong (China)
ADIPONECTIN MAY INHIBIT CHRONIC
INTERMITTENT HYPOXIA-INDUCED ENDOPLASMIC
RETICULUM STRESS AND CELL APOPTOSIS IN
GENIOGLOSSUS
Zhang Z, Hanpeng H
Monday - SD - Board #210
Presenting Author: Fida Tannous (Lebanon)
SLEEP PATTERNS AND SLEEP DISORDERS AMONG
UNIVERSITY STUDENTS IN LEBANON
Assaad S, Tannous F, Costanian C
Presenting Author: Raquel Canuto (Brazil)
SLEEP DEPRIVATION AND OBESITY IN SHIFT
WORKERS IN SOUTHERN BRAZIL
Canuto R, Anselmo Olinto M, Pattussi M, Henn R, Macagnan J
Presenting Author: Garance Dispersyn (France)
VALIDATION OF TOTAL SLEEP DEPRIVATION
MODEL IN MICE
Dispersyn G, Sauvet F, Drogou C, Ciret S, Gallopin T,
Chennaoui M
126
(
*
)
D
A
4
Presenting Author: Iris Haimov (Israel)
THE RELATIONSHIP BETWEEN OBJECTIVELY
MEASURED SLEEPINESS AND DRIVING ABILITY
Haimov I, Cale M, Shafran Y, Tzischinsky O
Presenting Author: Paulo Henriques Filho (Brazil)
OBSTRUCTIVE SLEEP APNEA AND P300
ABNORMALITIES IN CHILDREN WITH ATTENTION
DEFICIT
Henriques Filho P, Pratesi R, Gandolfi L, Nobrega Y, Tristao R
Presenting Author: Camila Hirotsu (Brazil)
THE ROLE OF SLEEP AND SILDENAFIL IN THE
PROGRESSION OF CHRONIC KIDNEY DISEASE:
A NEW THERAPEUTIC APPROACH
Hirotsu C, Tufik S, Andersen M
Presenting Author: Jee Hyun Kim (Republic of Korea)
FAULTY PERCEPTION OF SLEEP STATUS IN
KOREAN ADOLESCENTS
Kim J, Han S, Hong S
Presenting Author: Jin-Seong Lee (Republic of Korea)
EFFECTS OF SLEEP DEPRIVATION ON PAIN
SENSITIVITY IN HEALTHY SUBJECTS
Lee J, Kim J, Shin H
Presenting Author: Rong Liu (China)
ASSOCIATION BETWEEN POOR SLEEP QUALITY
AND C-REACTIVE PROTEIN:
Liu R, Liu X, Zheng Z, Zee P, Du J
Presenting Author: Sally Loomis (United Kingdom)
BEHAVIOURAL EVIDENCE THAT MODAFINIL AND
AMPHETAMINE DO NOT PRODUCE EQUIVALENT
QUALITIES OF WAKE PROMOTION IN SLEEP-
RESTRICTED RATS.
Loomis S, Mccarthy A, Edgar D, Tricklebank M, Gilmour G
Presenting Author: Andra Luz (Brazil)
DAYTIME WORK AND EVENING CLASSES: REPORTS
ON SLEEPINESS AMONG YOUNG WORKING
STUDENTS
Luz A, Fischer F
Presenting Author: Lia M. Maisuradze (Georgia)
A NOVEL EXPERIMENTAL DESIGN TO AVOID
REM SLEEP REBOUND
Maisuradze L, Lortkipanidze N, Oniani N
Presenting Author: Canastro Mrio (Portugal)
PARTIAL SLEEP DEPRIVATION IN PORTUGUESE
NAVY MILITARIES
Mrio C, Teresa P
Presenting Author: Srikant Nannapaneni (United States)
SLEEP FRAGMENTATION AND DEPRIVATION IN
CRITICALLY ILL PATIENTS IS NOISE A FACTOR?
Nannapaneni S, Ramar K, Morgenthaler T, Elmer J, Lee S
Presenting Author: Trond Sand (Norway)
THE EFFECT OF TWO NIGHTS OF PARTIAL SLEEP
RESTRICTION ON OBJECTIVE AND SUBJECTIVE PAIN
MEASUREMENTS
degrd S, Omland P, Nilsen K, Gravdahl G, Stjern M, Sand T
Presenting Author: Ossi Rahkonen (Finland)
INSOMNIA SYMPTOMS AND MORTALITY
Rahkonen O, Haaramo P, Lahelma E, Lallukka T
Presenting Author: Alireza Safaiyan (Iran)
NIGHT-WORK SHIFTS AND INFLAMMATORY MARKERS
Safaeian A
Presenting Author: Peter Schwarz (Canada)
SLEEP DEPRIVATION IMPAIRS FUNCTIONAL
MUSCLE RECOVERY FOLLOWING INJURY
Schwarz P, Graham W, Li F, Locke M, Peever J
Presenting Author: Liliane Teixeira (Brazil)
EXPOSURE TO BRIGHT LIGHT DURING EVENING
CLASS HOURS INCREASES SLEEP QUALITY AND
MOOD AMONG WORKING COLLEGE STUDENTS.
Teixeira L
Monday - T - Board #229
Presenting Author: Tomi Sarkanen (Finland)
LONG-TERM SLEEP MEASUREMENT WITH A
SMARTPHONE-CONNECTED FLEXIBLE BED
SENSOR STRIP
Paalasmaa J, Sarkanen T, Partinen M
Presenting Author: Mark Eller (United States)
EVALUATION OF DRUG-DRUG INTERACTIONS OF
SODIUM OXYBATE WITH DICLOGENAC: RESULTS FROM
A PHARMACOKINETIC/PHARMACODYNAMIC STUDY
Eller M, Skowronski R, Wesnes K, Alvarez-Horine S, Benson B,
Black J
Presenting Author: Pedro Pileggi Vinha (Brazil)
IS THERE A RELATIONSHIP BETWEEN THE EXTENT
OF MAXILLARY TRANSVERSE DISTRACTION AND
EXPANSION OF THE UPPER AIRWAY?
Vinha P, Mello-Filho F, Faria A
/J:H96N, *8ID7:G 1, 2013
Tuesday - A - Board #001
Presenting Author: Mara Aguilar Andjar (Spain)
PERIODIC LIMB MOVEMENTS DISORDER IN
PATIENTS WITH SPECIFIC LANGUAGE IMPAIRMENT:
AN IMPORTANT CAUSE OF SLEEP DISRUPTION
Aguilar-Andjar M, Ramos JimÉNez M, Guerrero
SÁNchez M, Menendez C
Presenting Author: Mara Aguilar Andjar (Spain)
SLEEP CHARACTERISTICS IN CHILDREN WITH
SPECIFIC LANGUAGE IMPAIRMENT: MACROSTRUCTURE
AND MICROSTRUCRURE ANALYSIS
Aguilar-Andjar M, Menndez De Len C, Ramos Snchez I,
Dinca Avarvarei L, Mrquez Luque A
127
/
0
.
D
A
4
Presenting Author: Soheir ElGhonemy (Egypt)
SLEEP PATTERNS IN A SAMPLE OF PATIENTS
WITH POST-TRAUMATIC DISORDER
Assad T, Sadek H, Elghonemy S, Sarag M
Presenting Author: Darwin Vizcarra-Escobar (Peru)
QUALITY OF LIFE IS IMPAIRED AMONG OLDER
ADULTS WITH OBSTRUCTIVE SLEEP APNEA
HYPOPNEA SYNDROME DESPITE DISEASE SEVERITY
Barbagelata-Aguero F, Vizcarra-Escobar D
Presenting Author: Sandra Carvalho Bos (Portugal)
COMPARISON BETWEEN SUBJECTIVE AND
OBJECTIVE ESTIMATIONS OF INFANTS SLEEP
Carvalho Bos S, Marques M, Soares M, Amaral A, Azevedo M,
Macedo A
Presenting Author: Sandra Carvalho Bos (Portugal)
SLEEP PATTERNS IN PORTUGUESE PRESCHOOL
AGED CHILDREN
Carvalho Bos S, Marques M, Soares M, Amaral A, Azevedo M,
Macedo A
Presenting Author: Patrizia Congiu (Italy)
NEUROPHYSIOLOGICAL EVALUATION OF SPINAL
EXCITABILITY IN PATIENTS AFFECTED BY PRIMITIVE
RESTLESS LEGS SYNDROME
Congiu P, Milioli G, Gioi G, Tacconi P, Fantini M,
Puligheddu M
Presenting Author: Cintia Fiori (Brazil)
HYPOXIA PREDICTS HIGH BLOOD PRESSURE IN
PATIENTS WITH SEVERE OBSTRUCTIVE SLEEP APNEA
Fiori C, Martins E, Lopez P, Martinez D
Presenting Author: Iaki G. De Gurtubay (Spain)
PERIODIC LIMB MOVEMENTS ON 713 CONSECUTIVE
VIDEO SUPPORTED POLYSOMNOGRAPHY VPSG
G.De Gurtubay I, Martin B, Alonso M, Morales G, Cascante J,
Eguia V
Presenting Author: Beln Gallego Ariza (Spain)
SLEEP QUALITY AND SLEEPINESS REPERCUSSION
ON COGNITIVE IMPAIRMENT IN COMMUNITY-
DWELLING OLDER MEN AND WOMEN
Gallego-Ariza B, Cabrera-Martos I, Cern-Lorente L,
Flores-Barba M, Torres-Snchez I, Valenza M
IMPACT OF A SUPERVISED MUSCULAR TRAINING ON
PERCEIVED QUALITY OF SLEEP AND HEALTH IN A
POPULATION WITH KNEE OSTEOARTHRITIS
Gallego-Ariza B, Mateos-Toset S, Cabrera-Martos I,
Correa-Toledo A, Badillo-Fontalvo M, Valenza M
Presenting Author: Mariam Gogichadze (Georgia)
DEVELOPMENT OF TOLERANCE TO ETHANOL IN
THE SLEEP-WAKEFULNESS CYCLE
Gogichadze M, Nemsadze M, Oniani N, Lortkipanidze N,
Khachturovy E, Aladashvili T
Presenting Author: Joke Jaarsma (The Netherlands)
DIAGNOSING RESTLESS LEGS SYNDROME:
THE PATIENT EXPERIENCE
Jaarsma J, Sevborn S
SICK LEAVE AND ABSENCE FROM WORK DUE TO
RESTLESS LEGS SYNDROME
DOSING PATTERNS OF DOPAMINE AGONISTS FOR
RESTLESS LEGS
Presenting Author: Isabelle Jaussent (France)
HYPNOTICS AND MORTALITY IN AN ELDERLY
GENERAL POPULATION: A 12-YEAR PROSPECTIVE
STUDY.
Jaussent I, Ancelin M, Berr C, Besset A, Ritchie K, Dauvilliers Y
Presenting Author: Laura Lillo (Spain)
RESTLESS LEGS SYNDROME IN A PATIENT WITH
DYSMETABOLIC IRON OVERLOAD SYNDROME AND
ABNORMAL IRON DEPOSITS IN BASAL GANGLIA
AND SUSBTANTIA NIGRA.
Lillo L, Del Castillo A, Morn M, Guzmn De Villoria J,
Guillem A, Peraita-Adrados R
Presenting Author: Mauro Manconi (Switzerland)
RESPIRATORY-RELATED LEG MOVEMENTS AND
PERIODIC LEG MOVEMENTS DURING SLEEP
Manconi M, Zavalko I, Bassetti C, Colamartino E, Pons M, Ferri R
Presenting Author: Nicolas Martin (Canada)
FUNCTIONAL IMAGING OF NREM RECOVERY SLEEP
SLOW WAVES IN YOUNG AND OLDER SUBJECTS :
PRELIMINARY RESULTS
Martin N, Godbout J, Pouliot P, Doyon J, Maquet P, Carrier J
Presenting Author: Obiabo Yahaya Olugbo (Nigeria)
PREVALENCE OF RESTLESS LEGS SYNDROME
AMONG TERTIARY HOSPITAL WORKERS IN
SOUTH-SOUTH NIGERIA.
Obiabo Y
Presenting Author: Roger Godbout (Canada)
STAGE 2 SLEEP AND INTELLIGENCE MEASURES IN
AUTISTIC CHILDREN
Tessier S, Lambert A, Chevrier , Scherzer P, Mottron L,
Godbout R
Tuesday - B - Board #022
Presenting Author: Momoko Kayaba (Japan)
DROWSINESS AND LOW ENERGY METABOLISM IN
THE FOLLOWING MORNING INDUCED BY
NOCTURNAL BLUE LIGHT EXPOSURE
Kayaba M, Iwayama K, Ogata H, Seya Y, Tokuyama K, Satoh M
128
/
0
.
D
A
4
EVALUATION OF DREAM CONTENT AMONG
PATIENTS WITH SCHIZOPHRENIA, THEIR SIBLINGS,
PATIENTS WITH PSYCHIATRIC DIAGNOSES OTHER
THAN SCHIZOPHRENIA, AND HEALTHY CONTROL
Khazaie H, Tahmasian M, Younesi G, Schwebel D, Rezaei M,
Rezaie L
Presenting Author: Jessica Lara-Carrasco (Canada)
DYSPHORIC DREAMING AND EVENINGNESS
DURING THE THIRD TRIMESTER OF PREGNANCY
PREDICT ADVERSE DELIVERY OUTCOMES
Lara-Carrasco J, Simard V, Nielsen T
QUALITY OF SLEEP AND QUALITY OF LIFE IN
HIGHER EDUCATION STUDENTS
Meiavia A, Marques D, Allen Gomes A
STRESS AND SLEEP DISORDERS IN TEACHERS
A BRAZILIAN STUDY
Ribeiro Do Valle L, Ribeiro Do Valle C, Valle E, Malvezzi S,
Reimo R
Presenting Author: Ana Paula Rivera Garcia (Mexico)
FACIAL MUSCLE CONTRACTIONS DURING REM
SLEEP AND ITS ASSOCIATION TO EMOTIONAL
DREAMED CONTENT
Rivera Garcia A, Ramirez Salado I, Lopez Ruiz E
Presenting Author: Maria-Raquel G. Silva (Portugal)
INADEQUATE SLEEP AND UNHEALTHY FOOD
HABITS IN PORTUGUESE ADOLESCENTS
Silva M, Silva H, Paiva T
SLEEP, PRECOMPETITIVE STRESS AND ACHIEVEMENTS
IN YOUNG PERFORMANCE ATHLETES
Silva M, Paiva T
SLEEP, TRAINING VOLUME AND BODY
COMPOSITION IN YOUNG GYMNASTS
Silva M, Paiva T
SLEEP DURATION AND ENERGY INTAKE IN FEMALE
GYMNASTS FROM PREPARATORY TRAINING PERIOD
TO COMPETITION SEASON
Silva M, Paiva T
Presenting Author: Graciela Silva (United States)
INCIDENCE AND REMISSION OF SLEEP RELATED
SYMPTOMS IN CHILDREN AND ASSOCIATIONS
WITH HEALTH-RELATED QUALITY OF LIFE; A 7-YEAR
FOLLOW-UP OF THE TUCASA COHORT
Silva G, Goodwin J, Archibald K, Vasquez M, Quan S
Presenting Author: Jiahong Zhang (China)
A REVIEW OF THE RELATIONSHIP BETWEEN
SOCIAL, EMOTIONAL AND BEHAVIOURAL
DIFFICULTIES(SEBD) AND THE SLEEP DISTURBANCE.
Zhang J, Lu N, Zhang J
Tuesday - C - Board #034
Presenting Author: Mohsin Ali (Canada)
CHARACTERIZING SLEEPWAKE CYCLES OF
PRE-HEALTH PROFESSIONAL STUDENTS
Ali M, Chu R, Nastos S, Whelan S
Presenting Author: R. Robert Auger (United States)
CHRONOTYPE DISTRIBUTION IN BIPOLAR
DISORDER AND MAJOR DEPRESSIVE DISORDER
IN AN IN-PATIENT SAMPLE AT A TERTIARY
CARE CENTER
Auger R, Das P, Cao H, Feeder S, Kashyap R, Frye M
PAIN SENSITIVITY IN HEALTHY YOUNG MEN
IS MODIFIED BY TIME-OF-DAY
Aviram J, Pud D, Shochat T
Presenting Author: Masoud Bagherian Lemraski (Iran)
THE COMPARISON OF SLEEP DISORDERS AMONG
SHIFT WORKERS AND NON-SHIFT WORKERS IN
DOOROD HOSPITAL
Bagherian Lemraski M
Presenting Author: Ahmed Bahammam (Saudi Arabia)
INTERMITTENT FASTING DOES NOT INFLUENCE
THE CIRCADIAN PATTERN OF MELATONIN WHEN
CONTROLLING FOR MEALS, LIGHT EXPOSURE AND
SLEEP SCHEDULES
Bahammam A
Presenting Author: Emmanuelle Bastille-Denis (Canada)
THE PRESENCE AND THE NATURE OF DYSFUNCTIONAL
COGNITIONS AND THE FOCUS OF ATTENTION
DURING PRE-SLEEP PERIOD IN SHIFT WORKERS.
Bastille-Denis E, Roy M, Vallires A
Presenting Author: Emmanuelle Bastille-Denis (Canada)
CATASTROPHIZATION PROCESS AND THEMES OF
WORRY IN SHIFT WORKERS.
Bastille-Denis E, Roy M, Vallires A
Presenting Author: Bjrn Bjorvatn (Norway)
A RANDOMIZED CONTROLLED TRIAL OF THE
EFFECTS OF BRIGHT LIGHT AND MELATONIN FOR
DELAYED SLEEP PHASE DISORDER
Bjorvatn B, Saxvig I, Wilhelmsen-Langeland A, Vedaa ,
Nordhus I, Pallesen S
Presenting Author: Diane B. Boivin (Canada)
CIRCADIAN VARIATION OF HEART RATE
VARIABILITY DURING DIFFERENT SLEEP STAGES
Boudreau P, Dumont G, Boivin D
129
/
0
.
D
A
4
Presenting Author: Raquel Canuto (Brazil)
ASSOCIATED FACTORS WITH METABOLIC
SYNDROME IN SHIFT WORKERS
Canuto R, Anselmo Olinto M, Pattussi M, Henn R,
Macagnan J
Presenting Author: Christian Lavedan (United States)
TASIMELTEON TREATMENT ENTRAINS THE
CIRCADIAN CLOCK AND DEMONSTRATES SIGNIFICANT
BENEFIT ON SLEEP AND WAKE PARAMETERS IN
TOTALLY BLIND INDIVIDUALS WITH NON-24 HOUR
CIRCADIAN RHYTHMS
Lockley S, Dressman M, Torres R, Lavedan C, Licamele L,
Polymeropoulos M
Presenting Author: Mara Jos Martnez Madrid (Spain)
INFLUENCE OF SHIFT-WORK SCHEDULE ON
CIRCADIAN DISRUPTION IN NURSING STAFF
Martnez Madrid M, Rol M, Gmez-Garca T,
Fuentelsaz-Gallego C, Madrid Prez J
Presenting Author: Mara Jos Martnez Madrid (Spain)
THE CHALLENGE OF CHRONODISRUPTION
ASSESSMENT. THE CASE OF NURSING STAFF
SHIFT WORKERS
Martnez Madrid M, Campos M, Madrid Prez J, Rol M,
Moreno-Casbas T
Presenting Author: Sofia Isabel Ribeiro Pereira (Brazil)
CIRCADIAN AND HOMEOSTATIC PROCESSES
INFLUENCE DAYTIME NAP ARCHITECTURE
Pereira S, Beijamini F, Spada R, Menon F, Clementin J, Louzada F
Presenting Author: Arcady Putilov (Germany)
A SIMPLIFIED APPROACH TO MODEL-BASED
ANALYSIS OF THE ULTRADIAN SLEEP HOMEOSTASIS
THROUGH FITTING TIME COURSES OF ITS EEG
INDICATORS OBTAINED ACROSS ROUTINE CLINICAL
SLEEP LAB RECORDINGS OF ALL-NIGHT SLEEP AND
MULTIPLE 20-MIN NAPPING ATTEMPTS
Putilov A
Presenting Author: Milva Maria Figueiredo De Martino (Brazil)
CIRCADIAN RHYTHM OF WRIST TEMPERATURE AND
NIGHT SHIFT-WORK
Ruiz Carmona Ferreira L
Presenting Author: Khosro Sadeghniiat-Haghighi (Iran)
EVALUATION OF SLEEP DISORDERS IN FLIGHT
CREW AND GROUND STAFF WORKER IN IRAN
PRIVATE FLIGHT AIRLINE
Sadeghniiat-Haghighi K, Khazaee S, Aminian O, Momeni P
Presenting Author: Khosro Sadeghniiat-Haghighi (Iran)
SLEEPINESS, FATIGUE AND ROAD TRAFFIC ACCIDENTS
Sadeghniiat-Haghighi K, Moradi Nia M, Aminian O,
Esmaeeli A
Presenting Author: M.G. Smits (The Netherlands)
PERSONALIZED SLEEP MEDICINE APPLIED TO
MELATONIN TREATMENT FOR CIRCADIAN RHYTHM
SLEEP DISORDERS: CURRENT STATUS AND FUTURE
Smits M, Keijzer H, Braam W, Vervoort J, Curfs L
Tuesday - E - Board #053
Presenting Author: Helena Azevedo (Portugal)
SUBJECTIVE DAYTIME SLEEPINESS, EATING
DISTURBANCES AND BODY MASS INDEX IN
EMALE STUDENTS
Arruda A, Marques M, Ferreira L, Maia B, Gomes A, Azevedo M
Presenting Author: Valrie Cochen De Cock (France)
HOW TO EVALUATE SLEEPINESS IN PARKINSONS
DISEASE?
Cochen De Cock V, Bayard S, Jaussent I, Dauvilliers Y
Presenting Author: Sarah Keane (Ireland)
KLEINE LEVIN SYNDROME PRESENTING AFTER
HINI VACCINE
Crowe C, Keane S, Purcell E
Presenting Author: Bomi Kim (Republic of Korea)
EXCESSIVE DAYTIME SLEEPINESS IN PATIENTS WITH
EPILEPSY: CONTRIBUTING FACTORS AND IMPACT
ON QUALITY OF LIFE
Kim B, No Y, Lee G, Lee S
Presenting Author: Geert Mayer (Germany)
MODAFINIL FOR THE TREATMENT OF IDIOPATHIC
HYPERSOMNIA RESULTS OF A RANDOMIZED,
DOUBLE-BLIND, PLACEBO CONTROLLED STUDY
Mayer G, Benes H, Young P, Rodenbeck A
Presenting Author: Giuseppe Tropeano (Italy)
THE RELATIONSHIP BETWEEN SLEEP DISTURBANCES
AND FATIGUE WITH MULTIPLE SCLEROSIS
A CASE REPORT
Peverini F, Tropeano G
Presenting Author: Seiji Nishino (United States)
SLEEP PHENOTYPE CHARACTERIZATION OF
PERIPHERAL AND CENTRAL MOUSE MODELS OF
MYOTONIC DYSTROPHY
Sakai N, Sato M, Charizanis K, Lee K, Swanson M, Nishino S
Tuesday - I - Board #061
Presenting Author: Tamar Basishvili (Georgia)
INSOMNIA COMPLAINTS AND ASSOCIATED
FACTORS IN GEORGIAN POPULATION
Basishvili T, Eliozishvili M, Lortkipanidze N, Maisuradze L,
Darchia N, Espa-Cervena K
Presenting Author: Louise Beattie (United Kingdom)
THE GLASGOW NORMAL SLEEP CHECKLIST (GNSC):
A RESEARCH TOOL FOR DESCRIBING CONTROL PAR-
TICIPANTS
Beattie L, Espie C, Biello S
130
/
0
.
D
A
4
Presenting Author: Kristoffer Bothelius (Sweden)
ACCEPTANCE OF INSOMNIA
Bothelius K, Jernelv S, Kyhle K, Broman J, Gordh T,
Fredrikson M
Presenting Author: Ulises Jimnez (Mexico)
VALIDITY AND RELIABILITY OF THE MEXICAN
SCALE OF SLEEP QUALITY
Fernndez K, Ramos M, Marn H, Haro R, Jimnez U
Presenting Author: Pau Giner-Bayarri (Spain)
TECHNOLOGICAL INSOMNIA AND ACTIGRAPHY
Giner-Bayarri P, Torres-Cao N, Oviedo-Monts T,
Quintero-Hernandez K, Mazzillo-Ricaurte A
Presenting Author: Danning He (United States)
MULTI-SCALE ENTROPY-BASED MEASURES OF
ELECTROENCEPHALOGRAM DURING SLEEP AS
QUANTITATIVE CRITERIA FOR CHRONIC INSOMNIA
He D, Gamaldo A, Smith M, Allen R, Gamaldo C, Salas R
Presenting Author: Denise C. Jarrin (Canada)
DOES VULNERABILITY TO STRESS-RELATED
INSOMNIA PREDICT FUTURE INCIDENT AND
PERSISTENT INSOMNIA AMONG GOOD SLEEPERS?
Jarrin D, Chen I, Ivers H, Morin C
Presenting Author: Sooyeon Suh (Republic of Korea)
CORTICAL THINNING IN PATIENTS WITH
PERSISTENT INSOMNIA AND ITS RELATION WITH
INSOMNIA PROGRESSION
Kim H, Suh S, Kim H, Cho E, Shin C
Presenting Author: Tak Ho Lam (China)
HYPNOSIS FOR INSOMNIA: AN EXAGGERATED
MYTH OR AN UNDERRATED INTERVENTION?
Lam T
Presenting Author: Michelangelo Maestri (Switzerland)
MACRO AND MICROSTRUCTURE SLEEP CHANGES
IN INSOMNIACS WITH HIGH DOSE ABUSE OF BZ
Maestri M, Ferri R, Bottasini V, Ferini-Strambi L , Manconi M
Presenting Author: Margaret Moline (United States)
TREATMENT PATTERNS AMONG THOSE WHO
EXPERIENCE MIDDLE-OF-THE-NIGHT AWAKENING
(MOTN)
Moline M, Brown D, Dibonaventura M, Lorenzo R, Shah D,
Ben-Joseph R
Presenting Author: Annika Norell Clarke (Sweden)
COGNITIVE BEHAVIOURAL THERAPY FOR
COMORBID INSOMNIA AND DEPRESSION:
A RANDOMISED, CONTROLLED STUDY
Norell-Clarke A, Jansson-Frjmark M, Tillfors M, Hollndare F,
Engstrm I
METACOGNITION SELECTIVELY DEFINES PRIMARY
INSOMNIA
Palagini L, Piarulli A, Lai E, Cheli E, Espie C, Gemignani A
CROSS-SECTIONAL STUDY ON RELATIONSHIPS
BETWEEN HYPERTENSION AND INSOMNIA
Palagini L, Piarulli A, Bergamasco M, Bruno R, Ghiadoni L,
Gemignani A
Presenting Author: Katalin Zsuzsanna Ronai (Hungary)
HIGH FREQUENCY SPECTRAL POWER OF SLEEP EEG
INCREASES WITH DEPRESSIVE AND INSOMNIA
SYMPTOMS IN KIDNEY TRANSPLANT RECIPIENTS
Ronai K, Szentkiralyi A, Alpar L, Mucsi I, Bodizs R, Novak M
Presenting Author: Margaret Moline (United States)
SLEEP ARCHITECTURE FOLLOWING TREATMENT
OF PATIENTS WITH MIDDLE-OF-THE-NIGHT
INSOMNIA WITH BUFFERED SUBLINGUAL
ZOLPIDEM COMPARED TO PLACEBO
Roth T, Singh N, Steinberg F, Waldron A, Moline M
Presenting Author: Sooyeon Suh (Republic of Korea)
SUBNUCLEI ATROPHY IN THE AMYGDALA IN
PATIENTS WITH PERSISTENT INSOMNIA AND ITS
RELATION WITH INSOMNIA PROGRESSION AND
DEPRESSION
Suh S, Kim H, Kim H, Cho E, Shin C
Presenting Author: Katrin Uehli (Switzerland)
NOT ALL ARE EQUAL: MODIFIERS OF THE EFFECT
OF POOR SLEEP QUALITY ON WORK INJURIES
Uehli K, Miedinger D, Holsboer-Trachsler E, Schindler C,
Kinzli N, Leuppi J
Presenting Author: Tzu - Wen Wang (Taiwan)
ENDOGENOUS OPIATES IN THE PARABRACHIAL
NUCLEUS MEDIATE THE ELECTROACUPUNCTURE -
INDUCE SLEEP ACTIVITIES IN RATS
Wang T
Presenting Author: Zhang Haisheng (China)
THE LATEST DEVELOPMENT OF LOW RESISTANCE
THOUGHT IMPRINT PSYCHOTHERAPY SLEEP-
REGULATING TECHNIQUE OF INSOMNIA
Weidong W, Haisheng Z, Hui D
Presenting Author: Rybel Wix Ramos (Spain)
HYPERAROUSAL IN INSOMNIA
Wix Ramos R, De Abreu Arvelo A, Wix Ramos R, Pastor
Gomez J
Tuesday - NA - Board #082
Presenting Author: Sophie Bayard (France)
EFFORT-BASED DECISION MAKING IN
NARCOLEPSY-CATAPLEXY
Bayard S, Cizeau J, Georges M, Dauvilliers Y
131
/
0
.
D
A
4
Presenting Author: Pierre-Alois Beitinger (Germany)
SUBSIDED INFECTIONS AND AUTOIMMUNE EVENTS
IN NARCOLEPSY
Beitinger P, Ising M, Kohl G, Steiger A
Presenting Author: Lawrence Carter (United States)
PATIENTS JOURNEYS TO A NARCOLEPSY DIAGNOSIS
Carter L, Acebo C, Kim A
Presenting Author: Dominguez-Ortega L (Spain)
NARCOLEPSY AND ODOUR: PRELIMINARY REPORT
Dominguez-Ortega D, Diaz Gallego E, Pozo F,
Garca-Armenter C, Serrano-Comino M,
Dominguez-Sanchez E
Presenting Author: Patricia Franco (France)
COGNITIVE CHARACTERISTICS OF CHILDREN
WITH NARCOLEPSY
Guignard-Perret A, Inocente C, Mazza, Phd S, Bayard S,
Herbillon V, Franco P
Presenting Author: Steen Gammeltoft (Denmark)
MIRNA PROFILING IN PLASMA FROM PATIENTS
WITH SLEEP DISORDERS REVEALS DYSREGULATION
OF MIRNAS IN NARCOLEPSY AND OTHER CENTRAL
HYPERSOMNIAS
Holm A, Bang-Berthelsen C, Knudsen S, Kornum B, Jennum P,
Gammeltoft S
Presenting Author: Seung Chul Hong (Republic of Korea)
COMPARISONS OF CLINICAL AND POLYSOMNOGRAPHIC
FINDINGS BETWEEN NARCOLEPSY WITHOUT
CATAPLEXY AND IDIOPATHIC HYPERSOMNIA
Hong S, Kim T, Joo S, Jeong J, Han J
Presenting Author: Magdalena Krcmarova (Czech Republic)
NARCOLEPSY WITH CATAPLEXY AND PARKINSONS
DISEASE - A CASE REPORT
Krcmarova M, Dusek P, Kovalska P, Roth B, Sonka K
Presenting Author: Eszter Maurovich Horvat (Germany)
HYPOTHALAMO-PITUITARY-ADRENAL AXIS,
GLUCOSE METABOLISM AND TNF- IN NARCOLEPSY
Maurovich-Horvat E, Keckeis M, Lattov Z, Wetter T, Sonka K,
Pollmacher T, Schuld A, Kemlink D
Presenting Author: Francesca Poli (Italy)
INFLUENCE OF CYTOCHROME P450 AND ABCB1
GENETIC POLYMORPHISMS ON DRUG EFFICACY IN
NARCOLEPSY WITH CATAPLEXY
Poli F, Moresco M, Riccardi L, Plazzi G, Ingravallo F, Pelotti S
Presenting Author: Gemma Sansa (Spain)
NON-RANDOM TEMPORAL DISTRIBUTION OF SLEEP
ONSET REM PERIODS IN THE MSLT IN NARCOLEPSY
Sansa G, Falup-Pecurariu C, Salamero M, Iranzo A, Santamaria J
NARCOLEPSY WITH COEXISTING TYPE 1 DIABETES:
A CASE REPORT
Sarkanen T, Huutoniemi A, Partinen M
Presenting Author: Wisse Van Der Meijden (The Netherlands)
TIME- AND STATE-DEPENDENT ANALYSIS OF
AUTONOMIC CONTROL IN NARCOLEPSY: HIGHER
HEART RATE WITH NORMAL HEART RATE VARIABILITY.
Van Der Meijden W, Fronczek R, Reijntjes R, Lammers G,
Van Dijk G, Thijs R
Tuesday - NE - Board #095
Presenting Author: C Cheng; A Rodriguez (United States)
COMPLIANCE WITH NASAL CONTINUOUS POSITIVE
AIRWAY PRESSURE (CPAP) IN EPILEPSY AND
Cheng C, Chiang V, Bernbaum M, Koziorynska E, Rodriguez A
Presenting Author: Catherine Duclos (Canada)
ASSOCIATION BETWEEN THE CONSOLIDATION OF
THE REST-ACTIVITY CYCLE AND BRAIN RECOVERY
IN THE ACUTE PHASE OF TRAUMATIC BRAIN INJURY
Duclos C, Dumont M, De Beaumont L, Wiseman-Hakes C,
Bernard F, Gosselin N
Presenting Author: Tzu-Rung Huang (Taiwan)
SLEEP ALTERATIONS IN THE INTERLEUKIN-1 TYPE 1
RECEPTOR KNOCKOUT MICE.
Huang T
Presenting Author: Alan Jurez (Spain)
SEVERE BRUXISM IN A PATIENT SUFFERING
NASU-HAKOLA DISEASE FOR TEN YEARS
Juarez A, Alcaide C, Muoz F, Montes C
Presenting Author: Raffaele Manni (Italy)
SUBJECTIVE SLEEP QUALITY IN EPILEPSY
PATIENTS WITH SLEEP-RELATED SEIZURES
Manni R, Cremascoli R, Sguazzin C, Terzaghi M
Presenting Author: Manana Nemsadze (Georgia)
THE SIGNS OF DEPRESSION IN DEPRESSIVE
AND NON-DEPRESSIVE RATS - CORRELATION
WITH DENSITY OF -RECEPTORS IN THE BRAIN
STRUCTURES
Nemsadze M, Gogichadze M, Datunashvili M, Basishvili T,
Shanshiashvili L, Mikeladze D
Tuesday - O - Board #101
Presenting Author: Cristina Bdalo (Spain)
HISTAMINE INTERACTION WITH THE VENTRAL
PART OF THE ORAL PONTINE TEGMENTUM: ITS
IMPLICATION IN REM SLEEP MODULATION
Bdalo C, De Andrs I
Presenting Author: Marta Callejo (Spain)
SLEEP, EEG AND BEHAVIORAL RESPONSES AFTER
SYSTEMIC ADMINISTRATION OF GABOXADOL IN
THE LABORATORY CAT
Callejo M, Garzn M, De Andrs I
132
/
0
.
D
A
4
Presenting Author: So-Young Cho (Republic of Korea)
RELATIONSHIPS BETWEEN SLEEP AND HEADACHE
IN NON-CLINICAL POPULATION
Cho S, Yun C, Park S, Chu M
Presenting Author: Ofra Flint-Bretler (Israel)
THE EFFECTS OF A PARENTAL INTERVENTION
ON ELECTRONIC MEDIA EXPOSURE AND SLEEP
PATTERNS IN ADOLESCENTS
Flint-Bretler O, Shochat T, Tzischinsky O
Presenting Author: Jimmy Fraigne (Canada)
OPTOGENETIC AND PHARMACOGENETIC PROBING
OF RAPID EYE MOVEMENT (REM) SLEEP CIRCUITRY
Fraigne J, Torontali Z, Adamantidis A, Kim J, Peever J
Presenting Author: Berit Hjelde Hansen (Norway)
SELF - AND PARENT REPORTED SLEEP PROBLEMS
IN CHILDREN AND YOUTHS WITH EPILEPSY.
PRELIMINARY FINDINGS FROM A STUDY IN A
TERTIARY EPILEPSY CENTER
Hansen B, Alfstad K, Van Roy B, Lossius M
Presenting Author: Talma Kushnir (Israel)
DO FATHERS SUFFER FROM POSTPARTUM FATIGUE?
THE ROLES OF SLEEP QUALITY AND STRESS
Kushnir T, Israeli-Tedgi S, Urkin J
Presenting Author: Nuria Madureira (Portugal)
POLYSOMNOGRAPHIC FINDINGS AND RESPIRATORY
MANAGEMENT IN LEIGH SYNDROME C A CASE
REPORT
Madureira N, Estevao M, Ferreira M, Garcia P, Felix M
Presenting Author: An Mariman (Belgium)
INTERRELATIONSHIP OF SLEEP QUALITY WITH
FATIGUE, NEUROTICISM AND GLOBAL HEALTH IN
UNEXPLAINED CHRONIC FATIGUE
Mariman A, Tobback E, Hanoulle I, Delesie L, Pevernagie D,
Vogelaers D
Presenting Author: Helena Cristina Loureiro (Portugal)
SLEEP HABITS IN A PEDIATRIC POPULATION OF A
SUBURBAN AREA OF LISBON
Martins A, Chaves P, Papoila A, Loureiro H
Presenting Author: Koutatsu Maruyama (Japan)
UNDERREPORT OF ENERGY INTAKE MODIFIED THE
ASSOCIATION BETWEEN SLEEP DISTURBANCE AND
OVERWEIGHT AMONG MIDDLE-AGED JAPANESE:
TOON HEALTH STUDY.
Maruyama K, Tanigawa T, Eguchi E, Sakurai S, Saito I
Presenting Author: Jacqueline Maria Resende Silveira Leite (Brasil)
WATSU THERAPY IN THE TREATMENT OF FI-
BROMYALGIA SYNDROME
Resende Silveira Leite J, Almeida Galdino Alves D, Alves Silva
D, Fernandes Do Prado L, Fernandes Do Prado G, Bizari Coin
De Carvalho L
Presenting Author: Celeste Thirlwell (Canada)
A MULTIMODAL APPRAOCH TO TREATING
PATIENTS WITH PSG EVIDENCE OF CYCLING
ALTERNATING PATTERN (CAP) AND/OR ALPHA
ELECTROENCEPHALOGRAPHY PATTERN
(ALPHA-EEG): STRATEGIES FOR FIBROMYALGIA
SYNDROME AND CHRONIC FATIGUE (FMS/CF).
Thirlwell C, Anand S, Love D, Janelle L
Presenting Author: Els Tobback (Belgium)
POLYSOMNOGRAPHIC AND MSLT DATA IN A
LARGE SAMPLE OF PATIENTS WITH UNEXPLAINED
CHRONIC FATIGUE: COMPARISON WITH A
REFERENCE SAMPLE AND RELATION WITH
SUBJECTIVE SCORES
Tobback E, Mariman A, Hanoulle I, Delesie L, Vogelaers D,
Pevernagie D
Presenting Author: Nevin Fayez Wanis Zaki (Egypt)
SLEEP DISORDERS IN A SAMPLE OF EGYPTIAN
HIGH RISK PREGNANT FEMALES
Zaki N, Mesbah Y, Shams M
Presenting Author: Zhijun Liu (China)
RELIABILITY AND VALIDITY OF CSHQ IN URBAN
PRESCHOOL-AGED CHILDREN OF MAINLAND CHINA
Liu Z
Tuesday - S - Board #117
Presenting Author: Luis V. F. Oliveira (Brazil)
OBSTRUCTIVE SLEEP APNEA AND PULMONARY
FUNCTION IN MORBID OBESITY BEFORE AND
AFTER BARIATRIC SURGERY: A RANDOMIZED
CONTROLLED CLINICAL TRIAL.
Aguiar I, Santos I, Nacif S, Freitas Junior W, Malheiros C,
Oliveira L
Presenting Author: Mohammed Al-Abri (Sultanate Of Oman)
CPAP CAN REDUCE BLOOD PRESSURE IN
SYMPTOMATIC PATIENTS WITH OSAS
Al-Abri D
Presenting Author: Oguz O Erdinc (Turkey)
THE FREQUENCY OF PATIENTS WITH
POLYSOMNOGRAPHIC DIAGNOSIS AS OBSTRUCTIVE
SLEEP APNEA SYNDROME (OSAS) DURING ONE
YEAR IN ESKISEHIR, TURKEY
Alisan M, Erdinc O, Metintas S, Tekgol Uzuner G, Fidan H
Presenting Author: Erna Sif Arnardottir (Iceland)
THE CLINICAL IMPORTANCE OF OBSTRUCTIVE
SLEEP APNEA IN ALZHEIMERS DISEASE
Arnardottir E, Hannesdottir K, Davidsdottir S, Valgardsdottir
A, Gislason T, Snaeligidal J
Presenting Author: Daniel Neu (Belgique)
COMPLEX SLEEP APNEA DURING CPAP TITRATION:
PREVALENCE AND PREDICTIVE FACTORS
Balkissou A, Neu D, Pefura-Yone E, Mairesse O, Noseda A
133
/
0
.
D
A
4
Presenting Author: Jonathan Cmara (Spain)
RELATIONSHIP BETWEEN AGE AND DURATION
EVENT NUMBER RESPIRATORY SYNDROME IN PA-
TIENTS WITH SLEEP APNEA-HYPOPNEA
Barrios Barreto D, Gotera Rivera C, Lazo Meneses P, Camara
Fernandez J, Esteban Calvo R, Maas Baena E
Presenting Author: Erla Bjrnsdttir (Iceland)
SYMPTOMS OF INSOMNIA AMONG OSA PATIENTS
BEFORE AND AFTER 2 YEARS OF PAP TREATMENT
Bjornsdottir E, Janson C, Arnardttir E, Pack A, Gislason T,
Benediktsdottir B
Presenting Author: Laura Cancelo (Spain)
CPAP TITRATION: CORRELATION BETWEEN 2
DIFFERENT EQUATIONS AND AUTOCPAP.
Cancelo L, Hernandez V, Bravo D, Martinez C, Egea C, Duran J
Presenting Author: Emerson Martins (Brazil)
SLEEP APNEA AND AGGRESSIVENESS
Carissimi A, Caruccio Montanari C, Jihe Kim L, Martins E,
Amestoy De Oliveira A, Martinez D
Presenting Author: Luis Vicente Franco De Oliveira (Brazil)
SLEEP STUDY AND PULMONARY FUNCTION IN
MORBIDLY OBESE
Carvalho Aguiar I, R Santos I, Rodrigues Freitas Junior W,
Malheiros C, Franco De Oliveira L
VENTILATORY MUSCLE STRENGTH AND QUALITY
OF LIFE IN OBESE PATIENTS UNDERGOING
BARIATRIC SURGERY. PRELIMIANRY RESULTS.
Carvalho Aguiar I, R Santos I, Rodrigues Freitas Junior W,
Malheiros C, Franco De Oliveira L
Presenting Author: Michael P. Chan (United States)
CHAN SCORE PREDICTS PRESENCE AND SEVERITY
OF SLEEP APNEA AT THE BEDSIDE BEFORE
POLYSOMNOGRAM SLEEP TEST
Chan M, Chan A, Ly A, Lim N
Presenting Author: Jae Wook Cho (Republic of Korea)
SLEEP APNEA AND SEXUAL DYSFUNCTION
Cho J, Kim D, Ki Kim K
Presenting Author: Franoise Cornette (Switzerland)
PREVALENCE AND PREDICTORS OF SLEEP
DISORDERED BREATHING IN PATIENTS
UNDERGOING CHRONIC AMBULATORY
INTERMITTENT HEMODIALYSIS
Cornette F, Ogna A, Forni V, Burnier M, Heinzer R
Presenting Author: Helio Fernandez (Belgium)
ONE YEAR MONITORING OF NOCTURNAL PERIODIC
BREATHING AT THE ANTARCTIC POLE
Fernandez H, Pattyn N, Mairesse O, Meeusen R,
Mcdonald-Nethercott E, Neyt X
Presenting Author: Marcos Fernndez-Barriales (Spain)
MANDIBULAR ADVANCEMENT DEVICES AS AN
ALTERNATIVE TO CONVENTIONAL TREATMENT
WITH CPAP IN SELECTED PATIENTS: A HEALTH
INTERVENTION ANALYSIS
Fernndez-Barriales M, Gonzlez M, Macas E, Martnez M,
De Carlos F, Cobo J
Presenting Author: Alex Ferre (Spain)
PRELIMINAR RESULTS OF ORAL APLIANCE DEVICE
IN MILD TO MODERATE OBSTRUCTIVE SLEEP
APNEA SYNDROME
Ferre A, Vila J, Gallardo E, Perello E, Romero O, Sampol G
Presenting Author: Vanessa Ferreira (Portugal)
IMPACT OF DIAGNOSIS AND TREATMENT OF
OBSTRUCTIVE SLEEP APNEA SYNDROME (OSAS)
WITH NON-INVASIVE VENTILATION (NIV)
Ferreira V, Nveda R, Lombarda E, Pimenta R, Condeo J,
Curado H
Presenting Author: Maria Teresa Martins De Arajo (Brazil)
ASSOCIATION BETWEEN CLINICAL SIGNS AND
SYMPTOMS RELATED TO SLEEP-DISORDERED
BREATHING IN MOUTH BREATHERS
SCHOOLCHILDREN
Finck N, Arajo M, Pacheco M
ASSESSMENT OF SURFACE EMG SUPRA-HYOID
MUSCLE ACTIVITY IN APNEIC PATIENTS COMPARED
TO HEALTHY SUBJECTS. A PILOT STUDY
Folha G, Mapelli A, Cardoso Pereira Valera F, Dantas Giglio L,
Vitaliano Voi Trawizki L, Maria De Felcio C
ARE COGNITIVE DEFICITS OBSERVED IN
OBSTRUCTIVE SLEEP APNEA ASSOCIATED WITH
COGNITIVE COMPLAINTS?
Fortin M, Gagnon K, Baril A, DAragon C, Gagnon J, Gosselin N
Presenting Author: Tomokazu Furukawa (Japan)
SNORING IS RELATED TO THE ELEVATION OF
MORNING BLOOD PRESSURE
Furukawa T, Nakano H, Tanahashi T , Yoshihara K, Sudo N
SLEEP PATTERN, QUALITY AND SLEEPINESS AMONG
PATIENTS WITH EXACERBATION OF CHRONIC
OBSTRUCTIVE PULMONARY DISEASE
Gallego-Ariza B, Torres-Snchez I, Flores-Barba M,
Cabrera-Martos I, Correa-Toledo A, Valenza M
Presenting Author: Catarina Gomes (Portugal)
SLEEP DISORDERED BREATHING AND GROWTH
HORMONE THERAPY IN CHILDREN WITH PRADER
WILLI SYNDROME
Gomes C, Pereira C, Ferreira R
134
/
0
.
D
A
4
Presenting Author: David Gozal (United States)
OBSTRUCTIVE SLEEP APNEA AND OBESITY ARE
ASSOCIATED WITH REDUCED GPR120 PLASMA
LEVELS IN CHILDREN.
Gozal D, Kheirandish-Gozal L, Carreras A, Khalyfa A, Peris E
Presenting Author: Tomasz Grochowski (Poland)
CAN SNORING BE A CAUSE OF AGGRESSIVE
BEHAVIOUR IN CHILDREN?
Grochowski T, Kukwa W, GaZka A, Gronkieiwcz Z, Kukwa
A, Krzeski A
Presenting Author: Keisuke Hosokawa (Finland)
SUBJECTIVE SLEEPINESS IS NOT REQUIRED TO
ADHERE TO CPAP THERAPY
Hosokawa K, Sariola R, Huhtala H, Polo O
Presenting Author: Kazuya Hosokawa (Japan)
A NOVEL TECHNIQUE TO DETECT CARDIAC
FUNCTION BY ANALYZING AIR-FLOW TO
FINGERTIP-OXYGEN LAG TIME ON
POLYSOMNOGRAPHY IN PATIENTS WITH SLEEP
DISORDERED BREATHING AND HEART FAILURE
Hosokawa K, Ando S, Tohyama T, Otsubo H, Nakamura R,
Kadokami T
Presenting Author: Poul Jennum (Denmark)
ALL-CAUSE MORTALITY OF SLEEP APNOEA WITH
AND WITHOUT CPAP TREATMENT IN MALE AND
FEMALE PATIENTS: A CONTROLLED NATIONAL
STUDY
Jennum P
MORTALITY OF OBESITY HYPOVENTILATION WITH
AND WITHOUT CPAP TREATMENT : A CONTROLLED
NATIONAL STUDY
Jennum P
Presenting Author: Ana Jimenez Romero (Spain)
SLEEP BREATHING DISORDERS AND PERIPHERAL
ARTERIAL DISEASE IN PATIENTS WITH CORONARY
ARTERY DISEASE
Jimenez Romero A, Leon Acua A, Perez Martinez P, Ordoez
Dios I, Lopez Miranda J, Jurado Gamez B
Presenting Author: Santiago Juarros (Spain)
SEARCH METHODS FOR MONITORING PATIENTS
WITH OBSTRUCTIVE SLEEP APNEA TREATED
WITH CPAP
Juarros S, Bejarano D, Del Olmo M, Muoz I, Ramos I, Macias E
Presenting Author: Su Young Jung (Republic of Korea)
ANATOMICAL ANALYSES OF MANDIBULAR
STRUCTURE USING THREE-DIMENSIONAL FACIAL
CT FOR EFFECTIVENESS AND PREVENTION OF
COMPLICATIONS IN GENIOGLOSSUS ADVANCEMENT
Jung S, Shin S, Lee K, Cho J, Kim S
Presenting Author: Mithri R. Junna (United States)
INCREASED CORTICAL AROUSAL PROPENSITY IN
OPIATE USERS WITH COMPLEX SLEEP APNEA
SYNDROME
Junna M, St. Louis E, Shepard P, Pao W, Somers V,
Morgenthaler T
Presenting Author: Hyun Jun Kim (Republic of Korea)
HEART RATE VARIABILITY (HRV) IN SLEEP APNEA
PATIENTS
Kim H, Bae J
Presenting Author: Sung Wan Kim (Republic of Korea)
CHANGE IN POSITION DEPENDENCY IN NON-
RESPONDERS AFTER MULTILEVEL SURGERY FOR
Kim S, Jung S
Presenting Author: Michele Romano (Italy)
AN ORTHODONTIC-ORTHOGNATHIC CONCEPTUAL
APPROACH TO OSAS SURGERY: OUR EXPERIENCE
AND RESULTS
Lagan F, Rossi D, Romano M, Giann A
Presenting Author: Michele Romano (Italy)
OSTEOTOMYTECHNIQUES A KEY IN OSAS
TREATMENT: A FIVE YEARS EXPERIENCE
Lagan F, Rossi D, Romano M, Manconi M, Giann A
Presenting Author: Julieta Lazarte (Canada)
THE EFFECTS OF OSA IN SLEEP, PHYSICAL
SYMPTOMS, AND MOOD IN PATIENTS WITH
COPD AND ASTHMA
Lazarte J, Ferreira I
Presenting Author: Sung Bu Lee (Republic of Korea)
EFFECTS OF SLEEP DISORDERED BREATHING
ON QUALITY OF LIFE
Lee S, Chung Y, Jo M
Presenting Author: Isabl Ordonez Dios (Spain)
METABOLIC SYNDROME IFLUENCES THE SEVERITY
OF SLEEP APNEA SYNDROME: FROM THE
CORDIOPREV STUDY
Leon Acuna A, Ordonez Dios I, Perez Martinez P, Jimenez
Romero A, Jurado Gamez B, Lopez Miranda J
Presenting Author: Eva Libman (Canada)
INSOMNIA SUBTYPES IN SLEEP APNEA:
IMPLICATIONS FOR SCREENING AND TREATMENT
Libman E, Creti L, Fichten C, Rizzo D, Baltzan M, Bailles S
Presenting Author: Ester Lpez Cadena (Spain)
ECHOCARDIOGRAPHY FINDINGS IN A SLEEP APNEA
PACIENTS WITH MORBID OBESITY
Lpez Cadena E, Salord Oleo N, Gasa Galmes M, Monasterio
Ponsa C, Aponte Torres E, Ruiz Majoral A
135
/
0
.
D
A
4
Presenting Author: Helena Cristina Loureiro (Portugal)
SLEEP DISTURBANCES IN PORTUGUESE ASTHMATIC
CHILDREN-PRELIMINARY RESULTS
Loureiro H, Sokolova A
Presenting Author: Almiro Jos Machado Jnior (Brasil)
MAXILLARY EXPANSION IN CHILDREN WITH
OBSTRUCTIVE SLEEP APNEA (OSA): META-ANALYSIS.
Machado Jnior A, Zancanella E, Crespo A
Presenting Author: Nria Madureira (Portugal)
OBSTRUCTIVE SLEEP APNEA SYNDROME IN
CHILDREN YOUNGER THAN 2 YEARS OF AGE
Madureira N
Presenting Author: Eva Maas Baena (Spain)
NOCTURNAL INTERMITTENT HYPOXEMIA: UTILITY
FOR THE EVALUATION OF SEVERITY SLEEP APNEA
AND CARDIOVASCULAR COMORBIDITY
Maas Baena E, Lazo Meneses P, Fernandez Camara J, Esteban
Calvo R, Pedrera Mazarro A, Perez Rodriguez E
Presenting Author: Serguei Marshansky (Canada)
IMPACT OF RESPIRATORY EVENTS ASSOCIATED
WITH AUTONOMIC AROUSALS USING TYPE 1 SLEEP
LABORATORY AND TYPE 3 AMBULATORY RECORDINGS
Marshansky S, Jobin V, Rompr P, Lavigne G, Mayer P
Presenting Author: Juan Antonio Madrid (Spain)
CIRCADIAN IMPAIRMENT OF THE WRIST
TEMPERATURE RHYTHM IN PATIENTS WITH SLEEP
DISORDERED BREATHING
Martinez-Nicolas A, Guaita M, Santamara J, Montserrat J,
Madrid J, Rol A
Presenting Author: Emerson Martins (Brazil)
SLEEP APNEA AND SLEEP EFFICIENCY AS
PREDICTORS OF SURVIVAL AFTER
POLYSOMNOGRAPHY
Martins E, Fiori C, Peukert B, Fagundes M, Martinez D
Presenting Author: Pedro Mayoral Sanz (Spain)
THREE-DIMENSIONAL CONE-BEAM COMPUTED
TOMOGRAPHY FOR ASSESSMENT OF AIRWAY
CHANGES WITH MANDIBULAR ADVANCE SPLINT
Mayoral Sanz P, Calvo E
Presenting Author: Pedro Mayoral Sanz (Spain)
PREDICTIVE VALUE OF LARYNGOSCOPY WITH
REFERENCE TO THE TREATMENT OF OBSTRUCTIVE
SLEEP APNEA WITH MANDIBULAR ADVANCE DEVICE
Mayoral Sanz P
Presenting Author: Shawnda A. Morrison (Slovenia)
ALTERATIONS IN CENTRAL SLEEP APNOEA
FOLLOWING 10-D EXPOSURE TO HYPOXIA:
INFLUENCE OF EXERCISE
Morrison S, Pangerc A, Eiken O, Mekjavic I, Dolenc-Groselj L
Presenting Author: Nato Darchia (Georgia)
EXCESSIVE DAYTIME SLEEPINESS AND THE RISK
FOR OBSTRUCTIVE SLEEP APNEA IN GEORGIAN
POPULATION
Nikoloz O, Datunashvili M, Saxelashvili I, Ibanez V,
Espa-Cervena K, Darchia N
Presenting Author: Rosario Ferreira (Portugal)
CONGENITAL CENTRAL HYPOVENTILATION
SYNDROME PRESENTING AS PULMONARY
HYPERTENSION
Nunes T, Ferreira R, Anjos R, Moldovan O, Bandeira T
Presenting Author: Roberto Ocn Quintial (Spain)
EVALUATION OF ADENOTONSILLECTOMY
OUTCOME FOR OBSTRUCTIVE SLEEP APNEA
SYNDROME IN CHILDREN, BY PRE AND
POSTOPERATIVE POLYSOMNOGRAPHY.
Ocn Quintial R, Martinez Martinez M, Wu Y, Cabello Najera
M, Gonzalez Martnez M, Molina Osorio J
Presenting Author: Junji Ono (Japan)
WE NEED TO PAY SPECIAL ATTENTION ON SLEEP
POSTURES AND HEART DISEASES IN DOWN
SYNDROME WITH SLEEP DISORDERED BREATHING
Ono J, Sawatari H, Chishaki A, Rahmawati A, Kuroda H,
Ando S
Presenting Author: Joaquin Terain (Spain)
OSA AND OXIDATIVE STRESS: PRELIMINARY
ANALYSIS
Ordax E, Tern-Santos J, Alonso M, Coma M, Peralta R
Presenting Author: Carmen Orte (Spain)
THE EFFECTIVENESS OF ADENOTONSILLECTOMY
IN CHILDREN WITH OBSTRUCTIVE SLEEP APNEA
Orte C, Vicente E, Herrero A, Rodriguez I, De Miguel F
Presenting Author: Sofa Isabel Cieza Ortiz (Spain)
RELEVANCE OF HYPOXIA IN SLEEP DISORDERED
BREATHING: DISTINCT CLINICAL, SLEEP, AND
AUTONOMIC FEATURES IN OBSTRUCTIVE SLEEP
APNEA WITH AND WITHOUT HYPOXIA
Palma Carazo J, Cieza Ortiz S, Urrestarazu Bolumburu E,
Artieda Gonzlez-Granda J, Alegre Esteban M, Iriarte Franco J
Presenting Author: Wipasinee Phuapradit (Thailand)
DETERMINING THE EFFICACY OF TEMPORARY
MANDIBULAR ADVANCEMENT SPLINT IN MILD TO
MODERATE OBSTRUCTIVE SLEEP APNEA PATIENTS
AT BASELINE POLYSOMNOGRAPHY.
Phuapradit W, Mahakit P
Presenting Author: Jeimmy Mabel Pinzn Martinez (Spain)
APOE GENOTYPE AND OBSTRUCTIVE SLEEP APNEA
SYNDROME .
Pinzn Martinez J, Daz J, Ortega J, Martinez C, Latorre M,
Ruiz P
136
/
0
.
D
A
4
Presenting Author: Anita Rahmawati (Japan)
MAGNETIC RESONANCE IMAGING STUDY OF
PERIPHARYNGEAL MUCOSAL INTENSITY IN
OBSTRUCTIVE SLEEP APNEA PATIENTS
Rahmawati A, Chishaki A, Nagao M, Adachi K, Nishizaka M,
Ando S
Presenting Author: Effat Rasul (United States)
OBSTRUCTIVE SLEEP APNEA OUT PATIENT
SCREENING STUDY
Rasul E, Patel A, Khan A
Presenting Author: Jacqueline Maria Resende Silveira Leite (Brasil)
ASSESSMENT QUESTIONNAIRE OF CHILDREN WITH
SLEEP APNEA (TUCASA): TRANSLATION, CULTURAL
ADAPTATION AND VALIDATION
Resende Silveira Leite J, Ruotolo Ferreira V, Fernandes Do
Prado L, Fernandes Do Prado G, Bizari Coin De Carvalho L
Presenting Author: Ville Rimpil (Finland)
TRANSCUTANEOUS CARBON DIOXIDE DURING
EPISODES OF APNEA AND UPPER AIRWAY FLOW-
LIMITATION
Rimpil V, Saaresranta T, Hosokawa K, Huhtala H, Polo O
Presenting Author: Duarte Ari Diogo Rocha (Portugal)
COMPARISON OF THE CLINICAL AND
POLYSOMNOGRAPHIC FINDINGS IN OSA
PATIENTS VS REM SDB
Rocha D, Matos E, Ferreira A, Calvo M
Presenting Author: Jimena Rugeles-Plata (Spain)
POLYSOMNOGRAPHY (PSG) CORRELATION IN
PATIENTS WITH MODERATE SEVERE OSAS AT
THE TIME OF DIAGNOSIS AND AFTER TREATMENT
WITH CPAP.
Rugeles-Plata J, Espn-Gimnez C, Guaba-Camilo M,
Fernandez-Caballos A, Ferrandis-Ballester F
Presenting Author: Muventhiran Ruthranesan (Malaysia)
PREVALENCE, CLINICAL SIGNIFICANCE, AND
PREDICTORS FOR SLEEP-RELATED
HYPOVENTILATION AMONG OBESE ASIANS
WITH OBSTRUCTIVE SLEEP APNEA SYNDROME
Ruthranesan M, Chirakalwasan N
Presenting Author: Lirios Sacristn Bou (Spain)
APPLICABILITY OF THE EPWORTH SLEEPINESS
SCALE TO FIBROMYALGIC WOMEN WITH SLEEP
APNEA-HYPOPNEA SYNDROME.
Sacristn Bou L, Pea Blas F, Hernndez Blasco L,
Pascual Lled F, Martn Serrano C
Presenting Author: Rute Sampaio (Portugal)
A NEW CHARACTERIZATION OF ADHERENCE
PATTERNS TO AUTO-ADJUSTING POSITIVE AIRWAY
PRESSURE IN SEVERE OBSTRUCTIVE SLEEP APNEA
SYNDROME: CLINICAL AND PSYCHOLOGICAL
DETERMINANTS
Sampaio R, Pereira M, Winck J
Presenting Author: Ken Satoh (Japan)
SCREENING OF SLEEP APNEA SYNDROME DURING
A FULL MEDICAL CHECKUP: A COMPARISON
BETWEEN AN OPTICAL FIBER-TYPE SLEEP APNEA
SENSOR AND AN OVERNIGHT PULSE OXIMETRY
Satoh K, Mitachi S
Presenting Author: Hiroyuki Sawatari (Japan)
SLEEP-DISORDERED BREATHING IN ADULTS
WITH DOWN SYNDROME: A CROSS CULTURAL
COMPARISON
Sawatari H, Hill E, Nishizaka M, Chishaki A, Riha R, Ando S
Presenting Author: Mariusz Sieminski (Poland)
AMPLITUDES OF BLOOD PRESSURE AND HEART
RATE DURING OBSTRUCTIVE APNEAS ARE RELATED
TO DURATION OF APNEA AND TO DESATURATION.
Sieminski M, Partinen M
Presenting Author: Guilherme Silva Julian (Brazil)
EVALUATION OF THE EXPRESSION OF PIGMENT
EPITELIUM DERIVED FACTOR (PEDF) IN CHRONIC
INTERMITTENT HYPOXIA: VALIDATION AND
CHOICE FOR BEST HOUSEKEEPING GENES IN
THE MODEL
Silva Julian G, Watanabe De Oliveira R, Cini Perry J, Tufik S,
Visniauskas B, Ribeiro Chagas J
Presenting Author: Kiril Terziyski (Bulgaria)
RESPONSE TO HYPOXIC PROVOCATION IN
PATIENTS WITH CHRONIC HEART FAILURE AND ITS
PREDICTIVE VALUE FOR CENTRAL SLEEP APNEA
Terziyski K, Draganova A, Aliman O, Ilchev I, Hristova A,
Kostianev S
Presenting Author: M. Fernanda Troncoso Acevedo (Spain)
METABOLOMIC FINGERPRINTING APPROACH TO
SLEEP APNEA DISORDER IN HUMAN PLASMA
Troncoso Acevedo M, Gmez Garca T, Ferrarini A, Ruperez F,
Garcia A, Gonzalez Mangado N
Presenting Author: Orna Tzischinsky (Israel)
DEVELOPING AND VALIDATING A QUESTIONNAIRE
TO SCREEN COMMERCIAL DRIVERS LICENSE
APPLICANTS FOR SLEEP-DISORDERED BREATHING
Tzischinsky O, Epstein R, Pillar G
Presenting Author: Heisl Vaher (Estonia)
MEASURING ATTENTION DEFICIT WITH DASS TEST
IN CHILDREN WITH OBSTRUCTIVE SLEEP APNEA
Vaher H, Vaikjrv R, Veldi M, Kasenmm P, Vasar V
Presenting Author: Darwin Vizcarra-Escobar (Peru)
QUALITY OF LIFE IMPAIRMENT. A REASON FOR
RETHINK THE IMPORTANCE OF UPPER AIRWAY
RESISTANCE SYNDROME.
Vizcarra-Escobar D, Barbagelata-Aguero F
137
/
0
.
D
A
4
Presenting Author: Renato Watanabe De Oliveira (Brasil)
EVALUATION OF THE EFFECT OF HYPOXIA ON THE
EXPRESSION AND ACTIVITY OF NEPRILYSIN (EC
3.4.24.11), A PROTEASE INVOLVED ON ALZHEIMERS
DISEASE.
Watanabe De Oliveira R, Silva Julian G, Cini Perry J, Tufik S,
Visniauskas B, Ribeiro Chagas J
Presenting Author: Chikara Yoshimura (Japan)
CONTINUOUS POSITIVE AIRWAY PRESSURE THERAPY
DECREASES PLASMA GLUCOSE LEVELS AFTER THE
GLUCOSE LOAD EVEN IN NON-DIABETIC PATIENTS
Yoshimura C, Tamura A, Kawano Y, Watanabe T, Ando S
Tuesday - T - Board #201
Presenting Author: Maryam Al Hooti (Sultanate Of Oman)
CPAP ACCEPTANCE AND COMPLIANCE IN SLEEP
APNEA PATIENTS IN OMAN
Al Hooti M, Jaju D, Abri M
Presenting Author: Thuraya Hamed Rashed Al Zuheibi (Sultanate Of Oman)
EFFECTS OF THREE MODES OF RESPIRONICS AUTO
CPAP MACHINES IN PATIENTS WITH OSAHS
Al Zuheibi, T, Al Abri M
Presenting Author: Maksim Alekhin (Russian Federation)
EVALUATION OF SLEEP DISORDERED BREATHING
USING NON-CONTACT REMOTE BIO- RADIOLOCATION
METHOD
Alekhin M, Anishchenko L, Zhuravlev A, Ivashov S,
Korostovtseva L, Sviryaev Y
Presenting Author: Willy C.M. Arends-Derks (The Netherlands)
MEDICAL TECHNOLOGY ASSESSMENT OF
POLYSOMNOGRAPHY, TYPE 2: FULL PSG AT
HOME - NIGHT TO NIGHT VARIABILITY IN APNEA
HYPOPNEA INDEX (AHI) AND PERIODIC LIMB
MOVEMENT INDEX (PLMI).
Arends-Derks W, Horst-Haverkamp M, Schreuder K,
Rohling L, De Weerd A
Presenting Author: Erna Sif Arnardottir (Iceland)
HOW TO MEASURE SNORING?
Arnardottir E, Sigurgunnarsdottir M, Sigurdsson G,
Saevarsson G, Hoskuldsson S, Gislason T
Presenting Author: Anna Bagu (Spain)
REVIEW OF GENIOGLOSSUS MUSCLE ELECTRICAL
STIMULATION EFECTIVENESS FOR THE TREATMENT
OF OBSTRUCTIVE SLEEP APNEA-HIPOPNEA (OSAHS)
Bagu A, Esteller E
Presenting Author: Patricia Souza Bastos (Brazil)
ANALYSIS OF MEAN TRANSCUTANEOUS CARBON
DIOXIDE TENSION DURING POLYSOMNOGRAPHIC
EXTENDED MONITORING IN SARAH NETWORK
HOSPITAL PATIENTS.
Bastos P, Pinnola G, De Oliveira S
Presenting Author: Caroline U. Blankvoort (The Netherlands)
POLYSOMNOGRAPHY, TYPE 2: FULL PSG AT HOME
HOW OFTEN DO TECHNICAL FAILURES OCCUR?
Blankvoort C, Steinebach H, Warnaar I, Rohling L, De Weerd A
Presenting Author: Agnes M J Bon (The Netherlands)
POLYSOMNOGRAPHY, TYPE 2: FULL PSG AT HOME.
DETECTION OF NAPS AND THEIR CLINICAL
CORRELATES.
Bon A, Bossche R, Mattern-Coren E, De Weerd A
Presenting Author: Maria Angeles Bonmati-Carrion (Spain)
AN INNOVATIVE METHOD FOR EVALUATING
ACTIVITY REST PATTERN BASED ON POSITION
CHANGES
Bonmati-Carrion M, Middleton B, Revell V, Skene D, Rol A,
Madrid J
Presenting Author: Camila De Castro Corra (Brazil)
ELECTRONIC TUTOR ABOUT OBSTRUCTIVE
SLEEP APNEA SYNDROME: DEVELOPMENT AND
EVALUATION OF A HEALTH COLLABORATIVE
NETWORK
Corra C, Berretin-Felix G, Fukushiro A, Blasca W
Presenting Author: Alexandre Domingues (Portugal)
SLEEP PARAMETER ESTIMATION FROM
PORTABLE DATA
Domingues A, Paiva T, Sanches J
CARDIORESPIRATORY POLYGRAPHY DIAGNOSTIC
ACCURACY IN MILD TO MODERATE OBSTRUCTIVE
SLEEP APNEA HYPOPNEA SYNDROME (OSAHS)
Ferre A, Rahnama K, Vila J, Cambrodi R, Jurado M, Romero O
Presenting Author: Ana Ferreira (Portugal)
POSITIONAL SLEEP APNEA THERAPY
OUR EXPERIENCE
Ferreira A, Vale A, Rocha D, Matos E, Calvo T
Presenting Author: Laree Fordyce (Canada)
CPAP COMPLIANCE THE FIRST YEAR AND BEYOND
Fordyce L, Siemens A, Rousseau R, Becerra E
Presenting Author: Teresa Gmez Garca (Spain)
UTILITY OF PULSE TRANSIT TIME IN THE
DETECTION OF HIGH BLOOD PRESSURE IN
PATIENTS ADMITTED IN A SLEEP UNIT.
Gmez Garca T, Acevedo M, Camacho G, Gonzalez M,
Sanabria J, Mangado N
138
/
0
.
D
A
4
RELATIONSHIP BETWEEN THE WRONG REASONS
FOR CLINICAL AND CHANGE CONTROL PRESSURE
ADJUSTMENT RESULTING WITH THERAPEUTIC
AUTOCPAP
Jurkojc Mohremberger C, Lazo Meneses P, Barrios Barreto D,
Manasbaena E, Garcia De Leaniz J, Esteban Calvo R
Presenting Author: Yan Ma (China)
A NEW APPROACH TO SLEEP STUDY: DOES HEART
TELL US A LOT?
Ma Y, Sun S
Presenting Author: J R Garmendia Leiza (Spain)
UTILITY OF THE STATISTICAL AND NONLINEAR
ANALYSIS FOR THE ACTIGRAPHIC SLEEP PATTERN
CHARACTERIZATION
Martin Martinez D, Casaseca De La Higuera P, Alberola Lopez
C, Garmendia Leiza J, Andres De Llano J, Alberola Lopez S
Presenting Author: Maxime Elbaz (France)
PERFORMANCE ASSESSMENT OF A MEDICAL DEVICE
FOR HOME MONITORING OF CPAP TREATMENT IN
PATIENTS WITH OBSTRUCTIVE SLEEP APNOEA
SYNDROME
Elbaz M, Joelle T, Amelie C, Benoit P, Claude W, Damien L
Presenting Author: Jussi Nupponen (Finland)
ASSESSMENT OF THE RELIABILITY OF THE
NOCTURNAL TCCO2 SIGNALS WITH TREND LINES
Nupponen J, Rimpil V, Salminen A, Polo O
Presenting Author: Kristin Anna Olafsdottir (Iceland)
DIFFERENCE BETWEEN AUTOMATIC AND MANUAL
ANALYSIS OF RESPIRATORY EVENTS IN SLEEP
STUDIES
Olafsdottir K, Sigurdardottir S, Gislason T, Johannesdottir O,
Hilmarsson O, Arnardottir E
Presenting Author: Beatriz Rodriguez (Spain)
AMBULATORY CIRCADIAN MONITORING (ACM),
A COMPLEMENTARY TOOL IN SLEEP MEDICINE
Rodriguez-Morilla B, Campos Martnez M, Paniagua Soto J,
Estivilldomnech C, Rol De Lama M, Madrid Prez J
Presenting Author: Lisette C. Rohling (The Netherlands)
POLYSOMNOGRAPHY, TYPE 2: FULL PSG AT HOME
DIFFERENCE OF TWO UNATTENDED PSG AT HOME
SYSTEMS.
Rohling L, Blankvoort C, Mattern-Coren E, De Weerd A
Presenting Author: Janet Scheper (The Netherlands)
POLYSOMNOGRAPHY, TYPE 2: FULL PSG AT HOME.
Scheper J, Bossche R, Jansen N, Rohling L, De Weerd A
Presenting Author: Eus J.W. Van Someren (The Netherlands)
AFFORDABLE SLEEP ESTIMATES USING
MICRO-ELECTRO-MECHANICAL-SYSTEMS
(MEMS) ACCELEROMETRY
Te Lindert B, Van Someren E
Presenting Author: Olalla Urdanibia (Spain)
EEG NEWBORN 60 MIN VS. 30 MIN
Urdanibia O, Otsubo H, Diaz M, Ciopat O, Blasco M,
Gmez E
Presenting Author: Timothy Morgenthaler (United States)
THERE IS NO MEANINGFUL DIFFERENCE IN THE
RESPIRATORY EVENT INDEX CALCULATED USING
THE ACTIGRAPH ESTIMATED SLEEP TIME VERSUS
TOTAL RECORDING TIME
Wittine L, Olson E, Morgenthaler T
Presenting Author: Ding Zou (Sweden)
ASSOCIATION OF -ADRENERGIC RECEPTOR
POLYMORPHISMS AND NOCTURNAL
CARDIOPULMONARY COUPLING IN THE SKARA
SLEEP COHORT
Zou D, Grote L, Bengtsson Bostrm K, Eder D, Lindblad U,
Hedener J
Presenting Author: Joseph De Koninck (Canada)
GENDER DIFFERENCES IN THE DREAMS OF
CANADIAN ADOLESCENTS
Dale A, Wong C, De Koninck J
Presenting Author: Talyta Cortez Grippe (Brazil)
EXACERBATED PHAGOCYTOSIS AND SLEEP
APNEA SYNDROME
Grippe T, Afflalo M, Gaio E, Couto S, Goncalves S, Mesquita
W, Muniz-Junqueira M
2:9C:H96N, *8ID7:G 2, 2013
Wednesday - A - Board #001
Presenting Author: Cristina Alcaide (Spain)
PARTIAL CONTINUOUS EPILEPSY AS THE INITIAL
CONDITION OF A PATIENT DIAGNOSED WITH
CREUTZFELDT-JAKOB DISEASE
Alcaide C, Juarez A, Marina L, Montes C
Presenting Author: Ximena Alvarado (Bolivia)
PREVALENCE OF RESTLESS LEGS SYNDROME
SECONDARY TO HEMODIALYSIS UNIT CLINICAS
HOSPITAL
Alvarado X
Presenting Author: Geetika Bajpai (India)
VALIDATION OF A MODIFIED HINDI VERSION
OF THE EPWORTH SLEEPINESS SCALE IN A NORTH
INDIAN POPULATION
Bajpai G, Shukla G, Pandey R, Gupta A, Goyal V,
Madhuri Behari A
139
2
D
)
.
D
A
4
Presenting Author: Rubn V. Rial (Spain)
MELATONIN REVERTS SIGNS OF AGING IN THE
SLEEP OF RATS
Barcel P, Akarir M, Fiol De Roque M, Valls G
THE SLEEP REGISTRY. AN INTERNATIONAL ONLINE
SURVEY AND COGNITIVE TEST ASSESSMENT TOOL
AND DATABASE FOR MULTIVARIATE SLEEP AND
INSOMNIA PHENOTYPING
Benjamins J, Migliorati F, Dekker K, Wassing R, Moens S, Van
Someren E, Hartescu L, Itzhacki J, Pinto T, Tesler N, Perrier J,
Garbazza C, Jarkiewicz M
Presenting Author: Anastasios Bonakis (Greece)
SLEEP IN FRONTOTEMPORAL DEMENTIA IS
EQUALLY OR POSSIBLY MORE DISRUPTED WHEN
COMPARED TO THAT IN ALZHEIMERS DISEASE.
Bonakis A, Economou N, Paparrgopoulos T, Di Coscio E,
Bonanni E, Papageorgiou S
Presenting Author: Luca Carnicelli (Italy)
DISRUPTION OF SLEEP-WAKE CONTINUUM IN
DEMENTIA AND MILD COGNITIVE IMPAIRMENT:
MACROSTRUCTURAL AND MICROSTRUCTURAL
FINDINGS
Carnicelli L, Maestri M, Economou N, Paparrigopoulos T,
Tognoni G, Bonanni E
Presenting Author: Andrea Crespo Sedano (Spain)
NONLINEAR ANALYSIS OF HEART RATE VARIABILITY
IN PATIENTS WITH SLEEP APNEA HYPOPNEA
SYNDROME (SAHS). A SEVERITY STUDY.
Crespo A, Del Campo F, Gmez J, lvarez D, Marcos J, Hornero R
Presenting Author: Andrea Crespo Sedano (Spain)
ASSOCIATION BETWEEN APOLIPOPROTEIN E GENE
POLYMORPHISM AND HYPERTENSION IN
OBSTRUCTIVE SLEEP APNEA SYNDROME PATIENTS.
Crespo A, Del Campo F, De Frutos J, Arroyo A, Ruiz T, Alonso M
Presenting Author: Rafael Del Ro Villegas (Spain)
EFFECTS OF TREATMENT WITH LITHIUM IN A CASE
OF KLEINE-LEVIN WITHOUT COMPULSIVE EATING
Del Ro R, Bravo-Ortiz M
Presenting Author: M.C. Nicolau (Spain)
BRIGHT LIGHT EXPOSURE IMPROVES THE SLEEP-
WAKE RHYTHM IN INSTITUTIONALIZED ELDER
Fiol De Roque M, Rubio J, Ottmann D, Muoz S, Nicolau M
Presenting Author: Paula Gimnez Rodrguez (Spain)
RESTLESS LEGS SYNDROME IN PREGNANCY
Gimnez P, Canet T, Adsuar E
Presenting Author: Paula Gimnez Rodrguez (Spain)
RESTLESS LEGS DURING PREGNANCY: THE ROLE
OF FERRITIN
Gimnez P, Canet T, Emma A
Presenting Author: Monica L. Andersen (Brazil)
INFLUENCE OF METHAMPHETAMINE SELF-
ADMINISTRATION ON SLEEP IN RHESUS MONKEYS
USING ACTIGRAPHY
L. Andersen M
Presenting Author: Neli Maglakelidze (Georgia)
SERIAL ELECTRICAL STIMULATIONS OF
HYPOTHALAMIC OREXIN-CONTAINING NEURONAL
REGIONS LEAD TO ELEVATION OF CSF OREXINA
CONCENTRATION AND FASTEN THE RECOVERY
OF SLEEP-WAKEFULNESS CYCLE FROM
EXPERIMENTALLY INDUCED COMATOSE STATE
Maglakelidze N, Chkhartishvili E, Dzadzamia S, Chijavadze E,
Babilodze M, Nachkebia N
Presenting Author: Martnez - Martnez M.A. (Spain)
PROPIOSPINAL MYOCLONUS AT SLEEP ONSET (PSM)
AFTER SPINAL ANESTHESIA IN A PATIENT WITH
RESTLESS LEGS SYNDROME (RLS) AND PERIODIC
LIMB MOVEMENTS DURING SLEEP (PLMS): A CASE
REPORT.
Maria ngeles M, Roberto O, Mnica G, Jessica Guadalupe M,
Andrs G, Jos Luis M
Presenting Author: Olga Mchedlidze (Georgia)
SERIAL ELECTRICAL STIMULATIONS OF
HYPOTHALAMIC OREXIN-CONTAINING NEURONAL
REGIONS LEAD TO ELEVATION OF CSF OREXINA
CONCENTRATION, SHORTEN ANESTHESIA TIME
AND FASTEN RECOVERY OF NORMAL SLEEP CYCLES
FROM DEEP ANESTHESIA INDUCED SLEEP
Mchedlidze O, Chkhartishvili E, Maglakelidze N, Tsomaia V,
Rogava N, Nachkebia N
Presenting Author: Merino-Andreu Mila (Spain)
POLISOMNOGRAPHIC PHENOTYPE IS LINKED WITH
GENETIC FINDINGS IN PRADER-WILLI SYNDROME
Mila M, Aguilera Vergara M, Martnez-Bermejo A,
Quero-Jimnez J
Presenting Author: Nargizi Nachkebia (Georgia)
MALFUNCTIONING OF BRAIN MUSCARINIC
CHOLINERGIC SYSTEM IN THE PERIOD OF EARLY
POSTNATAL DEVELOPMENT LEADS TO BEHAVIORAL
AND SLEEP DISTURBANCES IN ADULT AGE RATS
AND CHANGES IN DENSITY OF M2/M4 MUSCARINIC
RECEPTORS
Nachkebia N, Chkhartishvili E, Mchedlidze O, Dzadzamia S,
Maglakelidze N, Chijavadze E
Presenting Author: Teresa Rebelo-Pinto (Portugal)
HEADACHES, SLEEP AND ACADEMIC SUCCESS IN
ADOLESCENTS
Rebelo-Pinto T, Carneiro-Pinto J, Rebelo-Pinto H, Paiva T
Presenting Author: Patricio Peirano (Chile)
ASSOCIATION BETWEEN THE AMOUNT OF DAYTIME
SLEEP VARIABILITY AND COGNITIVE FLEXIBILITY IN
OLDER ADULTS
Reyes S, Algarn C, Bunout D, Peirano P
140
2
D
)
.
D
A
4
Presenting Author: Outi Saarenp-Heikkil (Finland)
CHILD SLEEP THE FINNISH BIRTH COHORT STUDY
Saarenp-Heikkil O, Paavonen J, Himanen S, Kylliinen A,
Plkki P, Paunio T
Presenting Author: Alan Luiz Eckeli (Brazil)
OBSTRUCTIVE SLEEP APNEA SYNDROME IN
PARKINSONS DISEASE: PRELIMINARY RESULTS
Sobreira Neto M, Pereira M, Sobreira E, Frana Fernandes R,
Tumas V, Eckeli A
Presenting Author: William Vanderheyden (United States)
INCREASE IN REM SLEEP FOLLOWING TRAUMA
EXPOSURE
Vanderheyden W, Urpa L, Poe G
Presenting Author: Ryuichiro Yamamoto (Japan)
THE RELATIONSHIPS BETWEEN SLEEP
DISTURBANCE AMONG ELEMENTARY SCHOOL
CHILDREN AND LIFESTYLES OF THEIR FAMILY
Yamamoto R, Maruyama M, Hojo R, Inaga M, Nagashima Y,
Sugimori N
Wednesday - B - Board #027
Presenting Author: Torbjorn Akerstedt (Sweden)
REPEATED SLEEPINESS RATINGS THROUGHOUT
THE DAY A NORMATIVE FIELD STUDY IN 800
INDIVIDUALS ACROSS ONE WORKING WEEK
Akerstedt T, Kecklund G, Hallvig D
Presenting Author: Juan Carrillo (Chile)
ALERT LEVEL ASSESSMENT ASSOCIATED WITH
AGE AND RECENT SLEEP IN MINING WORKERS
Anabalon H, Masaln P, Carrillo J, Berrizbeitia A,
Anabalon C, Bravo M
Presenting Author: Laura Cern-Lorente (Spain)
REPERCUSSION OF SLEEP QUALITY AND DAYTIME
SLEEPINESS ON POSTURAL STEADINESS IN
MENOPAUSAL WOMEN
Cern-Lorente L, Gallego-Ariza B, Cabrera-Martos I,
Badillo-Fontalvo M, Mateos-Toset S, Valenza M
Presenting Author: Vanessa R Ferreira (Brazil)
PSYCHOMOTOR ASSESSMENT IN SLEEP BREATHING
DISORDER CHILDREN PILOT STUDY
Ferreira V, Leite J, Prado L, Prado G, Carvalho L
Presenting Author: Elena Rueda (Spain)
TITLE EFFECT OF MULTICOMPONENT COGNITIVE
BEHAVIORAL THERAPY IN A SAMPLE OF CHRONIC
INSOMNIACS IN HYPNOTIC TREATMENT.
Guallar Ballester J, Agusti Visiedo J, Baguena Puigcerver M,
Rueda Ravasco E, Ortega Albs J
Presenting Author: Kerstin Hoedlmoser (Austria)
SLEEP TO BOOST (RE-)LEARNING A FINE-MOTOR SKILL
Hoedlmoser K, Petzka M, Birklbauer J, Gruber G, Benjamins J,
Van Someren E
Presenting Author: Janne Grnli (Norway)
EFFECTS OF SOCIAL DEFEAT ON SLEEP AND
BEHAVIOR: IMPORTANCE OF THE
CONFRONTATIONAL BEHAVIOR
Kinn Rd A, Murison R, Mrdalj J, Milde A, Jellestad F, Grnli J
Presenting Author: Shun Nakajima (Japan)
RELATIONSHIP AMONG NIGHTMARE, INSOMNIA
AND DEPRESSION AMONG RESIDENTS IN JAPANESE
RURAL COMMUNITY
Nakajima S, Yuichi I, Okajima I, Taeko S, Komada Y, Nomura T
Presenting Author: Amelia Piquer (Spain)
COMPARISON BETWEEN THE OBJECTIVELY
MEASURED AND THE SUBJECTIVE SLEEP IN A
GROUP OF PATIENTS
Piquer A, Cutillas A, Perales P, Besa G, Goyo D, Gomez Siurana E
Presenting Author: Iigo Saez-Uribarri (Spain)
MORE COMPLEX DREAMS WITH EMOTIONS OR
AGGRESSIONS ARE ASSOCIATED WITH LONGER
REPORTS
Saez-Uribarri I
Presenting Author: Iigo Saez-Uribarri (Spain)
RECALLING YOUR DREAMS WONT MAKE YOU
NERVOUS IN THE MORNING.
Saez-Uribarri I
Presenting Author: Oliver Todd (Germany)
POOR SLEEP- AN EARLY SIGN OF INCIPIENT
DELIRIUM, OR A RISK FACTOR IN ITSELF?
A CLINICAL OBSERVATIONAL STUDY.
Todd O
Presenting Author: Mark Lawrence Wong (China)
REVERSING DECLINE OF HIGHER ORDE
COGNITIVE FUNCTIONS DURING THE DAY WITH
A NAP
Wong M, Lau K, Lau E
Wednesday - C - Board #041
Presenting Author: Rubn V. Rial (Spain)
THE GLYCEMIC INDEX OF A MID MORNING SNACK
MODIFIES THE BODY TEMPERATURE RHYTHM
Belzunce J, Noguera C, Gen L, Rial R
NON DIPPING BLOOD PRESSURE PATTERN IS
RELATED TO AN INCREASE IN DAYTIME DISTAL
SKIN TEMPERATURE
Blazquez A, Martinez-Nicolas A, Rol A, Antonio J
ASSOCIATION BETWEEN THE IMPAIRMENT OF SKIN
TEMPERATURE RHYTHM AND HYPERTENSION
Blazquez A, Martinez-Nicolas A, Rol A, Antonio J
141
2
D
)
.
D
A
4
Presenting Author: Maria Angeles Bonmati-Carrion (Spain)
AMBULATORY MONITORING IN HUMANS: A NEW
METHOD TO OBJECTIVELY ASSESS CIRCADIAN
PHASE AS COMPARED WITH DIM LIGHT
MELATONIN ONSET (DLMO)
Bonmati-Carrion M, Middleton B, Revell V, Skene D, Rol A,
Madrid J
ANXIETY AND DEPRESSION ASSOCIATED WITH
SLEEP DISTURBANCES IN SHIFT WORKERS
Carrillo J, Becerra M
HYPERTENSION AND ITS ASSOCIATION WITH SHIFT
WORK, SLEEP-DISORDERED BREATHING AND PLACE
IN THE ORGANIZATIONAL HIERARCHY
Carrillo J, Bastias I, Contreras P, Mistretta D, Vargas C
Presenting Author: Katarina Danielsson (Sweden)
COGNITIVE BEHAVIOUR THERAPY: AN ADDITIVE
TREATMENT IN DELAYED SLEEP PHASE DISORDER.
Danielsson K, Jansson-Frjmark M, Broman J, Markstrm A
Presenting Author: Diane B. Boivin (Canada)
THE CIRCADIAN RHYTHM OF BLOOD PRESSURE IS
MASKED BY POSTURAL CHANGES
Hsein Yeh W, Boudreau P, Dumont G, Boivin D
Presenting Author: Manon Lamy (Canada)
SLEEP DIARIES FOR SHIFT WORKERS
Lamy M, Bastille-Denis E, Vallires A
Presenting Author: Cristina Martnez Null (Spain)
SOCIAL JETLAG MORE THAN THE EVENING
CROTOTYPE IS THE MAIN CAUSE OF CHRONIC
SLEEP PRIVATION IN TEEN PEOPLE
Martnez Null C, Lpez Picado A, Egea Santaolalla C, Manjn
Caballero J, Izaguirre Martnez I, De Andrs Eciolaza J
DAY-NIGHT CONTRAST AS SOURCE OF HEALTH
FOR HUMANS
Martinez-Nicolas A, Madrid J, Rol A
Presenting Author: Leon Lack (Australia)
PERIOD LENGTHS OF TEMPERATURE AND
MELATONIN CIRCADIAN RHYTHMS IN DELAYED
SLEEP PHASE DISORDER
Micic G, Lack L, Lovato N, Burgess H, Ferguson S
Presenting Author: Inmaculada Pitarch Castellano (Spain)
SLEEPING DISORDERS RELATED WITH ALTERATIONS
OF MELATONINE SECRETION CIRCADIAN RHYTHM
Pitarch Castellano I, Puertas Cuesta F, Perez Pitarch A
Presenting Author: Inmaculada Pitarch Castellano (Spain)
SALIVARY DETERMINATION OF DIM LIGHT
MELATONIN ONSET AS A TOOL IN ATTENTION
DEFICIT HYPERACTIVITY DISORDER DIAGNOSIS
Pitarch Castellano I, Puertas Cuesta F, Perez Pitarch A
HEMOSTATIC MARKERS IN SHIFT WORKING
FEMALE NURSES
Saharov G, Nadir Y, Zoran I, Keren A, Brenner B, Shochat T
Presenting Author: Marta Segura Aroca (Spain)
SLEEP QUALITY OF NURSES WORKING IN SIX
HOSPITALS OF THE SPANISH NATIONAL
HEALTH SYSTEM
Segura Aroca M, Gmez Garca T, Lopez Iborra M,
Alonso Poncelas E, Santos Serrano R, Domenech Lpez X
THE EFFECTS OF A SCHEDULED NAP DURING THE
NIGHTSHIFT ON PERFORMANCE, SLEEPINESS AND
VIGOR IN NURSES
Shochat T, Zion N
Presenting Author: Ana Viegas (Portugal)
MELATONIN IN PATIENTS WITH DELAYED SLEEP
PHASE DISORDER
Viegas A, Rebocho S, Paiva T
Wednesday - E - Board #059
Presenting Author: Marc Guaita (Spain)
DAYTIME PERIPHERAL TEMPERATURE CHANGES
DURING MWT AND MSLT
Guaita M, Martinez A, Madrid J, Rol M, Salamero M,
Santamaria J
Presenting Author: Marc Guaita (Spain)
HEART RATE VARIABILITY DURING THE MSLT AND
MWT IN PATIENTS WITH AND WITHOUT EXCESSIVE
DAYTIME SLEEPINESS
Guaita M, Umberto M, Montserrat V, Caminal P, Salamero M,
Santamaria J
Presenting Author: Stefan Mihaicuta (Romania)
LOWER LEVELS OF EPWORTH SLEEPINESS SCORE
PREDICTS SLEEP APNEA SYNDROME IN A SLEEP
LABORATORY
Mihaicuta S, Paralescu S, Toth I
Presenting Author: Mara Ruzafa (Spain)
CHRONOTYPE AND DAYTIME SLEEPINESS IN
NURSES WORKING IN SIX HOSPITALS OF THE
SPANISH NATIONAL HEALTH SYSTEM
Ruzafa Martneza M, Moreno Casbas T, Serrano Pinto A,
Gonzlez- Mara E, Heredia Reina M, Otero Fernndez A
142
2
D
)
.
D
A
4
Presenting Author: Karel Schreuder (The Netherlands)
PROLONGED DAYTIME DISSOCIATIVE NREM3 SLEEP
STATE IN HYPERSOMNOLENCE WITH KLEINE LEVIN
SYMPTOMATOLOGY, A CASE REPORT.
Schreuder K, Sie J, De Vries X, Hoekema A, Finnema K,
De Weerd A
Presenting Author: Tokusei Tanahashi (Japan)
CHANGES IN SUBJECTIVE EXCESSIVE DAYTIME
SLEEPINESS AFTER THE GREAT EAST JAPAN
EARTHQUAKE
Tanahashi T, Furukawa T, Hirayama K, Nakano H, Sudo N
Wednesday - I - Board #065
Presenting Author: Ainhoa Alvarez Ruiz De Larrinaga (Spain)
TRAZODONE AS CO-TREATMENT FOR INSOMNIAC
PATIENTS
Alvarez Ruiz-Larrinaga A, Majn Caballero J, Lpez Picado A,
Mendaza Ortiz M, Egea Santaolalla C, Duran-Cantolla J
Presenting Author: Francesca Canellas (Spain)
INSOMNIA GROUP THERAPY
Belber M, De La Fuente L, Canellas F
Presenting Author: Rafael Del Rio Villegas (Spain)
PERSONALITY AND SEVERITY OF PRIMARY
INSOMNIA
Bravo-Ortiz M, Valverde C, Herrero E, Melero J, Naranjo M,
Del Rio R
Presenting Author: Oliviero Bruni (Italy)
TOWARD A CLINICAL AND THERAPEUTIC
CLASSIFICATION OF INSOMNIA OF CHILDHOOD
Bruni O, Elisabetta A, Marco A, Assia R, Claudia D, Raffaele F
Presenting Author: Vanda Clemente (Portugal)
COIMBRA SLEEP ACTIVATION SCALE (C-SAS):
PSYCHOMETRIC PROPERTIES IN INSOMNIACS
Clemente V, Almeida J, Martins I, Allen Gomes A, Moutinho
Dos Santos J
Presenting Author: M. Montserrat (Spain)
CAN CBT FOR INSOMNIA ALSO IMPROVE PAIN
SENSITIVITY IN FIBROMYALGIA PATIENTS?: RESULTS
FROM A RANDOMIZED CLINICAL TRIAL
Edinger J, Sanchez Ortuo M, Stechuchak K, Coffman C,
Krystal A
Presenting Author: Kunihiro Futemma (Japan)
THE IMPACT OF HYPNOTICS USAGE ON DAYTIME
FUNCTION AND ASSOCIATED FACTOR FOR THE
USAGE IN SHIFTWORK NURSES.
Futemma K, Murakoshi A, Takaesu Y, Asaoka S, Komada Y,
Inoue Y
Presenting Author: Sanjive Jain (Canada)
INTRODUCING INSOMNIA MEDITATION THERAPY:
A NOVEL BEHAVIOURAL INTERVENTION FOR
INSOMNIA
Jain S, Shapiro G
Presenting Author: Aggeliki Konsta (Greece)
STRESS MANAGEMENT TECHNIQUES IN PRIMARY
INSOMNIA: A RANDOMIZED CONTROLLED TRIAL
Konsta A, Dikeos D, Bonakis A, Economou N, Chrousos G,
Darviri C
Presenting Author: Diego Mazzotti (Brazil)
INSOMNIA AND MORTALITY AMONG OLDER
PEOPLE IN FIVE LATIN AMERICAN COUNTRIES:
A POPULATION BASED COHORT STUDY
Mazzotti D, Garbuio S, Ferri M, Tufik S, Ferri C
Presenting Author: Merino-Andreu Mila (Spain)
EVALUATION OF ORAL IRON SUPPLEMENTATION
IN PEDIATRIC MAINTENANCE INSOMNIA
Mila M, Cecilia A, Gracia A, Antonio M, Oscar T, Patricio P
Presenting Author: Jesus Moo Estrella (Mexico)
TYPES OF INSOMNIA AND PHYSICAL ACTIVITY
IN COLLEGE STUDENTS
Moo Estrella J, Rosado Narvaez C, Yaez Lora A,
Valencia Flores M
Presenting Author: Markku Partinen (Finland)
SLEEP DIFFICULTIES IN PARKINSONS DISEASE
Partinen M, Ylikoski a, Martikainen K
Presenting Author: Campolo Benedetta (Italy)
SLEEP AND PULMONARY INTENSIVE CARE:
INSOMNIA AND THE PARADOX OF
Roccia F, Campolo B, Gallelli L
DIFFERENTIAL BRAIN STRUCTURAL CORRELATES
OF INSOMNIA IN DEPRESSION VS. ANXIETY
Stoffers D, Van Tol M, Penninx B, Veltman D, Van Der Wee N,
Van Someren E
Presenting Author: Vladimir Svetnik (United States)
COMPARISON OF EEG POWER SPECTRA BETWEEN
PATIENTS WITH PRIMARY INSOMNIA AND GOOD
SLEEPER CONTROLS, ACCOUNTING FOR THE
EFFECTS OF AGE, GENDER, AND SLEEP PERIOD,
USING A LARGE COMPILATION OF PSG RECORDINGS
FROM THREE CLINICAL TRIALS.
Svetnik V, Snyder E, Ivgy-May N, Ma J, Tao P, Herring W
Presenting Author: Dora Zalai (Canada)
THE SILENCE OF SLEEP DISORDERS. HIGH
PREVALANCE OF INSOMNIA AND OBSTRUCTIVE
SLEEP APNEA SYMPTOMS IN CHRONIC HEPATITIS
C INFECTION
Zalai D, Mcshane K, Sherman M, Fornadi K, Shapiro C,
Carney C
143
2
D
)
.
D
A
4
Presenting Author: Dora Zalai (Canada)
ARE YOU CONCERNED ABOUT YOUR FATIGUE?
FATIGUE PERCEPTIONS MEDIATE THE
RELATIONSHIP BETWEEN INSOMNIA AND FATIGUE
RELATED FUNCTIONAL IMPAIRMENT IN CHRONIC
HEPATITIS C INFECTION
Zalai D, Mcshane K, Sherman M, Fornadi K, Shapiro C,
Carney C
Wednesday - NA - Board #083
Presenting Author: Maria Albanese (Italy)
CSF BETA-AMYLOID LEVELS ARE ALTERED IN
NARCOLEPSY: A LINK WITH THE INFLAMMATORY
HYPOTHESIS?
Albanese M, Liguori C, Placidi F, Izzi F, Marciani M, Romigi A
Presenting Author: Ximena Alvarado (Bolivia)
CASE REPORT
Alvarado X
Presenting Author: Yves Dauvilliers (France)
EFFECT OF SODIUM OXYBATE (SXB), MODAFINIL
AND COMBINATION ON DISRUPTED NIGHTTIME
SLEEP IN NARCOLEPSY
Dauvilliers Y, Roth T, Guinta D, Alvarez-Horine S, Dynin E,
Black J
Presenting Author: Claire E.H.M. Donjacour (The Netherlands)
ENERGY EXPENDITURE IN NARCOLEPSY PATIENTS
AND CONTROLS
Donjacour C, Schoffelen P, Overeem S, Lammers G, Pijl H,
Westerterp K
Presenting Author: Patricia Franco (France)
CHARACTERISTICS OF NARCOLEPSY ACCORDING
TO THE AGE OF DIAGNOSIS
Inocente C, Lecendreux M, Dauvilliers, Md, Phd Y, Drouot X,
Arnulf I, Franco P
Presenting Author: Masako Kohsaka (Japan)
TWENTY-FOUR-HOUR SLEEP-WAKE MONITORING
IN NARCOLEPSY: COMPARISON WITH MSLT
Kohsaka M, Fukuda N
Presenting Author: Jess Paniagua Soto (Spain)
MULTIPLE SLEEP LATENCY TEST IN PATIENTS WITH
SUSPECTED NARCOLEPSY. REVIEW OF 45 CASES.
Paniagua-Soto J, Ruiz-Garca J, Iznaola-Muoz M, Ruiz-Serrano L
Presenting Author: Thomas Roth (United States)
EFFECT OF SODIUM OXYBATE ON SLEEP STAGE
SHIFTS AND SLEEP QUALITY IN PATIENTS WITH
NARCOLEPSY
Roth T, Dauvilliers Y, Guinta D, Alvarez-Horine S, Dynin E,
Black J
Presenting Author: John Peever (Canada)
PHARMACOGENETIC INHIBITION OF THE
SUBCOERULEUS REGION INFLUENCES REM SLEEP
AND CATAPLEXY IN NARCOLEPTIC MICE.
Sanghera K, Kim J, Peever J
SYMPTOMS OF NARCOLEPSY IN RELATION TO
PANDEMRIX VACCINATION AND CSF-HYPOCRETIN-1
LEVELS
Sarkanen T, Huutoniemi A, Partinen M
Presenting Author: M Berta Silva (Portugal)
PREDICTIVE POWER OF HLA-DQB1* TO IDENTIFY
NARCOLEPTIC PATIENTS
Silva M, Lopes J, Carvalho C, Cunha D, Pinho Costa P,
Martins-Da-Silva A
Presenting Author: Ana Viegas (Portugal)
LOW HLA DQB1 0602 IN PORTUGUESE
NARCOLEPTICS
Viegas A, Rebocho S, Paiva T, David A
Wednesday - NE - Board #095
Presenting Author: Amaury Jos Asencio Guerra (Spain)
FATAL FAMILIAL INSOMNIA (FFI) IN BASQUE
COUNTRY. CLINICAL MANIFESTATIONS,
POLYSOMNOGRAPHIC PATTERNS AND
PATHOLOGIC FINDINGS IN THREE CASES.
Asencio Guerra A, Alvarez Ruiz De Larrinaga A,
Egea Santaolalla C, Durn Cantolla J, Alvarez Vadillo E,
Julin Villaverde F
Presenting Author: Eter Chijavadze (Georgia)
EFFECT OF INDUCED HYPOGLYCEMIA ON
SLEEP-WAKING CYCLE IN RATS
Chijavadze E, Babilodze M, Mchedlidze O, Chkhartishvili E,
Nachkebia N
POLISOMNOGRAPHYC RESULTS IN CHIARI
MALFORMATION TYPE I
Ferre A, Poca M, De La Calzada M, Moncho D, Romero O,
Sahuquillo J
SLEEP RELATED BREATHING DISORDERS (SRBD)
IN PATIENTS WITH CHIARI TYPE I MALFORMATION
BEFORE AND AFTER POSTERIOR FOSSA
DECOMPRESSION
Ferre A, Poca M, De La Calzada M, Moncho D, Romero O,
Sahuquillo J
Presenting Author: Masaya Segawa (Japan)
FAILURE IN RESTRICTING ATONIA IN REM STAGE
CAUSED DYSFUNCTION OF THE DOPAMINE
NEURON IN CHILDHOOD
Segawa M
144
2
D
)
.
D
A
4
Wednesday - O - Board #100
Presenting Author: Alison Bentley (South Africa)
THE EFFECT ON SLEEP INERTIA ON PAIN
PERCEPTION DEPENDS ON THE TYPE OF PAIN
Benjamin D, Inkley R, Bentley A
Presenting Author: Isabel Caballero-Martinez (Spain)
SLEEP DISORDERS IN PATIENTS WITH EPILEPSY
Caballero-Martinez M, Caballero-Martinez M,
Vazquez-Rodriguez R, Martinez-Agredano P, Arenas-Cabrera C,
Jimenez-Hernandez M
Presenting Author: Caballero-Martinez (Spain)
PAROXYSMAL MOTOR DISORDERS OF SLEEP
MISDIAGNOSED AS EPILEPSY
Caballero-Martinez M, Caballero-Martinez M,
Martinez-Agredano P, Arenas-Cabrera C, Vazquez-Rodriguez R,
Jimenez-Hernandez M
Presenting Author: Suzana V. Schnwald (Brazil)
PRIMARY SLEEP DISORDER CATEGORIZATION INTO
CLINICAL PRACTICE: A PILOT STUDY WITH THE
PRIMSC CODING SYSTEM
Carvalho D, Margis R, Schuh A, Gerhardt G, Rieder C,
Schnwald S
Presenting Author: Laura Cern-Lorente (Spain)
SLEEP DISTURBANCES AND MANUAL DEXTERITY
IN FIBROMYALGIA
Cern-Lorente L, Badillo-Fontalvo M, Cabrera-Martos I,
Torres-Snchez I, Gallego-Ariza B, Valenza M
Presenting Author: Gregory Collet (Belgium)
SLEEP DURING AN ANTARCTIC OVERWINTERING:
COMPARING AN ALTITUDE BASE AND A COASTAL
STATION
Collet G, Mairesse O, Mcdonald-Nethercott E, Ducrot Y,
Meeusen R, Pattyn N
Presenting Author: Laura Creti (Canada)
EFFECTS OF SLEEP DISTURBANCE IN THE
POSTPARTUM: ARE NEW MOTHERS AN EXCEPTION
TO THE RULE?
Creti L, Rizzo D, Fichten C, Bailes S , Libman E
Presenting Author: Antonio Pedrera Mazarro (Spain)
THE PENELOPE SYNDROME NOT ALWAYS MEANS
BAD PROGNOSIS
Cullar-Ramos N, Corts-Jimnez V, lvarez-Snchez J,
Pedrera-Mazarro A
Presenting Author: Manuel De Entrambasaguas (Spain)
INSOMNIA AND DEATH OF MARILYN MONROE
De Entrambasaguas M
Presenting Author: Sara Cabrera Garca-Armenter (Spain)
INCIDENCE OF SLEEP DISORDERS IN A SIMPLE OF
DOWN SYNDROME PATIENTS.
Dominguez Ortega L, Cabrera Garca-Armenter S, Daz Gllego
E, Serrano Comino M
Presenting Author: Jack D. Edinger (United States)
A COLLABORATIVE CARE MODEL FOR IMPROVING
SLEEP DISORDERS MANAGEMENT IN PRIMARY CARE.
Edinger J, Grubber J, Ulmer C, Zervakis J, Olsen M
Presenting Author: Lamia Afifi (Egypt)
SLEEP DISORDERS IN CHRONIC RENAL FAILURE
PATIENTS
Eltawdy M, Rabah A, Nada M, Refaat R, Afifi L
Presenting Author: Lgia Ferreira (Portugal)
CYCLIC ALTERNATING PATTERN IN CONGENITAL
DEAF - QUANTITATIVE AND TOPOGRAPHIC
ANALYSIS
Ferreira L, Paiva T
Presenting Author: Catarina Ferreira (Portugal)
MANDIBULAR ADVANCEMENT SPLINT FOR THE
TREATMENT OF OBSTRUCTIVE SLEEP APNEA
Ferreira C, Teixeira F, Vaz Rodrigues L, Carvalho F, Moutinho
Dos Santos J
ARE SLEEP COMPLAINTS FOLLOWING MILD
TRAUMATIC BRAIN INJURY ASSOCIATED WITH
CHANGES IN THE CHARACTERISTICS OF SLEEP
SLOW WAVES?
Gagnon K, Khoury S, Carrier J, Montplaisir J, Lavigne G,
Gosselin N
AN 8-WEEKS EXERCISE MUSCLE TRAINING
IMPROVES SUBJECTIVE FATIGUE AND QUALITY
OF SLEEP IN PARKINSON DISEASES PATIENTS
Gallego-Ariza B, Cabrera-Martos I, Correa-Toledo A,
Mateos-Toset S, Flores-Barba M, Valenza M
SLEEP QUALITY IN WOMEN WITH SYSTEMIC
LUPUS ERYTHEMATOSUS
Gholamrezaei A, Hosseini N, Sayed Bonakdar Z
Presenting Author: Sandra Gimnez Badia (Spain)
SLEEP QUALITY IN INTENSIVE CARE UNIT
Gimnez Badia S, Batet S, Italiano S, Roche-Campo F,
Antonijoan R
BRIEF INSOMNIA AND QUALITY OF SLEEP SCALE
(BIQSS): RELIABILITY AND VALIDITY IN HIGHER
EDUCATION STUDENTS
Gomes A, Marques D, Tavares J, Azevedo M
Presenting Author: Jean-Philippe Gouin (Canada)
HEART RATE VARIABILITY PREDICTS SLEEP
EFFICIENCY
Gouin J, Wenzel K, Deschenes S, Dang-Vu T
145
2
D
)
.
D
A
4
Presenting Author: Nadia Tobback (Switzerland)
EFFECTS OF REAL VS SIMULATED ALTITUDE ON
SLEEP AND SLEEP DISORDERED BREATHING
Heinzer R, Saugy J, Tobback N, Rupp T, Haba-Rubio J, Millet G
Presenting Author: Rosa Martins (Portugal)
IS THERE A CORRELATION BETWEEN CLINICAL
FACTORS AND NOCTURNAL OXIMETRY IN CYSTIC
FIBROSIS CHILDREN?
Martins R, Silva A, Mexia S, Asseiceira I, Pereira L, Ferreira R
Presenting Author: A Martins Da Silva (Portugal)
SLEEP DISORDERS DIAGNOSIS BY GENETIC
ASSESSMENT
Martins-Da-Silva A, Ramalheira J, Silva L, Cunha D, Brs S,
Carvalho C
Presenting Author: Rie Miyata (Japan)
DAILY ALTERATION OF MELATONIN AND OXIDATIVE
STRESS MARKERS IN DEVELOPMENTAL DISORDERS
Miyata R, Tanuma N, Hayashi M, Kohyama J
Presenting Author: Stella Maris Valiensi (Argentina)
INFLUENCE OF THE OBSTRUCTIVE SLEEP APNEA
TREATMENT IN THE GLAUCOMA CONTROL
Moussalli M, Bekerman J, Cuello Oderiz C, Valiensi S
Presenting Author: Bikemgl zkara (Turkey)
THE APPLICATION OF CONTINUOUS POSITIVE
AIRWAY PRESSURE IN ASSOCIATION WITH
OBSTRUCTIVE SLEEP APNEA SYNDROME AND
SUBCONJUNCTIVAL HEMORRHAGE DUE TO
HYPERTENSIVE ATTACKS: CASE REPORTS
zkara B, evketbeyolu H, Ta D
CHILDREN SLEEP CLINIC IN CLINICAL
NEUROPHYSIOLOGY SERVICE IN VIRGEN DE LAS
NIEVES HOSPITAL IN GRANADA (SPAIN)
Paniagua-Soto J, Iznaola-Muoz M, Ruiz-Garca J, Ruiz-Serrano L
Presenting Author: Silvia Pucci (Portugal)
THE ROLE OF PSYCHOLOGICAL MORBIDITY ON
SLEEP QUALITY AND LIFESTYLE IN ADOLESCENTS
Pucci S, Graa Pereira M
Presenting Author: Tim Weysen (The Netherlands)
CREATING A SLEEP-PERMISSIVE CONDITION
USING BED WARMING
Weysen T, Mst E, Raymann R
Presenting Author: Zohreh Yazdi (Iran)
ASSESSING THE KNOWLEDGE AND ATTITUDE
GENERAL PHYSICIAN ABOUT SLEEP MEDICINE IN
QAZVIN, IRAN
Yazdi z, Jalilolghadr S, Rezaiean S
Wednesday - PS - Board #130
Presenting Author: Maha Abou-Khadra (Egypt)
SLEEP, SYMPTOM-RATINGS AND SERUM FERRITIN
LEVELS IN CHILDREN WITH ADHD
Abou-Khadra M, Amin O, Shaker O, Rabah T
Presenting Author: Pasquale Alvaro (Australia)
INSOMNIA, DEPRESSION AND SUBTYPES OF
ANXIETY: DOES CHRONOTYPE UNIQUELY MEDIATE
THESE RELATIONSHIPS DURING ADOLESCENCE?
Alvaro P, Roberts R, Harris J
Presenting Author: Maha Abou-Khadra (Egypt)
SLEEP PATTERNS AND PROBLEMS AMONG
EGYPTIAN CHILDREN WITH ADHD: THE IMPACT
OF SYMPTOMS SEVERITY AND SUBTYPES
Amin O, Abou-Khadra M
Presenting Author: Samya Ashour (Egypt)
SLEEP DISTURBANCES IN CHILDREN WITH
ATTENTION DEFICIT
Ashou Helal S
IS CORTISOL ASSOCIATED WITH POOR SLEEP IN
AUTISM? A LABORATORY STUDY IN HIGH
FUNCTIONING ADULTS.
Chicoine M, Limoges , Chevrier , Lupien S, Mottron L,
Godbout R
Presenting Author: Mnica Daz Romn (Spain)
SLEEP AND ADHD
Ciopat O, Daz Romn M, Urdanibia Centelles O,
Rubio Snchez P, Gomez Siurana E, Goyo Ibarra D
Presenting Author: Xavier Estrada Prat (Spain)
SLEEP ARCHITECTURE DISTURBANCES IN
CHILDREN WITH BIPOLAR DISORDER VERSUS
ATTENTION DEFICIT AND HYPERACTIVITY
DISORDER: A PILOT STUDY
Estrada Prat X, Alvarez Guerrico I, Principe A, Batlle Vila S,
Martn Lpez L, Du Ambrs L
Presenting Author: Iris Haimov (Israel)
THE EFFECTS OF ACUPUNCTURE TREATMENT
ON SLEEP QUALITY AND ON EMOTIONAL
MEASURES AMONG INDIVIDUALS LIVING WITH
SCHIZOPHRENIA
Haimov I, Bloch B, Vadas L, Ravid S, Kremer I, Reshef A
Presenting Author: Jesus Escrib-Alepuz (Spain)
SLEEP HABITS AND SLEEP DISORDERS IN CHILDREN
WITH ATTENTION DEFICIT-HYPERACTIVITY
DISORDER. INFLUENCE OF TREATMENT. A
MULTICENTER STUDY
Jesus E, Soria-Bretones C, Pau G, Alberto D, Teresa O,
M. ngeles G
146
2
D
)
.
D
A
4
Presenting Author: Deependra Kumar (Germany)
CAV1.2 CALCIUM CHANNEL IS INVOLVED IN THE
CIRCADIAN REGULATION OF SLEEP
Kumar D, Dedic N, Flachskamm C, Deussing J, Kimura M
SLEEP IN CHILDREN WITH HIGH FUNCTIONING
AUTISM: POLYSOMNOGRAPHY, QUESTIONNAIRES
AND DIARIES IN A NON-COMPLAINING SAMPLE.
Lambert A, Tessier S, Chevrier , Scherzer P, Mottron L,
Godbout R
WAKE EEG COHERENCE BEFORE AND AFTER SLEEP
IN ADULTS WITH AUTISM: DECREASED MORNING
FRONTAL CONNECTIVITY.
Lveill C, Bolduc C, Limoges , Chevrier , Mottron L,
Godbout R
Presenting Author: Maria-Cecilia Lopes (Brazil)
SLEEP COMPLAINT AS A BIOMARKER OF BIPOLAR
DISORDER IN CHILDREN AND ADOLESCENT
Lopes M
Presenting Author: Maria-Cecilia Lopes (Brazil)
THE RELATIONSHIP BETWEEN SLEEP COMPLAINTS
AND SUICIDAL BEHAVIOUR IN A MILD TO SEVERE
DEPRESSED SAMPLE OF CHILDREN AND ADOLESCENTS
Lopes M
Presenting Author: Azad Maroufi (Iran)
COMPARISON OF FREQUENCY OF SLEEP DISORDERS
IN MMT VOLUNTEERS AND OPIUM DEPENDANT
PATIENTS
Maroufi A, Khazaie H
Presenting Author: Mara Natalia Pereira (Spain)
SLEEP AND MOOD DISORDERS IN EPILEPSY
Pereira M, Zuccolo L, Cieza Ortiz S, Urrestarazu Bolumburu E,
Iriarte Franco J
Presenting Author: Olivier Potvin (Canada)
SUBJECTIVE SLEEP CHARACTERISTICS ASSOCIATED
WITH ANXIETY AND DEPRESSION IN OLDER
ADULTS: A POPULATION-BASED STUDY
Potvin O, Lorrain D, Belleville G, Grenier S, Prville M
Presenting Author: Guanghai Wang (China)
SLEEP DISUTBANCES AND EMOTIONAL/BEHAVIORAL
PROBLEMS AMONG CHINESE SCHOOL-AGED
CHILDREN: PREVALENCE AND ASSCOAITON
Wang G, Xu G, Lu N, Ren F, Geng L, Sun Y
Wednesday - REM - Board #148
Presenting Author: Susumu Abe (Japan)
SLEEP BRUXISM AND MASSETER MUSCLE ACTIVITY
DURING REM SLEEP OF REM SLEEP BEHAVIOR
DISORDER PATIENTS: A CASE CONTROL STUDY
Abe S, Gagnon J, Montplaisir J, Rompr P, Kawano F, Lavigne G
Presenting Author: Alan Eckeli (Brazil)
REM SLEEP BEHAVIORAL DISORDER IN
PARKINSON`S DISEASE: PRELIMINARY RESULTS
Eckeli A, Sobreira Neto M, Sobreira E, Chagas M, Tumas V,
Frana Fernandes R
Presenting Author: Arturo Garay (Argentina)
ANALYSIS OF CICLIC ALTERNATING PATTERNS IN
AGRYPNIA EXCITATA (AE): INSIGHTS FROM A CASE
OF LIMBIC AUTOINMUNE ENCEPHALOPATHY
(AE-LAE)
Garay A, Blanco S
Presenting Author: Katie Hancock (United States)
PILOT QUANTITATIVE ANALYSES OF REM SLEEP
WITHOUT ATONIA IN CHILDREN AND
ADOLESCENTS WITH REM SLEEP BEHAVIOR
DISORDER
Hancock K, Mccarter S, St. Louis E, Kotagal S, Lloyd R, Boeve B
PARKINSONISM AS AN OUTLIER DETECTION
PROBLEM
Kempfner J, Jennum P
Presenting Author: Daniele Lo Cocco (Italy)
REM SLEEP BEHAVIOR DISORDER AND PERIODIC
LEG MOVEMENTS IN SLEEP IN PATIENTS WITH
AMYOTROPHIC LATERAL SCLEROSIS
Lo Cocco D, Mattaliano P, Gioi G, Congiu P, Fantini M,
Puligheddu M
Presenting Author: Masayuki Miyamoto (Japan)
STRIATAL DOPAMINE TRANSPORTER IMAGING
(FMT-PET) IN PATIENTS WITH IDIOPATHIC RAPID
EYE MOVEMENT SLEEP BEHAVIOR DISORDER-
A CROSS-SECTIONAL STUDY
Miyamoto M, Miyamoto T, Hirata K
Presenting Author: Shady Rahayel (Canada)
PATTERNS OF CORTICAL THINNING IN IDIOPATHIC
RAPID EYE MOVEMENT SLEEP BEHAVIOR DISORDER
Rahayel S, Montplaisir J, Monchi O, Bedetti C, Postuma R,
Gagnon J
Presenting Author: Friederike Sixel-Dring (Germany)
REM SLEEP BEHAVIOR DISORDER IS ABSENT IN DE
NOVO PARKINSON DISEASE PATIENTS WITH PARKIN
MUTATIONS: A REPORT FROM THE DENOPA
COHORT
Sixel-Dring F, Lohmann K, Klein C, Mollenhauer B,
Trenkwalder C
Presenting Author: Friederike Sixel-Dring (Germany)
REM SLEEP BEHAVIORAL EVENTS (RBE): A NEW
MARKER FOR NEURODEGENERATION IN EARLY
PARKINSONS DISEASE?
Sixel-Dring F, Trautmann E, Mollenhauer B, Trenkwalder C
147
2
D
)
.
D
A
4
Presenting Author: Koh-Ichiro Taniguchi (Japan)
HOW DO NEUROLOGICAL AND PSYCHIATRIC SIGNS
AND SYMPTOMS WHICH ARE INDICATIVE OF LEWY
BODY DISEASE APPEAR IN APPARENT IDIOPATHIC
REM SLEEP BEHAVIOR DISORDER? A DESCRIPTIVE
STUDY IN THE CLINICAL SETTING
Taniguchi K, Oguri T, Sugiyama H, Hamano T, Tachibana N
Presenting Author: Ari Ylikoski (Finland)
PARASOMNIAS IN PARKINSONS DISEASE
Ylikoski A, Martikainen K, Partinen M
Presenting Author: Marielle Zoetmulder (Denmark)
INCREASED MOTOR ACTIVITY DURING REM
SLEEP IS LINKED WITH DOPAMINE FUNCTION
IN IDIOPATHIC REM SLEEP BEHAVIOUR DISORDER
AND PARKINSONS DISEASE
Zoetmulder M, Nikolic M, Biernat H, Korbo L, Friberg L,
Jennum P
Wednesday - R - Board #161
Presenting Author: Salma Batool-Anwar (United States)
LIFESTYLE FACTORS AND RISK OF RESTLESS LEGS
SYNDROME: PROSPECTIVE COHORT STUDY
Batool-Anwar S, Li Y, De Vito K, Winkelman J, Malhotra A,
Gao X
Presenting Author: Karla Carlos (Brazil)
PHYSICIANS WITH RESTLESS LEGS SYNDROME ARE
MORE LIKELY TO FAIL IN THE WRITTEN TEST TO
GET IN THE RESIDENCY PROGRAM IN BRAZIL.
Carlos K, Carvalho L, Prado A, Prado L, Prado G
Presenting Author: Cristian Falup-Pecurariu (Romania)
PREVALENCE OF RESTLESS LEGS SYNDROME IN
CHRONIC LIVER DISEASES CASE-CONTROL STUDY
Falup-Pecurariu C, Coman F, Moraru G, Alexandru R
Presenting Author: Cristian Falup-Pecurariu (Romania)
HIGH PREVALENCE OF RESTLESS LEGS SYNDROME
IN SYSTEMIC LUPUS ERYTHEMATOSUS
Falup-Pecurariu C, Duca L, Moarcas M
Presenting Author: Fernando Prieto (Spain)
TREATMENT OF RESTLESS LEGS SYNDROME WITH
LACOSAMIDE. REPORT OF EIGHT CASES
Prieto F, Saus R, Puertas FJ
Presenting Author: David Gabelia (Austria)
ASSESSMENT OF FRAGMENTARY MYOCLONUS IN
HEALTHY SLEEPERS
Gabelia D, Mitterling T, Bregler D, Ehrmann L, Hgl B,
Frauscher B
Presenting Author: Jos Haba-Rubio (Switzerland)
ANTIDEPRESSANTS AND RLS/PLMS IN THE
GENERAL POPULATION
Haba-Rubio J, Marques-Vidal P, Andries D, Tobback N, Tafti
M, Heinzer R
CLINICAL CASE: TEN- YEAR -OLD GIRL WITH
IMPOSSIBILITY TO WAKE UP
Paniagua -Soto J, Ruiz L, Iznaola C, Ruiz J
Presenting Author: Sofia Kasradze (Georgia)
SLEEP-RELATED PROBLEMS AND RESTLESS LEGS
SYNDROME IN THE CHILDREN WITH LEARNING
AND DEVELOPMENTAL DISORDERS
Kasradze S, Ediberidze T, Alkhidze M, Maisuradze L
Presenting Author: Carmen Montes (Spain)
FACIOMANDIBULAR MYOCLONUS DURING SLEEP:
VIDEO-EEG RECORDING RULE OUT EPILEPSY AS A
CAUSE OF NOCTURNAL TONGUE BITING
Montes C, Alcaide C, Juarez A, Segundo J, Cabeza C
Presenting Author: Pablo A. Ruiz-Elena (Spain)
ROTIGOTINE USE IN LONG-TERM TREATMENT
OF RESTLESS LEGS SYNDROME: EXPERIENCE IN
GENERAL UNIVERSITY HOSPITAL OF CASTELLON.
Ruiz-Elena P, Pinzon-Martinez J, Gomis-Devesa A,
Barreda-Altaba I, Ortega-Albas J, Estarelles-Marco M
Presenting Author: Domingo Sanchez Ruiz (Spain)
OBJECTIVE EVALUATION OF RLS DAYTIME
SYMPTOMS BY MEANS OF THE MULTIPLE
SUGGESTED IMMOBILIZATION TEST (M-SIT)
Sanchez Ruiz D, Garcia Borreguero D
Presenting Author: Taeko Sasai-Sakuma (Japan)
CHANGE IN HEART RATE VARIABILITY PRECEDES
THE OCCURRENCE OF PERIODIC LEG MOVEMENTS
DURING SLEEP: AN OBSERVATIONAL STUDY
Sasai-Sakuma T, Matsuura M, Inoue Y
Presenting Author: Denise Sharon (United States)
RLS AROUND THE GLOBE: DIAGNOSIS AND
EPIDEMIOLOGY
Sharon D, Shamsnia M, Mack C
Presenting Author: Carmen Soria-Bretones (Spain)
RESTLESS LEGS SYNDROME IN ATTENTION
DEFICIT-HIPERACTIVITY DISORDER: WHAT ABOUT
THE ROLE OF TREATMENT? A MULTICENTER STUDY
Soria-Bretones C, Escrib-Alepuz J, Giner-Bayarri P,
Hernndez-Muelas S, Oviedo-Monts T, Garca-Jimnez M
Presenting Author: Andras Szentkiralyi (Germany)
MULTIMORBIDITY AND THE RISK OF RESTLESS LEGS
SYNDROME IN TWO PROSPECTIVE COHORT STUDIES
Szentkiralyi A, Vlzke H, Hoffmann W, Trenkwalder C, Berger K
Presenting Author: Magdalena Szklarek (Poland)
THE IMPACT OF THE USE OF AMALGAMS IN THE
DENTITION ON THE APPEARANCE OF THE
SYMPTOMS OF RESTLESS LEGS SYNDROME
DEVELOPED BY OLDER PEOPLE.
Szklarek M, Kostka T
148
2
D
)
.
D
A
4
Presenting Author: Irina Zavalko (Russian Federation)
POLYSOMNOGRAPHIC EVALUATION OF
AUGMENTATION IN PATIENTS WITH RESTLESS
LEGS SYNDROME
Zavalko I, Maestri M, Ferini-Strambi L, Marelli S , Manconi M
Wednesday - S - Board #180
Presenting Author: Andre-Ann Baril (Canada)
REDUCTION IN REGIONAL CEREBRAL BLOOD
FLOW IN OBSTRUCTIVE SLEEP APNEA DURING
WAKEFULNESS: A HIGH-RESOLUTION SPECT STUDY
Baril A, Gagnon K, Montplaisir J, Soucy J, Gagnon J, Gosselin N
Presenting Author: Matthias Boentert (Germany)
SLEEP QUALITY AND SLEEP-RELATED SYMPTOMS IN
POMPE DISEASE
Boentert M, Karabul N, Wenninger S, Schoser B, Mengel E, Young P
Presenting Author: Joan Brunso Casellas (Spain)
OSTEOTOMY GUIDES AND CUSTOMISED
OSTEOSYNTHESIS PLAQUES MADE WITH CAD-CAM
AND RAPID PROTOTYPING TECHNOLOGY IN THE
SKELETAL SURGICAL TREATMENT OF SEVERE OSA
Brunso J, Amilibia J, Cabriada V, Municio J, Gimeno J,
Santamaria J
Presenting Author: Teresa Canet (Spain)
DETECTING SLEEP RESPIRATORY DISTURBANCES
IN PREGNACY
Canet T, Gimenez P
Presenting Author: Antonio Q. Chan (United States)
MECHANISM OF SUDDEN CARDIAC DEATH IN
OBSTRUCTIVE SLEEP APNEA, REVISITED
Chan A, Antonio N
Presenting Author: Ennio A. Vivaldi (Chile)
A NEW RESPIRATORY DISTURBANCE VARIABLE (RDV)
BASED ON THE ENVELOPE ANALYSIS OF THE
AIRFLOW SIGNAL AND ITS RELATIONSHIP TO AHI
Daz J, Arancibia J, Bassi A, Vivaldi E
Presenting Author: Joaquin Duran-Cantolla (Spain)
A NEW VIBRATORY POSTURAL DEVICE FOR THE
TREATMENT OF POSITIONAL OBSTRUCTIVE SLEEP
APNEA (OSA). A PILOT STUDY
Duran-Cantolla J, Barbe F, Rigau J, Oreja D, Martinez-Null C,
Egea Santaolalla C
Presenting Author: Kelly Escajadillo Vargas (Spain)
THE ROLE OF CENTRAL SLEEP APNEA IN ASSESSING
INFANTS WITH APPARENT LIFE-THREATENING EVENT
Escajadillo-Vargas K, Cullar-Ramos N, Pedera-Mazarro A,
Buenache-Espartosa R, Villadniga-Zambrano M,
Lamas-Ferreiro A
SLEEP STUDY ON PATIENTS WITH NON-CYSTIC
FIBROSIS BRONCHIECTASIS: A PILOT STUDY
Faria Jnior N, Santos I, Pasqual R, Leito Filho F, Jardim J, Oliveira L
Presenting Author: Catarina Ferreira (Portugal)
HOW SLEEP STUDIES ARE IMPORTANT TO INITIATE
NONINVASIVE VENTILATION IN DUCHENNE
MUSCULAR DYSTROPHY
Ferreira C, Martins V, Lopes G, Madureira N, Moita J
Presenting Author: Jonathan Camara (Spain)
COMORBIDITY AND GENDER IN PATIENTS WITH
SLEEP APNEA-HYPOPNEA SYNDROME REQUIRING
PERFORMANCE OF AUTOCPAP
Gotera Rivera C, Barrios Barreto D, Lazo Meneses P, Maas
Baena E, Jurkojc C, Camara J
Presenting Author: Jos Haba-Rubio (Switzerland)
PREVALENCE AND CHARACTERISTICS OF SLEEP
DISORDERED BREATHING IN PRE- AND
POST-MENOPAUSAL WOMEN
Haba-Rubio J, Vat S, Andries D, Tobback N, Tafti M,
Heinzer R
P-WAVE DURATION AND DISPERSION IN HOLTER
ELECTROCARDIOGRAPHY OF PATIENTS WITH
Hashemi Jazi M, Amra B, Yazdchi M, Jahangiri M, Tabesh F,
Gholamrezaei A
Presenting Author: M. Blanca Hoyo (Spain)
SLEEP APNEA AND/OR OHS IN MORBID OBESITY:
ANALYSIS OF GENDER DIFFERENCES
Hoyo M, Lopez E, Ibaez M
USAGE OF PSYCHOTROPIC MEDICATION IN
OBSTRUCTIVE SLEEP APNEA: A CONTROLLED
NATIONAL STUDY
Jennum P
Presenting Author: Mara Jos Jurado (Spain)
ASSESSMENT OF NONINVASIVE PACO2 AND
NASAL-CANNULA PRESSURE TRANSDUCER DURING
POLYSOMNOGRAPHY IN CHILDREN YOUNGER
THAN 3 YEARS WITH OSAS.
Jurado M, Sampol G, Romero O
Presenting Author: Yan Ma (China)
DETECTING PEDIATRIC SLEEP APNEA:
CONSISTENCY ON CARDIOPULMONARY
COUPLING AND OXIMETRY MEASUREMENT
Ma Y, Yeh J, Sun S, Qiao J, Peng C
Presenting Author: Cristina Martnez Null (Spain)
PREVALENCE OF SLEEP APNEA-HYPOPNEA
SYNDROME (SAHS) AMONG A BRUXISM
POPULATION. PRELIMINARY DATA.
Martnez Null C, Anitua Aldecoa E, Durn Carro J, Aguirre J,
Durn Cantolla J
149
2
D
)
.
D
A
4
Presenting Author: Aida Matevosyan (Armenia)
DIAGNOSTIC VALUE OF BERLIN QUESTIONNAIRE AS
A SCREENING TOOL FOR OBSTRUCTIVE SLEEP
APNEA-HYPOPNEA SYNDROME
Matevosyan A, Podosyan G, Khandanyan G, Shukuryan A
Presenting Author: Stefan Mihaicuta (Romania)
OBESITY STRATIFICATION AS A PREDICTOR FOR
SLEEP APNEA SYNDROME
Mihaicuta S, Frent S, Deleanu O
Presenting Author: Susana Mota-Casals (Spain)
HOSPITAL SLEEP UNIT AND PRIMARY CARE
COLLABORATION IN DIAGNOSIS OF RESPIRATORY
SLEEP DISEASES: ASSESSMENT OF A SIX-YEAR
EXPERIENCE
Mota-Casals S, Obrador-Lagares A, Eizaguirre Antn S,
Haro-Estarriol M
Presenting Author: Paula Contreras (Chile)
SLEEP BREATHING DISORDERS SCREENING IN
CHILEAN MINERS
Santin J, Moya P, Contreras P, Pincheira E
Presenting Author: Hyojung Nam (Republic of Korea)
ANALYSIS OF AGE EFFECT TO DETERMINE OPTIMAL
NASAL PRESSURE IN KOREAN PATIENTS WITH
Nam H, Shin W, Yoo R, Sung M, Cho H, Shon Y
Presenting Author: Ana Jimenez Romero (Spain)
IMPORTANCE OF CPAP SCHOOL. IMPROVING
TREATMENT ADHERENCE?
Ordonez Dios I, Jimenez Romero A, Garcia Amores M, Villar
Pastor B, Feu Collado N, Jurado Gamez B
Presenting Author: Rogelio Peralta Lepe (Spain)
UTILITY OF SLEEP STUDY IN CHILDREN WITH
LARYNGOMALACIA
Peralta Lepe R, Castao De Las Pozas G, Alonso lvarez M,
Cordero Guevara J, Ordax Carbajo E, Tern Santos J
Presenting Author: N. Pelletier-Fleury (France)
THE EFFECTIVENESS OF A COMMUNITY
PHARMACIST-LED INTERVENTION TO IMPROVE
SCREENING FOR SLEEP APNEA IN PRIMARY CARE
A COHORT STUDY
Perraudin C
Presenting Author: Juan Antonio Pia Fernandez (Spain)
IS THERE A CORRELATION BETWEEN OF THE
EPWORTH SLEEPINESS SCALE AND THE CPAP
ADHERENCE ?
Pia Fernandez J, Mochon Doa A, Cuellar Raya P,
Cebrian Gallardo J
THE OSA PATIENT IN A SPECIFIC SLEEP NURSE
DEPARTMENT
Pia Fernandez J, Mochon Doa A, Cuellar Raya P, Cebrian
Gallardo J
IMPORTANCE OF NURSE INTERVENTION IN THE
ADAPTATION OF PATIENT TREATED WITH CPAP
Pia Fernandez J, Mochon Doa a, Cuellar Raya p, Cebrian
Gallardo J
Presenting Author: Lucila Prado (Brazil)
OBSTRUCTIVE SLEEP APNEA AND SNORE
TREATMENT WITH TONGUE STABILIZER DEVICE:
RANDOMIZED CLINICAL TRIAL, PRELIMINARY DATA
Prado L, Jung A, Prado A, Carlos K, Carvalho L, Prado G
Presenting Author: Leon Rosenthal (United States)
THE IMPACT OF SLEEP POSITION PREFERENCE
ON SUPINE SLEEP DURING OVERNIGHT
POLYSOMNOGRAPHY
Rosenthal L, Rosenthal A
Presenting Author: M. Montserrat And Sanchez Ortuno (Spain)
INTERVENTIONS TO IMPROVE ADHERENCE TO PAP
IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA:
DOES THE PATIENTS PERSONALITY MATTER?
Sanchez Ortuno M, Lee-Chiong T, Goelz K, Harrington J,
Edinger J, Aloia M
Presenting Author: Colin Shapiro (Canada)
THATS ONE SMALL BOOK FOR A MAN, ONE GIANT
LEAP FOR CPAP COMPLIANCE. ASSOCIATION
BETWEEN PATIENT EDUCATION AND CPAP
COMLIANCE IN AN URBAN AND A RURAL SETTING
IN CANADA.
Shapiro C, Zalai D
Presenting Author: Milan Sova (Czech Republic)
THE INFLUENCE OF CONTINUOUS POSITIVE
AIRWAY PRESSURE THERAPY ON PREVALENCE OF
MASKED HYPERTENSION IN PATIENTS WITH
Sova M, Sovova E, Hobzova M, Kamasova M, Kolek V
Presenting Author: Milan Sova (Czech Republic)
ANALYSIS OF PHARMACOTHERAPY AND
COMPENSATION OF ARTERIAL HYPERTENSION
IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA
Sova M, Sovova E, Hobzova M, Kamasova M, Kolek V
Presenting Author: Yoshikazu Tkakaesu (Japan)
IS ORAL APPLIANCE AS EFFICACIOUS AS NCPAP
IN PATIENTS WITH POSITIONAL-DEPENDENT
OBSTRUCTIVE SLEEP APNEA?
Takaesu Y, Tsuiki S, Kobayashi M, Komada Y, Inoue Y
150
2
D
)
.
D
A
4
Presenting Author: Aneliya Draganova (Bulgaria)
PREVALENCE OF CENTRAL SLEEP APNEA AMONG
HEART FAILURE PATIENTS WITH PRESERVED
EJECTION FRACTION
Terziyski K, Draganova A, Aliman O, Ilchev I, Hristova A,
Kostianev S
Presenting Author: Orna Tzischinsky (Israel)
FACTORS AFFECTING THE INTENTION AND
DECISION TO BE TREATED FOR
Tzischinsky O, Shahrabani S, Givati G, Dagan Y
Presenting Author: Jorge Vale (Portugal)
CHIARI MALFORMATION AND CENTRAL SLEEP
APNEA: SUCCESSFUL THERAPY WITH ADAPTIVE
PRESSURE SUPPORT SERVO-VENTILATION.
Vale J, Silva E, Gil I, Sanchez A, Marques C, Simes Torres A
Presenting Author: Jorge Vale (Portugal)
THE IMPACT OF OBSTRUCTIVE SLEEP APNEA
IN DIABETES MELLITUS
Vale J, Manuel P, Oliveira A, Gil I, Nascimento E, Sanchez A
Presenting Author: Matilde Valencia-Flores (Mexico)
STOP-BANG QUESTIONNAIRE IS A GOOD TEST IN
DISCRIMINATING OSA IN OBESE WOMEN BUT NO
IN MEN
Valencia-Flores M, Santiago-Ayala V, Resendiz-Garca M,
Castao-Meneses V, Mendoza-Pacheco A, Garca-Ramos G
Presenting Author: Sopharat Vat (Switzerland)
PREVALENCE OF THE UPPER AIRWAY RESISTANCE
SYNDROME IN THE GENERAL POPULATION
Vat S, Haba-Rubio J, Andries D, Tobback N, Tafti M, Heinzer R
Presenting Author: Sopharat Vat (Switzerland)
SCREENING FOR SLEEP-DISORDERED BREATHING
IN THE GENERAL POPULATION: PREDICTIVE
PERFORMANCE OF FOUR QUESTIONNAIRES
Vat S, Haba-Rubio J, Andries D, Tobback N, Tafti M, Heinzer R
Presenting Author: Javier Vila (Spain)
PARTIAL RESECTION OF THE BASE OF THE TONGUE
WITH HARMONIC SCALPEL: A PROMISING SURGICAL
APPROACH FOR SLEEP APNEA.
Vila J
Presenting Author: William Wohlgemuth (United States)
CPAP ADHERENCE AS A MEDIATOR BETWEEN
CO-MORBID INSOMNIA, OSA AND SUBJECTIVE
DAYTIME SLEEPINESS
Wohlgemuth W, Wallace D, Tetali P
Presenting Author: Toms Zamora (Spain)
STUDY OF THERMAL PROPERTIES, TOXICITY
EMISSIONS AND REBREATHING AVOIDANCE AS
EXOGENOUS STRESSORS OF SUDDEN INFANT
DEAD SYNDROME IN BABY MATTRESSES. DESIGN
RECOMMENDATIONS
Zamora T, Pin G, Barber V, Morell M, Aznar M, Huertas P
Wednesday - YI - Board #226
Presenting Author: Maria Jose Elso Tinoco (Chile)
CHARACTERIZATION OF SLEEP DISORDERS ON
PATIENTS WITH PARKINSONS DISEASE IN CHILE
Elso Tinoco M, Zenteno Araos F, Zenteno Araos D, Avello R,
Mery Canales V
Presenting Author: Shirley X. Li (China)
FACTORS ASSOCIATED WITH TREATMENT
RESPONSES IN PATIENTS WITH REM SLEEP
BEHAVIOR DISORDER
Li S, Lam S, Zhang J, Yu M, Wing Y
Presenting Author: Elaheh Solemannejad (Canada)
HYPODOPAMINERGIC MICE HAVE A SLEEP
PHENOTYPE THAT RESEMBLES HUMAN
PARKINSONS DISEASE
Soleimannejad E, Burgess C, Salahpour A, Peever J
Presenting Author: Viara Mileva (The Netherlands)
MOTHER-CHILD BED-SHARING ASSOCIATED
WITH MORE WHEEZING IN EARLY CHILDHOOD
Luijk M, Mileva-Seitz V, Sonnenschein - Van Der Voort A, Van
Ijzendoorn M, De Jongste J, Duijts L
151
152
.EDCHDGH
6C9 M=>7>IDGH
153
154
M=>7>IDG !ADDG +A6C
(JC9>E=6GB6 $CI:GC6I>DC6A '>B>I:9
LLL.BJC9>E=6GB6.8DB
Mundipharma is one of the Purdue/Mundipharma/Napp
independent associated companies - privately owned
companies and joint ventures covering the world's
pharmaceutical markets. Te companies worldwide are
dedicated to bringing to patients with severe and
debilitating diseases the benefts of novel treatment
options in felds such as severe pain, rheumatoid arthritis,
haemato-oncology and respiratory disease.
0CB
LLL.J87.8DB
UCB, Brussels, Belgium is a global biopharmaceutical
company focused on the discovery and development of
innovative medicines and solutions to transform the lives
of people living with severe diseases of the immune
system or of the central nervous system.
*JG .EDCHDGH
Tis activity is supported in part by educational grants from the following companies in accordance with ACCME Standards.
155
B-*)5 .+*).*-.
%6OO +=6GB68:JI>86AH LLL.?6OOE=6GB6.8DB
Jazz Pharmaceuticals is a specialty biopharmaceutical company that identifes, develops and commercializes products to meet
unmet patient needs in narcolepsy, oncology, pain and psychiatry. Our US products in these areas include: Xyrem (sodium
oxybate), Erwinaze (asparaginase Erwinia chrysanthemi), Prialt (ziconotide), Luvox CR (fuvoxamine maleate), and FazaClo
(clozapine, USP).
+=>A>EH -:HE>GDC>8H LLL.E=>A>EH.8DB/-:HE>GDC>8H
For more than three decades, Philips Respironics has been a leading global provider of innovative solutions for the
sleep and respiratory markets. Its products help manage a broad spectrum of sleep-disordered breathing, chronic
obstructive pulmonary disease, asthma, and restrictive lung disorders. Philips Respironics has made a commitment to
align with clinicians and provide integrated solutions that lead to better sleep and breathing, healthier living, and
healthier practices. For more information, visit our website www.philips.com/Respironics.
-:H(:9 LLL.G:HB:9.8DB
ResMed is a global leader in the development, manufacturing and marketing of medical products for the diagnosis, treatment
and management of respiratory disorders, with a focus on sleep-disordered breathing. ResMed is dedicated to developing
innovative products to improve the lives of those who sufer from these conditions and to increasing awareness among patients
and healthcare professionals of the potentially serious health consequences of untreated SDB.

.$'1- .+*).*-.
A8I>"G6E=
LLL.68I><G6E=8DGE.8DB
ActiGraph is a leading provider of actigraphy monitoring
hardware and software solutions for the global scientifc
community. ActiGraphs innovative suite of wireless actigraphy
monitors are among the most widely used and extensively
validated devices of their kind, delivering objective and reliable
24 hour sleep/wake and daily activity data to customers in over
70 countries.
A.+$
LLL.6:HE>.C:I
Te Spanish Restless Legs Association, AESPI, was founded in
2004 and is registered as # 584249 in the national registry of
associations. We have several publications, a book, "Te Devil
Tat Wakes Me Up When I Sleep," and a weekly magazine, as
well as a digital magazine which comes out every two months
and a web site, www.aespi.net.
C69L:AA
LLL.869L:AA.8DB
Cadwell has developed useful and innovative devices for
physiatrists, neurologists, neurophysiologists and technologists
who want the best devices to provide superior patient care since
1979. Products include the Cascade family for IONM, the
Easy family for all types of EEG and PSG and the Sierra family
for EMG, NCV and clinical EP.
C6B)I:8= 'I9
LLL.86BCI:8=.8DB
CamNtech are leaders in the development of innovative
miniature physiological recorders. CamNtech has considerable
experience and a proven track record in the feld of ambulatory
monitoring devices. CamNtech has a range of products that
record Heart rate, HRV, ECG, EEG, EMG and Physical
Activity with a multitude of application areas.
CDBEJB:9>8H 'I9
LLL.8DBEJB:9>8H.8DB
Compumedics, an Australian company founded in 1987, is a
global leader in technological solutions for sleep diagnostics,
neurodiagnostics and cardiology. Compumedics ofers a
comprehensive range of innovative solutions for in-lab,
ambulatory, home and research applications including world's
frst such as the High-Defnition GraelHD and the Bluetooth-
enabled PSG-Anywhere SomtPSG
DNB:9>M D>6<CDHI>8H
LLL.9NB:9>M.8DB
Dymedix Diagnostics ofers disposable sensors and reusable
sensors for sleep disorder diagnostic testing. Te advanced
technology in our Airfow Sensors and Respiratory Efort
Sensors provides accurate data, reliability, and ease of use.
Neonate, Pediatric, and Adult Sensors are compatible on most
PSG systems and home testing devices.
CDBB:G8>6A CDBE6C>:H 6C9 M=>7>IDGH
156
AH:K>:G
LLL.:AH:K>:G.8DB
ELSEVIER is a leading publisher of health science
publications, advancing medicine by delivering superior
reference information & decision support tools to doctors,
nurses, health practitioners & students. Elsevier has a selection
of leading Neurology journals on display. Visit our stand and
collect your free sample copy.
JGDE:6C AAA>6C8: ;DG -:HIA:HH ':<H .NC9GDB:
LLL.:6GAH.:J
EARLS is a non-proft Alliance of National Patient
Organizations from various European countries that will
engage in activities which contribute to greater awareness of
Restless Legs Syndrome in the broadest sense. EARLS will raise
important issues at a European level common to all members.
")A8I>K
LLL.<:C:68I>K.8D.J@
Te GENEActiv range of wrist-worn, raw data accelerometers
are designed for objectively measuring activities within free-
living and clinical research. Along with standard sleep
actigraphy outputs, the raw data format allows further analysis
possibilities. GENEActiv has been proven in both small scale
studies and large international cohorts of over 10,000 subjects.
$CHE>G: (:9>86A .NHI:BH, $C8.
LLL.>CHE>G:HA::E.8DB
Inspire Medical Systems Inc. is the leading developer of
innovative, implantable neurostimulation systems to treat
Obstructive Sleep Apnea. Utilizing technologies from the felds
of cardiac pacing and neurostimulation, Inspire has developed
an Upper Airway Stimulation therapy, designed to improve
sleep and enrich the lives of people sufering from sleep apnea.
$CI:GC6I>DC6A -'. .IJ9N "GDJE
LLL.>GAHH<.DG<
Te International Restless Legs Syndrome Study Group
(IRLSSG) is an organization of professionals committed to
advancing basic and clinical research on Restless Legs
Syndrome (RLS). Teir mission includes the cooperative
planning, implementation, analysis, and reporting of multi-
center studies with an international emphasis.
%0./ ..A.,.!
LLL.?JHI:.:H
JUSTE, S.A.Q.F. is a family-owned Spanish company actively
engaged in researching, developing and distributing
pharmaceutical products and APIs for pharmaceutical
specialties. In addition, we develop and manufacture
pharmaceutical products and food supplements in soft gelatine
capsules. JUSTE is present in Central America and the
Caribbean through the afliated companies of Juste
Internacional, and in several countries all over the world
through distributors.
157
)6G8DA:EHN ):ILDG@
LLL.C6G8DA:EHNC:ILDG@.DG<
Narcolepsy Network is a national patient support organization
for people with narcolepsy, their families, friends and treating
professionals. Te organization's goals include raising awareness
of narcolepsy, advocating for all people with narcolepsy,
providing education and supporting research.
)6IJH (:9>86A $C8DGEDG6I:9
LLL.C6IJH.8DB
Natus is a leading provider of healthcare products used for the
screening, detection, treatment, monitoring and tracking of
common medical ailments in newborn care, neurological
dysfunction, epilepsy, sleep disorders, and balance and mobility
disorders. Product oferings include computerized
neurodiagnostic systems, polysomnography and software
systems for managing and tracking disorders and diseases for
public health laboratories.
)><=IB6A6C8: B.1.
LLL.C><=I76A6C8:.8DB
Te NightBalance Sleep Position Trainer (SPT) is a new
medical aid for the treatment of Positional Obstructive Sleep
Apnea. Te SPT trains patients efectively and comfortably not
to sleep in supine position through gentle vibrations. Te SPT
is tested over more than 25.000 nights in clinical research.
)DB>8H
LLL.CDB>8H.7:
A surrogate for oesophageal pressure and recognition of
breathing efort. Nomics marketed the Jawac (for Jaw Activity),
a new sensor that revolutionizes the diagnosis of sleep-
disordered breathing both for children and adults. By
measuring mandibular movements during sleep, the Jawac
sensor ofers a powerful and simple solution to assess breathing
eforts during sleep.
)DM (:9>86A :=;
LLL.CDMB:9>86A.8DB
Nox Medical is a leading provider of Sleep Diagnostics systems.
By introducing the NOX T3 and now the Nox A1, Nox Medical
has created a breakthrough in the portable sleep diagnostics
market. Behind the revolutionary design and wireless solution are
decades of clinical and engineering excellence.
*GI=DAEC:6
LLL.DGI=D6EC:6.8DB
OrthoApnea, S. L. is a Spanish manufacturer of oral devices
for the treatment of sleep apnea and snoring. Te patented
OrthoApnea appliance stands out among other solutions for
the improved efectiveness and patient comfort. OrthoApnea
is currently present in over 25 countries through its network
of international collaborators.
*M><:C .6AJ9 ..A.
LLL.DM><:CH6AJ9.8DB
OXIGEN salud es una empresa familiar que desarrolla la
asistencia domiciliaria en el mbito de las terapias respiratorias
suministrando, de manera innovadora, productos y servicios que
aporten un valor mayor a los pacientes. Queremos dar el mejor
servicio a cada paciente al mejor precio para nuestros clientes.
158
.6A>B:IG>8H
LLL.H6A>B:IG>8H.8DB
Exciting times at Salimetrics, World Leader in Salivary
Bioscience. Our continuing success refects the increasing use
of our Assays for measuring Biomarkers in Saliva. Our Cortisol
Assay proven to be the Best Commercially Available Our new
Salivary Melatonin Assay Te Most Time Efcient, Precise and
Easiest to use Assay Protocol aiding studies such as Sleep
Regulation, Insomnia, Sleep Wake Cycle.
.:C/:8 A"
LLL.H:CI:8.8=
SenTec is a Swiss manufacturer of a non-invasive patient
monitoring system (SDMS) providing transcutaneous
capnometry (tcPCO2) and SpO2/PR in real time. Te SDMS
reliably refects patient ventilation and oxygenation from spot-
check to long time (overnight) measurements and features an
associated remote monitoring system called V-CareNeT.
Please visit http://jiddet.net/sleep_sentec for Sleep-Studies.
.:K:C DG:6B:GH '67DG6IDG>:H
LLL.H:K:C9G:6B:GH.8DB
Seven Dreamers Laboratories is a R&D focused medical device
manufacturer, which performs research and development of
medical devices for worldwide markets. Following our motto,
Pursuing a better life with wisdom through innovative
technology", we have developed a new device for OSAS. Please
come by our booth to see the NaStent.
.A::E (JAI>B:9>6, $C8
LLL.HA::EBJAI>B:9>6.8DB
SleepMultiMedia is a computerized textbook of sleep medicine
with text, sound, graphics, animation, and video. Updated
annually, the program covers sleep research, sleep physiology, and
clinical sleep medicine, including orofacial management of sleep
apnea. SleepMultiMedia features over 5,000 Abstracts, 135
CME credits, extensive information on polysomnography, an
updated sleep center policy and procedure manual, and printable
interactive patient care programs in Spanish and English.
.A::EK>GIJ6A
LLL.HA::EK>GIJ6A.8DB
Sleepvirtual/Neurovirtual USA Inc., develops/markets
neurological devices to hospitals and clinics worldwide. We
ofer solutions for EEG, and PSG monitoring. Our mission
is to improve our customers quality of service and their
patients quality of life with superior products and responsive
customer support.
/=: .D8>:IN ;DG 2DGA9L>9: (:9>86A M8=6C<:
LLL.LDGA9L>9:B:9>86A:M8=6C<:.DG<
Te Society for Worldwide Medical Exchange (SWME) is an
international non-proft organization uniting doctors around
the world to advance global health through medical education.
Recognizing health as a fundamental human right, we work to
strengthen health care delivery by breaking down barriers to
quality medical education.
159
.*()*B:9>8H "B7#
LLL.HDBCDB:9>8H.:J
SOMNOmedics manufactures, distributes and services
products dedicated to sleep diagnostics. SOMNOmedics
devices are small, light-weight, highly-reliable and patient-
worn. Te SOMNOtouch is the smallest respiratory screener
available and can also be used for ambulatory sleep testing.
Our wireless solution allows patients data to be observed from
any environment.
.E6C>H= .A::E .D8>:IN
LLL.H:H.DG<.:H
Te Spanish Society on Sleep Medicine is the highest exponent
for the development of the investigation and impulse of Sleep
Medicine in Spain. As a Scientifc Society, it gathers more than
300 professionals and investigators of diferent tracks:
medicine, psychology, biology, nursing and technologists of
polysomnography. Every year the Society organizes its National
Congress, where professionals can fnd a platform for
discussion and can update their knowledge experiences.
16A@:: *N
LLL.K6A@::.8DB
Valkee Bright Light Headset is a personal med-tech product,
based on the positive health efects of regular and adequate
light. Valkee substitutes mood-elevating efects of the sun
when enough ambient light is not available, by channeling
bright light directly to photosensitive regions of the brain
through the ear canal. Valkees bright light afects hormonal
activity, similar to what sunlight does, and as a result increases
energy during winter days and acts as a preventative and
treatment of mood swings.
1>I6AA>G:
LLL.K>I6A6>G:.:H
VitalAire is part of Air Liquide group, the world leader in gases
for industry, health and the environment (present in 80 countries
with close to 50,000 employees) VitalAire, provides homecare,
enabling patients to enjoy better quality of life. VitalAire is one
of the more innovative companies in the homecare, for more
than 20 years VitalAire is contributing to facilitate treatment at
home. A dedicated team of more than 10,000 employees
worldwide supplies more than 7,500 hospitals and clinics and
serves more than one million patients at home.
2DGA9 AHHD8>6I>DC D; .A::E (:9>8>C:
LLL.L6HBDCA>C:.DG<
WASMs mission is to advance sleep health worldwide. WASM
fulflls this mission by promoting and encouraging education,
research, and patient care. Our 5th World Congress on Sleep
Medicine in Valencia, Spain will bring together sleep clinicians
and researchers to discuss advances made in sleep research and
clinical knowledge.
2:>CB6CC
LLL.L:>CB6CC.9:
Weinmann partner for life. We develop, produce and market
diagnostic and therapeutic system solutions. Reliability and the
best possible quality is our promise. We create innovative,
economical and customized products for valid diagnoses and a
broad therapy spectrum for the beneft of patient, doctor and
cost carrier
160
/=: 2>AA>H-@7DB D>H:6H: (2D) !DJC96I>DC
L>AA>H-:@7DB.DG<
Te Willis-Ekbom Disease (WED) Foundation (formerly the
Restless Legs Syndrome Foundation is a non-proft patient
organization providing the latest information about RLS. Te
goals of the Foundation are to increase awareness, improve
treatments, and through research, fnd a cure for RLS -- a
neurological disease severely afecting millions of individuals.
2>H:EG:HH (:9>86A BDD@H=DE
LLL.L>H:EG:HH.8DB
Wisepress are Europes principal conference bookseller. We
exhibit the leading books, sample journals and digital content
relevant to this meeting. Books may be purchased at the booth,
and we ofer a postal service. Visit our online bookshop for
special ofers and follow us on Twitter for the latest news
@WisepressBooks.
2DGA9 .A::E D6N
LLL.LDGA9HA::E96N.DG<
World Sleep Day is an annual event, intended to be a
celebration of sleep and a call to action on important issues
related to sleep, including medicine, education, social aspects
and driving. It is organized by the World Sleep Day Committee
of the World Association of Sleep Medicine (WASM) and aims
to lessen the burden of sleep problems on society through better
prevention and management of sleep disorders.
161
)DI:H:
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
Membership Information
Te goal of WASM is to advance knowledge about sleep and sleep disorders among health care personnel and among the public
worldwide. By establishing international exchanges among physicians, psychologists, nurses, technologists, and other medical
personnel interested in the sleep feld, and sharing insights and information with basic researchers, the feld of sleep medicine is
an advance for all populations. Increasing knowledge about sleep medicine will have a benefcial impact on the quality of life of
individuals around the world. Individuals who are sleep health professionals are encouraged to become members. Membership
benefts include:
1. $125 discount on WASM congress.
2. Sleep Medicine journal (online access for all memberships, print copy for Full membership)
3. Voting rights at biennial meeting.
4. Eligible for committee participation.
5. Knowledge that you fnancially support the work of WASM.
Step A Demographic Information
_________________________ _________________________
First Name Last Name
_________________________ _________________________
MD/PhD/Technician/Other Specialty
Gender: M F
Email: _________________________________
Address _________________________________
Hospital _________________________________
Street _________________________________
City _________________________________
State _________________________________
Zip _________________________________

Country _________________________________
Phone _________________________________
Fax _________________________________
Step B Membership Type
______ Full 2 year membership 2014-2015 (US$250)
______ 2 year membership 2014-2015 (US$100)
______ Full 1 year membership 2014 (US$135)
______ 1 year membership 2014 (US$55)
______ Student membership 2014 (US$25)
Step C Credit Card Payment Details
Card Holder Name: __________________________
Street: _____________________________________
City: ______________________________________
Country: ___________________________________
Zip Code: __________________________________
Amount in US $: ____________________________
VISA or MasterCard Number:
___________________________________________
Expiration Month and Year (MM /YY): __________
3 digit Verifcation Number: ___________________
Signature: __________________________________
Step D Send Information to WASM
Online: www.wasmonline.org
Mail: World Association of Sleep Medicine
3270 19th Street NW, Suite 109
Rochester, MN 55901
Phone: +1-507-316-0084
Fax: +1-877-659-0760
Email: info@wasmonline.org
Please allow one week for your membership to be processed. An email will be sent providing access to the membership website.
.IDE 7N DJG 7DDI= ;DG 9:I6>AH! BDDI= #2
2DGA9 AHHD8>6I>DC D; .A::E (:9>8>C: !DJC96I>DC
3270 19I= .I. )2 .J>I: 109
-D8=:HI:G, () 55901 0.A
/: 507.316.0084 >C;D@L6HBDCA>C:.DG<
LLL.L6HB8DC<G:HH.8DB
.NBEDH>JB .J7B>HH>DC D:69A>C::
June 30, 2014

WASM 2013 Valencia Final Program 1

Enviado por

Dados do documento

Direitos autorais

Formatos disponíveis

Compartilhar este documento

Compartilhar ou incorporar documento

Opções de compartilhamento

Você considera este documento útil?

Este conteúdo é inapropriado?

Direitos autorais:

Formatos disponíveis

WASM 2013 Valencia Final Program 1

Enviado por

Direitos autorais:

Formatos disponíveis

S

Você também pode gostar